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abstract 
Respiratory and vascular outcomes of preterm and term-born children 
By Martin Oliver Edwards 
 
This thesis is a combination of three interlinking projects exploring the association of 
gestational age at birth with abnormal vascular function measurements, increased respiratory 
symptoms and reduced exercise capacity in childhood.  The main aim of my thesis was to 
identify any evidence of early disease processes (respiratory or vascular) in children born 
preterm. My first objective was to investigate the association between preterm birth and 
markers of vascular disease in childhood using data from Avon Longitudinal Study of Parents 
and Children (ALSPAC), and to review the literature reporting on arterial stiffness and/or 
endothelial dysfunction in preterm-born children.  In my second project I conducted a 
systematic review of the literature with the objective to answer the question: Do survivors of 
preterm birth have reduced cardiorespiratory exercise capacity?  My final project was to set up 
a cross-sectional study of children in Wales to test if lower gestational age at birth is associated 
with increased respiratory symptoms, admission rates to hospital and inhaler use for 
respiratory disease; independent of atopy.   
 
My first research project, using data from ALSPAC, noted an association between 
gestational age and SBP but not with measures of vascular function in childhood suggesting 
that alternative mechanisms may be responsible for increased SBP in preterm-born children. 
These results were supported by the findings of the seventeen articles identified by my 
systematic review.   In my second project, a systematic review of the literature, I noted that 
despite marked deficits in lung spirometry, preterm-born children have only marginally 
decreased O2max, which is unlikely to be of great clinical significance.  Finally in my cross-
sectional survey, I showed that increasing prematurity, and children who were born at early 
term, are associated with increased respiratory symptoms and utilization of healthcare 
services throughout childhood, which is independent of a family history of atopy or mode of 
delivery.  
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CHAPTER ONE: INTRODUCTION 
1.1 Preface 
The introduction starts with an explanation of the research work undertaken for this 
thesis, thus helping to clarify the time frame of the different projects involved and the role of 
the thesis author.  This includes a brief summary of the two study cohorts used during my 
research for this thesis; firstly the Avon Longitudinal Study of Parents and Children (ALSPAC), 
and secondly the Respiratory And Neurodevelopmental Outcomes of children born Preterm 
Study (RANOPS).  My thesis will focus in detail on explaining how these two study cohorts have 
been investigated to help identify the short and medium term outcomes associated with being 
born preterm or early term.  The thesis has been divided into four main chapters each 
representing a separate research project completed for my PhD, which has an overall focus on 
the respiratory and vascular outcomes of children born preterm or early term.  Chapter two 
reviews my assessment of the association of preterm birth with vascular function, using data 
from ALSPAC.  The third chapter is based on my systematic review and meta-analysis of the 
exercise capacity of children born preterm.  The fourth and fifth chapters assess the cross-
sectional survey of respiratory symptoms in children born preterm and early term, using data 
from RANOPS. 
In the introductory chapter I will identify the gap in our scientific knowledge about the 
outcomes of survivors of preterm birth, particularly focusing on respiratory and vascular 
outcomes in childhood.  It is essential to first clarify the definitions used and indicate why it is 
important to examine more closely the whole of the gestational age range from 24 to 43 
weeks and not just focus on those individuals born prior to 32 weeks of gestation.  Researchers 
have often caused confusion over the years by combining preterm- and term-born children in 
cohorts based on the birth weight of the subjects i.e. low birth weight (infants born less than 
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2.5 kg). Thus to understand the impact of gestational age at time of delivery and birth weight, 
these two important factors need to be assessed separately and in this chapter I will discuss 
our understanding of the impact of gestational age and birth weight on the development of 
disease in later life.  I will describe the epidemiology of preterm birth and discuss the recent 
changes in the definitions of preterm- and term-birth, and also discuss the definitions of 
chronic lung disease (CLD) and intra-uterine growth retardation (IUGR).  Definitions for asthma 
and childhood wheezing will also be briefly discussed, although more detail can be found in 
chapter 4.  I will then go on to discuss the embryology of the respiratory and vascular systems, 
because a key point to understanding later disease progression in adulthood is having some 
foreknowledge of the foetal development and what effect being born preterm has on the 
development of specific organs.  The causes of preterm birth and other factors relating to 
preterm birth such as use of corticosteroids and supplemental oxygen are also discussed to 
highlight the difficulty in separating out these factors when assessing the impact of preterm 
birth on the development of disease in later life.  Finally, in this chapter I will review the 
literature in terms of preterm birth and the association with respiratory and cardiovascular 
disease in later life and conclude with the main hypotheses for each research project. 
 
1.2 My research work (chronology) 
My research for this thesis came about from a meeting with Professors Sailesh Kotecha 
and Frank Dunstan in October 2010.  We discussed the idea of investigating the respiratory, 
cardiovascular and neurological outcomes of children born preterm.  The Child Health 
Department at Cardiff University, led by Professor Kotecha, had already used data from 
ALSPAC to show that children born full term with IUGR have reduced lung function (Kotecha, 
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Watkins et al. 2010).  In 2011 Sarah Kotecha, a researcher at Cardiff University, used data from 
ALSPAC to show the association between preterm birth and lung function in children and 
adolescents (Kotecha, Watkins et al. 2012).  As a result of this we decided to start my research 
work by further assessing the ALSPAC data and we set the hypothesis: is preterm birth 
associated with reduced vascular function in childhood and is the reduced vascular function 
of children born preterm associated with poor lung function?  At this point I also recognised 
that the ALSPAC cohort was not ideal to specifically assess outcomes of children born preterm 
as it was established as a whole population cohort with relatively low numbers of preterm 
born subjects.  Therefore we came up with the idea of establishing a new cohort of preterm 
born children, including those born 32 to 36 weeks of gestation, with term born controls to 
assess the effect of preterm birth on later health outcomes such as respiratory disease and 
neurological impairment.   
My analysis of the ALSPAC vascular data started in early 2011.  At the same time I started 
to write a study protocol to establish a cohort of preterm born children in Wales and I was also 
involved in a large systematic review and meta-analysis assessing the impact of preterm birth 
on later lung function.  During the first year of my PhD I gained further training in medical 
statistics and to improve my statistical skills I completed an Open University degree level 
course on generalised linear modelling.  I successfully completed the course while establishing 
the cohort of children for RANOPS in 2013.  During 2012, I evaluated the vascular data from 
ALSPAC, which forms chapter 2 of my thesis, which did not confirm my original hypothesis and 
thus I opted not to explore the data any further.  However, the data from ALSPAC that I had 
analysed was published with myself as first author and I made suggestions for further vascular 
research work on preterm-born survivors, which has been discussed in the conclusion of this 
thesis (Edwards, Watkins et al. 2014).  As I had completed the ALSPAC research work earlier 
4 
 
than expected, I was able to start another research project whilst establishing the RANOPS 
cohort.   
During my involvement on the systematic review of preterm birth and later lung function, 
it became clear that there were many studies assessing different aspects of the respiratory and 
cardiovascular outcomes of children and adults born preterm.  There was evidence that being 
born preterm and having chronic lung disease may affect vascular function but it was unclear 
whether the poor lung function or the premature birth affects cardiorespiratory function, 
especially exercise capacity.  As a result of this I led the new systematic review to answer the 
question does preterm birth impact later exercise capacity? Sarah Kotecha led the first 
systematic review on lung function and I led the second systematic review on exercise capacity 
in 2012-13, which has been included as part of this thesis (chapter 3).  Both systematic reviews 
have been published (Kotecha, Edwards et al. 2013, Edwards, Kotecha et al. 2015).  We also 
led a joint systematic review on the use of bronchodilators in preterm born survivors in 2014, 
which has also been published but has not been included in this thesis (Kotecha, Edwards et al. 
2015).   
My research project to establish a cohort of preterm born children in Wales was a major 
undertaking (see appendix pages: 271-76).  Needing to gain research and development 
approval from all seven health boards in Wales complicated this by taking considerable effort 
and time.  The full details of the establishment of the RANOPS cohort are described in chapter 
4.  The project started collecting data in April 2013 and the data were ready for analysis from 
October 2013.  During this time of data collection, I was involved in the two systematic reviews 
assessing the exercise capacity and use of bronchodilators in survivors of preterm birth.  In 
summary my thesis has been placed in chronological order with the first project being my 
assessment of the vascular function in children born preterm as set out in chapter 2 using data 
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from ALSPAC.  I then worked on my systematic review as discussed in chapter 3 and finally I 
established and analysed the initial data obtained from RANOPS in chapters 4 and 5.  In each 
chapter I shall further explain the hypothesis at the beginning and any changes that have been 
made to my original research questions. 
 
1.3 Cohort studies 
Of note are the overlapping effects of prematurity and birth weight on respiratory and 
cardiovascular outcomes and these are often intermingled in the literature.  Therefore in any 
research it is important to clearly define the population being studied and where possible 
reduce the risk of confounding factors.  Cohort studies are a useful method to assess the 
outcomes of children born preterm for example EPICure, which is a study of later health 
outcomes in survivors of extremely preterm birth. Thus I have used two cohort studies my 
research work and I have included a brief description of these here as they have already been 
mentioned, however more details are included in the relevant chapters. 
1.3.1 Avon Longitudinal Study of Parents and Children (ALSPAC) Population Profile: 
Part of my research work for this thesis has involved the use of data from the Avon 
Longitudinal Study of Parents and Children (Boyd, Golding et al. 2013). To summarise briefly, 
14,541 pregnant women, in three health authorities in Bristol, with an expected delivery date 
of 1st April 1991 to 31st December 1992 were enrolled in this longitudinal study.  They gave 
birth to 14,049 live born singleton children who were subsequently followed up annually by 
questionnaires and clinical assessments.   Further studies using the same cohort have also 
been carried out and collected data such as arterial structure and function in all children 
6 
 
attending for clinical assessment at age 10-11 years (Donald, Charakida et al. 2010).  Further 
details of the data used from ALSPAC are given in chapter 2. 
1.3.2 Respiratory and Neurological Outcomes of Children born Preterm Study (RANOPS) 
Population Profile: 
The final part of my research for this thesis involved establishing a cohort of children in Wales, 
the respiratory and neurological outcomes of children born preterm study (RANOPS).  RANOPS 
is a cross-sectional cohort of children born in Wales, which was established in 2013 to assess 
the respiratory and neurological outcomes of children born preterm.  Full details of the study 
are discussed in chapter 4.  In brief, 26,722 children born in Wales from 1st January 2003 to 31st 
December 2011 were invited to take part in a questionnaire survey.  In total 7,148 families 
returned completed questionnaires relating to the health of their child (26.7% response rate).  
Information on participants from completed questionnaires and from the Welsh healthcare 
database systems has been collated to create a database for the RANOPS cohort.   These data 
were analysed to assess the original aims of the project.   
 
1.4 Definitions and Epidemiology 
My research on preterm born children relies upon the accuracy of the recorded gestational 
age at birth.  Gestational age refers to the time in weeks and days from the last menstrual 
period (LMP) as compared to conceptional age, which measures the actual foetal age from the 
time of conception.  These terms are often used interchangeably.  The measurement of 
gestational age relies upon the recall of LMP or the accuracy of antenatal scans.  The estimated 
date of delivery (EDD) is based on the LMP plus 280 days, however it has been shown that 
many women are unable to accurately recall the date of their LMP (Campbell, Warsof et al. 
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1985).  Also the average length of pregnancy has been shown to be shorter in Black and Asian 
women compared to white European women (Patel, Steer et al. 2004).  The time of ovulation, 
fertilisation and implantation is also unknown, with a recent study suggesting that the 
ovulation to implantation stage can vary by up to 11 days, which will affect the foetal size 
(Mahendru, Daemen et al. 2012). This is important as the accuracy of antenatal scans relies on 
a standard size for the foetus at a given age, however this has been shown to be more 
accurate in early pregnancy (Caughey, Nicholson et al. 2008).  It is recommended that during 
the ‘first-trimester the crown-rump length is the best parameter for determining gestational 
age and should be used whenever appropriate’ (Butt, Lim et al. 2014).  
For each study that I have conducted for this thesis, I shall discuss the methods used to 
assess the gestational age of the children involved.  It is important to note that, at the time of 
writing my thesis, the definition of preterm birth was any infant born at less than 37 weeks of 
gestation, although more recently in the US ‘full term’ birth is being redefined as 39 to 41 
weeks of gestation, with 37 to 38 weeks of gestation being defined as early term 
(ACOG_No_579 2013).  Thus chapters two, three and four have used the traditional definition 
of term delivery i.e. 37 to 43 weeks of gestation.  The research in this thesis has been placed in 
chronological order of when it was conducted and so the analysis work in chapter 5 was 
performed after the concept of early term birth (37 to 38 weeks of gestation) had become 
more established.  The definitions and terminology of preterm birth are discussed in more 
detail below.  However, in each chapter I have clearly described the definition of the preterm- 
and term-born groups used.   
1.4.1 Preterm birth 
The long-term outcomes of infants born extremely preterm (i.e. less than 28 weeks of 
gestation) has been the focus of neonatal research for many years.  As the survival of these 
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tiny (often less than 1,000g) infants has increased so has interest in their long-term outcomes.  
Longitudinal cohort studies such as EPICure have shown the many difficulties that face 
survivors of extreme preterm delivery, including those relating to respiratory and 
cardiovascular disease and neurodevelopmental problems (Fawke, Lum et al. 2010, McEniery, 
Bolton et al. 2011, Bolton, Stocks et al. 2012, Moore, Hennessy et al. 2012).  Fawke et al 
identified that reduced lung function and respiratory symptoms were prevalent in children 
born extremely preterm up to 11 years of age, especially those with bronchopulmonary 
dysplasia (BPD, which is explained in more detail below) (Fawke, Lum et al. 2010).  Also in the 
same cohort, McEniery et al suggested that children born extremely preterm have changes in 
arterial blood flow and further showed an association between decreased lung function and 
impaired arterial function (McEniery, Bolton et al. 2011, Bolton, Stocks et al. 2012).   Then 
Moore et al showed an association between the gestational age at birth and 
neurodevelopmental impairment in early childhood in the EPICure and EPICure 2 cohorts, 
although the assessment of the neurological impairment is beyond the scope of my thesis 
(Moore, Hennessy et al. 2012).  However, in recent years it has become apparent that the 
outcomes of infants born later than 32 weeks of gestation have received little attention from 
the research community.   
Infants born between 32 to 37 weeks of gestation have been labelled with several terms 
over the last decade including late preterm, moderate preterm, near term and even early 
term, which in part has caused some confusion for researchers and clinicians.  It is becoming 
apparent that even the definition of term birth being 37 to 43 weeks of gestation is too broad 
and full term is now being considered as 39 to 41 weeks of gestation, whereas 37 to 38 weeks 
of gestation is being classified as early term (Spong 2013). In general, those born less than 28 
weeks of gestation are regarded as extremely preterm, less than 32 weeks as very preterm, 33 
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to 34 weeks as moderate preterm, 35 to 36 weeks as late preterm (sometimes called near 
term) and 37 to 38 weeks as early term.  Those born after 42 weeks are referred to as post-
term.  I have clearly defined the terms I have used at the beginning of each chapter.  
The main reason for changing the definitions of the term population in my research was 
that in the US in October 2013, the American College of Obstetricians and Gynecologists 
(ACOG) redefined term delivery and promoted the use of the following: Early Term (37 to 38 
weeks 6 days), Full Term (39 to 40 weeks 6 days), Late Term (41 to 41 weeks 6 days) and Post-
term (42 weeks and beyond) (ACOG_No_579 2013).  The World Health Organization (WHO) 
has not specifically defined term delivery, however it states that preterm delivery is less than 
37 weeks of gestation and it states that ‘induction or caesarean birth should not be planned 
before 39 completed weeks unless medically indicated’ (WHO 2014).  In the UK, the Royal 
College of Obstetricians and Gynaecologists (RCOG) still define term delivery as 37 to 42 weeks 
and 6 days.  As stated the definition of term and preterm delivery has been clearly described at 
the start of each chapter.  My research work started in 2011 prior to the changes to the 
definition of full term delivery, so most of the work uses the RCOG definition of term (37 to 42 
weeks 6 days of gestation), however the final study (in chapter 5) was conducted in 2013 and 
uses the ACOG definitions of full term, early term, late term and post term. 
1.4.2 Chronic lung disease of infancy (CLDI) 
There has been much discussion over the use of the terminology chronic lung disease 
(CLD) and bronchopulmonary dysplasia (BPD).  Some researchers and clinicians favour the use 
of the term BPD as it offers a physiological explanation for the disease (Ryan 2006), however 
others have favoured the use of the more generic term, chronic lung disease of infancy (CLDI) 
and more specifically the term relating to preterm birth, chronic lung disease of prematurity 
(CLDP) (Allen, Zwerdling et al. 2003).  CLDI relates to any acute lung injury in infancy, so 
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includes respiratory distress syndrome (RDS), pneumonia, meconium aspiration syndrome, 
congenital abnormalities of the lung etc.  However, CLDP was initially termed BPD by 
Northway describing the changes in the lungs of preterm infants with severe respiratory 
disease (Northway, Rosan et al. 1967).  The terms CLD and BPD were used interchangeably.  
However the American Thoracic Society (ATS) has promoted the use of CLDI as a more generic 
term to describe lung disease in infancy and CLDP as a more specific term to describe the 
respiratory problems associated with preterm birth and CLD as the term used for on going 
pulmonary symptoms in later childhood, whether due to CLDI or CLDP (Allen, Zwerdling et al. 
2003).   
BPD was more formally described by Jobe and Bancalari and they established diagnostic 
criteria for BPD, which defines it as infants who were born ≤32 weeks of gestation and require 
oxygen supplementation at 36 weeks of corrected gestational age or infants who were born 
>32 weeks of gestation and require oxygen supplementation at 28 days of life (Jobe and 
Bancalari 2001). This has been validated as a system to classify BPD according to severity: mild, 
moderate and severe BPD (Ehrenkranz, Walsh et al. 2005).  Advances in neonatal medicine 
over the last 10 years have led to changes in the pathophysiology and epidemiology of CLDI 
and now the majority of children with CLD are born extremely preterm (<28 weeks of 
gestation) (Jobe 2011).  Children with CLD are known to have increased respiratory morbidity 
and poor lung function (Filippone, Bonetto et al. 2009).  So in any cohort of preterm-born 
children it is important to identify those individuals with CLD, as this will influence the results 
especially when assessing respiratory outcomes.     
Throughout this thesis the term CLD has been used to refer to children born preterm with 
CLD. However it is felt that CLDP is part of the spectrum of respiratory disease in those born 
preterm and that CLDP is at the severe end. That means it is assumed respiratory morbidity 
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secondary to preterm birth is due to being born at an earlier stage of lung development, then 
it stands to reason that the severity of the respiratory disease will relate to the degree of 
prematurity i.e. those born most premature will have the most severe symptoms and disease. 
It is therefore important in any research work relating to those born preterm to assess the full 
spectrum of disease from those born very preterm with CLD to those born late preterm and 
early term.   Briefly it is important to note whether children with CLD were included or not in 
each of my studies.  In chapter 2, the ALSPAC cohort had not identified those children with 
CLD, although it is recognised that many children born extremely preterm in the 1990’s have 
CLD.  In chapter 3, my systematic review of exercise capacity in children born preterm, the 
definition of CLD and the inclusion of participants with CLD were dependent on the criteria of 
each study included in my meta-analysis and the decade during which the cohort of 
participants were born.  Many of these studies referred to CLD as BPD.  In chapter 4, the 
RANOPS cohort, I was able to identify participants with CLD and so a separate analysis was 
performed to assess the impact of CLD on respiratory outcomes in these children.   
 1.4.3 Moderate, late preterm and early term birth: the size of the problem 
The global rate of preterm delivery is rising each year with the moderate and late preterm 
deliveries forming the majority of these deliveries at 12.5 million births worldwide in 2010 
(84% of the total preterm births) (Blencowe, Cousens et al. 2012).  However the rates of 
preterm birth for each country vary considerably from 5% to 18%.  In the USA, the rate has 
increased from 9.5% in 1981 to 12.7% in 2005, with 80% of the preterm births occurring at 32 
– 36 weeks of gestation (Goldenberg, Culhane et al. 2008). Encouraging recent data from the 
USA shows the rate decreased to 11.4% in 2015, this was felt to be a modest reduction 
secondary to public health interventions, however the preterm birth rate is still felt to be too 
high in the USA (Frey and Klebanoff 2016).  On a local basis, in Wales, the average number of 
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live-born deliveries over the last five years was 34,464 per annum; approximately 2,000 live 
births each year are born between 23 and 36 weeks gestation with over 1,500 being born 
between 32 and 36 weeks of gestation (Kotecha, Dunstan et al. 2012).  The total percentage of 
infants born preterm in Wales each year was around 7% and surprisingly for those born early 
term it was about 17% (Figure 1).  The rates for early term birth in the USA are much higher at 
around 29% of the total live birth rate (Ananth, Friedman et al. 2013).   
At birth, most moderate and late preterm-born infants only require supportive care and 
have relatively low mortality in the neonatal period, however their long term morbidity is 
unclear (Lawn, Davidge et al. 2012).  As they are born in the final few weeks of gestation, this 
corresponds with a key stage of maturation of the respiratory and neurological systems, which 
thus may lead to later disease (Kugelman and Colin 2013).  It should be noted that in 
comparison to term-born infants, moderate and late preterm-born infants have increased 
morbidity in the neonatal period (Engle, Tomashek et al. 2007, Kugelman and Colin 2013).  
More recently it has also been noted that the early term-born infants have increased 
morbidity including respiratory and mortality during the neonatal period when compared to 
those born at 39-42 weeks of gestation (Engle 2011, Ghartey, Coletta et al. 2012).  The findings 
of these studies alongside others prompted the ACOG to adjust their definition of full term 
birth and to advocate that non-medically indicated deliveries prior to 39 weeks are not 
appropriate (Hibbard, Wilkins et al. 2010, ACOG_No_561 2013).  In the UK, the RCOG has 
continued to define full term delivery as 37 to 42 weeks. 
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Figure 1: Chart of live birth rates in Wales (2002-2011) 
 
The chart shows the total number of live births for Wales over a ten-year period.  The overall birth rate 
in Wales has increased, although the percentage of early term and preterm births has stayed the same.  
Data taken from AWPS (Kotecha, Dunstan et al. 2012). 
 
The lack of outcome data for the late preterm infants has been discussed on an 
international level and groups such as the National Institute of Child Health and Human 
Development in the USA have recognized the importance of this group of infants (Raju, Higgins 
et al. 2006).  As a result several retrospective studies have published data to show the 
outcomes of these infants are not as good as previously believed.  Much of this published work 
focuses on the neuro-developmental and educational outcomes, but more recently data has 
been published to show that children born late preterm also have increased respiratory and 
general health problems compared to those born at full term (McGowan, Alderdice et al. 2011, 
Boyle, Poulsen et al. 2012, Kotecha, Watkins et al. 2012, Boyle 2013, Kugelman and Colin 2013, 
Vrijlandt, Kerstjens et al. 2013).  In brief these studies highlight the need for further research 
to assess the impact of being born late, moderate preterm or early term on later health 
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outcomes.  McGowan et al in their literature review identified studies that suggest an 
increased risk of neurodevelopmental problems and poor academic achievements in those 
born late preterm but only up to 7 years of age (McGowan, Alderdice et al. 2011).  Boyle et al 
showed specifically a gradient effect for gestational age and poor general health outcomes 
including hospital admissions for young children born late and moderate preterm and also 
early term (Boyle, Poulsen et al. 2012).  However, they only assessed children up to 5 years of 
age.  Kotecha et al using the ALSPAC cohort have shown reduced lung function in children born 
late preterm, however their lung function appeared to improve in adolescence (Kotecha, 
Watkins et al. 2012).  Vrijlandt et al have also shown increased respiratory symptoms for 
children born moderately preterm whilst Paranjothy showed increased hospital admissions for 
respiratory illness in children born late and moderate preterm and early term; however both 
studies only assessed children up to 5 years of age (Paranjothy, Dunstan et al. 2013, Vrijlandt, 
Kerstjens et al. 2013).  
The situation for data on the outcomes of children born early term is worse as there has 
been no international consensus on promoting research in this area.  Thus further research 
data is required to establish the extent of the health related problems for children and adults 
born not only moderate and late preterm but also for those children and adults born early 
term and therefore promoting the idea of assessing the whole gestational age range when 
conducting research as shown by Paranjothy et al and Boyle et al in the studies described 
above.  It is becoming evident that gestational age at birth leads to a spectrum of respiratory 
disease with those born extremely preterm developing more severe disease and those born 
closer to full term having milder disease (Boyle, Poulsen et al. 2012, Paranjothy, Dunstan et al. 
2013).   
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1.4.4 Other contributory factors to health outcomes of preterm born survivors  
There are approximately 700,000 live births each year in England and Wales, and nearly 
7% are born preterm and 18% are born early term, thus a quarter of the live births every year 
are born with the potential for increased risk of later morbidity, especially respiratory disease 
(ONS).  Research not only needs to establish to what extent these infants are at increased risk 
of later morbidity but also needs to assess or take into account some of the other possible 
contributing factors.  The long-term problems may relate to the stage of foetal development 
when the infant is born i.e. underdeveloped lungs leading to increased risk of respiratory 
distress in the neonatal period.  On the other hand, the increased morbidity associated with 
preterm and early term birth may be related to the underlying cause for the premature 
delivery i.e. foetal or maternal disease (such as intrauterine growth restriction or maternal 
asthma, smoking or pre-eclampsia) or the mode of delivery (such as by Caesarean section).  It 
has been shown that maternal asthma may lead to an increased risk of preterm delivery and a 
family history of asthma has also been linked with increased risk of childhood asthma (Kelly, 
Brabin et al. 1995, Burke, Fesinmeyer et al. 2003).   
A recent systematic review has shown that preterm birth increases the risk of wheezing 
disorders in childhood (Been, Lugtenberg et al. 2014).  Thus it is clearly important to 
understand whether being born preterm with lung immaturity leads to the childhood 
wheezing disorders, or whether the underlying causes of preterm delivery lead to the 
childhood wheezing disorders or do both have a role to play?  There are several other factors 
that need to be considered such as the effects of LBW, which is discussed in more detail below, 
possible genetic links, as a recent study has identified 258 genes associated with CLD (Li, Yu et 
al. 2015), and the modality of neonatal treatment, which has changed over the last 10-20 years 
and includes the effects of ventilatory support, supplemental oxygen and use of postnatal 
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corticosteroids.   Also the mode of delivery may play a role in the development of childhood 
wheezing disorders as a recent systematic review has shown an increased risk of childhood 
‘asthma’ following delivery by Caesarean section (CS), although this did not take into account 
the gestational age at birth of the children (Thavagnanam, Fleming et al. 2008).  This may be 
due to the effects being born via CS has on the gastrointestinal and/or the respiratory 
microbiome and thus subsequent atopic disease such as asthma (van Nimwegen, Penders et 
al. 2011).  Plus a recent systematic review identified multiple environmental factors such as 
exposure to antibiotics or tobacco smoke or pets increases the risk of childhood wheezing 
disorders, but acknowledged that no single exposure leads to childhood wheezing disorders, 
thus it would appear a complex set of interactions leads to the development of childhood 
wheezing disorders (Dick, Friend et al. 2014).  In children with wheezing it may also be that risk 
factors such as early exposure to antibiotics are a marker of other underlying disease 
processes such as impaired immunity, which may play a more significant role in the 
development of respiratory disease than the use of antibiotics (Semic-Jusufagic, Belgrave et al. 
2014).   
1.4.5 Childhood wheezing disorders including asthma 
 The diagnosis of asthma in children is difficult as there is no single investigation or 
symptom that can accurately diagnose asthma.  Thus childhood asthma is defined as a clinical 
diagnosis that has no gold standard, which is challenging for both clinicians and researchers.  
The British Thoracic Society defines asthma based on a pattern of episodic signs and symptoms 
with no other explanation (James and Lyttle 2016). These include respiratory symptoms such 
as wheeze, cough, difficulty breathing or chest tightness, which are frequent, recurrent and 
worse at night or early morning, and worse with triggers such as exercise or exposure to 
allergens. There is often a past medical history of atopic disease such as eczema and a family 
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history of asthma or atopy.  Furthermore, these symptoms improve with adequate treatment 
such as bronchodilators or corticosteroids.  Unfortunately there is evidence to show that 
doctors over diagnose asthma in children, which may lead to over treating or even under 
treating the child’s respiratory symptoms (Caudri, Wijga et al. 2011, Looijmans-van den Akker, 
van Luijn et al. 2016).  The confusion over the diagnosis of asthma in childhood may be due to 
there being many causes of childhood wheezing and this has led to their being a debate over 
the use of phenotypes particularly for wheezing in preschool children.  Bush and Nagakumar 
promote the use of ‘Hargreave-driven’ methods for describing the preschool wheezing 
phenotypes in their review article (Bush and Nagakumar 2016). They state that ‘the phrase 
doctor-diagnosed asthma should vanish from literature and a more clinically relevant form of 
phenotyping should be used’ (Bush and Nagakumar 2016). 
For research purposes it is often easier to use the simple methods for establishing a 
diagnosis of ‘asthma’ and that has often been based on responses to questions such as ‘has 
your child ever had asthma and was this confirmed by a doctor?’ taken from the gold standard 
for ascertaining asthma outcomes in epidemiological studies, the International Study of 
Allergies and Asthma in Childhood (ISAAC) questionnaire (Asher, Keil et al. 1995).  Thus, given 
that the term asthma has been so heterogeneous, many epidemiological studies of childhood 
wheezing focus on symptoms and signs to describe phenotypes, although this method also has 
problems as it relies on participants or parents understanding the term wheezing.  Cane et al 
have shown that parents report wheezing in different ways due to the variation of their 
understanding of wheezing, and this can lead to variation in reported rates of childhood 
wheezing disorders (Cane, Ranganathan et al. 2000, Michel, Silverman et al. 2006).  However 
many studies have described phenotypes of childhood wheezing and used analysis such as 
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latent class analysis to define categories of wheezing and develop clinically relevant models of 
childhood wheezing disorders (Spycher, Silverman et al. 2010, Depner, Fuchs et al. 2014).   
A Task Force in 2008 proposed the use of the terms episodic viral wheeze and multi-trigger 
wheeze to help define the two main phenotypes of preschool wheeze disorders (Brand, Baraldi 
et al. 2008).  This has helped to establish guidelines for the management of preschool 
wheezing and helped researchers to avoid using the term asthma and instead describe the 
wheezing disorder (Turner, Friend et al. 2012).  Thus in my research work the term ‘asthma’ 
has only been used as part of the ISAAC questionnaire and has been discussed in more detail in 
chapters 4 and 5.  The use of accurate terminology to describe childhood respiratory disorders 
is important to ensure clinicians use appropriate treatment, so that over and under use of 
certain medications such as corticosteroids, can be avoided (Caudri, Wijga et al. 2011).  Thus 
my research will suggest the use of the term prematurity-associated wheeze, which relates to 
respiratory symptoms that develop due to preterm birth, possibly as a result of being born at 
an early stage of lung development, which has often been referred to as ‘asthma’ (Edwards, 
Kotecha et al. 2016). The airway disease related to preterm birth maybe different to asthma in 
that it maybe fixed and have variable airflow obstruction not related to inflammation and so 
may not respond to inhaled corticosteroids.  Thus the treatment of the different wheezing 
disorders in childhood, particularly prematurity-associated wheeze needs further evaluation, 
so that clear guidelines can be created for clinicians to follow. Also there are multiple possible 
causes for children to develop frequent respiratory symptoms, which include preterm birth, 
early exposure to viruses such as rhinovirus, low birth weight and maternal smoking (Perez-
Yarza, Moreno et al. 2007, O'Callaghan-Gordo, Bassat et al. 2013, Been, Lugtenberg et al. 2014, 
Mebrahtu, Feltbower et al. 2015, Silvestri, Franchi et al. 2015).  Thus in studies assessing the 
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possible association of specific risk factors with childhood wheezing disorders, it is essential 
that the impact of potential confounding factors is also taken into account.   
1.4.6 Low Birth Weight and Intrauterine Growth Restriction 
In reviewing the literature, it is evident that some studies do not have well defined cohorts 
for exploring the long-term health outcomes, such as wheezing disorders, of children born 
preterm.  Studies often have a combination of preterm- and term-born children within groups 
defined as Low Birth Weight (LBW) or Very Low Birth Weight (VLBW).  LBW is defined as a birth 
weight of less than 2,500 g and VLBW as a birth weight of less than 1,500 g, both of which 
would include the majority of preterm-born infants and would also include many term-born 
infants with intrauterine growth restriction (IUGR).  Those born preterm have morbidity 
associated with their immaturity, however those born term with low birth weight have normal 
maturity, but growth restriction, which is also associated with morbidity.  Thus it is important 
to distinguish between the possible effects of these two risk factors for later disease.  Preterm 
cohorts also need to clearly distinguish between infants born small for gestational age (SGA) or 
appropriate for gestational age (AGA) to help identify the independent effects of birth weight 
and gestational age on later life respiratory or vascular disease.   
IUGR is defined as less than 10 per cent under predicted foetal weight for gestational age 
(WHO 4-6 December, 2002).  IUGR has been associated with an increased risk of preterm 
delivery and so it is more commonly observed in preterm-born infants compared with those 
born at term (Zeitlin, Ancel et al. 2000, Loftin, Habli et al. 2010, Shapiro-Mendoza and Lackritz 
2012).  IUGR and preterm birth are both independent risk factors for later disease and it is 
important to examine both these causes separately in any research. When exploring the 
outcomes of a whole birth cohort (i.e. the Millennium cohort study) it is important to include 
gestational age and birth weight in any analysis plan, as shown in Boyle et al’s paper on the 
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health outcomes of young children according to gestational age at birth (Boyle, Poulsen et al. 
2012).  In the research for this thesis I have clearly distinguished between these two 
overlapping groups and the focus has been on the impact of preterm birth on later morbidity 
with IUGR and/or LBW as a confounding or contributing factor.  
 
1.5 Organogenesis 
-The origin and development of organs 
1.5.1 Respiratory development 
Preterm infants are born with organs that are in earlier stages of development compared 
to term-born infants.  For lung development this means that infants born at 32-36 weeks of 
gestation are born in the saccular stage as shown in Table 1 (Kotecha 2000), and it is not 
known if lung growth and development continue normally in the extra-uterine environment 
after preterm birth (O'Reilly, Sozo et al. 2013).  It is, however increasingly recognized that late 
preterm and early term infants have increased respiratory morbidity in the neonatal period, 
especially from respiratory distress syndrome (RDS), transient tachypnoea of the newborn 
(TTN) and pneumonia (Ecevit, Olgac et al. 2010, Hibbard, Wilkins et al. 2010, Sengupta, Carrion 
et al. 2013).  Thus with increasing birth rates, especially of those born 32-38 weeks of 
gestation, even a relatively small increased risk of subsequent respiratory morbidity in the 
infants born moderate or late preterm or early term, would contribute substantially to the 
number of individuals affected by respiratory disease associated with early birth.  Whether the 
increased morbidity extends beyond the neonatal period is unclear and is part of the reason 
for the research work that forms part of my thesis.   
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To understand why preterm birth might lead to respiratory morbidity it is necessary to 
briefly review the embryology of a foetus.  Lung development begins at 3 weeks of embryonic 
life and then progresses through several morphological stages up to early adulthood.  The 
stages of human lung growth are summarised in table 1 and images of changes in foetal lung 
development are shown in Figure 2.  Preterm infants are born in the pseudoglandular or 
saccular stages of lung development, which has short and long term implications for the 
cardiopulmonary development of the infant.  It is known that alveolar multiplication continues 
in the postnatal period up to 2-3 years of age and that alveolar size and surface area also 
continue increasing up to early adulthood (Kotecha 2000, Hislop 2002, Altes, Mata et al. 2006).  
However the impact on alveolar development of being born at 38 weeks or earlier instead of 
40 weeks of gestation is unclear and requires further investigation.    
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Table 1 Stages of lung growth (Joshi and Kotecha, 2007) 
Stage Time Events 
Embryonic 0–7 weeks Formation of trachea, right and left main bronchi, 
segmental bronchi, and vasculogenesis around 
airway buds 
Canalicular 7–17 weeks Differentiation of epithelial cells, formation of 
conduction airway and terminal bronchioles, 
formation of pulmonary arteries and veins 
Pseudoglandular 17–27 weeks Formation of respiratory bronchioles, alveolar 
ducts and primitive alveoli, differentiation of type 
I and type II pneumocytes and formation of 
alveolar capillary barrier 
Saccular 28–36 weeks Increment in gas exchange areas, further 
differentiation of type I and type II cells 
Alveolar 36 weeks–2 years Septation and multiplication of alveoli 
 Until 18–22 years Enlargement of terminal bronchioles and alveoli 
Micro vascular maturation Birth to 2–3 years Fusion of double alveolar capillary network into a 
single layer 
 
Figure 2: Axial T2-weighted images of foetuses aged 24 GW (a) and 31 GW (b). 
 
The lungs of the older foetus are brighter and structurally more heterogeneous (b) compared to the 
rather dark and homogenous appearance of the lungs in the younger foetus (a). Signal intensity of the 
foetal lungs is increased from hypo- (a) to isointense (b) compared to cerebrospinal fluid 
(arrows).(Kasprian, Balassy et al. 2006)  
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1.5.2 Postnatal development of the lungs 
The development of the lungs continues after full-term birth with the postnatal process 
divided into the alveolar stage, the micro vascular maturation and possibly a late 
alveolarization stage (Burri 2006).  An understanding of postnatal lung development is 
important so that the pathological impact of preterm birth and other risk factors such as early 
respiratory tract infections (bronchiolitis) can be assessed.  The late alveolarization stage 
possibly continues into late adolescence as shown by helium-3 magnetic resonance imaging 
plus the assessment of lungs from autopsies of children (Narayanan, Owers-Bradley et al. 
2012, Herring, Putney et al. 2014).  The lungs appear to have the potential to repair and 
regrow after an insult such as preterm birth.  It may potentially explain why lung function has 
been noted to be reduced in childhood in preterm born subjects but showed improvement in 
adolescence, with those born later preterm showing near normal lung function as teenagers 
(Kotecha, Watkins et al. 2012).   
As mentioned there are various factors that can affect prenatal growth and development 
of the lungs, which include foetal nutrition leading to IUGR, maternal disease, maternal drug or 
alcohol abuse, maternal smoking and other forms of air pollution, and being born preterm 
(Stocks, Hislop et al. 2013).  In preterm born infants, especially those born in the saccular stage 
of the lung development there may be failure to progress to the normal alveolarization stage, 
which then leads to reduced numbers of alveoli and therefore possibly increased respiratory 
symptoms and increased susceptibility to respiratory disease.  Disappointingly there have been 
few studies assessing the pathological processes occurring in prematurity-associated 
respiratory disease.   So far there are many theories behind the mechanisms by which risk 
factors such as preterm birth could lead to respiratory disease in later life such as chronic 
obstructive pulmonary disease (COPD) (Baraldi, Carraro et al. 2009), but further research 
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needs to be conducted to understand the pathogenesis of respiratory disease such as ‘asthma’ 
and COPD, and indeed respiratory disease associated with preterm birth.   
1.5.3 Cardiovascular development 
Along side the respiratory development, the cardiovascular system develops to provide 
oxygen and nutrients to the body organs and remove waste products and is the first system to 
develop during organogenesis.  The cardiovascular system starts developing from the third 
week of gestation. In the cardiogenic mesoderm the angiocysts form a pair of endothelial 
tubes and this is the single primitive heart, the angiocysts also develop into veins and arteries.  
By 21 days this primitive heart tube is divided into a number of chambers separated by 
grooves with the truncus arteriosus coming from cranial end and the sinus venosus from the 
caudal end. The endoderm then induces the cardiogenic mesoderm to differentiate into four 
distinct layers surrounded by a pericardial cavity.  In the fourth week the vascular system 
develops with three main pairs of arteries, to the head, to the yolk sac and to the placenta 
with three corresponding veins draining into the sinus venous.  The heart tube starts to fold 
and becomes an ‘S’ shape and the heart wall further develops leading to the formation of the 
four chambers of the heart, the primitive ventricles and atria. Blood starts to flow through the 
heart from the middle of the fourth week.  The main walls of the heart continue to develop 
into the endocardial tissue up to the 5-6th weeks.  Development of the heart and vascular 
system is mostly complete by 10 weeks of gestation, however the physiology of the 
cardiovascular system continues to develop up to term.   
1.5.4 Postnatal adaptation and development of the cardiovascular system 
In a term-born infant the cardiovascular system goes through a process of adaptation to 
extra-uterine life.  This occurs due to changes in oxygen concentration in the blood and 
reduced pulmonary vascular pressures plus increased systemic resistance.  These changes lead 
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to the closure of the foramen ovale and ductus arteriosus, causing blood to flow through the 
pulmonary system and back into the heart prior to being circulated around the body (adult 
circulation pattern).  A surge of steroid hormones such as cortisol and other vasoactive 
hormones prior to delivery may mediate the increase in the cardiac output in term-born 
infants (Heymann, Iwamoto et al. 1981, Hillman, Kallapur et al. 2012).  The impact that being 
born preterm has on the adaption of the cardiovascular system to extra-uterine life is 
important to understand in order to prevent or reduce the risks of later cardiovascular disease, 
which includes increased mortality, associated with preterm birth (Crump, Sundquist et al. 
2011, Norman 2013).  
 Young people born very preterm have been shown to have smaller arterial vessels 
compared to those born at term and this might lead to later cardiovascular disease (Schubert, 
Muller et al. 2011).  Preterm-born infants are also affected by a difference in adrenergic 
receptors compared to term-born infants along with other immaturities of the cardiovascular 
system, which may lead to impaired cardiac function (Lee, Kimball et al. 1992, Groves, Chiesa 
et al. 2011). It has been shown that the vascular system may stop growing in preterm-born 
infants and may be smaller compared to term-born infants with altered vascular dynamics 
(Bonamy, Bendito et al. 2005, Lekakis, Abraham et al. 2011, Norman 2013). However there is 
still a lack of knowledge around the on going development of the cardiovascular system 
following preterm delivery and so the implication of being born preterm or even early term is 
unclear.  Lewandowski et al showed an increased left ventricular mass and a change in cardiac 
function in association with lower gestational age when assessed in adults using cardiac 
magnetic resonance imaging (Lewandowski, Augustine et al. 2013).  Lewandowski et al then 
showed that preterm birth was associated with reduced right ventricular size, increased 
myocardial mass and impaired right ventricular function greater than that observed in the left 
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ventricles (Lewandowski, Bradlow et al. 2013).   Studies have also shown that adults born 
extremely preterm have increased risk of cerebrovascular disease such as stroke (Koupil, Leon 
et al. 2005) and increased risk factors for cardiovascular disease such as hypertension (Dalziel, 
Parag et al. 2007), although at present there appears to be a lack of association with ischaemic 
heart disease.  However some studies have associated low birth weight with ischaemic heart 
disease (Kaijser, Bonamy et al. 2008, Abitbol and Rodriguez 2012). Evidence from adult 
survivors of preterm birth is limited, although Kajantie et al recently did not show an 
association between preterm birth and coronary heart disease in old age from a large 
population cohort in Helsinki (Kajantie, Osmond et al. 2015).  Thus it is clear that children and 
young adults born preterm have increased risk factors for later cardiovascular disease 
including mortality, so understanding how these risks develop and the long term implications 
is important to help guide clinicians on the early preventative management.   
 
1.6 Life course factors 
The Barker hypothesis states that abnormal development in utero increases the risk of 
developing disease, such as ischaemic heart disease, in adulthood (Barker 2003).  There are 
many factors throughout the life-course that have direct and indirect influence on disease in 
adulthood.  For example Tennant et al. using the Newcastle Thousand Families Study 
confirmed that sex, height and smoking are the most important predictors of forced expiratory 
volume in one second (FEV1) and also showed that birth weight, breast feeding and childhood 
lower respiratory tract infections (LRTIs) have a significant relationship with FEV1 (Tennant, 
Gibson et al. 2008).   The increased risk of heart disease associated with low birth weight 
(LBW) was initially identified by Barker (Barker 1994) and since then many studies have gone 
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on to replicate the findings and also identified the increased risk of LBW with other adult 
diseases such as stroke, diabetes etc. (Barker 2004).  Our understanding of how each early life 
factor interacts and leads to disease later in life is still unknown.  There is also a gap in our 
understanding of the links/associations between preterm birth, birth weight and the 
development of pathological processes that occur in childhood or adulthood such as 
cardiovascular and respiratory diseases.  The effects of being born at an early stage of 
development for the lungs and cardiovascular system may be the initial step in the 
pathogenesis of cardiorespiratory disease.  Furthermore, poor foetal and maternal nutrition 
leads to IUGR and thus LBW may be a contributing factor to the poor development of the 
foetal organs/systems, which may further exacerbate the effects of preterm birth.  However it 
is also vital to disentangle the underlying causes of preterm birth and LBW in preterm and 
term born infants, to understand their individual roles in the development of disease 
processes in the later life of those born preterm and/or LBW. 
1.6.1 Causes of preterm birth and low birth weight 
 The causes for preterm birth and low birth weight are delivery for maternal or foetal 
indications (labour is induced or delivery is by Caesarean section), spontaneous preterm 
labour, and preterm premature rupture of the membranes or sometimes non-medically 
indicated due to maternal choice. About 30-35% of preterm birth is indicated due to maternal 
or foetal problems and it is thought that this has caused the increase in preterm delivery in 
recent years (Goldenberg, Culhane et al. 2008).  There are multiple risk factors that can lead to 
preterm labour as are shown in Figure 3.  The optimal timing of delivery secondary to maternal 
or foetal illness has a poor evidence base, although the risk of still-birth or neonatal death 
needs to be considered (Ananth, Friedman et al. 2013).  Efforts to reduce the preterm and 
early term delivery rates are currently being addressed e.g. the American College of 
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Obstetricians and Gynecologists Committee opinion on Medically Indicated Late-Preterm and 
Early-Term Deliveries (ACOG_No_561 2013). Also the World Health Organization recommends 
that delivery by Caesarean section should only occur when medically indicated (Vogel, Betran 
et al. 2015), however the RCOG released a statement in April 2015 supporting the NICE 
guidelines on elective Caesarean section and the right for a woman to request a Caesarean 
section (NICE 2013).  As a result there will continue to be infants born early term and preterm 
due to medically indicated and non-medically indicated reasons thus it is important to 
establish if the long term risks associated with early birth are due to the underlying indication 
for delivery or due to being born too early i.e. immaturity and the effects of birth at early 
stages of development. This thesis has taken into account, where possible, potential risk 
factors for preterm and early term birth and included them in the analysis, as contributing or 
confounding factors.   
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Figure 3: Risk factors for preterm birth 
The diagram shows the multiple factors that may be involved in causing preterm birth.  Many of theses 
may also have a role to play in the development of disease in later life. 
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1.6.2 Respiratory morbidity: 
Few studies have reported later respiratory outcomes in children born late preterm 
(Todisco, de Benedictis et al. 1993, Friedrich, Pitrez et al. 2007) and predominantly these 
studies have assessed lung function in survivors of preterm birth and focused on those born 
very preterm (≤32 weeks) as this group of preterm-born survivors is at greatest risk of 
developing chronic lung disease of prematurity (CLDP) (Baraldi, Carraro et al. 2009).  Friedrich 
et al. compared healthy infants born at 30-34 weeks of gestation with term-born controls, 
reporting decreased forced expiratory flow between 25% and 75% of forced vital capacity 
(FEF25-75) but not forced vital capacity (FVC) at 4 and 16 months of age (Friedrich, Pitrez et al. 
2007).  Data assessing late preterm infants into later childhood have only recently been 
reported and data on childhood symptoms of respiratory disease, particularly wheezing 
disorders, are poor.  So are preterm born survivors more susceptible to respiratory morbidity 
due to the immature stage of lung development at the time of birth or do other factors such as 
use of postnatal corticosteroids or antibiotics, affect the respiratory system in early life that 
then contributes to an increased risk of respiratory morbidity? 
There are various risk factors that can contribute to lung inflammation in infancy and 
therefore respiratory morbidity throughout childhood.  These include postnatal interventions 
such as mechanical ventilation, postnatal nutrition, neonatal infections and being born IUGR.  
For example Kotecha et al showed from data taken from the ALSPAC study that children at 8-9 
years of age, born full term with IUGR (n=576), have significantly lower FEV1 when compared 
to children born at a normal birth weight at term (n=3,462), and this study specifically 
excluded prematurely born children (Kotecha, Watkins et al. 2010).  As already mentioned 
many factors including preterm birth affect lung function and these factors possibly cause or 
may lead to respiratory symptoms and disease in childhood and later life.  
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As shown recently by Kotecha et al, when they studied the ALSPAC children who were 
born preterm and who had spirometry at 8-9 (n=6712) and/or 14-17 (n=4513) years of age and 
were divided into 4 groups for analysis: 25-32 (very preterm), 33-34 (moderate preterm), 35-
36 (late preterm) and ≥37 (term controls) weeks of gestation (Kotecha, Watkins et al. 2012).  
At 8-9 years of age, all spirometry measures (except forced vital capacity, FVC, in the very 
preterm group) were significantly lower in both late and moderate preterm groups compared 
to term controls. The 35-36 weeks gestation and term groups had similar values. At 14-17 
years of age, most spirometry measures in the 25-32 and 33-34 week gestation groups were 
not different from term controls except for lower forced expiratory flow between 25% and 
75% of FVC (FEF25-75) and FEF25-75/FVC in both 25-32 and 33-34 weeks gestation groups and 
lower FEV1/FVC in the latter group. The abnormalities in lung function at 8-9 years of age were 
of similar magnitude in the 33-34 weeks and 25-32 weeks gestation groups, although these 
differences from term-born infants were reduced by 14-17 years of age.  So they identified 
that even children born moderate preterm have reduced lung function.  However it is not clear 
whether these children are also at an increased risk of respiratory morbidity and symptoms.  It 
is also unclear whether preterm-born children with normal lung function, such as those born 
at 35-36 weeks in the ALPSAC cohort with lung function similar to term-born controls, may 
suffer from respiratory symptoms and thus would not be detected by lung function testing 
alone.  The evidence suggests, that despite being born preterm, the lungs continue to develop 
with further alveolarization occurring in childhood and there may be some regeneration of 
damaged lung tissue.  This may be reflected by the improved lung function in the same cohort 
of participants from childhood to adolescents.  However, it is unclear whether respiratory 
symptoms, if present from a young age, also improve in adolescence and whether this also 
reflects ongoing lung growth and possible repair.   
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It should be noted that it is not only the very preterm or moderately preterm born infants 
that have been shown to have an increased respiratory morbidity.  In a study of a large 
American population consisting of 233,844 deliveries (born in 2002-2008), where they 
compared late preterm-born infants (34-38 weeks) to term-born infants (>38 weeks), the 
incidence of RDS was found to be 10.5% in the late preterm.  However it was noted to be only 
0.3% in the term population (Hibbard, Wilkins et al. 2010). This suggests that the respiratory 
morbidity during the neonatal period in late preterm and early term-born infants is greater 
than in the term-born population.  Note the confusion in the terminology used with the late 
preterm-born group being defined as 34-38 weeks of gestation, which combines the late 
preterm (34-36 weeks of gestation) and early term-born (37-38 weeks of gestation) children in 
one group.   
This only accounts for morbidity during the neonatal period.  Respiratory morbidity has 
also been measured in terms of re-hospitalization and respiratory disease in later life. Walter 
et al carried out a large case control study in USA, on 18-27 year old adults with a history of 
low birth weight, although no information was given on gestational age.  They showed an 
increased risk of hospitalization for respiratory illness with an odds ratio of 1.83 (95% CI 1.28 
to 2.62, p=0.001) for VLBW and 1.34 (95% CI 1.17 to 1.52, p=<0.005) for moderate LBW 
subjects (Walter, Ehlenbach et al. 2009).   In Walter et al’s study there was most likely a mixed 
population of children born preterm and those born term with IUGR, so it is important to 
assess which of these factors play a major role in later respiratory morbidity.  This has partly 
been shown in the preterm population, using the large electronic health database (Secure 
Anonymised Information Linkage database - SAIL) held in Swansea University, by Paranjothy et 
al, who showed the risk of emergency respiratory admission up to age 5 years decreased with 
increasing gestational age at birth, having taken birth weight into account (Paranjothy, 
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Dunstan et al. 2013).  It should be noted that Paranjothy et al had no data on the respiratory 
symptoms for this population.   
In brief there have been many studies assessing the affect of LBW on respiratory 
symptoms in childhood, which have shown mixed results.  Recently Mebrahtu et al conducted 
a systematic review and meta-analysis of birth weight and childhood wheezing disorders, 
which suggested that LBW is an independent risk factor for childhood wheezing disorders 
(Mebrahtu, Feltbower et al. 2015).  In the systematic review there was no assessment of the 
gestational age of the participants in each of the studies included and the authors have not 
commented on the confounding effect of preterm birth on the overall results.  Mebrahtu et al 
also reviewed their own cohort of children (the Born in Bradford Cohort) and confirmed an 
association between LBW and an increased risk of wheezing disorders with adjustment made 
for confounding factors such as gestational age at birth and gender (Mebrahtu, Feltbower et 
al. 2015).  However, it was unclear from the study findings whether gestational age was used 
as a continuous variable or a binary outcome as in the results the variable is referred to as 
preterm and term.  This is relevant because researchers are continuing to confuse clinicians by 
discussing LBW and gestational age as risk factors.  Many researchers often fail or are unable 
to account for the confounding effects of these factors and also the effect of IUGR.  IUGR, as 
discussed is a combination of gestational age and birth weight, and has many possible 
associated factors such as poor nutrition, which also need to be considered when assessing the 
association of gestational age and birth weight with respiratory symptoms.  Researchers need 
to a make a clear distinction between LBW and gestational age at birth (plus IUGR) and their 
respective association with childhood wheezing disorders in all future studies. 
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1.6.3 Cardiovascular disease (CVD): 
Preterm birth and LBW also have associations with later cardiovascular disease as 
previously discussed, particularly Baker hypothesis.  This is important because heart disease is 
one of the main causes of death in many industrialized countries and is becoming a major 
cause of morbidity and mortality in many developing countries (Yusuf, Reddy et al. 2001, 
Yusuf, Reddy et al. 2001).  The recognition of risk factors of cardiovascular disease in 
childhood, such as atherosclerosis (fatty deposits within arteries), has now been established 
but it is unclear as to the mechanisms that lead to these changes occurring (Tuzcu, Kapadia et 
al. 2001, Freedman, Mei et al. 2007, Donald, Charakida et al. 2010).  There is good evidence 
that early life events, such as LBW, are linked to developing heart disease in adulthood (Barker 
1994).  Several studies have linked low birth weight (LBW) with a higher blood pressure (BP) in 
adolescence and early adult life (Norman 2008) .   However the association of LBW with a 
higher BP in adult life has not been consistently identified in all studies (Libby, McEwan et al. 
2008).   This may be accounted for by the fact that some studies use LBW as a measure of 
IUGR in term born infants, whereas many preterm-born infants are also in the LBW or VLBW 
categories, which will affect the results of studies if included.  As with the studies assessing the 
respiratory outcomes of children born with LBW, the studies assessing cardiovascular 
outcomes also do not clearly explore the confounding risk of preterm birth.  This is necessary 
because there is a similar situation with gestational age in that some studies have identified an 
increased risk of high BP in early adulthood with prematurity (Johansson, Iliadou et al. 2005, 
Bonamy, Bengtsson et al. 2008).  However others have shown no association as noted by 
Kaijser et al who identified LBW as an independent risk factor for ischaemic heart disease and 
no association with gestational age (Kaijser, Bonamy et al. 2008).  However recently McEniery 
et al suggested an association between extreme prematurity and altered arterial 
haemodynamics in childhood using data from the EPICure study (Bolton, Stocks et al. 2012).  It 
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is also important to take account of other major risk factors when assessing the relationship 
between LBW or gestational age at birth and cardiovascular disease. 
For example the role of body fat, size and mass needs to be considered when assessing the 
cardiovascular risks of any individual taking part in a study.  A high body mass index (obesity) 
has been clearly associated with increased risk of cardiovascular disease and this should be 
considered as a confounding factor when assessing the impact of being born preterm on the 
risk of developing cardiovascular disease in later life (Berenson, Srinivasan et al. 1998, Bjorge, 
Engeland et al. 2008).  Whilst the prevalence of obesity in preschool children has been shown 
to be increasing across the world (de Onis, Blossner et al. 2010) although the obesity rates in 
children born preterm is not known.  However, it has been shown that children born preterm 
have a different body composition to those born at full term (Euser, de Wit et al. 2008).  How 
this difference in body composition affects cardiovascular risk is unclear. 
There are several methods that have been developed and researched to assess for early 
signs of cardiovascular disease.  These include measuring the arterial stiffness, which is an 
important marker for later vascular disease (Vlachopoulos, Aznaouridis et al. 2010), and can be 
assessed using the aortic pulse wave velocity.  The endothelial function can also be measured, 
which is another marker for later vascular disease and can be assessed using the flow-
mediated dilatation (FMD).  However, there has been a paucity of information on the 
cardiovascular outcomes of survivors of preterm birth especially with regards to 
measurements of arterial stiffness and endothelial dysfunction.  Recently new non-invasive 
methods to assess these vascular markers have been used for research. These include pulse 
wave velocity (PWV), FMD, augmentation index (AI) and distensibility coefficient (DC), which 
are discussed in further detail in chapter 2. These new methods have been used to 
demonstrate reduced endothelial function and arterial stiffness in cohorts of children with 
36 
 
obstructive sleep apnoea (OSA) (Bhattacharjee, Kim et al. 2012, Li, Au et al. 2013).   Recently 
Chan et al demonstrated endothelial dysfunction in a cohort of children with OSA, which was 
reversible when these children had adenotonsillectomy performed (Chan, Au et al. 2015).   
 These measures have also been shown to change over time in study cohorts and to relate 
to increased risk of future cardiovascular disease (Halcox, Schenke et al. 2002, Willum-Hansen, 
Staessen et al. 2006, Halcox, Donald et al. 2009, Shechter, Issachar et al. 2009).  Halcox and 
Schenke et al assessed coronary endothelial function in adults undergoing cardiac 
catheterization and showed that endothelial dysfunction was able to independently predict 
acute cardiovascular events (Halcox, Schenke et al. 2002).  Willum-Hansen et al have shown 
that aortic PWV was a useful marker to predict cardiovascular outcomes in a cohort of Danish 
adults (Willum-Hansen, Staessen et al. 2006).  Halcox and Donald et al demonstrated an 
association between endothelial dysfunction, measured by brachial artery FMD, and preclinical 
carotid arteriosclerosis in a longitudinal study of adults (Halcox, Donald et al. 2009).  Finally 
Shechter et al have shown that abnormalities in the FMD of the brachial artery could predict 
cardiovascular events in healthy adults (Shechter, Issachar et al. 2009).  These non-invasive 
markers are able to detect early signs of vascular disease and are able to predict risk of later 
cardiovascular events.  However, few studies have explored the use of these vascular 
assessments in children born preterm.  
1.6.4 Atherogenesis: 
In brief the main process that leads to cardiovascular disease is atherogenesis and this is 
the developmental process by which atheromatous plaques form in arteries throughout the 
vascular system.  The non-invasive vascular measures, mentioned above, could be used to 
assess the development of atherosclerosis, which is normally considered a disease of later 
adulthood.  Recent research has shown that the early stages of atherosclerotic build up in 
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arteries can be detected in childhood using FMD to assess endothelial function (Charakida, 
Deanfield et al. 2007). Abnormal FMD indicates endothelial dysfunction and this represents 
endothelial activation, which gives an indication as to whether atherogenesis has started or 
not.  Many factors are involved in the development of atherosclerosis and it is important to 
build an understanding of each of these risk factors. 
For example it has been hypothesised that a decreased synthesis of elastin in the large 
arteries may lead to arterial stiffness and thus an increased risk of cardiovascular disease in 
later life (Deanfield, Donald et al. 2005).  It is unclear whether this reduced elastin production 
occurs as a result of IUGR or prematurity or due to other as yet undetermined factors such as 
pre-eclampsia (Corretti, Anderson et al. 2002).  Recent data shows arterial stiffness and 
endothelial dysfunction may be increased in those born prematurely (Singhal, Cole et al. 2004, 
Rossi, Tauzin et al. 2011).  Singhal et al identified accelerated weight gain in early life of 
preterm-born children as a risk for endothelial dysfunction as measured by brachial artery 
FMD.  However they had small sample numbers in the study (Singhal, Cole et al. 2004).  Rossi 
et al assessed PWV in carotid and radial arteries and showed preterm-born children have 
increased arterial stiffness, which was not shown in children born term with IUGR (Rossi, 
Tauzin et al. 2011). 
1.6.5 The relationship between poor lung function and cardiovascular disease 
As stated the results of our systemic review on lung function in survivors of preterm birth 
showed reduced FEV1 in children and adults born preterm compared to term born controls 
(Kotecha, Edwards et al. 2013).  In the long term, poor lung function in a preterm-born child 
may be associated with the development of cardiovascular disease in later life.   Reduced FEV1 
in adults has been shown to be associated with increased cardiovascular mortality (Sin, Wu et 
al. 2005).  Sin and colleagues showed that individuals with the lowest FEV1 had the highest risk 
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of cardiovascular mortality, independent of age, gender and smoking (Sin and Man 2005).  
Altered vascular function (arterial stiffness) is a plausible mechanism for this increased risk of 
cardiovascular disease.  However, there are few data on linking respiratory disease to 
development of cardiac disease assessed as arterial stiffness in children of school age. 
It is important to state in the introduction that my research work involving the ALSPAC 
data included the hypothesis that lung function abnormalities in children born preterm would 
be associated with abnormal vascular function and that the vascular function abnormalities 
would be related to the magnitude of lung function decrements.  I had planned to do this by 
assessing the cardiovascular measurements from the ALSPAC data, which includes FMD, PWV 
and DC, however my analysis found no association of abnormal vascular function in children 
born preterm.  This is discussed in full detail in chapter 2, however it affected by research 
aims, as the data could not be used to assess the hypothesis.  There are several reasons why 
this might have occurred which include the sensitivity of the data, however this will be 
explored in more detail in chapter 2.  However Bolton et al have shown in a group of extremely 
preterm born adolescents, that reduced FEV1 is linked to increased AI values and thus is 
suggestive of increased cardiovascular risks in adult life (Bolton, Stocks et al. 2012).  So it is 
clearly important to explore these links further particularly in children born late or moderate 
preterm.   
 
1.7 Research questions and aims for the impact of preterm birth on long-term health 
outcomes 
Gestational age at birth has already been linked with poor health outcomes in children 
aged 3 to 5 years (Boyle, Poulsen et al. 2012), but are uncertain if the risk continues into later 
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childhood and adult life, and if other explanatory or contributing factors are involved. Also 
health outcomes for children born early term have not been investigated.  The main objective 
for my thesis was to test the hypothesis if lower gestational age at birth is associated with 
increased risk of respiratory symptoms in childhood, reduced vascular function in childhood 
and lower exercise capacity in older children and young adults.  The specific hypotheses for 
each project are stated clearly at the start of each of the relevant chapters.   
1.7.1 Research questions and aims of the vascular study 
1. The research question for my first project on the assessment of vascular function was: Is 
preterm birth associated with abnormal vascular function, specifically endothelial dysfunction 
and arterial stiffness, in children?  The specific aim was to test if non-invasive markers of 
vascular function and arterial wall stiffness (as measured by FMD, PWV, DC) were abnormal in 
children born preterm compared to term-born controls, using data from the ALSPAC cohort. 
2. The systematic review for my first project set out to answer the question: ‘is there 
evidence to suggest any association between gestational age at birth and arterial stiffness 
and/or endothelial dysfunction in later life?’.  The main aim of the systematic review was to 
review the current literature for all research articles relating to preterm birth and it’s 
association with vascular function, specifically endothelial dysfunction and arterial stiffness as 
assessed by FMD, PWV and/or DC, with a view to completing a meta-analysis if possible.   
1.7.2 Research question and aim of the exercise capacity study 
1. For my second project I set out to answer the review question: ‘does being born 
preterm, either with or without CLD, result in decreased exercise capacity in later life 
compared with term-born controls?’ by completing a systematic review and meta-analysis.  
The main aim of this systematic review was to assess the current literature for all research 
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articles relating to preterm birth and its impact on exercise capacity, specifically focusing on 
studies using VO2max measured in ml/kg/min on a treadmill or cycle ergometer, and to 
complete a meta-analysis if possible.    
1.7.3 Research questions and aims of the respiratory outcomes study 
1.  For my final research project the main question was: ‘Is preterm birth associated with 
greater respiratory morbidity in childhood and does this lead to increased hospital 
admissions?’  This was assessed by establishing a new cohort of children in Wales and then by 
linking healthcare data with the collected research data.   The main aim was to test if children 
born preterm have increased respiratory symptoms (such as wheezing and coughing) and 
increased health care utilisation (such as hospital admissions), mainly due to respiratory 
morbidity, in infancy and early childhood compared to term-born controls.  RANOPS had 
several other secondary research questions, which included: 
1.1.  Is the increased respiratory morbidity in children born preterm due to an increased 
prevalence of atopy amongst children born preterm? The aim was to test if the 
increased respiratory morbidity in children born preterm is due to an increased rate 
of family history of atopy or other related risk/confounding factors. 
1.2. Do children born preterm with respiratory symptoms such as wheezing receive 
inhalers more frequently than children born term with respiratory symptoms? The 
aim was to test if children born preterm, with and without current respiratory 
symptoms, have increased treatment with inhaler medication compared to term-born 
controls. 
1.3.  Is early-term birth associated with greater morbidity in childhood? The main aim was 
to test if children born early term have increased respiratory morbidity, such as 
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respiratory symptoms and hospital admissions, in childhood compared with full term-
born controls. 
1.4. Is the increased respiratory morbidity in children born early term due to an increased 
prevalence of atopy amongst children born early term? Or is the increased respiratory 
morbidity in children born early term due to an increased rate of Caesarean section in 
children born early term?  The aim was to test if the increased respiratory morbidity 
in children born early term is due to increased rates of family history of atopy and/or 
due to mode of delivery. 
 
1.8 Summary of introduction and outline of thesis 
This chapter has reviewed the definition of preterm birth and its association with 
respiratory and vascular morbidity in later life.  I then have briefly explained the two study 
cohorts that form the main part of this thesis.  It has briefly described the embryology of the 
foetal cardiopulmonary system and why being born prior to full term may result in a disruption 
of the normal developmental process of the respiratory and vascular systems. The other 
potential confounding factors for later respiratory or vascular morbidity in children born 
preterm have also been discussed.  From the literature it was noted that studies often use 
mixed cohorts of LBW or VLBW participants, which are a combination of those born preterm 
and also those born term with IUGR.  Thus it is important in any research assessing the 
outcomes of children born preterm to clearly define the population being studied and to take 
into account both the birth weight and gestational age of the subjects.  
Chapter 2 will discuss the first research project for this thesis, which involved assessing the 
vascular outcomes of children born preterm using data from the ALSPAC cohort and also a 
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systematic review of the literature to identify any association between vascular function and 
being born preterm.  Both the ALSPAC data and studies from the literature review use non-
invasive measurements to assess the vascular function, which may help in identifying early 
disease processes.  If disease or pathology can be identified at an early stage there may be the 
opportunity to prevent or reduce the risk of later morbidity/mortality.  Then chapter 3 will 
discuss the second research project for this thesis, which consisted of a systematic review and 
meta-analysis of the exercise capacity of survivors of preterm birth.  This also relates to the 
cardio-respiratory outcomes of children and adults born preterm and reviews the ability to 
identify whether children and adults born preterm have reduced exercise capacity and how 
their bodies may have adapted to any deficits in cardio-respiratory function.   
Then chapters 4 and 5 will describe the design, set up and establishment of the RANOPS 
cohort.  First the respiratory outcomes of children born preterm will be discussed and how the 
children born preterm may have a different underlying pathology to children with wheezing 
disorders such as viral associated/episodic wheezing or multi-trigger wheezing.  Next the 
RANOPS cohort data was used to review the outcomes of children born early term and discuss 
the possible implications that being born even a few weeks early might have on later health 
outcomes.  In the final chapter the results of the three projects involved in this thesis will be 
reviewed and future directions for research will be discussed. 
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2.0 CHAPTER TWO: THE RELATIONSHIP OF PRETERM BIRTH WITH 
MARKERS OF VASCULAR DISEASE 
 
This chapter presents the analysis of ALSPAC data on vascular outcomes of preterm-born 
children and the results of a systematic review of research linking vascular markers and 
preterm birth. I wrote the research protocol and analysed the ALSPAC data and also performed 
the systematic review of the literature.  The study and review have been published with myself 
as the first author in the journal Acta Paediatrica in September 2014 (copy in the appendix).  
The co-authors include my doctoral supervisors and members of the child health research 
team at Cardiff University.  
There were two main hypotheses of the research for this chapter: 
1. By using data from the ALSPAC cohort I set out to test if non-invasive markers of 
vascular function and arterial wall stiffness were abnormal in children born preterm 
compared to term-born controls. 
2. By performing a systematic review I set out to answer the review question: ‘is there any 
association between gestational age at birth and arterial stiffness and/or endothelial 
dysfunction in later life?’ 
2.1 Introduction  
The long-term effects of being born preterm, especially on cardiovascular outcomes, are 
becoming more established in the literature (Norman 2013).  Barker’s hypothesis on the 
influence of early life events on later cardiovascular disease has pushed the effort to 
understand the underlying mechanisms, which trigger these events (Barker 2007).  If children 
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or adults born preterm or term with IUGR have an increased risk of cardiovascular disease in 
later life, then it is important we are able to establish the degree of risk.  More importantly, if 
early signs of cardiovascular disease can be identified in early childhood, then there is the 
possibility of preventing or minimizing the long-term effects by developing treatment 
strategies (Sipola-Leppänen and Kajantie 2015).   
As discussed in the introduction chapter, much of the research to date has assessed the 
influence of low birth weight on cardiovascular disease, and only a few studies have clearly 
distinguished between participants born at term or preterm with IUGR and those born 
preterm with normal birth weight or appropriate for gestational age (AGA) (Irving, Belton et al. 
2000, Doyle, Faber et al. 2003, Kaijser, Bonamy et al. 2008).  In 2000 Irving et al showed that 
preterm-born babies, with or without IUGR, were predisposed to similar cardiovascular risks 
(increased blood pressure) as young adults, but only with small numbers (n=61).  Doyle et al 
showed that IUGR was not significantly related to an increase of blood pressure in adolescents 
born with VLBW, however did not include gestational age.  And Kaijser et al in 2008 showed 
that LBW and the increased risk of ischemic heart disease in adulthood was mediated entirely 
by IUGR and not affected by gestational age at birth.  So these studies suggest that birth 
weight and gestational age at birth may both, independently, have affected cardiovascular risk 
in different ways.  Thus it depends upon the cohort being studied and also the measurements 
being assessed.  
In many studies reviewing cardiovascular outcomes for those born with LBW, the cohorts 
have been a mixture of term with IUGR, preterm with SGA and preterm with AGA, so whether 
those born preterm have a similar risk of later cardiovascular disease as those born term or 
preterm with IUGR/LBW is unclear (Norman 2008, De Buyzere 2011, de Jong, Monuteaux et al. 
2012).  It is not known whether the mechanisms for increased blood pressure and 
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cardiovascular disease with those born LBW are due to preterm birth or IUGR.  Norman 
concluded in his review of the vascular tree and LBW ‘that there is clear evidence for changes 
in vascular function and structure in human infants born small for gestational age and/or 
prematurely’, which has implications for cardiovascular risk in later life and he also observed 
that ‘the selective contributions to this risk from foetal growth restriction and preterm birth 
are likely to vary over time and between different populations’ (Norman 2008).  De Buyzere in 
his editorial argues that IUGR is more important in the development of hypertension and 
cardiovascular disease in later life than preterm birth (De Buyzere 2011).  
However, some studies have clearly reported that preterm-born children are at increased 
risk of developing later vascular disease such as hypertension and atherosclerosis (Chan, 
Morris et al. 2010, Skilton, Viikari et al. 2011). Evidence of vascular disease in young adults 
born preterm has been identified in a recent systematic review and meta-analysis, which 
reported a higher systolic blood pressure (mean difference 2.5 mmHg) in 17.8 year old (mean 
age) participants born preterm compared to term-born controls (de Jong, Monuteaux et al. 
2012).  Although this difference in systolic blood pressure is unlikely to be associated with 
current cardiovascular disease, it is associated with an increased risk of cardiovascular disease 
in later life (Lewington, Clarke et al. 2002).  Thus the identification of risk factors in early life 
for later cardiovascular disease may help to alleviate the disease burden. 
2.1.1 Vascular markers 
From the literature, it has been shown that survivors of preterm birth and also those born 
with IUGR, have increased risk of cardiovascular disease in later life.  But is it possible to 
identify those at greatest risk of developing cardiovascular disease by using markers or 
identifying signs of early disease (i.e. screening tools)? In recent years, researchers have 
explored new ways of assessing vascular function particularly non-invasive measures.  These 
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include pulse wave velocity (PWV), flow mediated dilatation (FMD), augmentation index (AI) 
and distensibility coefficient (DC), and these have been shown to identify possible early signs 
of atherosclerotic disease in participants in longitudinal cohorts (Halcox, Schenke et al. 2002, 
Willum-Hansen, Staessen et al. 2006, Halcox, Donald et al. 2009, Shechter, Issachar et al. 
2009).  In brief, the FMD reflects the endothelial-dependent relaxation as mediated by 
endothelium-derived nitric oxide.  Many studies have shown a change in FMD secondary to a 
range of cardiovascular risk factors including obesity (Charakida, Masi et al. 2010).  The PWV 
and DC provide an assessment of the structure of the arterial wall (Donald, Charakida et al. 
2010). PWV is a measure of the velocity of the propagation of the arterial wave and reflects 
the stiffness of the arterial walls.  The arterial DC is a measure of the arterial ability to expand 
and contract through the cardiac cycle and has been shown to be associated with 
atherosclerotic risk factors in children (Leeson, Whincup et al. 2000, Tounian, Aggoun et al. 
2001).  So these vascular measurements can be used to help identify early disease in a 
population with high risk of later cardiovascular disease. 
As mentioned non-invasive methods to assess vascular function have been shown to be 
useful in identifying signs of early disease in cohorts of children with OSA and obesity.  Chan et 
al assessed endothelial function in children with OSA and showed children with OSA have 
lower FMD (7.9% SD +/- 1.3) compared to control subjects (FMD = 8.3% SD +/- 0.8, p= 0.04), 
however this was reversible and when children with OSA had adenotonsillectomy performed, 
their baseline results of FMD 7.7% SD +/- 1.5, improved post-op and showed FMD 8.1% SD +/- 
1.2 (Chan, Au et al. 2015).  The FMD was measured using a similar method to that used on the 
ALSPAC cohort of children.  Also Dangardt et al showed altered arterial stiffness in obese 
adolescents using PWV measured along the carotid to radial segment of artery, and control 
subjects had PWV results of 7.0 m/s SD +/- 0.9 and surprisingly the obese subjects had PWV 
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results 6.2 m/s SD +/- 0.8 (Dangardt, Osika et al. 2008).  However a difference was detected 
and so these measurements of endothelial function and arterial stiffness are robust enough to 
identify significant differences between selected subjects and controls in study cohorts.   
Increased arterial stiffness may be associated with decreased synthesis of elastin in large 
arteries which may arise as a result of prematurity, IUGR or other factors such as maternal pre-
eclampsia during pregnancy, and is associated with an increased risk of cardiovascular disease 
in later life (Martyn and Greenwald 1997, Singhal, Cole et al. 2004). More recently there has 
been interest in understanding how vascular function is affected by being born preterm (Rossi, 
Tauzin et al. 2011, Skilton, Viikari et al. 2011, Kerkhof, Breukhoven et al. 2012).  It is not clear 
from individual studies whether preterm birth is associated with increased arterial stiffness or 
endothelial dysfunction in childhood or later life.  So my research aim was to analyse data from 
the ALSPAC cohort with regards to preterm birth and vascular function measurements in 
childhood, and also to establish from the wider literature what evidence there was for an 
association between vascular function and preterm birth.   A research team had already 
performed vascular function measurements on the ALSPAC cohort (Donald, Charakida et al. 
2010)and so it was a good opportunity to analyse the data for any association with preterm 
birth.  However this meant the vascular measurements, which included FMD, PWV and DC, 
had already been selected.   
The vascular measurements performed on the children from the ALSPAC cohort used the 
brachial artery for FMD and radial-carotid arterial segment for PWV.  There have been 
discussions that the smaller arteries may not show early signs of vascular disease and so may 
not be sensitive enough to detect differences, however as mentioned, these vascular 
measurements have been performed on cohorts of children and statistically significant 
differences have been noted.  Khandelwal et al showed a difference in endothelial function 
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between children with chronic kidney disease and healthy controls using FMD as measured on 
the brachial artery (Khandelwal, Murugan et al. 2016).  And Tawadrous et al showed a 
difference in arterial stiffness between children with end stage renal disease and healthy 
controls using PWV as measured on the radial-carotid segment (Tawadrous, Kamran et al. 
2012).   Other vascular studies of children born preterm have assessed FMD and PWV, 
however studies have also assessed measurements such as augmentation index (AI) and 
carotid intima-media thickness (cIMT).  Some of these vascular measurements will be 
discussed in the systematic review of the literature.   
2.1.2 Relationship of pulmonary and functional vascular outcomes in prematurity 
As mentioned in the introduction Kotecha et al, in 2012, have already identified an 
association between preterm birth and poorer lung function in childhood using data from the 
ALSPAC cohort (Kotecha, Watkins et al. 2012).  The study identified a gradient effect of 
gestational age at birth for reduced lung function in childhood, showing that children born late 
preterm also have reduced lung function and not just those born very preterm.  Thus it is 
important to establish whether children born preterm, also have reduced vascular function 
and if this also shows a gradient effect for gestational age at birth. The ALSPAC cohort had 
vascular assessments performed at 10 years of age by a separate group of researchers.  Sin et 
al showed in a longitudinal study of adults that reduced lung function is a marker of 
cardiovascular mortality independent of smoking and age (Sin, Wu et al. 2005). Thus, if an 
abnormality in vascular function is identified in the ALSPAC cohort born preterm, then it may 
also be necessary to see if there is any association with the reduced lung function and whether 
these two disease processes are linked.  Recently Bolton et al have shown that poor lung 
function in children born extremely preterm is associated with increased AI, using data from 
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EPICure (Bolton, Stocks et al. 2012).  So it is important to assess whether the results from 
EPICure cohort are repeatable in another cohort study such as ALSPAC.   
 
2.2 Hypothesis and Aims 
The research question for chapter two: is preterm birth associated with abnormal vascular 
function, specifically endothelial dysfunction and arterial stiffness, in children? The main 
hypothesis to test was: Children born preterm show increased arterial stiffness and decreased 
endothelial function compared to children born at term. 
My main aims were: 
1. By using the ALSPAC cohort, I aimed to test if non-invasive markers of vascular function 
and arterial wall stiffness (FMD, PWV, and DC) are abnormal in preterm-born children when 
compared to term-born children. 
2. By performing a systematic review (and meta-analysis, if possible), I aimed to test if non-
invasive markers of endothelial function and arterial wall stiffness are abnormal in preterm-
born subjects (children and adults) when compared to term-born control subjects. 
The specific objectives of my study were as follows: 
1.a) To analyse the data from ALSPAC according to gestational age at birth by assessing the 
results of vascular dysfunction and arterial stiffness as measured by PWV, FMD and DC, and 
other cardiovascular measurements including arterial blood pressure (systolic and diastolic) 
and heart rate.  
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1.b) To analyse the vascular function data from ALSPAC and identify potential independent 
factors that affect the vascular measurements.  To use these contributing factors in a general 
linear model thus adjusting the results for gestational age at birth. 
1.c) To assess for any association between vascular function in children born preterm and 
their lung function.  
2.a) To systematically review the scientific literature on the association of arterial stiffness 
and/or endothelial dysfunction with gestational age at birth, specifically focusing on studies 
that included FMD, PWV and DC in survivors of preterm birth.  
2.b) To group studies according to vascular measurements used and subjects studied to 
see if meta-analysis on results can be performed.   
 
2.3 Methodology:  Study Design 
2.3.1 Avon Longitudinal Study of Parents and Children (ALSPAC) 
As described in the introduction, data were used from the Avon Longitudinal Study of 
Parents and Children (Boyd, Golding et al. 2013).  14,541 pregnant women, in three health 
authorities in Bristol, with an expected delivery date of 1st April 1991 to 31st December 1992 
were enrolled in this large longitudinal study.  14,062 live born children have been followed up 
by questionnaires and clinical assessments on an annual basis. The study website contains 
details of all the data that is available through a fully searchable data dictionary 
(<http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/>). The ALSPAC Law 
and Ethics Committee and the local research ethics committees granted ethical approval.  To 
use the ALSPAC dataset, it was necessary to submit a research proposal to the executive 
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committee and they gave approval for the requested data to be transferred to the child health 
department at Cardiff University. 
2.3.2 Dataset 
I applied to the ALPSAC executive committee to have access to a specific dataset and to 
use the data to test my hypothesis on the vascular function of children born preterm.  The 
anonymised data were securely transferred from Bristol University to the child health research 
department at Cardiff University.  I created a new dataset combining variables from data 
already held by the child health team to assess the lung function outcomes of the children 
born preterm with the new data on the vascular function outcomes of the children born 
preterm.  The ALSPAC dataset for this research project had 904 variables and 14,064 individual 
records.  The statistical programme, Predictive Analytics Software (PASW, formerly SPSS; 
version 18, SPSS Inc, Chicago, IL, USA) was used to create the research database and to 
perform the statistical analysis.  I created a management folder for using the data set, which 
contained details of all the variables and also guidance for creating new variables. For the 
analysis of the vascular data, there were 7557 individual records and over 100 variables were 
used.  Each of the variables used was reviewed, to check for normal distribution and to assess 
that the appropriate statistical method of analysis was used.  All the variables were 
approximately normal or not amenable to transformation in which case non-parametric tests 
were used. I opted to use the simplest method of analysis, so that any findings could be easily 
interpreted and understood by clinicians, following the principle of parsimony 
(Vandekerckhove, Matzke et al. 2014).  The participants were categorized into groups 
according to gestational age at birth, because this gave us results that are easier to interpret in 
a clinical setting and also previous studies by our research group had used these groups. 
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2.3.3 Gestational groups 
Thus the data was analysed according to gestational group as per the recorded gestational 
age at birth, which was based on maternal reporting of the last menstrual period and a 
medical assessment at birth for the majority of the cohort, with antenatal ultrasound scan 
results being available in only a minority of cases as discussed by Lawlor et al in their paper 
using the same dataset from ALSPAC (Lawlor, Cooper et al. 2008).   Children born with a 
gestational age of ≤25 or ≥44 weeks were excluded, as we felt these individuals might skew the 
data given that they are on the extreme ends of the data range for gestational age.  These 
gestational ages may also be inaccurate and so, along with participants with missing data on 
gestational age, 412 participants were excluded.   All children who had cardiovascular 
measurement data at 10.8 years of age were divided into groups according to the gestational 
age at birth: 25-32 weeks (very preterm), 33-34 weeks (late preterm), 35-36 weeks (near term) 
and >37-43 weeks (term control) as previously (Kotecha, Watkins et al. 2012).  Since the 
previous study the groups have changed and for this project were: 25-32 weeks (very 
preterm), 33-34 weeks (moderate preterm), 35-36 weeks (late preterm) and >37-43 weeks 
(term controls).   
2.3.4 Clinical and vascular measurements of ALSPAC participants 
ALSPAC participants were invited to attend a research clinic at 10-11 years of age.  With 
the help of research assistants employed by Bristol University, ALSPAC collected all the data.  
7,557 children (age 9.8-12.3 years) underwent vascular assessment (Figure 4).  The research 
assistants were not aware of the gestational age of the children being analysed, however, they 
were not specifically blinded to this information.  Several measurements and assessments 
were performed during the clinic appointment.  SECA scales (seca GmbH & Co. KG, Hamburg, 
Germany) were used to measure weight to the nearest 0.1kg with the child wearing 
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underwear and a Leicester scale was used to measure the height to the nearest 0.1cm.  Body 
mass index (BMI) was calculated using the formula: weight (kg) /height (m)2. The heart rate, 
diastolic and systolic arterial blood pressures were measured during the same session as the 
vascular function measurements.  The average of 2 seated readings with an automated 
oscillometric device (Omron M5-I; Omron, Kyoto, Japan) on the left arm.  Cuff size was 
determined by the circumference of the child’s arm, so if the arm circumference was ≤ 25cm a 
child size cuff was used and if >25cm a regular adult cuff was used.  The heart rate was 
measured at the same time (Dinamap 9301 vital signs monitor; GE Healthcare, Little Chalfont, 
UK).  The protocol for the vascular assessments can be found on the ALSPAC website 
(http://www.bristol.ac.uk/alspac/).  Our research team at Cardiff University had no 
involvement in the assessment of the participants of ALSPAC.   
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Figure 4: Study profile: number of children analysed per gestational group.   
ALSPAC, Avon Longitudinal Study of Parents and Children. 
 
2.3.5 Vascular function measurements 
The vascular function and arterial stiffness were measured via carotid to radial pulse wave 
velocity (PWV), brachial artery distensibility coefficient (DC), brachial artery flow-mediated 
dilatation (FMD), and systolic and diastolic arterial blood pressure (SBP and DBP, respectively) 
as previously described (Donald, Charakida et al. 2010).  There were no restrictions applied to 
the children prior to measurements being performed and information on dietary intake such 
as caffeine in the 2 hours prior to the study was collected via a questionnaire completed by the 
parent/s.   
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2.3.6 Endothelial function 
The FMD measures a change in the diameter of the artery by ultrasound and is expressed 
as the percentage change of the arterial diameter from the baseline vessel size.  In the ALSPAC 
participants this was performed on the right brachial artery using high-resolution ultrasound 
imaging (Aloka 5500, Hitachi, Japan).  FMD was induced by inflation to 200 mmHg of a 
pneumatic cuff for five minutes, placed around the forearm immediately below the medial 
epicondyle, followed by rapid deflation using an automatic air regulator.  Measurement of 
FMD was performed on the right brachial artery using high-resolution ultrasound (Aloka 5500, 
Hitachi, Japan). 
2.3.7 Arterial stiffness 
PWV is a non-invasive measure of arterial stiffness expressed as m/s.  In the ALSPAC 
participants the pressure pulse waveforms were recorded transcutaneously from the radial 
and carotid pulse using a high-fidelity micromanometer (SPC-301, Millar Instruments, Houston, 
TX, USA).  The waveforms were synchronised using the ECG signal and processed using integral 
software to calculate the mean time difference between R-wave and pressure wave on a beat-
to-beat basis over 10s.  The PWV was then calculated using the mean time difference and 
arterial path length between the two recording points (SphygmoCorversion 7.1, Scanmed, UK).   
Arterial distensibility (DC) is the reciprocal of arterial stiffness. DC is usually calculated as 
the change in cross-sectional area between diastole and systole. In the ALSPAC participants the 
DC was measured from ultrasound images of the right brachial artery (Aloka 5500, Japan).  The 
distension of the artery was determined by measuring the change in luminal diameter from 
diastole to systole.  DC was calculated from the distension and the pulse pressure, and was 
expressed as mean percentage change in cross-sectional area per unit change in blood 
pressure.   
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2.4 Data analysis of the ALSPAC vascular measurements 
I linked with our research assistant at the ALSPAC office, Bristol University, to gain further 
data for my research project.  We completed the necessary application forms and the child 
health department, Cardiff University, was provided with data on the cardiovascular 
measurements linked to the lung function data that had already been provided.  The data 
were then analysed according to the four gestational groups (as discussed above) with results 
being checked by my co-supervisor, Dr W John Watkins.  Vascular function values were 
summarised as the mean ± standard deviation (SD).   As mentioned the data were assessed for 
normality and the residual plots were reviewed to decide on the fit of the model.  Checking 
that the plots have a random distribution did this.  Methods used for statistical analysis were 
forward (then backward) stepwise linear regression to identify independent variables that may 
have an effect on each of the eight cardiovascular items measured; SBP, DBP, PWV, FMD, 
FMD%, DC, pulse and brachial artery diameter.  Independent factors considered were: sex, 
gestational group, age, small for gestational age, social class status based on father’s 
occupation, ethnicity of the child, systolic arterial blood pressure, maternal smoking in 
pregnancy and childhood, BMI, room and skin temperature at time of testing, recent infections 
or vaccinations, recent ingestion of caffeine or fried foods.  Factors that showed an effect size 
(‘t’ <-2 or >2) and remained statistically significant (p<0.05) in the regression models for each 
cardiovascular item were included in general linear modelling along with the gestational 
groups. The linear regression models for each of the vascular measurements and the 
significant variables included in their modelling have been included (see appendix pages 244 - 
252: data tables for ALSPAC analysis).  The four gestational groups were compared using t-
tests and ANOVA with posthoc Bonferroni correction.  The Bonferroni correction is the 
simplest method for testing the difference between the individual groups analysed in an 
ANOVA test although it can over compensate for Type 1 errors. PASW (version 18.0. Chicago, 
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IL; SPSS Inc) was used to complete analyses and the effect size, 95% confidence intervals along 
with statistical significance (p<0·05) were used to interpret the results.   
2.4.1 Sample size  
When we first conceptualised and designed the study we considered how to calculate a 
suitable sample size.  However prior to performing the analysis of the data we did not have 
measures of variability in the measures of vascular function in these children and so a formal 
sample size calculation was not possible. However analyses of this cohort on other outcome 
measures suggested that the sample size would be large enough to identify moderate 
associations between vascular function and gestational age at birth. 
 
2.5 Methodology for the systematic review 
To better elucidate the mechanism behind any observed differences between the 
gestational age groups, I also performed a systematic review.  The review question to be 
answered was: is there any association between gestational age at birth and arterial stiffness 
and/or endothelial dysfunction in later life? The systematic review was conducted for studies 
published between January 1946 and January 2013 examining arterial stiffness and/or 
endothelial function in preterm-born children, adolescents or adults compared to term-born 
control subjects. I performed a search strategy to include the following words: “preterm birth” 
OR “prematurity” OR “gestational age” AND “endothelial function” OR “arterial stiffness” OR 
“FMD” OR “PWV” OR “DC” OR “cardiovascular disease” as outlined in table 2.  Databases 
searched included: PubMed, OvidSP, Medline, Embase and Web of Knowledge.  To identify 
additional relevant articles the ‘related citations’ function in PubMed was used and hand-
58 
 
searched references of all of the articles that met the inclusion criteria along with all review 
articles. The original search was run in February 2013.     
Table 2: Search strategy for vascular assessments in children/adults born preterm 
Number Search Term 
1 exp preterm* or prematur*or infant .mp. 
2 exp gestation* .mp. 
3 exp infant low birth-weight/ .mp. 
4 exp newborn or neonate or term infant .mp. 
5 1 or 2 or 3 or 4 
6 Endothelial function .mp. 
7 Arterial stiffness .mp. 
8 Cardiovascular disease .mp. exp 
9 “FMD” or “DC” or “PWV”.mp. 
10 6 or 7 or 8 or 9 
11 5 and 10 
Search terms used to extend the search strategy used for the systematic review on lung 
function. This search strategy was used in OvidSp where ‘.mp.’ means a multipurpose search 
across all areas of an article; exp means to explode a term; / indicates that all sub headings are 
searched for; * indicates that the term has been truncated 
 
2.5.1 Eligibility criteria for the systematic review 
Studies on vascular measurements in children or adults born preterm compared to term 
controls with results of endothelial function and/or arterial stiffness as measured by FMD, 
PWV or DC were included.   The preterm-born participants were defined as being <37 weeks 
gestation and the term-born controls were defined as ≥37 weeks gestation.  A child was 
defined as <18 years old and adults as ≥18 years old.  Other measures of vascular function 
(such as basal skin perfusion or aortic index) were reviewed.  Studies from all countries were 
included but only those published in English.  All papers were identified according to the 
inclusion criteria.   
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2.5.2 Data extraction and quality assessment for the systematic review 
Data were extracted using a proforma as outlined in the appendix (pages 260-262).  
Duplicate studies were removed and characteristics of the population studied including 
gestation, numbers studied and age at study; data on blood pressure and other cardiovascular 
measurements including FMD, PWV and DC were extracted by myself with an independent 
check of three articles that were extracted by Mrs Sarah Kotecha.  The quality of the studies 
included was assessed during data extraction, using a proforma from our previous systematic 
review based on the Newcastle Ottawa criteria and the Cochrane risk of bias tool; see last 
section of proforma in the appendix (Kotecha, Edwards et al. 2013). 
2.5.3 Outcome measures and statistical analysis for the systematic review 
The main outcome measures were FMD%, FMD, PWV, DC, basal skin perfusion and arterial 
stiffness index.  Due to the high level of heterogeneity of the studies, which included 
differences in measurements and variations in study populations, it was not possible to 
perform meta-analysis.  Therefore the results of each included study have been discussed and 
presented in this chapter.   
 
2.6 Results  
The results of my analysis of the ALSPAC data are detailed below and shown in the 
accompanying tables.  I have then outlined the selection process for the systematic review in 
more detail.   As it was not possible to perform a meta-analysis there are no results tables, 
although I have summarised each of the included studies. 
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2.6.1 Characteristics of the ALSPAC participants in the vascular study 
From 14049 live singleton births, 7049 children at 10.8 (mean) years of age had at least 
one vascular measurement performed as part of their cardiovascular assessment (Figure 4).  
Table 3 shows characteristics of non-participants compared to participants.  A higher 
percentage of the non-participants were male, had higher exposure to maternal smoking and 
lower rates of breast-feeding compared to the participants.  Table 4 shows the characteristics 
of children that attended by gestational group.  For the participants, the 25-32 week gestation 
group had a higher proportion of males (64%), a higher prevalence of maternal smoking (27%), 
rate of IUGR (16%) and families in a lower social class (48%) compared to the term group; 
(49%, 18%, 9% and 39% respectively).  In addition, 72% of the ≤32 weeks gestation group and 
19% of the 33-34 weeks gestation group required mechanical ventilation in the newborn 
period, compared with 1.5% of the 35-36 weeks gestation and 0.2% of the term group. Prior to 
vascular studies, a greater proportion of children in the 25-32 week gestation group reported 
recent ingestion of fried food (9%) or caffeine (15%) compared with the term group (5% and 
8% respectively), and a higher prevalence of recent infection (26%) compared with the term 
group (16%).   
Table 3 Characteristics of participants and non-participants 
 Children who had any 
vascular measurement 
Children who did not 
attend clinic  
Number 7,049 6,912 
Mean birth weight (g) (SD) 3,412 (551)* 3,371 (567) 
Mean gestation (weeks) (SD) 39.42 (1.87)* 39.35 (1.97) 
Male N (%)  3,487 (49.5%)* 3,725 (54%) 
Maternal smoking N (%) 1,277 (18.1%)* 2,128 (30.7%) 
Manual workers N (%) 2,524 (35.8%) 2,489 (36%) 
Exclusively breast-fed for at 
least 3 months N (%) 
825 (11.7%)* 507 (7.3%) 
*indicates statistically significant difference (p<0.05) between the two groups. There was 
missing data for some of the variables reported 
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Table 4 Characteristics of gestation groups 
 25-32 weeks 
gestation 
33-34 weeks 
gestation 
35-36 weeks 
gestation 
Term (37-42 
weeks gestation) 
Total live born 185 169 522 13,148 
Survivors at 1 year 160 165 519 13,117 
Had BP at 10 yrs 67 (42%) 73 (44%) 246 (47%) 6,445 (49%) 
Had FMD at 10 yrs 63 (39%) 67 (41%) 233 (45%) 5,905 (45%) 
Had PWV at 10 yrs 65 (41%) 73 (44%) 246 (47%) 6,397 (49%) 
Had DC at 10 yrs 66 (41%) 71 (43%) 229 (44%) 6,097 (46%) 
Total number in group who had any 
vascular measurement 
69 74 256 6,650 
 Male (%) 44 (64%) 41 (55%) 142 (56%) 3,260 (49%) 
Maternal smoking during pregnancy (%) 18/67 (27%) 19/71 (27%) 49/251 (20%) 1,191/6525 (18%) 
Manual workers (social status during 
pregnancy) (%) 
22/46 (48%) 27/65 (42%) 105/237 
(44%) 
2,370/6,142 
(39%) 
Exclusively breast-fed for at least 3 
months (%) 
5/65 (8%) 9/72 (13%) 21/254 (8%) 790/6516 (12%) 
Incidence of IUGR (<10th Centile for birth 
weight) (%) 
11/68 (16%) 8/71 (11%) 21/253 (8%) 584/6577 (9%) 
At arterial measurements at 10 years of 
age: 
Mean age in years (yrs, SD) 
10.8 (.35) 10.7 (.28) 10.7 (.28) 10.6 (.26) 
Mean height (cm, SD) 141.7 (8.3) 142.5 (6.4) 144.3 (6.5) 144.0 (6.7) 
Mean weight (kg, SD) 35.8 (9.4) 35.5 (6.4) 38.2 (8.8) 38.1 (8.6) 
Mean BMI (SD) 17.6 (3.7) 17.4 (2.6) 18.1 (3.2) 18.3 (3.2) 
     
For children who had any arterial 
measurements: 
Recent ingestion of fried food (%) 
6/69 (9%) 7/74 (10%) 16/255 (6%) 321/6,640 (5%) 
Recent ingestion of caffeine (%) 10/69 (15%) 9/74 (12%) 15/255 (6%) 503/6,640 (8%) 
Recent vaccination (%) 0/69 (0%) 1/74 (1.4%) 1/255 (.4%) 11/6,641 (.2%) 
Recent infection (%) 18/69 (26%) 14/74 (19%) 39/255 (15%) 1054/6,641 (16%) 
 
2.6.2 Vascular function results of the ALSPAC data 
The results of the vascular measurements are shown in Table 5.  This shows the 
comparison using t-tests and ANOVA to compare each gestational group with each other.  The 
differences between each gestational group and the term control group are shown with 95% 
confidence intervals (95% CI), both unadjusted and adjusted.  The adjusted results have 
various contributing factors included in the modelling as discussed in the methodology section.  
The list of contributing factors for each vascular measurement can be seen under Table 5 
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(further details in the appendix, pages 244-251).  Systolic arterial blood pressure was higher in 
the 25-32 weeks gestation group (adjusted: 4.59, 95% CI 2.33, 6.85 mmHg, p=<0.0001), the 33-
34 weeks gestation group (adjusted: 1.91, 95% CI -0.15, 3.97 mmHg, p=0.069) and the 35-36 
weeks gestation group (adjusted: 1.44, 95% CI 0.30, 2.60 mmHg, p=0.014) when compared to 
the term-born group as shown by the multivariate analysis.  The differences for SBP were 
robust to adjustment for BMI, age at study, room and skin temperature at time of assessment, 
and caffeine ingestion prior to assessment. However the Bonferroni post hoc correction for 
multiple comparisons identified a significant difference only for the extremely preterm-born 
group. A contrast analysis using linear regression demonstrated a significant (p<0.001) linear 
trend in SBP to gestational age, although this is only a very small correlation (r2=0.003, which 
explains 0.3% variance) as can be seen in Figure 5.  The r2 is a determination of how well the 
regression line approximates real data points and an r2 = 1 is a perfect fit.  A quadratic trend 
was assessed but this also only gave a very small correlation (r2=0.003).  This was an 
unadjusted analysis and from Table 5, it can be seen that there was an increase in the 
differences in SBP with adjustment. Heart rate and diastolic arterial blood pressure were 
similar between gestational groups. 
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Figure 5: Scatter plot showing linear relationship between systolic BP at 10.8 years of age 
and gestational age at birth. 
 
 
The results of the vascular measurements showed that the brachial artery diameter was 
marginally smaller in the extremely preterm-born group compared with the term-born group 
(2.65 ±SD 0.3 vs. 2.67 ± 0.3mm, respectively, p=0.04), but there was no evidence of differences 
in PWV, FMD or DC between the extremely preterm-born group and the term-born group 
(Table 5).  The only other significant result was for the brachial DC between the 35-36 week 
group and term-born group (adjusted difference of 0.01% per mmHg, 95% CI 0.001, 0.018; p-
value = 0.024).  Both of these results were not felt to be of any clinical significance.  Generally 
children born very preterm were smaller (lower BMI) compared to those born at term.  
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Figure 6: Scatter plot showing linear relationship between systolic BP and BMI at 10.8 
years of age. 
 
 
Of the variables included in the general linear models (footnote of Table 5) BMI had the 
strongest association with SBP at 11 years of age for the whole population (term and preterm 
children included) with a Pearson correlation coefficient of 0.193 (r2=0.037, which explains 
3.7% of the variance; p <0.001).  Again there has been no adjustment for confounding factors 
in this simple correlation analysis (Figure 6).  Again it should be noted that the correlation 
effect is very small.  However we know that increased BMI is linked to increased BP.   
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 Table 5 Results of vascular study measurements on ALSPAC children at 10.8 years of age 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25-32 weeks Term 
 
Difference and 
95% CI 
(unadjusted) 
Difference and 
95% CI 
(adjusted) 
P-value for 
adjusted 
analysis 
 Mean SD Mean SD    
Pulse 73.01 
n=70 
11.60 71.94 
n=6685 
11.18 1.07 (-1.57, 
3.72) 
0.83 (-1.76, 
3.43) 
0.53 
Systolic BP 
(mmHG) 
108.4 
n=67 
12.61 104.12 
n=6445 
9.08 4.28 (2.09, 
6.48) 
4.59 (2.33, 6.85) <0.0001 
Diastolic BP 
(mmHG) 
61.39 
n=67 
9.59 60.10 
n=6445 
7.95 1.29 (-0.63, 
3.21) 
-0.42 (-2.25, 
1.41) 
0.65 
Brachial artery 
diameter (mm) 
2.65 
n=63 
0.31 2.67 
n=5907 
0.31 -0.02 (-0.096, 
0.056) 
-0.07 (-0.142, -
0.003) 
0.04 
FMD (%) 7.85 
n=63 
3.11 8.09 
n=5905 
3.35 -0.24 (-1.07, 
0.59) 
-0.25 (-1.08, 
0.58) 
0.56 
FMD absolute 
(mm) 
0.21 
n=63 
0.08 0.21 
n=5905 
0.09 -0.007 (-0.28, 
0.14) 
-0.009 (-0.03, 
0.01) 
0.41 
PWV (m/s) 7.62 
n=65 
1.46 7.56 
n=6397 
1.22 0.06 (-0.24, 
0.36) 
0.07 (-0.24, 
0.38) 
0.64 
Brachial DC (% 
per mmHg) 
0.12 
n=66 
0.06 0.13 
n=6097 
0.06 -0.004 (-0.019, 
0.011) 
-0.005 (-0.021, 
0.011) 
0.54 
 33-34 weeks 
 
Term 
 
Difference 
and 95% CI 
(unadjusted) 
Difference and 
95% CI 
(adjusted) 
p-value for 
adjusted 
analysis 
 Mean SD Mean SD    
Pulse 72.89 
n=74 
11.47 71.94 
n=6685 
11.18 0.95 (-1.62, 
3.53) 
1.11 (-1.36, 
3.59) 
0.38 
Systolic BP 
(mmHG) 
105.8 
n=73 
9.26 104.12 
n=6445 
9.08 1.65 (-0.45, 
3.75) 
1.91 (-0.15, 
3.97) 
0.07 
Diastolic BP 
(mmHG) 
60.27 
n=73 
8.16 60.10 
n=6445 
7.95 0.17 (-1.66, 
2.02) 
-0.53 (-2.09, 
1.03) 
0.51 
Brachial artery 
diameter (mm) 
2.64 
n=67 
0.29 2.67 
n=5907 
0.31 -0.03 (-0.12, 
0.04) 
-0.026 (-0.93, 
0.04) 
0.43 
FMD (%) 8.66 
n=67 
3.51 8.09 
n=5905 
3.35 0.57 (-0.24, 
1.37) 
0.66 (-0.16, 
1.48) 
0.12 
FMD absolute 
(mm) 
0.22 
n=67 
0.08 0.21 
n=5905 
0.09 0.01 (-0.01, 
0.03) 
0.014 (-0.006, 
0.03) 
0.18 
PWV (m/s) 7.71 
n=73 
1.16 7.56 
n=6397 
1.22 0.15 (-0.13, 
0.44) 
0.035 (-0.24, 
0.31) 
0.81 
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35-36 weeks 
 
Term 
 
Difference 
and 95% CI 
(unadjusted) 
Difference 
and 95% CI 
(adjusted) 
p-value 
for 
adjusted 
analysis 
 Mean SD Mean SD    
Pulse 71.31 
n=258 
12.3
6 
71.94 
n=6685 
11.18 -0.63 (-2.03, 
0.77) 
-0.77 (-2.13, 
0.59) 
0.27 
Systolic BP 
(mmHG) 
105.4 
n=246 
8.99 104.12 
n=6445 
9.08 1.24 (0.08, 
2.40) 
1.44 (0.30, 
2.59) 
0.01 
Diastolic BP 
(mmHG) 
60.41 
n=246 
8.13 60.10 
n=6445 
7.95 0.31 (-0.70, 
1.33) 
-0.19 (-1.03, 
0.64) 
0.65 
Brachial artery 
diameter (mm) 
2.73 
n=233 
0.29 2.67 
n=5907 
0.31 0.06 (0.015, 
0.094) 
0.032 (-
0.003, 0.067) 
0.08 
FMD (%) 7.94 
n=233 
3.24 8.09 
n=5905 
3.35 -0.15 (-0.59, 
0.29) 
-0.18 (-0.62, 
0.26) 
0.42 
FMD absolute 
(mm) 
0.21 
n=233 
0.09 0.21 
n=5905 
0.09 0.002 (-0.009, 
0.013) 
0.000 (-
0.011, 0.011) 
0.95 
PWV (m/s) 7.60 
n=246 
1.21 7.56 
n=6397 
1.22 0.04 (-0.11, 
0.20) 
0.014 (-0.14, 
0.17) 
0.86 
Brachial DC (% 
per mmHg) 
0.11 
n=229 
0.05 0.13 
n=6097 
0.06 0.009 (0.001, 
0.017) 
0.01 (0.001, 
0.018) 
0.02 
 
Mean and SD of raw scores of vascular measures with confidence intervals for the difference 
of means (preterm – term), unadjusted and adjusted for various factors that had a significant 
effect on each vascular variable (details below).   
Pulse adjusted for systolic BP, sex, skin temperature, fried food in last two hours, caffeine in 
last two hours, vaccination within last week and age in years, all at the time of the assessment. 
Systolic BP adjusted for BMI, skin temperature, room temperature, caffeine in last two hours 
and age in years, all at the time of the assessment. 
Diastolic BP adjusted for systolic BP, skin temperature, room temperature, fried food in last 
two hours, caffeine in last two hours, vaccination within the last week, age in years, sex, recent 
infections, BMI and ethnic group, all at the time of the assessment. 
Brachial artery diameter adjusted for BMI, sex, skin temperature, room temperature, age in 
years, recent infections and IUGR(<10th Centile for birth weight), all at the time of the 
assessment. 
FMD% adjusted for sex, skin temperature, room temperature, caffeine in last two hours and 
IUGR, all at the time of the assessment. 
FMD adjusted for skin temperature, room temperature, sex, BMI, caffeine in the last two 
hours and vaccination within the last week, all at the time of the assessment. 
PWV adjusted for BMI, room temperature, skin temperature, systolic BP, sex, age in years, 
fried food within last two hours, caffeine within last two hours and recent infection, all at the 
time of the assessment. 
DC adjusted for systolic BP, room temperature, age in years, BMI and vaccination within the 
last week, all at the time of the assessment.  
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2.6.3 Results of systematic review: studies selected 
This was a review of the literature and only partially followed the PRISMA guidelines.  
From 950 articles identified, 924 were excluded after reviewing the title and abstract by myself 
and the remaining 26 full text articles reporting the arterial stiffness and/or endothelial 
function in preterm-born children were reviewed in full by myself.  Of these 26 articles, I 
excluded fourteen articles, because five did not report gestational age of the participants, five 
used methods other than FMD, PWV or DC to measure vascular function, two were review 
articles, and two reported data on the same subjects as articles already included.  Since there 
was wide variation in participants, gestational ages, methodology, sub-group analyses, etc. a 
formal meta-analysis was not possible for the 12 articles using FMD, PWV or DC.  Thus the five 
papers that reported methods other than FMD, PWV and DC and should have been excluded, 
are summarised along with the other 12 articles in Table 6. The other methods included basal 
skin perfusion, stiffness index and augmentation index (AI), which all measure arterial stiffness 
or endothelial function.   
In summary the studies reviewed used different methods and showed varying results.  The 
five studies reporting FMD in relation to preterm birth used the brachial artery but followed 
different protocols.  Three studies did not find differences between the preterm and term-
born groups although in two of these studies, it was suggested that growth restriction in 
preterm-born children affected the outcome measurement (Singhal, Kattenhorn et al. 2001, 
Evensen, Steinshamn et al. 2009, Lazdam, de la Horra et al. 2010). Additionally, Lazdam et al 
reported that children born preterm after hypertension during pregnancy had differences of 
FMD compared with term-born children and those born preterm following non-hypertensive 
pregnancies. The other two studies showing FMD differences between gestational ages 
reported marginal differences only (Hovi, Turanlahti et al. 2011, Skilton, Viikari et al. 2011).  
The measurements reported by Hovi et al of 6.9% and 5.8% for FMD for the preterm and term-
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born groups respectively failed to reach significance (p=0.06).  Skilton and colleagues reported 
a modest difference between relatively mature preterm (mean 33.5 weeks gestation) and 
term-born children (7.9% and 8.6% respectively) and also between term-born infants with 
growth restriction and appropriately grown term-born infants (7.8% and 8.6% respectively).  
Seven studies of preterm-born subjects assessed PWV using either the carotid to femoral 
arteries or the carotid to brachial arteries, mostly with the SphygmoCor (AtCor Medical) (4 out 
of 7 studies), but again using different protocols.  Five of seven studies measuring PWV did not 
show a difference between those born preterm- and term-born controls (Oren, Vos et al. 2003, 
Bonamy, Bendito et al. 2005, Lazdam, de la Horra et al. 2010, McEniery, Bolton et al. 2011, 
Kerkhof, Breukhoven et al. 2012). The remaining two studies did showed differences between 
appropriately grown preterm and term-born children and suggested that preterm-born 
children with growth restriction may be at greater risk of later vascular abnormalities (Cheung, 
Wong et al. 2004, Rossi, Tauzin et al. 2011). 
One study measuring DC of the abdominal aorta reported that growth restricted preterm-
born infants had significantly lower measurements compared with appropriately grown 
preterm-born infants at 5 days of age, which remained low at 7 weeks of age (Tauzin, Rossi et 
al. 2006).  The only long-term follow-up study so far investigating aortic arterial stiffness after 
preterm birth found less stiff arterial walls of the aorta in adolescent girls born preterm as 
compared to those born at term (Bonamy, Bendito et al. 2005).  However this study used the 
arterial stiffness index, which included the same variables/measurements as for calculation of 
DC, but the ratio is expressed in a reciprocal manner. This means that DC and arterial stiffness 
index measure the arterial stiffness by the same components.  
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2.6.4 Systematic review: The risk of bias 
The 17 studies all scored between 13-18 out of a possible 22 for the quality score.  The 
representativeness of the study cohorts showed a moderate risk of selection bias, as only 1 
study scored 3 out of 4 points, although 16 scored the maximum 3 points for the selection of 
an appropriate control group.  In 15 out of 17 studies the ascertainment of the exposure 
(recording of the gestational age at birth) showed low risk as they scored the maximum 3 
points.  When it came to assessing the details of the outcome of the ascertainment (how 
vascular measurement was assessed) only 4 studies scored 3 or more out of a possible 4 and 
10 studies gave no details of how the vascular measurements were conducted.  There was a 
low risk of attrition bias (complete follow up of participants) with 13 studies scoring 3 or more 
out of a maximum 4 points.
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Table 6 Literature Review: Summary of studies showing prematurity and endothelial dysfunction and/or arterial stiffness 
 
Reference 
Gestational 
age (SD) 
weeks 
Age 
(SD) 
year
s 
 
Male 
% 
Sample 
size (n) 
Outcome 
measured Method 
 
 
Results 
 
 
P 
Association between prematurity 
& vascular outcome (Quality 
score ?/22) 
(Singhal, 
Kattenhorn et 
al. 2001)UK 
31 (2.7) 15.0 
(0.9) 
45 216 FMD 
(Brachial) 
High resolution 
ultrasonography 
FMD 0.225 (0.1) mm  P = 0.78 ‘LBW as a result of preterm birth 
was not associated with endothelial 
dysfunction.’  
15/22 
40 (1.2) 14.7 
(0.8) 
48 61 FMD 0.22  (0.1) mm 
(Evensen, 
Steinshamn 
et al. 2009) 
Norway 
28 VLBW 18.2 
(0.1) 
54 37 FMD 
(Brachial) 
Vivid 7 System FMD 12.4 (1)% N.S. 
 
‘There were no group differences in 
endothelial function.’ 
18/22 39 SGA 18.5 
(0.1) 
36 47 FMD 10.7 (0.8)% 
40AGA 18.6 
(0.1) 
46 63 FMD 11.1 (0.7)% 
(Hovi, 
Turanlahti et 
al. 2011) 
Finland 
29.5 (2.4) 
VLBW 
22.6 
(2.2) 
43 92 FMD, cIMT 
(Carotid) 
Ultrasound 
(Vivid 4,5 or 7) 
FMD 6.9 (4.0) % 
IMT 8.9 (1.6) % 
P=0.06 
P=0.03 
‘Detected no impaired endothelial 
function in young adults born at 
VLBW.  IMT was higher in the 
VLBW group.’ 16/22 
40.2 (1.1) 
Term 
43 68 FMD 5.8 (3.3) % 
IMT 8.4 (1) % 
 
(Skilton, 
Viikari et al. 
2011) 
Finland 
33.5 (1.8) 
Preterm 
31.9 
(4.9) 
46 253 FMD, cIMT 
 (Carotid & 
brachial) 
Ultrasound 
studies, Sequoia 
512  (results 
represented in 
graph format) 
FMD 7.9% 
cIMT 0.59 mm 
P=0.03 
P=0.005 
‘found that both reduced foetal 
growth and preterm birth increased 
the severity of subclinical carotid 
atherosclerosis & reduced arterial 
endothelial  function in early 
adulthood.’ 15/22 
 
Term 
SGA 
32.0 
(5.2) 
49 207 FMD 7.8% 
cIMT 0.59 mm 
P=0.02 
P=0.02 
Term 
AGA 
31.8 
(5.2) 
45 835 FMD 8.6 % 
cIMT 0.58 mm 
 
 
vs. AGA 
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(Lazdam, de 
la Horra et al. 
2010) 
UK 
30.31+/-2.93 
Hypertensive 
pregnancy 
24.7
1 
42 19 FMD, PWV 
& cIMT. 
(Carotid- 
femoral & 
brachial) 
SphymoCor, 
Philips Sons 
5500 ultrasound.   
FMD 4.25 (4) % 
PWV 5.42 (0.73) m/s 
cIMT 0.52 (0.04)mm 
All preterm  
vs. term 
‘Preterm children of normotensive 
pregnancy show no significant 
difference in FMD or PWV 
compared with term controls. But 
preterm children of hypertensive 
pregnancies have evidence of 
impaired endothelial function.’ 
13/22 
 
30.31+/-2.93 
Normotensive 
pregnancy 
24.4
8 
48 52 FMD 6.79 (4) % 
PWV 5.92 (0.84) m/s 
cIMT 0.48 (0.06)mm 
P=0.45 
P=0.09 
P<0.0001 
Term 24.4
6 
53 38 FMD 6.87 (5) % 
PWV 5.56 (1.09) m/s 
cIMT 0.36 (0.06)mm 
 
(Oren, Vos et 
al. 2003)  
Holland 
34 (0.2) 28.2 
(0.9) 
42 26 PWV 
(Carotid- 
femoral) 
SphygmoCor PWV 6.1 (0.3) m/sec P=0.31 ‘Premature birth was related to 
increased aortic PWV, independent 
of BP.’ 13/22 
40 (0.1) 46 381 PWV 6.0 (0.1) m/sec 
43.1 (0.3) 33 15 PWV 5.6 (0.4) m/sec 
(Cheung, 
Wong et al. 
2004) 
Hong Kong 
32.3 (2.0) 
SGA 
7.4 
(1.4) 
66 15 PWV 
 (Brachio-
radial) 
Photoplethysmo
-graphic 
technique 
PWV 9.45 (1.79)m/s P<0.001 
vs. AGA 
‘Peripheral conduit arterial stiffness 
is increased in children born 
preterm and SGA, however 
children born AGA are not 
predisposed to such cardiovascular 
risk factors despite GA.’ 15/22 
29.4 (2.9) 
AGA 
8.3 
(1.8) 
39 36 PWV 7.29 (1.85) m/s P=1.0 
Vs. Term 
39.5 (2.1) 
AGA 
8.4 
(1.6) 
43 35 PWV 7.09 (1.2) m/s  
(Rossi, 
Tauzin et al. 
2011) 
France 
34.4 (1.8) 
AGA 
13-
14 
yrs 
52 25 PWV 
(Carotid-
radial) 
Complior. PWV 7.5 (1.1) m/s P=0.01 
(anova) 
‘adolescents born preterm exhibited 
higher arterial stiffness in 
comparison with those born at 
term.’   
16/22 
38.6 (1.1) 
SGA 
50 24 PWV 6.9 (1.3) m/s 
39.3 (1.0) 
AGA 
49 41 PWV 7.1 (1.5) m/s 
(Kerkhof, 
Breukhoven 
et al. 2012) 
Holland 
32.0 (2.2) 20.8 
(1.7) 
51 163 PWV & 
cIMT 
(Carotid-
femoral) 
SphygmoCor PWV 7.6 (1.0) m/s 
cIMT 0.52 (0.1) mm 
N.S. ‘there was no effect of GA on PWV 
and cIMT.’ 
14/22 
 
 
 
39.2 (1.7) 20.9 
(1.7) 
38 243 PWV 7.59 (0.9) m/s 
cIMT 0.52 (0.05) mm 
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(McEniery, 
Bolton et al. 
2011) 
UK 
24.9 (0.8) 11.1
8 
(0.34
) 
49 68 PWV  & AI 
(Brachial & 
radial) 
High fidelity 
micromanomete
r, SphygmoCor 
PWV 4.5 (0.75) m/s  
AI 7.3 (9.4) %  
N.S. 
P<0.01 
‘findings that arterial wave 
reflections were significantly 
elevated in the extremely preterm 
children, however aortic stiffness 
was not different.’  15/22 N/A 
Controls 
11.2
7 
(0.47
) 
44 90 PWV 4.7 (0.76) m/s  
AI 2.4 (8.7) % 
 
(Bonamy, 
Bendito et al. 
2005) 
Sweden 
29.1 (0.5) 16.5 
(0.3) 
Only 
girls 
34 PWV, basal 
skin 
perfusion 
(Carotid-
radial) 
Stiffness 
index (β) 
aorta 
Ultrasonic B-
mode images & 
Laser Doppler 
instrument and 
micro 
pharmacology 
system.   
PWV 7.8 (0.4) m/s 
Endothelial response 
to Ach 107 (8.8) PU 
Aortic β = 3.3 (0.17) 
P=0.54 
N.S. 
 
P=0.02 
‘No evidence of endothelial 
dysfunction or arterial stiffness 
related to preterm birth.’ 
15/22 
39.6 (0.2) 16.5 
(0.3) 
32 PWV 7.5 (0.4) m/s 
Endothelial response 
to Ach 117 (9.0) PU 
Aortic β = 3.9 (0.18) 
 
(Tauzin, 
Rossi et al. 
2006)  France 
SGA 
28.6 (0.6) 
5 
days 
old 
 
64 11 DC 
(abdominal 
aorta) 
Ultrasonic B-
mode images. 
DC 70.9 
(18.3)106/kPa 
P<0.001 ‘DC in VLBW premature infants are 
reduced as early as the 5th day of 
life.’ 
18/22 
AGA 
35.5 (0.8) 
5 d 
old 
64 11 DC 154.2  
(39.6)10-6/kPa 
 
(Norman and 
Martin 2003) 
Sweden 
28.8 (0.3) 
SGA 
3 
mont
hs 
old 
61 18 Basal skin 
perfusion 
(Skin micro-
vessels) 
Laser-Doppler 
instrument & 
micro 
pharmacology 
system  
Endothelial response 
to Ach 109 (19) PU 
 ‘There were no significant 
relationships between gestational 
age and endothelium-dependent 
vasodilation.’ 
15/22 
28.5 (0.3) 
AGA 
47 17 Endothelial response 
to Ach 113 (16) PU 
 
39.6 (0.4) 
SGA 
67 9 Endothelial response 
to Ach 56 (13) PU 
P<0.05 vs. 
term 
40.0 (0.3) 
AGA 
50 10 Endothelial response 
to Ach 109 (8.2) PU 
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(Bonamy, 
Martin et al. 
2007) 
Sweden 
28.9 (1.6) 
51% SGA 
9.1 
(1.7) 
49% 39 Basal skin 
perfusion 
(Dorsum of 
hand) 
Laser Doppler 
instrument and 
micro 
pharmacology 
system.   
Endothelial response 
to Ach 96.9 (8) PU 
P=0.98 ‘The endothelial function did not 
differ between the groups.’ 
13/22 40.3 (1.0) 0% 
SGA 
9.7 
(1.5) 
53% 21 Endothelial response 
to Ach 97.3 (11) PU 
 
(Mikkola, 
Leipala et al. 
2007) 
Finland 
28.5 (2.5) 
SGA 
5 yrs 68 22 Basal skin 
perfusion 
(Dorsum of 
hand) 
Laser Doppler 
instrument and 
micro 
pharmacology 
system.   
Endothelial peak 
perfusion 78 (38) PU 
P=0.7 
(Anova) 
‘found no differences in 
cardiovascular function between 
SGA & AGA preterm children at 
age 5 years.’  
15/22 
27.6 (0.8) 
AGA 
60 25 Endothelial peak 
perfusion 85 (34) PU 
 
40.4 (1.8) 
AGA 
46 13 Endothelial peak 
perfusion 68 (33) PU 
 
(Bonamy, 
Andolf et al. 
2008) 
Sweden 
29.1 (0.3) 
SGA 
9.0 
(0.4) 
45 20 Stiffness 
index  
(Left 
common 
carotid) 
B-mode 
ultrasonic 
measurements. 
Carotid stiffness 
index 4.7 (0.25) 
P=0.18 
(Anova) 
‘found no link between very preterm 
birth and smaller or stiffer carotid 
arteries.’ 
15/22 
28.7 (0.3) 
AGA 
9.3 
(0.4) 
53 19 Carotid stiffness 
index 5.3 (0.25) 
 
40.2 (0.3) 
AGA 
9.6 
(0.4) 
53 17 Carotid stiffness 
index 4.7 (0.27) 
 
(Chan, Morris 
et al. 2010) 
Australia 
31 SGA 13.5 50 14 AI  
(Right 
radial) 
Applanation 
tonometry using 
SphygmoCor  
AI results only 
shown as box plot 
P=0.007 
(Anova) 
‘There were significant differences 
of arterial stiffness across the 4 
groups.’ 
14/22 
30 AGA 14.1 56 25 
39 SGA 13.6 71 7 
40 AGA 13.6 52 25 
74 
 
2.7 Discussion 
My analysis of the ALSPAC vascular data showed that systolic blood pressure was higher in 
preterm-born children compared with term-born controls; however heart rate and diastolic 
blood pressure were similar between all gestational groups.  The adjusted difference of systolic 
blood pressure between the very preterm (25-32 weeks gestation) and term-born groups was 
4.6 mmHg (95% CI: 2.3, 6.9), which was similar to the mean difference of 2.5 mmHg (95% CI: 
1.7, 3.3 mmHg) in de Jong et al’s meta-analysis (de Jong, Monuteaux et al. 2012).  It has 
already been shown that BP tracks with age (Chen and Wang 2008) and therefore these 
differences may amplify in older age (Davies, Smith et al. 2006). Other population-based 
studies have shown higher heart rates in children born preterm, which may indicate an 
underlying biochemical difference in cardiovascular control, but we did not observe such a 
difference (Bonamy, Martin et al. 2007, Johansson, Norman et al. 2007, Kerkhof, Breukhoven 
et al. 2012).   
2.7.1 The association between preterm birth and endothelial dysfunction or arterial 
stiffness 
One possible mechanism for the increased systolic blood pressure is an increased 
peripheral vascular resistance, which may be due to increased arterial stiffness or due to 
abnormal endothelial function. Thus it was interesting to note that I did not find any evidence 
that children born preterm had impaired endothelial function, as measured by FMD, compared 
with term-born controls, which is consistent with several similar studies that I identified in my 
literature search (Singhal, Kattenhorn et al. 2001, Evensen, Steinshamn et al. 2009, Hovi, 
Turanlahti et al. 2011).  FMD measurement was performed on the brachial artery in the 
ALSPAC children. This method has been shown to reflect central endothelial function and is 
reproducible (Deanfield, Donald et al. 2005).  My systematic review did not reveal any 
convincing differences in FMD between preterm- and term-born children but results of some 
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studies suggested that underlying maternal or foetal disease resulting in prematurity 
associated with growth restriction may be associated with subtle differences in endothelial 
function in later life (Lazdam, de la Horra et al. 2010, Skilton, Viikari et al. 2011), including 
adulthood.  It is interesting to speculate whether marginal differences of endothelial function 
measured by FMD in children or young adults may manifest themselves as disease in later life.  
In our study, arterial stiffness measured by PWV and DC, was also similar between the 
preterm and term-born groups. The peripheral arterial stiffness was assessed by carotid to 
radial applanation tonometry, which has been shown to be associated with cardiovascular risk 
factors in children (Willum-Hansen, Staessen et al. 2006). From my systematic review the 
following studies reporting PWV as the main outcome measure support my findings (Oren, Vos 
et al. 2003, Bonamy, Bendito et al. 2005, Lazdam, de la Horra et al. 2010, McEniery, Bolton et 
al. 2011, Kerkhof, Breukhoven et al. 2012).  Although two studies showed a difference 
between preterm-born and term-born control subjects, the data suggested that the results of 
these studies was more likely to be associated with abnormal prenatal growth patterns than 
preterm birth alone.  Cheung et al reported that preterm birth with growth restriction was 
associated with increased arterial stiffness in later life (Cheung, Wong et al. 2004) and Rossi et 
al showed preterm born adolescents of normal birth weight have increased PWV compared to 
term born controls (Rossi, Tauzin et al. 2011).  Also Lazdam et al showed differences in PWV 
only in preterm births associated with hypertensive pregnancies (Lazdam, de la Horra et al. 
2010), which is an important factor for growth restriction.  
From my systematic review I found that DC has only been reported in preterm-born 
children in one other study conducted at 5 days of age with repeat measurement at 7 weeks of 
age.  Tauzin et al describe decreased DC in VLBW premature infants at 5 days of age when 
compared to near term controls remaining reduced at 7 weeks of age (Tauzin, Rossi et al. 
2006). However, only 12 preterm-born infants were included with VLBW (mean birth weight 
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1.09 kg) so these results may also suggest that growth restriction in preterm-born infants may 
affect arterial stiffness.  Another study by Bonamy et al reported the stiffness index (β), which 
is a reciprocal of arterial stiffness, with a lower aortic stiffness in preterm-born girls compared 
to control girls, although the same study noted that the carotid stiffness was similar between 
those born preterm and term-born controls (Bonamy, Bendito et al. 2005).  This was a small 
study of only 34 preterm-born adolescents with 9 being born SGA (26%) and so the effect of 
being born IUGR needs to be taken into consideration.  To my knowledge, my analysis of the 
ALSPAC vascular data is the only other study assessing DC in childhood however I found no 
differences between gestational groups.   
In my systematic review of the literature, I also identified studies using other methods to 
assess vascular function. These included endothelial response to Acetylcholine (Ach), 
augmentation index (AI) and carotid intima-media thickness (cIMT).  All four studies using 
acetylcholine report similar findings between preterm and term-born children (Norman and 
Martin 2003, Bonamy, Bendito et al. 2005, Bonamy, Martin et al. 2007, Mikkola, Leipala et al. 
2007) although Norman et al suggest that foetal growth restriction may be a risk factor for 
future arterial disease.  However three of the four studies measuring cIMT reported higher 
values in preterm-born groups (greater for subjects with growth restriction in two studies) 
compared with term-born groups, although the subjects were in their 20-30s in two of the 
studies showing a difference, which imply that growth restriction may have long lasting effects 
(Lazdam, de la Horra et al. 2010, Hovi, Turanlahti et al. 2011, Skilton, Viikari et al. 2011).   
Assessment of AI has been reported in only two studies, which both showed a difference 
between preterm and term-born children (Chan, Morris et al. 2010, McEniery, Bolton et al. 
2011).  Chan et al only report the ANOVA result for a four-group analysis, which included IUGR 
but from the graphical representation of the results, it is likely that the preterm-born group 
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with growth restriction may be responsible for the differences in AI.  There were no posthoc 
analysis results in the published study to confirm this finding.   
2.7.2 Other associations with abnormal vascular measurements in preterm-born children 
McEniery et al also showed a difference in AI for extremely preterm-born children and 
have more recently reported an association between impaired lung function and increased AI 
values, suggesting that respiratory disease of preterm-born infants may be a risk factor for 
future cardiovascular disease (Bolton, Stocks et al. 2012).  This was an original aim of my 
research project to review the association of reduced FEV1, in the ALSPAC preterm-born 
children, to the FMD, PWV and DC measurements.  However as none of the vascular 
measurements showed any significant difference in the preterm or term population, I did not 
conduct further analysis of the data to assess for any association with poor lung function.   
Other explanations for the increased blood pressure in children born preterm may include 
central cardiovascular dysfunction, genetic, metabolic, endocrine or renal causes. Preterm-
born children are born with relative renal immaturity with lower numbers of nephrons but 
appear to have normal renal function during childhood and beyond (Black, Sutherland et al. 
2012, Zohdi, Sutherland et al. 2012). Many preterm-born children are exposed to 
corticosteroid treatment, which may be both antenatally and postnatally, during their 
neonatal course.  Historically, repeated courses of antenatal corticosteroids were not 
uncommon but there remains doubt about whether these have long lasting effects on the 
cardiovascular system.  Washburn et al. found no effects of dexamethasone in infancy on BP at 
8 to 11 years of age and Norberg et al showed that repeated courses of antenatal 
corticosteroids did not correlate to SBP, DBP or arterial stiffness in adolescence (Washburn, 
Nixon et al. 2006, Norberg, Stalnacke et al. 2013).  However, Kelly et al noted that antenatal 
steroids in preterm infants were associated with increased aortic stiffness in early adulthood, 
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but showed no difference for SBP (Kelly, Lewandowski et al. 2012).  There continues to be 
speculation over the cause of hypertension in adults born prematurely but the evidence 
suggests that growth restriction, renal, metabolic and endocrine problems may be involved 
(Alexander 2006, Abitbol and Rodriguez 2012, Alexander and Intapad 2012).  My review of the 
literature suggested that intrauterine growth restriction, which is common in preterm births, 
could be associated with endothelial dysfunction in later life.  This suggests that endocrine and 
metabolic factors resulting from relative growth failure in preterm-born children may be 
responsible for the increased systolic blood pressure observed in this population.  
2.7.3 Study limitations of vascular measurements 
Part of my research aim was to test if non-invasive vascular measurements could be used 
to detect vascular disease in those born preterm at an early stage.  However no differences 
between those born preterm and term-born controls were noted for the three vascular 
measurements used in this study, which may be due to limitations of the measurements 
themselves or the groups being assessed.  In adults it has been shown that endothelial 
dysfunction and arterial stiffness are well recognised events in the development of 
atherosclerosis (Ross 1993). Brachial FMD has been shown to predict cardiovascular events in 
adults and children (Corretti, Anderson et al. 2002, Lekakis, Abraham et al. 2011) and it has 
been reported to be abnormal in obese children (Meyer, Kundt et al. 2006), although data 
from the ALSPAC cohort suggests this is potentially preventable (Charakida, Jones et al. 2012). 
It is open to speculation whether the ALSPAC data using FMD as a measurement does or does 
not reflect the central arterial stiffness (Laurent, Cockcroft et al. 2006).  There was a clear 
association between increased systolic blood pressure and preterm birth in the ALSPAC cohort 
but my data does not support this increase being due to increased peripheral vascular 
resistance. This may be due to the lack of sensitivity of the vascular measurements being used.  
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Another reason for not identifying any association was that the ALSPAC participants for the 
vascular study showed higher rates of being breast fed exclusively for at least 3 months and 
lower rates of maternal smoking than the non-participants, which may have led to an 
underestimation of the vascular measurements in the cohort.  It should also be noted that the 
PWV in the ALSPAC cohort was measuring the pulse wave transit along a muscular segment of 
artery.  However PWV is often measured from the carotid to femoral arteries, which assesses a 
more elastic segment of artery, thus this may have affected my results.  In the systematic 
review, some of the studies have used this method of measuring PWV and they also showed 
no differences for those born preterm, and also other measurements of endothelial function, 
such as basal skin perfusion, showed no difference.    So it could be argued that the 
measurements were accurate enough to assess for a difference and that there is no difference 
to be identified.  It should also be noted that several studies in the review included groups 
with IUGR or SGA with some identifying a difference and others none.    
2.7.4 Study limitations of cohort studies 
There are several limitations to note around the data coming from a cohort study.  The 
populations studied were predominantly white British and so it is not possible to draw 
conclusions from the data based on ethnicity (Fraser, Macdonald-Wallis et al. 2013).   Also 
there were gaps in some of the data including the information on pubertal staging at the time 
of the vascular measurements.  So in the analysis of the ALSPAC data the stage of pubertal 
development is not included, and this was justified as most children were unlikely to have 
been in advanced stages of puberty at the time of measurement (Bellis, Downing et al. 2006).  
As with all cohort studies, bias can occur due to non-random loss to follow-up but several 
studies indicate that this may introduce only minimal bias into a number of exposure- outcome 
associations (Wolke, Waylen et al. 2009, Greene, Greenland et al. 2011, Pizzi, De Stavola et al. 
2011). The vascular study of the ALSPAC children used standardised methodology as previously 
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reported (Donald, Charakida et al. 2010) but they did not restrict the children’s diet or caffeine 
intake prior to the measurements.   This may have affected the results.  The methods used to 
record gestational age at birth may have led to errors as the information was based on 
maternal recall of LMP.  As stated in the introduction to this thesis, the gold standard for 
gestational age measurements is to use antenatal ultra-sound scanning (Campbell, Warsof et 
al. 1985).  However the analysis performed assessed the data by grouping of gestational age at 
birth and so hopefully this helped to limit any errors caused by inaccurate gestational ages.  
Also the definitions of term and preterm groups have now changed, however it is felt that this 
would not affect the results of my study.  For example changing the term group from 37-43 
weeks of gestation to 39-42 weeks of gestation should not affect the results, and this should 
also be the case if we were to assess the difference between those born early term and full 
term, as no difference was noted between any of the gestational groups already analysed.   
2.7.5 Study limitations of systematic review  
Limitations for the systematic review included only assessing papers written in English, 
although this may only have excluded a small number of studies.  Also the review was limited 
as due to the heterogeneity of the data it was not possible to perform a meta-analysis. It 
should also be noted that several studies did not accurately report the gestational age at birth 
of participants included and, even those who did report accurate gestational age at birth, were 
studying relatively mature preterm-born infants.  In the ALSPAC cohort it was not possible to 
identify children with CLD and so I was not able to take account of the association of CLD with 
vascular measurements.  The role of CLD was also not assessed in the systematic review, and it 
may be that preterm-born survivors with CLD are at greater risk of developing vascular disease 
due to their respiratory disease and not the prematurity (McEniery, Bolton et al. 2011, Bolton, 
Stocks et al. 2012).  The ALSPAC data allowed for an assessment of infants who were born at 
different stages of prematurity, hence the four gestational groups analysed. As noted in the 
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risk of bias assessment of the studies reviewed, the majority of studies reported poorly on the 
outcome assessment.   Also it was not possible to perform a meta-analysis of the results, so it 
is still not clear from the literature whether survivors of preterm birth have some degree of 
endothelial dysfunction or arterial stiffness, as results varied depending upon the 
measurements being used.  It should be recommended that future studies use a standardised 
method for assessing the vascular function, so that comparisons between studies can be made 
more easily.  The most appropriate standardised method would be one that is quick, easy, 
reliable, repeatable and acceptable to the patients, which may be measuring cIMT.  The 
Association for European Paediatric Cardiology Working Group on Cardiovascular Prevention 
have published a statement on the methods to be used when assessing cIMT, which should 
help to promote standard practice for vascular measurements in children (Dalla Pozza, 
Ehringer-Schetitska et al. 2015).   
 
2.8 Conclusion 
In summary, my analysis of the ALSPAC data showed an increase in systolic blood pressure 
at 9.8 – 12.3 years of age in children born preterm when compared with children born at term 
(37-43 weeks gestation).  Since SBP tracks throughout life, the differences I have observed for 
SBP are likely to be significant for the future development of hypertension and cardiovascular 
disease (Davies, Smith et al. 2006, Chen and Wang 2008). Clinically lowering blood pressure 
(even by 2 mm Hg) towards a normotensive value can reduce the risk of mortality associated 
with vascular disease (Lewington, Clarke et al. 2002).  So finding the mechanism for this 
increased blood pressure in preterm-born children will help to suggest some practicable 
method to reduce their risk of vascular disease in later life (such as increased exercise and/or 
reduced salt intake (Whelton, Appel et al. 2012)).   
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However I did not detect clinically significant differences between gestational age groups 
for vascular measurements including FMD, PWV and DC as a possible explanation for the 
difference in SBP. These data question whether peripheral vascular dysfunction is the 
explanatory mechanism for increased systolic blood pressure in preterm-born children, 
although foetal growth restriction may, as in term-born children, have a role in the 
development of increased arterial stiffness and endothelial dysfunction. Data reported in the 
literature largely supported my findings. Causes of increased systolic blood pressure are largely 
unknown but future studies need to include potential assessment of the endocrine, metabolic, 
genetic, central cardiovascular and renal systems.   Future research should also consider 
assessing children born early term and across the whole range of gestational age.   The ALSPAC 
cohort have had repeated vascular function measurements performed as young adults and it 
would be interesting to assess the results for any association with gestational age and to see if 
any evidence of tracking can be found, if there were evidence of poor vascular function.   
 
2.9 Summary of Chapter Two 
In this chapter the analysis of ALSPAC data on vascular measurements in children born 
preterm compared to term-born controls has been described and discussed.   Children born 
preterm are known to have increased systolic blood pressure measurements in childhood and 
adolescents, which was confirmed in the ALSPAC cohort. The cause of this increased blood 
pressure is unknown although changes in the vascular structure and function have been 
suggested. The ALSPAC data did not show any differences of vascular function as measured by 
FMD, PWV and DC between the gestational groups.   Furthermore the systematic review of the 
literature concerning the vascular function assessment of survivors of preterm birth also 
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lacked a conclusive answer.  The studies identified showed varying results, although the 
majority showed no difference between AGA preterm- and term-born subjects.   
So future research needs to focus on developing a standardised method of assessing 
vascular function and arterial stiffness.  It would also be beneficial to understand the 
pathological process that leads to the increased blood pressure in those born preterm as then 
targeted therapy could be offered to reduce the risk of later cardiovascular disease.  The data 
from ALSPAC was from a single time point and so future research should aim to assess serial 
measurements in the same cohort to establish the existence of tracking in the preterm-born 
survivors.  Recently the EPICure cohort of extremely preterm-born survivors have had 
repeated vascular studies performed at 19 years of age and this may help provide evidence of 
disease progression.  However the ALSPAC cohort have also had repeat vascular studies 
performed and so it would be interesting to assess if at 17 to 18 years of age there are any 
differences to detect between those born preterm and those born term.     
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3.0 CHAPTER THREE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 
EXERCISE CAPACITY IN CHILDREN AND ADULTS BORN PRETERM 
 
This chapter presents the results of a systematic review and meta-analysis of research on 
the exercise capacity of survivors of preterm birth.   I performed the systematic review of the 
literature and the meta-analysis with support from research colleagues in the department of 
child health.  The review has been published with myself as the first author in the journal 
Pediatric Pulmonology in March 2015 (copy in the appendix, pages 256-60).  The co-authors 
include my doctoral supervisors and members of the child health research team at Cardiff 
University.  
The main hypothesis and research question for this chapter was: 
1.  The hypothesis to test: Children and adults born preterm, especially those with CLD, 
have lower levels of exercise capacity, as measured by O2max, compared to those born at 
term.  This would be done by performing a systematic review and meta-analysis and setting 
out to answer the review question: ‘does being born preterm, either with or without CLD, 
result in decreased exercise capacity in later life compared with term-born controls?’ 
 
3.1 Introduction  
From the ALSPAC cohort it has been shown that preterm-born children have reduced lung 
function and have increased blood pressure in childhood compared to term-born controls 
(Kotecha, Watkins et al. 2012, Edwards, Watkins et al. 2014).   These findings have been 
confirmed by two recent systematic reviews; in the first, de Jong et al showed increased blood 
pressure in those born preterm in later life (de Jong, Monuteaux et al. 2012), and in the 
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second, Kotecha et al showed reduced %FEV1 in those born preterm, with or without CLD, in 
later life (Kotecha, Edwards et al. 2013).  The effect of being born preterm on the development 
of hypertension and reduced lung function may also have an effect on their exercise capacity. 
Thus in this chapter a further systematic review of the literature was performed to assess for 
evidence of reduced exercise capacity in preterm-born children. 
3.1.1 Rationale for performing a review of preterm birth and exercise capacity 
Preterm-born children may have difficulties undertaking physical activity for numerous 
reasons.  These include deficits in lung function and neurological impairment, which have been 
reported in children and adults born preterm with and without BPD (Baraldi and Filippone 
2007, Chakraborty, McGreal et al. 2010, Colin, McEvoy et al. 2010, Kotecha, Watkins et al. 
2012, Joshi, Powell et al. 2013). In addition preterm-born subjects have increased 
cardiovascular risks such as arterial hypertension and atherosclerosis in adult life, which can 
also impact on the ability to exercise in adulthood (Chan, Morris et al. 2010, de Jong, 
Monuteaux et al. 2012, Poon, Edwards et al. 2013).  From our systematic review on lung 
function, we have already shown that children born preterm have reduced lung function and I 
have also confirmed with the data from the ALSPAC study that the preterm-born children have 
higher systolic blood pressure compared to term-born controls, although there were no 
differences in the endothelial function or arterial stiffness (Kotecha, Edwards et al. 2013, 
Edwards, Watkins et al. 2014).  Thus children and adults born preterm may also have reduced 
exercise capacity.  Bolton et al have recently shown an association between impaired lung 
spirometry and increased augmentation index (AI), a measure of arterial stiffness using the 
EPICure cohort (Bolton, Stocks et al. 2012), and Welsh et al have identified a reduced peak 
O2 in preterm-born children compared to term-born controls using the EPICure cohort (Welsh, 
Kirkby et al. 2010). Thus the effect of altered cardiorespiratory outcomes associated with 
prematurity and/or CLD on a child’s or adult’s exercise capacity is not clear.  
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The reduced physical activity and exercise of children born preterm may also be due to 
physical deconditioning.  So physical inactivity and lack of exercise leads to poor physical 
strength and stamina, which may mean that children born preterm are unable to exercise at 
the same level as those born term, because they lack the physical strength and ability.  So lack 
of exercise in children and adults with chronic disease leads to further deconditioning 
(Durstine, Painter et al. 2000).  Finn et al showed that lower physical activity levels in 
preschool children is associated with preterm birth (Finn, Johannsen et al. 2002) and so it may 
be possible to prevent or reverse the affects of reduced physical activity by offering a program 
of rehabilitation.  Gomes-Neto et al recently performed a systematic review and meta-analysis 
to examine the effects of exercise training on aerobic capacity in children and adolescents 
after congenital heart disease surgery and showed an association with increased peak VO2 
(Gomes-Neto, Saquetto et al. 2016).   
Another reason why children born preterm may have reduced exercise capacity could be 
secondary to poor gas exchange in the lungs.   Mitchell et al suggested that preterm-born 
children with BPD have reduced alveolar surface area and that could limit gas transfer before 
and during exercise, which they confirmed in their findings (Mitchell and Teague 1998).  
However Mitchell et al only studied 10 subjects with BPD and compared them to 10 healthy, 
term born controls and 10 preterm-born children without BPD, and also showed no difference 
in gas exchange between those born preterm without BPD and the term-born controls, which 
would suggest BPD and not preterm birth was the main factor (Mitchell and Teague 1998).   
However Narang et al have shown that adults born preterm have reduced gas exchange at 
rest, but this has no impact of their exercise capacity when compared to healthy term-born 
controls (Narang, Bush et al. 2009).  
To date there have been only a limited number of studies assessing the cardio-respiratory 
exercise capacity of children or adults born preterm.  The results of these studies vary which 
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may be explained by the different methods used to assess the exercise capacity.  The gold 
standard is to measure the oxygen uptake at maximal or peak exercise ( O2max), which can 
be measured using various laboratory based exercise methods (2003).  Treadmill or cycle 
ergometer are most frequently used in children to accurately assess their O2max, although 
the Léger 20-m shuttle run assessment has also be used to estimate O2max (Armstrong and 
Welsman 2007) and has been shown to be a reliable substitute for lab-based tests in children 
with developmental difficulties (Cairney, Hay et al. 2010). 
The O2max is the amount of oxygen available for muscle consumption and is equal to 
the cardiac output (stroke volume multiplied by heart rate) multiplied by the difference in 
arterial-venous oxygen content (Fick 1870).  Therefore O2max is dependent upon the 
pulmonary, cardiovascular and muscular systems and is affected by age, sex, ethnicity, body 
size and composition. During exercise in adults the consumption of oxygen ( O2) increases 
with increasing workload as seen in Figure 7, but reaches a plateau ( O2max). In children, 
such a plateau in O2 does not necessarily occur thus the highest O2 observed at exhaustion 
during an exercise test is reported as the O2max, also referred to as O2peak (Armstrong 
and Welsman 2007).   
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Figure 7: Oxygen consumption to workload graph  
 
(Graph designed on excel and demonstrates the plateau effect of oxygen consumption). 
Several studies have also assessed the lung function of preterm-born survivors during and 
after exercise testing, to observe for any patterns that differ to term-born controls.  If preterm-
born survivors have reduced exercise capacity, this may be secondary to the reduced lung 
function that has already clearly been identified (Kotecha, Edwards et al. 2013).  I, therefore, 
also reviewed the lung function parameters of preterm-born participants during exercise.  This 
has been assessed using maximal minute ventilation (VEmax) the amount of air inhaled or 
exhaled over one minute at maximal exercise.   
3.1.2 Review question  
Since there had not been a previous systematic review of studies examining the 
association between preterm birth and exercise capacity in later life, I performed a systematic 
review of the literature and a meta-analysis to compare O2max during childhood and 
adulthood between subjects born preterm, with and without CLD, and those born at term.  
The review question set to be answered was: does being born preterm, either with or without 
CLD, result in decreased exercise capacity in later life compared with term-born controls? 
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3.2 Methodology for the systematic review on exercise capacity 
 I performed the systematic review according to the Preferred Reporting Items for 
Systematic reviews and Meta-Analyses (PRISMA) statement.  The PRISMA statement has a 
checklist of 27 items, informing researchers how they should conduct and report their 
systematic reviews, so that the highest standards are ensured from published reviews (Moher, 
Liberati et al. 2009).  As stated in the PRISMA statement I specified search terms and the 
exclusion criteria prior to the search.  I performed a search strategy including the keywords 
preterm, prematurity, exercise capacity and O2max as outlined in table 7.  I used eight 
databases to perform the search and these were CINAHL, Embase, Medline, Web of 
Knowledge, SCOPUS, HMIC, OpenSIGLE and Science Citation Index Expanded (further details in 
appendix, page 260).  The search strategy was adapted from another systematic review on the 
lung function of survivors of preterm birth (Kotecha, Edwards et al. 2013).  This review on lung 
function parameters was performed in October 2011 and as I was involved in reviewing the 
articles I identified many articles relating to preterm birth and exercise capacity.  Thus a 
further adapted search strategy was run for exercise capacity in preterm-born subjects in 
March 2013 to ensure that all the relevant articles had been identified.  Three charity websites 
were also checked to widen the search (Action Medical Research, SPARKS and Wellcome 
Trust). Finally the articles were reviewed and any relevant references that referred to exercise 
capacity in subjects born preterm were hand-searched.  
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Table 7: Search strategy for exercise capacity in subjects born preterm 
Number Search Term 
1 exp preterm* or prematur*or infant .mp. 
2 exp gestation* .mp. 
3 exp infant low birth-weight/ .mp. 
4 exp newborn or neonate or term infant .mp. 
5 1 or 2 or 3 or 4 
6 Exercise capacity .mp. 
7 exercise tolerance .mp. 
8 exercise testing .mp. 
9 VO2max .mp. 
10 exp exercise* .mp. 
11 6 or 7 or 8 or 9 or 10 
12 5 and 11 
Search terms used to extend the search strategy used for the systematic review on lung 
function. This search strategy was used in OvidSp where ‘.mp.’ means a multipurpose search 
across all areas of an article; exp means to explode a term; / indicates that all sub headings are 
searched for; * indicates that the term has been truncated 
 
3.2.1 Eligibility criteria 
All articles reporting on exercise capacity in children or adults born preterm with or 
without CLD compared to term-born controls with results of the O2max  (ml/kg/min) using 
either a treadmill or cycle ergometer or 20m shuttle run test were included (2003). Studies 
were included if they used preterm-born participants, where preterm birth was defined as 
birth at <37 weeks gestation and if the term-born control group were defined as ≥37 weeks 
gestation.  The recruitment of subjects in some studies was based on their birth-weight, but 
only those that reported the gestational age of the subjects were included in the review.  
CLD/BPD was defined as either (a) dependence on supplementary oxygen at 28 days of life, or 
(b) dependence on supplementary oxygen at 36 weeks postmenstrual age (PMA).  The term 
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BPD has been used in many of the studies assessed for inclusion in this systematic review and 
so I have opted to use the term BPD and CLD interchangeably throughout this chapter.  A child 
was defined as less than 18 years of age and adults as ≥18 years of age. I included studies in all 
languages and from all countries.  Studies were excluded if they did not use one of the three 
methods of assessing exercise capacity, if they did not report the O2max  (ml/kg/min) or if 
they gave no details of the gestational age of the subjects being studied or if there was no 
term-born control group. 
3.2.2 Study Selection  
Two reviewers (myself and Sarah Kotecha) identified all papers according to the inclusion 
criteria. Each reviewer independently entered details of each paper onto a predesigned 
proforma (data extraction form in appendix, pages 260-262). In the majority of cases the 
completed proforma from both reviewers agreed 100% on the inclusion of papers.  On further 
discussion between the two reviewers all studies included in the systematic review were 
agreed.   
3.2.3 Data collection process 
Data were extracted using the same proforma as inclusion criteria (see Appendix, pages 
260-262).  Every included study had data extracted by at least two reviewers (myself, Sarah 
Kotecha, John Lowe, John Watkins – all members of the child health research team).  I 
extracted data from all the included studies.  For one study, the authors had to be contacted in 
order to get further details and they were able to provide further data to allow this study to be 
included (Welsh, Kirkby et al. 2010). Another study presented their results in graphical format 
only, so these data were extracted by reading the graphs as accurately as possible (Clemm, 
Roksund et al. 2012). I used the highest resolution image of the graphs and then used a ruler 
to get as accurate a number for the O2max  (ml/kg/min) as possible.  I entered the data from 
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the included studies into Review Manager version 5.2 and then used this software to analyse 
the data.   
3.2.4 Assessing the quality of the study and risk of bias 
To assess the quality of the studies included, I used a proforma based on the Newcastle 
Ottawa criteria and the Cochrane risk of bias tool, which had been developed for the previous 
systematic review on lung function in preterm-born survivors.  I performed the data extraction 
for the quality and risk of bias assessment and I randomly chose three papers to be checked 
for consistency by a second reviewer (Sarah Kotecha).  There were no differences between us 
on the three papers reviewed. In brief each study was assessed and given a score for (i) 
representativeness of the cohort (max score = 4); (ii) appropriate selection for control group 
(max score = 3); (iii) exposure ascertainment (max score 3); (iv) outcome assessment (max 
score 4); (v) length of follow up (max score 2); and (vi) adequacy of follow up (max score 4). 
The minimum score possible was 6 and the maximum 20. 
3.2.5 Outcome measures 
The primary outcome measure was O2max in ml/kg/min (ml of oxygen per minute per kg 
of body weight).  Secondary outcome measures of cardiorespiratory exercise capacity were 
reviewed including ventilatory threshold (VEmax in l/min) and CO2max (ml/kg/min).  
3.2.6 Statistical analysis 
The data were categorised into four groups, depending on the subjects studied:   
1. Preterm-born subjects including those with or without CLD (excluding groups 
biased towards CLD); 
2. Preterm-born subjects excluding those with CLD; 
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3. Preterm-born subjects with CLD28, defined by supplemental oxygen-dependency at 
28 days of life; 
4. Preterm-born subjects with CLD36, defined by supplemental oxygen-dependency at 
36 weeks PMA. 
Only studies including a control term-born group were included as this allowed a mean 
difference to be calculated. Thus a meta-analysis of the mean difference and standardised 
mean difference in O2max was conducted using Review Manager 5.2. The standardised 
mean difference was calculated (mean difference divided by the pooled standard deviation) as 
a measure of effect size. I used random effects for each group analysis as each study included 
had different treatment effects (there was a degree of heterogeneity).  The heterogeneity was 
assessed based on the I2, so results between 0-40% are probably not important, 30-60% 
suggest moderate heterogeneity, 50-90% suggest considerable heterogeneity and 75%-100% 
suggest significant heterogeneity.  So any results with heterogeneity I2= >50% were considered 
to have high heterogeneity, which was the case with all groups analysed and so random effects 
were used for each group analysis.  I also performed a sensitivity analysis on the different 
methods of exercise testing to see if there were differences between the pooled results of the 
different testing regimes used. To assess for any risk of publication bias I used Review Manager 
to create funnel plots.  These use a scatterplot graph of the effect size against a measure of 
the study size.   
To briefly explain my choice of random effects: if all included studies in a meta-analysis 
were 100% precise then I could simply calculate the mean of the difference to get an effect 
size.  In reality some studies will be more accurate (closer to the true mean) than others and so 
it is necessary to calculate a weighted mean, with some studies contributing more to the effect 
size (greater weighting) than others.  In order to assign weights to included studies there are 
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two options, which are a fixed effect model or a random effects model.  Both make different 
assumptions and lead to different mechanisms for assigning weights.  So in the fixed effect 
model all the included studies are estimating the same effect size and so weights are applied 
to each study based on the amount of information captured by that study.  So a large study 
(i.e. high number of participants) will have a greater weighting than a smaller study (i.e. low 
number of participants).  In contrast the random effects model is trying to estimate the mean 
of a distribution of the true effects.  Each included study, regardless of size, is estimating a 
different effect size, and each of these effect sizes help to estimate the true population mean.  
So the weights assigned under random effects are more balanced and the large studies do not 
dominate the analysis, therefore allowing smaller studies to contribute to the overall result.  I 
chose the random effects model because there were different testing methods used with the 
potential for every study included to have a different effect size and there were varying 
populations studied, in terms of age and era of birth. 
 
3.3 Results  
3.3.1 Studies selected and their characteristics 
A flowchart of the study selection process is shown in Figure 8.  Following the full search 
strategy over fourteen thousand titles and abstracts were identified.  A total of 36 full text 
articles were assessed for eligibility; 11 were excluded as they did not meet the inclusion 
criteria; in addition one was excluded as it had no control group, one used the same data as 
another included study and one reported different units of measurement for O2max 
(ml/min/m2) (Narang, Bush et al. 2009).   
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Of the 22 included studies, 12 provided data on preterm-born participants without CLD 
and preterm-born participants with CLD compared to a term-born control group; 6 on 
preterm-born participants without CLD only compared to a term-born control group; and 4 on 
preterm-born participants with CLD only compared to a term-born control group. One study 
included data on two different cohorts of children (Clemm, Roksund et al. 2012).  Brief 
descriptions of the methodology and results of each of the studies included in the meta-
analysis are shown in Tables 8-11.  The tables are sectioned according to the four groups 
analysed.  The full demographics for all included studies are given in table 12 (x in the table 
refers to missing data).  From all the included studies there were 680 control subjects, 685 
preterm subjects and 311 CLD subjects, who were born between 1973-2002, and were 
assessed at ages ranging from 5 to 21 years.  The neonatal characteristics of the subjects 
including gestational age, birth-weight and year of birth, which varied widely are shown in the 
tables.  Two studies were published in foreign languages (French and Portuguese), however 
both articles were published in journals that provided an English translation. 
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Figure 8: Flow chart of study selection 
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Table 8: Description of the included studies all preterm groups compared to term-born controls  
STUDY QUALITY 
SCORE 
OBJECTIVE STUDY 
DESIGN 
AGE (YEARS) STUDY GROUP CONTROL 
GROUP 
OUTCOME 
MEASURES 
Abreu (Abreu 
LR, Costa-
Rangel RCA et 
al. 2007) 
14 To assess cardiorespiratory capacity 
and investigate the presence of 
exercise induced bronchospasm 
among children with 
bronchopulmonary dysplasia 
Case 
control 
study 
BPD group mean 
8.5 years; Preterm 
group mean 8.3 
years; Term group 
8.2 years. 
13 children with 
BPD and 13 
Preterm-born 
children with no 
history of BPD 
14 term-born 
controls 
Cycle ergometer 
(including VO2max & 
VEmax) 
 
Baraldi 
(Baraldi, 
Zanconato et 
al. 1991) 
12 To assess the cardiorespiratory and 
metabolic response to exercise in 7 
to 12 year old VLBW children 
Area 
cohort 
study 
VLBW group mean 
9.9 years; Control 
group mean 9.7 
years. 
15 VLBW children 
(9 AGA & 6 SGA) 
26 term-born 
controls 
Treadmill (including 
VO2max) 
 
Barker(Barker
, Merz et al. 
2003) 
16 To assess the long-term outcome in, 
lung function, submaximal, and peak 
exercise capacity among a local 
cohort of school children with a 
history of treatment in a NICU after 
preterm birth at VLBW 
Area 
cohort 
study 
BPD group mean 
9.8 years; preterm 
group mean 10.4 
years; control 
group mean 10.5 
years 
13 BPD & 13 
preterm (no BPD). 
13 healthy 
children born at 
term matched 
for age, height 
and weight 
Cycle ergometer 
(including VO2max & 
VEmax) 
Burns(Burns, 
Danks et al. 
2009) 
16 To investigate the fitness levels and 
motor competency of non-disabled 
ELBW children as they were 
reaching adolescence. It also aimed 
to determine whether a relationship 
exists between their motor 
competence and physical fitness 
independent of their growth and 
respiratory status 
Case-
control 
study 
ELBW mean 12.5 
years SD 8 months, 
control children 
12.4 years SD 11 
months 
54 ELBW 
(<1000g)  
55 term 
controls  
Cardio respiratory 
endurance by 20 m 
shuttle run test 
(including VO2max) 
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Clemm a & b 
(Clemm, 
Roksund et al. 
2012) 
17 To compare aerobic capacity and 
exercise performance of children 
and adolescents born extremely 
preterm and at term, and to relate 
findings to medical history and life 
style factors.  
Two area 
cohort 
studies 
(group 1 (b) 
– 1982-85; 
group 2 (a) 
– 1991-92) 
Group 1  mean 
17.6 years; group 2 
10.6 years 
Group 1 preterms 
40 (10 non BPD, 
18 mild & 12 M/S 
BPD); group 2 
preterms 35 (9 
non BPD, 14 mild 
& 12 M/S BPD) 
Age, sex 
matched term-
born controls.  
Group 1 Term 
40; Group 2 
Term 35. 
Treadmill (including 
VO2max) 
 
Evensen(Even
sen, 
Steinshamn 
et al. 2009) 
19 To evaluate associations between 
LBW and body fat, BP, lung and 
endothelial function, and maximal 
oxygen uptake in young adults 
Longitudina
l follow up 
study 
VLBW mean 18.2 
years; SGA mean 
18.5 years; 
Controls 18.6 years 
37 Preterm with 
VLBW (<1501g); 
47 SGA (term). 
63 controls with 
NBW 
Treadmill (including 
VO2max 
& VEmax) 
Gross(Gross, 
Iannuzzi et al. 
1998) 
19 To assess long-term pulmonary 
outcome of a regional cohort of 
children born <32 weeks’ gestation 
compared with a matched term 
control group 
Cohort 
study 
7 years 53 Preterm (no 
BPD); 43 Preterm 
with BPD 
108 healthy 
term (38 to 42 
weeks 
gestation) 
controls 
Treadmill (including 
VO2max) 
 
Hebestreit 
(Hebestreit, 
Staschen et 
al. 2000) 
16 To assess intra- and inter-evaluator 
reliability and validity of ventilatory 
threshold determination in children 
Cohort 
study 
Preterm mean 8.9 
years; Term mean 
9 years 
30 preterm (no 
details of BPD) 
20 term-born 
controls 
Cycle ergometer  
(Including VO2max) 
Jacob (Jacob, 
Lands et al. 
1997) 
17 To describe exercise responses in 
patients with a history of severe 
BPD 
Cohort 
study 
BPD mean 10.6 
yrs; Preterm mean 
11.2 yrs; Term 
mean 10.6 yrs 
15 BPD; 15 
preterm (no BPD) 
13 healthy 
term-born 
controls 
Cycle ergometer  
(including VO2max) 
Joshi (Joshi, 
Powell et al. 
2013) 
16 To assess for exercise induced 
bronchoconstriction in 8 to 12 year 
old children who had CLD in infancy. 
Cohort 
study 
CLD mean 10.2 
years; Preterm 
mean 10.3 yrs; 
term mean 10.5yrs 
29 CLD; 33 
preterm (no CLD) 
30 health term-
born controls 
Cycle ergometer  
(including VO2max) 
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Kilbride(Kilbri
de, Gelatt et 
al. 2003) 
11 To assess pulmonary function and 
exercise capacity of apparently 
asymptomatic children who were 
born EP 
Longitudina
l follow up 
study 
ELBW group mean 
11.3; 
NBW mean 11.1  
47 ELBW children 
<801g (mean 26.1 
wks) 
25 age matched 
NBW children 
>37 weeks 
gestation & 
>2500g BW 
Treadmill (including  
VO2max) 
 
Kriemler(Krie
mler, Keller et 
al. 2005) 
15 To identify pulmonary and exercise 
related effects of CLD versus 
prematurity without CLD in children 
5 to 7 years old who were born 
preterm with VL or ELBW. 
Cohort 
study 
CLD range 5.8-7.0 
years; Preterm 
range 6.1-7.8 
years; Term range 
5.5-7.4 years 
16 BPD; 12 
preterm (no BPD) 
24 term 
controls 
Cycle ergometer 
(including VO2max & 
VEmax) 
O’Dea 
(O'Dea, Logie 
et al. 2011) 
11 To determine the ventilatory 
response to exercise in term and 
Preterm-born children with and 
without a diagnosis of BPD. 
Cohort 
study 
9-11 years 29 BPD; 25 
preterms (no 
BPD) 
28 term-born 
controls 
Treadmill (including 
VO2max) 
Parat(Parat, 
Moriette et 
al. 1995) 
17 Pulmonary function and exercise 
tolerance were evaluated in late 
childhood in two groups of Preterm-
born children. 
Cohort 
study 
BPD mean 7.9 
years; Preterm 7.8 
years. 
6 BPD; 5 preterms 
(no BPD) 
5 term-born 
controls 
Cycle ergometer 
(including VO2max & 
VEmax) 
Pianosi(Piano
si and Fisk 
2000) 
13 To compare exercise ventilation and 
cardiac output in a sample of 
childhood survivors of lung disease 
of prematurity with those of a 
control group to elucidate reasons 
for lower peak VO2. 
Cohort 
study 
BPD mean 8.8 
years; Preterm 
mean 8.5 years; 
Term mean 8.2 
years. 
17 BPD, 15 
preterm (no BPD) 
15 term-born 
controls 
Cycle ergometer 
(including VO2max & 
VEmax) 
Smith(Smith, 
van Asperen 
et al. 2008) 
17 To assess the 10 year lung function 
and fitness outcomes for children 
who were born weighing <1000g 
and before 32 weeks gestation 
Cross-
sectional 
study 
Preterm mean 10.1 
years; Control 
group mean 11.6 
years 
125 preterm 
(<1000g and <32 
weeks gestation) 
includes BPD 
34 term-born 
controls 
20 m shuttle run test 
(including VO2max) 
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Svien(Svien 
2003) 
17 To investigate heart related fitness 
and physical activity levels of 7 to 10 
year old children with histories of 
preterm birth 
Cross-
sectional 
case-
control 
study 
Preterm mean 8.5 
years; term mean 
8.8 years 
22 preterm (No 
BPD) 
22 Term-born 
controls 
Treadmill (including 
VO2max) 
Vrijlandt(Vrijl
andt, 
Gerritsen et 
al. 2006) 
18 To investigate the long term effects 
of prematurity on lung function and 
exercise capacity in ex-preterms 
compared with healthy peers 
Prospective 
cohort 
study 
Preterm mean 19 
years; term mean 
20.8 years. 
42 Preterm 
(gestational age 
<32 weeks and/or 
birth-weight 
under 1500g) 
48 healthy term 
controls 
Cycle ergometer 
(including VO2max & 
VEmax) 
Welsh 
(Welsh, 
Kirkby et al. 
2010) 
17 To compare maximal exercise 
ventilation characteristics and 
physical activity levels at 11 years of 
age in children born EP with those 
of full-term controls. 
Longitudina
l cohort 
study 
Preterm mean 11.1 
years; Term mean 
11.0 years 
Preterm 15 (No 
BPD); Preterm 
(BPD) 23 
38 Term-born 
controls 
Cycle ergometer 
(including VO2max & 
VEmax) 
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Table 9: Description of all included studies with only preterm groups (excluding BPD) compared to term-born controls 
STUDY QUALITY 
SCORE 
OBJECTIVE STUDY 
DESIGN 
AGE (YEARS) STUDY GROUP CONTROL 
GROUP 
OUTCOME MEASURES 
Abreu (Abreu 
LR, Costa-
Rangel RCA et 
al. 2007) 
14 To assess cardiorespiratory 
capacity and investigate the 
presence of exercise induced 
bronchospasm among children 
with bronchopulmonary dysplasia 
Case 
control 
study 
BPD group mean 
8.5 yrs; Preterm 
group mean 8.3 
years; Term 
group 8.2 years. 
13 children with 
BPD and 13 
Preterm-born 
children with no 
history of BPD 
14 term-born 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
 
Baraldi 
(Baraldi, 
Zanconato et 
al. 1991) 
12 To assess the cardiorespiratory and 
metabolic response to exercise in 7 
to 12 year old VLBW children 
Area cohort 
study 
VLBW group 
mean 9.9 years; 
Control group 
mean 9.7 years. 
15 VLBW children 
(9 AGA & 6 SGA) 
26 term-born 
controls 
Treadmill (including 
VO2max) 
 
Barker(Barker, 
Merz et al. 
2003) 
16 To assess the long-term outcome 
in, lung function, submaximal, and 
peak exercise capacity among a 
local cohort of school children with 
a history of treatment in a NICU 
after preterm birth at VLBW 
Area cohort 
study 
BPD group mean 
9.8 years; 
preterm group 
mean 10.4 years; 
control group 
mean 10.5 years 
13 BPD & 13 
preterm (no BPD). 
13 healthy 
children born 
at term 
matched for 
age, height 
and weight 
Cycle ergometer (including 
VO2max & VEmax) 
Clemm  
(Clemm, 
Roksund et al. 
2012) 
17 To compare aerobic capacity and 
exercise performance of children 
and adolescents born extremely 
preterm and at term, and to relate 
findings to medical history and life 
style factors.  
Two area 
cohort 
studies 
(group 1 (b) 
1982-85; 
group 2 (a)  
1991-92) 
Group 1  mean 
17.6 years; group 
2 10.6 years 
Group 1 preterms 
40 (10 non BPD, 18 
mild & 12 M/S 
BPD); group 2 
preterms 35 (9 non 
BPD, 14 mild & 12 
M/S BPD) 
Age, sex 
matched term-
born controls.  
Group 1 Term 
40; Group 2 
Term 35. 
Treadmill (including 
VO2max) 
 
Gross(Gross, 
Iannuzzi et al. 
1998) 
19 To assess long-term pulmonary 
outcome of a regional cohort of 
children born <32 weeks’ gestation 
Cohort 
study 
7 years 53 Preterm (no 
BPD); 43 Preterm 
with BPD 
108 healthy 
term (38 to 42 
weeks 
Treadmill (including 
VO2max) 
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compared with a matched term 
control group 
gestation) 
controls 
Jacob (Jacob, 
Lands et al. 
1997) 
17 To describe exercise responses in 
patients with a history of severe 
BPD 
Cohort 
study 
BPD mean 10.6 
years; Preterm 
mean 11.2 years; 
Term mean 10.6 
years 
15 BPD; 15 preterm 
(no BPD) 
13 healthy 
term-born 
controls 
Cycle ergometer (including 
VO2max) 
Joshi (Joshi, 
Powell et al. 
2013) 
16 To assess for exercise induced 
bronchoconstriction in 8 to 12 year 
old children who had CLD in 
infancy. 
Cohort 
study 
CLD mean 10.2 
yrs; Preterm 
mean 10.3 yrs; 
term mean 10.5 
yrs 
29 CLD; 33 preterm 
(no CLD) 
30 health 
term-born 
controls 
Cycle ergometer (including 
VO2max 
Kriemler(Kriem
ler, Keller et al. 
2005) 
15 To identify pulmonary and exercise 
related effects of CLD versus 
prematurity without CLD in 
children 5 to 7 years old who were 
born preterm with VL or ELBW. 
Cohort 
study 
CLD range 5.8-7.0 
years; Preterm 
range 6.1-7.8 
years; Term range 
5.5-7.4 years 
16 BPD; 12 preterm 
(no BPD) 
23 term 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
O’Dea (O'Dea, 
Logie et al. 
2011) 
11 To determine the ventilatory 
response to exercise in term and 
Preterm-born children with and 
without a diagnosis of BPD. 
Cohort 
study 
9-11 years 29 BPD; 25 
preterms (no BPD) 
28 term-born 
controls 
Treadmill (including 
VO2max) 
Parat(Parat, 
Moriette et al. 
1995) 
17 Pulmonary function and exercise 
tolerance were evaluated in late 
childhood in two groups of 
Preterm-born children. 
Cohort 
study 
BPD mean 7.9 
years; Preterm 
7.8 years. 
6 BPD; 5 preterms 
(no BPD) 
5 term-born 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
Pianosi(Pianosi 
and Fisk 2000) 
13 To compare exercise ventilation 
and cardiac output in a sample of 
childhood survivors of lung disease 
Cohort 
study 
BPD mean 8.8 
years; Preterm 
mean 8.5 years; 
17 BPD, 15 preterm 
(no BPD) 
15 term-born 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
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of prematurity with those of a 
control group to elucidate reasons 
for lower peak VO2. 
Term mean 8.2 
years. 
Svien(Svien 
2003) 
17 To investigate health-related 
fitness and physical activity levels 
of 7 to 10 year old children with 
histories of preterm birth 
Cross 
sectional 
case 
control 
study 
 
Preterm mean 8.5 
years; term mean 
8.8 years 
22 preterm (No 
BPD) 
22 Term-born 
controls 
Treadmill (including 
VO2max) 
Welsh (Welsh, 
Kirkby et al. 
2010) 
17 To compare maximal exercise 
ventilation characteristics and 
physical activity levels at 11 years 
of age in children born EP with 
those of full-term controls. 
Longitudina
l cohort 
study 
Preterm mean 
11.1 years; Term 
mean 11.0 years 
Preterm 15 (No 
BPD); Preterm 
(BPD) 23 
38 Term-born 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
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Table 10: Description of included studies with preterm-born participants with BPD (oxygen dependency for at least 28 days from birth) compared to term-born 
controls 
STUDY QUALITY 
SCORE 
OBJECTIVE STUDY 
DESIGN 
AGE (YEARS) STUDY GROUP CONTROL 
GROUP 
OUTCOME MEASURES 
Abreu (Abreu LR, 
Costa-Rangel RCA 
et al. 2007) 
14 To assess cardiorespiratory 
capacity & investigate the 
presence of exercise induced 
bronchospasm among children 
with BPD 
Case 
control 
study 
BPD group 
mean 8.5 
years; 
Preterm 
group mean 
8.3y; Term 
group 8.2 
years. 
13 children with 
BPD; 
13 Preterm-
born children 
with no history 
of BPD 
14 term-born 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
 
Bader(Bader, 
Ramos et al. 1987) 
12 To determine the long-term 
pulmonary sequelae and effect 
on exercise tolerance of BPD 
Area cohort 
study 
BPD group 
mean 10.4 
years; Control 
group mean 
10.1 years 
10 BPD  8 age 
matched 
term 
children 
 
 
Treadmill (including  
VO2max & VEmax) 
Barker(Barker, 
Merz et al. 2003) 
16 To assess the long-term outcome 
in, lung function, submaximal, 
and peak exercise capacity 
among a local cohort of school 
children with a history of 
treatment in a NICU after 
preterm birth at VLBW 
Area cohort 
study 
BPD group 
mean 9.8 
years; 
preterm 
group mean 
10.4 years; 
control group 
mean 10.5 
years 
13 BPD & 13 
preterm (no 
BPD). 
 
 
 
 
 
 
13 healthy 
children born 
at term 
matched for 
age, height 
and weight 
Cycle ergometer (including 
VO2max & VEmax) 
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Clemm (Clemm, 
Roksund et al. 
2012) 
17 To compare aerobic capacity and 
exercise performance of children 
and adolescents born extremely 
preterm and at term, and to 
relate findings to medical history 
and life style factors.  
Two area 
cohort 
studies 
(group 1 (b) 
– 1982-85; 
group 2 (a) 
– 1991-92) 
Group 1  
mean 17.6 
years; group 
2 10.6 years 
Group 1 
preterms 40 (10 
non BPD, 18 
mild & 12 M/S 
BPD); group 2 
preterms 35 (9 
non BPD, 14 
mild & 12 M/S 
BPD) 
Age, sex 
matched 
term-born 
controls.  
Group 1 
Term 40; 
Group 2 
Term 35. 
Treadmill (including 
VO2max) 
 
Karila(Karila, 
Saulnier et al. 
2008) 
14 To confirm children who have 
survived BPD display lower 
ventilation during exercise than 
healthy children, and to 
determine whether alveolar 
hypoventilation associated with 
exercise induced hypoxemia 
occurred in these children 
Prospective 
cohort 
study 
BPD mean 
10.1 years; 
Controls 
mean 9.9 
years 
20 BPD 18 healthy 
term 
matched 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
Kriemler(Kriemler, 
Keller et al. 2005) 
15 To identify pulmonary and 
exercise related effects of CLD 
versus prematurity without CLD 
in children 5 to 7 years old who 
were born preterm with VL or 
ELBW. 
Cohort 
study 
CLD range 
5.8-7.0 yrs; 
Preterm rge 
6.1-7.8 yrs; 
Term range 
5.5-7.4 yrs 
17 BPD; 14 
preterm (no 
BPD) 
24 term 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
Parat(Parat, 
Moriette et al. 
1995) 
17 Pulmonary function and exercise 
tolerance were evaluated in late 
childhood in two groups of 
Preterm-born children. 
Cohort 
study 
BPD mean 7.9 
years; 
Preterm 7.8 
years. 
6 BPD; 5 
preterms (no 
BPD) 
5 term-born 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
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Pianosi(Pianosi 
and Fisk 2000) 
13 To compare exercise ventilation 
and cardiac output in a sample 
of childhood survivors of lung 
disease of prematurity with 
those of a control group to 
elucidate reasons for lower peak 
VO2. 
Cohort 
study 
BPD mean 8.8 
years; 
Preterm 
mean 8.5 
years; Term 
mean 8.2 
years. 
17 BPD, 15 
preterm (no 
BPD) 
15 term-born 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
Santuz(Santuz, 
Baraldi et al. 
1995) 
15 To evaluate the lung function of 
BPD children at school age and 
to assess the level of exercise 
tolerance of BPD survivors by 
comparing ventilation and gas 
exchange during exercise of BPD 
and healthy children 
Cohort 
study 
BPD group 
mean 8.1 
years; 
controls 
mean 8.1 
years 
12 BPD 16 healthy 
controls 
matched in 
age, height, 
weight and 
level of 
physical 
activity 
 Treadmill (including  
VO2max & VEmax) 
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Table 11: Description of all included studies with preterm-born participants with BPD (oxygen dependency at 36 weeks PMA) compared to term-born controls  
STUDY QUALITY 
SCORE 
OBJECTIVE STUDY 
DESIGN 
AGE (YEARS) STUDY GROUP CONTROL GROUP OUTCOME MEASURES 
Clemm (Clemm, 
Roksund et al. 
2012) 
17 To compare aerobic capacity 
and exercise performance of 
children and adolescents 
born extremely preterm and 
at term, and to relate 
findings to medical history 
and life style factors.  
Two area 
cohort 
studies 
(group 1 (b) 
– 1982-85; 
group 2 (a) 
– 1991-92) 
Group 1  mean 
17.6 years; 
group 2 10.6 
years 
Group 1 preterms 
40 (10 non BPD, 18 
mild & 12 M/S 
BPD); group 2 
preterms 35 (9 non 
BPD, 14 mild & 12 
M/S BPD) 
Age, sex matched 
term-born 
controls.  Group 1 
Term 40; Group 2 
Term 35. 
Treadmill (including VO2max) 
 
Gross (Gross, 
Iannuzzi et al. 
1998) 
19 To assess long-term 
pulmonary outcome of a 
regional cohort of children 
born <32 weeks’ gestation 
compared with a matched 
term control group 
Cohort 
study 
7 years 53 preterm (no 
BPD); 43 preterm 
with BPD  
108 healthy term 
(38 to 42 weeks 
gestation) 
controls 
Treadmill (including VO2max) 
 
 
Jacob (Jacob, 
Lands et al. 
1997) 
17 To describe exercise 
responses in patients with a 
history of severe BPD 
Cohort 
study 
BPD mean 10.6 
years; Preterm 
mean 11.2 
years; Term 
mean 10.6 years 
15 BPD; 15 
preterm (no BPD) 
13 healthy term-
born controls 
Cycle ergometer (including 
VO2max) 
Joshi (Joshi, 
Powell et al. 
2013) 
16 To assess for exercise 
induced bronchoconstriction 
in 8 to 12 year old children 
who had CLD in infancy. 
Cohort 
study 
CLD mean 10.2 
years; Preterm 
mean 10.3 
years; term 
mean 10.5 years 
 
 
29 CLD; 33 preterm 
(no CLD) 
30 health term-
born controls 
Cycle ergometer (including 
VO2max 
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Kilbride(Kilbride, 
Gelatt et al. 
2003) 
11 To assess pulmonary 
function and exercise 
capacity of apparently 
asymptomatic children who 
were born EP 
Longitudinal 
follow up 
study 
ELBW group 
mean 11.3; 
NBW mean 11.1  
47 ELBW children 
<801g (mean 26.1 
wks) 
25 age matched 
NBW children >37 
weeks gestation & 
>2500g BW 
Treadmill (including VO2max) 
O’Dea (O'Dea, 
Logie et al. 2011) 
11 To determine the ventilatory 
response to exercise in term 
and Preterm-born children 
with and without a diagnosis 
of BPD. 
 
Cohort 
study 
9-11 years 29 BPD; 25 
preterms (no BPD) 
28 term-born 
controls 
Treadmill (including VO2max) 
Welsh (Welsh, 
Kirkby et al. 
2010) 
17 To compare maximal 
exercise ventilation 
characteristics and physical 
activity levels at 11 years of 
age in children born EP with 
those of full-term controls. 
Longitudinal 
cohort 
study 
Preterm mean 
11.1 years; 
Term mean 11.0 
years 
Preterm 15 (No 
BPD); Preterm 
(BPD) 23 
38 Term-born 
controls 
Cycle ergometer (including 
VO2max & VEmax) 
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Table 12: Demographics of all included studies (x - refers to missing data) 
STUDY COUNTRY SUBJECTS 
(GENDER) 
GA (WEEKS) BW (GRAMS) MECHANICAL 
VENTILATION 
(DAYS) 
AGE TESTED 
(YEARS) 
YEAR 
OF 
BIRTH 
SURFAC-
TANT 
GIVEN 
METHOD OF 
EXERCISE TESTING 
Abreu (Abreu LR, 
Costa-Rangel RCA 
et al. 2007) 
Brazil 
PT group (8M, 
5F); BPD group 
(9M, 4F); 
Control group 
(9M, 11F) 
PT group mean 
35 SD 2.3 range 
28-36; BPD 
group mean 32 
SD 1.5 range 30-
34; Control 
group term 
PT group mean 
1765 SD 621 
range 850-2800; 
BPD group mean 
1037 SD 229 
range 830-1670;  
Control group X 
PT group mean 
1 SD 2 range 0-
6; BPD group 
mean 11 SD 6.6 
range 3-26 
Control group X 
PT group mean 
8.3 SD 1.11, BPD 
group mean 8.5 
SD 0.97, Control 
mean 8.2 SD 1.14 
1993-
1996 
X Cycle ergometer 
(Biotic-1800) 
Bader(Bader, 
Ramos et al. 1987) 
USA 
10 BPD (6m, 
4F); 
8 control (4M, 
4F) 
BPD group 
mean 29 SEM 
0.7, range 26-
32; control 
group mean 40 
SEM 0.3, range 
39-41 
BPD group mean 
1173 SEM 120, 
range 765-2000; 
control group 
mean 3248 SEM 
166, range 
2500-3960 
BPD group IPPB 
mean 44 days, 
SEM 6, range 7-
65; 
Control group 0 
BPD group mean 
10.4, SEM 0.6, 
range 7.3-12.2; 
Control group 
mean 10.1 SEM 
0.9, range 7.5-14 
1973-
1979 
X Graded exercise 
stress test on 
treadmill 
Baraldi (Baraldi, 
Zanconato et al. 
1991) 
Italy 
VLBW (6M, 9F); 
Controls (6M, 
9F) 
VLBW mean 
32.1 SD 3.0 
range 28-37; 
control mean 
39.9 SD 0.6 
range 37-41 
VLBW mean 
1287 SD 143 
range 1000-
1500; 
Control mean 
3226 SD 167 
range 2140-
3850 
VLBW 7/15 
duration 1-8 
days 
VLBW mean 9.9 
SD 1.8 range 7.8-
12.2; control 
mean 9.7 SD 1.9 
range 7.3 -12.8 
1976-
1979 
X Progressive exercise 
tests on a treadmill 
Barker (Barker, 
Merz et al. 2003) 
BPD group (7M, 
6F); Non BPD 
BPD group 
mean 30.3 
BPD group mean 
1139 range 710-
BPD group 
mean 30.3 
BPD group mean 
9.8 range 8-14; 
1983-
1989 
X Cycle ergometer at 
constant rate for 25 
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Germany group (5M, 8F); 
Control group 
(8M, 5F) 
range 28-33; 
Non BPD group 
mean 33.5, 
range 30-36; 
control group 
term 
1480; Non BPD 
group mean 
1264, range 
900-1490, 
Control group X 
range 7-81; Non 
BPD group 
mean 2.1 days, 
range 0-13; 
control group X 
Non BPD group 
mean 10.4 (range 
8-14), control 
group mean 10.5 
(8-12) 
mins with applied 
protocol of 
increasing watts to 
reach maximal effort 
Burns (Burns, 
Danks et al. 2009) 
Australia 
ELBW 
(31M,23F) 
Controls 
(28M,27F) 
ELBW mean 
26.6 SD 2.1; 
Controls at least 
37 weeks 
ELBW mean 769 
SD 148 
Controls X 
X ELBW mean 12 
years 6 months 
SD 8 months; 
control children 
12 years 5 
months SD 11 
months 
1992-
1994 
X 20m shuttle run test 
Clemm a (Clemm, 
Roksund et al. 
2012)   
Norway 
1990’s cohort 
PT (22F,13M) 
control 
(22F,13M) 
Non-BPD 
(10)mean 28.3 
SD 1.4, mild BPD 
(14) mean 26.5 
SD 1.5, M/S BPD 
(12) mean 25.8 
SD 1.5 
Non-BPD (10) 
mean 1053 SD 
153, mild BPD 
(14) mean 927 
SD 208, M/S 
BPD (12) mean 
851 SD 203 
Non-BPD 
median 0.5 (0-
1.7); Mild BPD 
median 3.0 
range 0-40, M/S 
BPD median 
12.6 rg 1.7-54.5 
PT mean 10.5 SD 
0.4; control mean 
10.6 SD 0.4 
1991-
1992 
18 (51%) 
received 
surfactant 
Incremental 
treadmill test (ELG 
70) 
Clemm b (Clemm, 
Roksund et al. 
2012)   
Norway 
1980’s cohort 
PT (18F,22M) 
control 
(18F,22M); 
 
Non-BPD (9) 
mean 28.3 SD 
1.6, mild BPD 
(18) mean 27.1 
SD 1.1, M/S BPD 
(12) mean 27.0 
SD 1.2 
Non-BPD (9) 
mean 1170 SD 
150, mild BPD 
(18) mean 1023 
SD 192, M/S 
BPD (12) mean 
887 SD 126 
Non-BPD 
median 0.4 (0-
4.8); Mild BPD 
median 8.0 
range 0.8-25.2, 
M/S BPD 
median 25.4 
range 0.7-54 
PT mean 17.5 SD 
1.1; control mean 
17.7 SD 1.2 
1982-
1985 
None Incremental 
treadmill test (ELG 
70) 
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Evenson(Evensen, 
Steinshamn et al. 
2009)  
Norway 
VLBW group 37 
(20M, 17F), 
Controls 63 
(29M, 34F) 
VLBW group 
median 28, 
range 24-35; 
Control median 
40, range 37-42 
VLBW group 
median 1245, 
range 800-1500; 
Control median 
3700, range 
2670-5140 
VLBW X, 
Control 0/63 
VLBW group 
mean 18.2, SE0.1, 
Control group 
mean 18.6 SE 0.1 
1986-
1988 
X Treadmill running 
test (Metamax 
portable system) 
Gross (Gross, 
Iannuzzi et al. 1998) 
USA 
Non BPD group 
(27M, 26F); BPD 
group (23M, 
20F); 
Control group 
(62M, 46F) 
Non BPD group 
mean 29 SD 2; 
BPD group 
mean 27 SD 2; 
Control group 
mean 40.1 SD 
1.1 
Non BPD group 
mean 1270 SD 
306; BPD group 
mean 1053 SD 
356; Control 
group mean 
3565 SD 427 
55% of non BPD 
group median 6 
95% of BPD 
group median 
34 
7 1985-
1986 
0 Graded treadmill 
exercise test 
(Marquette 
Electronics T 2000) 
Hebestreit(Hebestr
eit, Staschen et al. 
2000)  
Germany 
PT (21F, 14M); 
controls (14F, 
6M) 
PT mean 29.7 
SD 1.3; Controls 
mean 39.8 SD 
0.7 
PT mean 1140 
SD 187; Controls 
3425 SD 434 
X PT mean 8.9 SD 
1.4; controls 
mean 9 SD 1.4 
X X Continuous 
incremental exercise 
test on a calibrated 
cycle 
ergometer.(Erometr
X CardiO2 cycle) 
Jacob (Jacob, Lands 
et al. 1997) 
Canada 
BPD (6M, 9F); 
Non BPD (6M, 
9F); Controls X 
BPD group 
mean 28.7 SD 
2.1; Non BPD 
group mean 
28.5 SD 2.6; 
Control group 
term 
BPD group mean 
1110 SD 328; 
Non BPD group 
mean 1044 SD 
262.9 
Control group X 
BPD group days 
of ventilatory 
assistance 
median 56.0, 
IQR 21.0-77.0; 
Non BPD group 
days of vent. 
assistance 
median 8.0, IQR 
BPD group mean 
10.6 
SD 1.7; Non BPD 
group mean 11.2 
SD 1.5 
Control group 
10.6 SD 2.1 
1981-
1987 
X Symptom limited 
progressive exercise 
test on a cycle 
ergometer 
  
 
112 
 
4.0-32.0; 
Control group X 
Kilbride (Kilbride, 
Gelatt et al. 2003) 
USA 
All ELBW (16M, 
34F) 
Control (11M, 
14F) 
ELBW mean 
26.1 SD 1.6 
NBW >37 
ELBW mean 701 
SD 80 
NBW >2500 
ELBW mean 33 
days SD 20 
range 0-78 
ELBW group 
mean 11.3, SD 1.6 
NBW mean 11.1 
SD 1.3 
1983-
1989 
X Graded treadmill 
test 
Joshi (Joshi, Powell 
et al. 2013) 
UK 
29 BPD (17M, 
12F) 
33 PT (15M, 
18F) & 30 Term 
(15M, 15F)  
BPD mean 27.3 
SD 2.1 
PT mean 30 SD 
2.0 
Term mean 39.8 
SD 1.5 
BPD mean 1100 
SD 400 
PT mean 1500 
SD 400 
Term mean 
3400 SD 500 
BPD median 28 
range 5-80 
PT median 3 
range 0-50 
Term none 
BPD 10.2 SD 1.4 
PT 10.3 SD 1.1 
Term 10.5 SD 1.5 
X BPD – 
100% 
PT – 45% 
Term -0 
Cycle ergometer 
(Jaeger) 
Karila(Karila, 
Saulnier et al. 2008) 
France 
20 BPD (13M, 
7F) 
18 controls 
(8M, 10F) 
BPD group 
mean 31 SD 2; 
Control X 
BPD group mean 
1441 SD 523 
Control X 
BPD group 
mean duration 
mechanical 
ventilation 
145.1 days SD 
130.1 not 
counting 
nocturnal home 
ventilation 
which was used 
by 7 children for 
mean 21.1 
months SD 9.3  
BPD group mean 
10.1 SD 2.3; 
control 9.9 SD 2.0 
X 6 in BPD 
group 
received 
Cycle ergometer 
(Marquette 
Electronics) 
Kriemler (Kriemler, 
Keller et al. 2005) 
Canada 
BPD group (7M, 
10F); PT group 
(8M, 6F); 
BPD group 
mean 27.1 SD 
1.9; PT group 
BPD group mean 
970 SD 285; PT 
group mean 
BPD mean 30.3 
SD 19.4 
BPD group range 
5.8-7.0; PT group 
range 6.1-7.8; 
1988-
1990 
X Graded exercise test 
on cycle ergometer 
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Control group 
(15M, 9F) 
mean 28.3 SD 
1.7; Control X 
1108 SD 202; 
control group 
mean 3455 SD 
595 
controls range 
5.5-7.4 
O’Dea (O'Dea, 
Logie et al. 2011) 
Australia 
No details BPD & PT 
groups <32 wks 
No details No details 9-11  No 
details 
X Incremental 
treadmill exercise 
test 
Parat (Parat, 
Moriette et al. 
1995) 
France 
BPD group 
(6M);non BPD 
group (5M); 
Control group 
(5M) 
BPD mean 29.6 
SD 2.8; non-BPD 
mean 30.3 SD 
1.7; control 
term 
BPD mean 1367 
SD 548; non-
BPD 1440 SD 
376; control X 
BPD mean 48 
days SD 25.4; 
non-BPD mean 
0.6 days SD 
0.73; control X 
BPD mean 7.9 SD 
0.6; non-BPD 
mean 7.8 SD 0.22; 
controls X 
1986 X Cycle ergometer 
Pianosi (Pianosi 
and Fisk 2000) 
Canada 
BPD group (9M, 
8F); 
Non BPD group 
(9M, 6F); 
Controls X 
CMV BPD  
median 27, IQR 
26.8,29 
HFV BPD 
median 28, IQR 
26, 28.8; CMV 
non BPD  
median 29, IQR 
28,30 
HFV non BPD 
median 29.5 IQR 
27.5, 31; 
Control term 
CMV BPD  
median 1060, 
IQR 888, 1373 
HFV BPD median 
1025, IQR 895, 
1155; CMV non 
BPD  median 
1140, IQR 1045, 
1280 
HFV non BPD 
median 1400, 
IQR 1038, 1765 
Control X 
CMV BPD  
median 13 days, 
IQR 8, 44 
HFV BPD 
median 24 days, 
IQR 9, 33; CMV 
non BPD  
median 5.5 
days, IQR 5,19 
HFV non BPD 
median 11 days, 
IQR 6.5, 25 
Control X 
8-9 1986-
1987 
X Progressive exercise 
test on cycle 
ergometer. 
Santuz(Santuz, 
Baraldi et al. 1995) 
Italy 
BPD group (9M, 
3F) 
Control group 
BPD group 
mean 30, SD 2, 
range 27-32, 
BPD group mean 
1400, SD 335, 
range 890-1900, 
BPD group 
12/12 ventilated 
mean 20 SD 15, 
BPD group mean 
8.1 SD 1.8, range 
6-12, controls 
1981-
1987 
X Step-wise exercise 
test on treadmill 
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(11M, 5F) Control group 
mean 39, SD 1, 
range 37-40 
Control group 
mean 3335, SD 
418, range 
2800-4100 
median 17, 
range 7-60 
Control group X 
mean 8.1 SD 1.5, 
range 6-12 
Smith(Smith, van 
Asperen et al. 2008) 
Australia 
PT – 53% F 
Control – 41% F 
PT mean 26.9 
SD 1.7, Controls 
mean 39.4 SD 
1.2 
PT mean 862.4 
SD 160.9, 
Controls mean 
3400.5, SD 
512.5 
PT 100 required 
intubation 
PT mean 10.1 SD 
1.1, Control group 
mean 11.6 SD 0.8 
1992-
1994 
X 20m shuttle run tests 
Svien (Svien 2003) 
USA 
PT (11F, 11M); 
control (11F, 
11M) 
PT mean 32 
range 30-35; 
control mean 40 
range 38-40 
PT mean 1884 
range 1248-
2460; Control 
mean 3435 
range 2700-
4460 
X PT mean 102 
months range 84-
130; control 
mean 106 months 
range 84-135 
X X Graded treadmill 
test 
Vrijlandt(Vrijlandt, 
Gerritsen et al. 
2006) 
Holland 
BPD group (8M, 
0F) 
Control group 
(16M, 32F) 
Whole PT group 
including BPD 
group mean 30 
SD 2, range 26-
36, Control 
group term 
range 37-42 
Whole PT group 
including BPD 
group mean 
1246 SD 232, 
range 720-1750, 
Control group X 
Whole PT group 
including BPD 
group mean 6.3 
days SD 12, 
range 0-51, 
Control group X 
Whole PT group 
including BPD 
group mean 19 
SD 0.3, range 19-
20, Control group 
mean 20.8 SD 1.2, 
range 18-22 
PT 
group 
1983 
0/42 Incremental cycle 
ergometer test (type 
ER 900 L) 
Welsh (Welsh, 
Kirkby et al. 2010) 
UK 
Preterm (no 
BPD) (5M, 10F) 
BPD (6M, 17F) 
Control group 
(15M, 23F) 
Preterm (all) 
mean 25 range 
24.7-25.1 
Control group 
term 40 
Preterm (all) 
mean 740 SD 
107 control 
group mean 
3360 SD 527 
No details given Preterm (no BPD) 
mean 11.1 SD 0.5 
BPD mean 11.1 
SD 0.3 Control 
group mean 11.0 
SD 0.5 
1995 34/38 
Preterms 
and 0 
control 
group 
Braked cycle 
ergometer 
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3.3.2 Risk of bias 
All 22 studies scored above 10 out of a possible 20 for quality score, ranging from 11 to 19 
(individual study scores can be seen in tables 8-11).  The representativeness of the studies 
showed a moderate risk of selection bias, as only 3 studies scored the maximum 4 points, 
although 16 studies scored the maximum 3 points for their selection of an appropriate control 
group. The exposure ascertainment has a low risk of bias across the studies, as 16 studies 
scored the maximum 3 points for providing details of how the assessment of measuring the 
gestation of the baby at birth was performed.  10 studies gave no description of how outcomes 
(measurement of O2max) were ascertained, however 12 studies gave full details of outcome 
ascertainment and scored 3 or more out of a maximum 4 points.  Finally, the complete follow 
up of subjects showed a high risk of attrition bias, with only 4 of the 22 studies reporting these 
details.  In 4 studies, there was no statement about follow up.  The funnel plots showed a low 
risk of publication bias with symmetric distribution of the study results and only a few studies 
lying outside the 95% confidence interval lines (Figures 9-10).  
V
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Figure 9: Funnel plot of comparison of all preterm-born groups (including CLD) vs. term-
born controls, outcome: VO2 max [ml/kg/min].  
  
SE,standard error; MD,mean difference. 
 
Figure 10: Funnel plot of comparison of preterm-born participants with CLD compared to 
term-born controls, outcome: VO2 max [ml/kg/min]. 
 
SE,standard error; MD,mean difference. 
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3.3.3 Synthesis of results 
The main results are shown in Figures 11-15.  Figure 11 compares the preterm and term-
born groups; 14 of 20 studies showed a lower O2max in individuals born preterm.  The pooled 
estimated mean difference in O2max was -2.20 ml/kg/min (95% CI -3.70, -0.70) and the 
standardised mean difference (SMD) was -0.33 (95% CI -0.58, -0.09) for the preterm-born 
group (which included CLD cases) compared to term-born controls.  When CLD cases were 
excluded, the estimated mean difference was -2.26 ml/kg/min (95% CI -4.44, -0.07) and the 
SMD was -0.28 (95% CI -0.56, -0.01) between the preterm and term-born groups (Figure 12).  
For the CLD28 and CLD36 groups when compared to term controls, the mean differences were -
3.04 ml/kg/min (95%CI -5.48, -0.61) (Figure 13), SMD -0.31 (-0.57, -0.06) and -3.05ml/kg/min 
(95%CI -5.93, -0.18) (Figure 14), SMD -0.44 (95%CI -0.87, -0.02) respectively. Figure 15 shows 
the difference for mixed preterm studies (some preterm only, others CLD only) compared to 
term control for minute ventilation at maximal exercise and the pooled mean difference for 
VEmax were -6.24 l/min (95%CI -10.16, -2.32), SMD -0.54 (95%CI -0.75, -0.33).  However, the 
groups included in this analysis were highly heterogeneous as they consisted of different 
cohorts of participants, used different methodology and the results were not adjusted for the 
weight of the children, which in some studies removed any significant difference.  By 
combining different study populations, for example studies with only preterm-born children 
excluding those with CLD and studies with only preterm-born children with CLD, leads to 
clinical diversity and this can lead to statistical heterogeneity, making it difficult to interpret 
the results of a meta-analysis. Thus Figure 15, showing the results of the meta-analysis for 
VEmax, was excluded from my published work.   There was insufficient data for a meta-
analysis of the VCO2 max.   
V
V
  
 
118 
 
Figure 11: All preterm-born groups (including participants with CLD) compared to term-born controls (absolute mean difference for VO2max )  
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Figure 12: Only preterm-born groups (excluding groups with CLD) compared to term-born controls (absolute mean differences for VO2 max). 
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 Figure 13: CLD (oxygen-dependency at 28 days of age) compared to term controls (absolute mean differences for VO2 max). 
 
 
 
 
 
 
Figure 14: CLD (oxygen-dependency at 36 weeks PMA) compared to term controls (absolute mean difference for VO2 max). 
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Figure 15: All preterm-born groups (including groups with CLD) compared to term-born controls (absolute mean difference for VEmax). 
                         
 
 
 
Key to Figures 11-15: 
1 = Cycle ergometry 
2 = Treadmill 
3 = 20m shuttle run 
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There was a wide range of absolute values for the O2max, although the standardised 
mean differences (SMD) for all studies were similar.  The lowest values for the O2max were 
shown in the study of Kriemler et al for the preterm-born (excluding CLD) group with a mean 
O2max of 29 ml/kg/min (SD 9.73) and Joshi et al for the term group with 31.1 ml/kg/min (SD 
8.42) (Kriemler, Keller et al. 2005, Joshi, Powell et al. 2013).  Both these studies used cycle 
ergometry to assess the maximal oxygen consumption.  The highest values were recorded by 
the study of Evensen et al for the preterm-born group with a mean VO2max of 48.8 ml/kg/min 
(SD 7.92) and O’Dea et al for the term group with 50.3 ml/kg/min (SD 5.9) (Evensen, 
Steinshamn et al. 2009, O'Dea, Logie et al. 2011).  These studies used treadmill tests to 
measure the maximal oxygen consumption. A sensitivity analysis comparing the mean 
difference and SMD between exercise testing methods used shows that treadmill testing is 
more likely to identify a difference than cycle ergometry (table 13). However the 20m shuttle 
run test was most likely to identify a difference, although there may be methodological 
problems with using this test in preterm-born survivors.   
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 Table 13: Sensitivity analysis for each group vs. term-born controls according to exercise test used in the studies 
 
 
Exercise 
Test: 
Cycle ergometer: Treadmill: 20m shuttle run test: 
 Mean difference 
ml/kg/min 
(95%CI) 
Standardised 
mean difference 
(95%CI) 
Total 
preterms 
Total 
controls 
Mean difference 
ml/kg/min 
(95%CI) 
Standardised 
mean difference 
(95%CI) 
Total 
preterms 
Total 
controls 
Mean difference 
ml/kg/min 
(95%CI) 
Standardised 
mean difference  
(95%CI) 
Total 
preterms 
Total 
controls 
Preterm 
(including 
CLD) 
-0.84 
(-3.29, 1.60) 
-0.11  
(-0.43, 0.20) 
183 215 -2.86  
(-5.45, -0.26) 
-0.38  
(-0.73, -0.04) 
269 335 -3.96  
(-5.24, -2.68) 
-0.96  
(-1.38, -0.54) 
179 89 
Preterm 
(excluding 
CLD) 
-1.32  
(-4.51, 1.86) 
-0.16  
(-0.55, 0.22) 
112 148 -3.24  
(-6.55, 0.07) 
-0.42  
(-0.84, 0.01) 
134 259 -3.38  
(-5.42, -1.34) 
-0.63  
(-1.03, -0.23) 
48 55 
CLD28 -2.34  
(-5.34, 0.66) 
-0.26  
(-0.62, 0.10) 
86 89 -4.35  
(-8.92, 0.21) 
-0.40  
(-0.82, 0.01) 
54 99 - - - - 
CLD36 -1.16  
(-7.33, 5.01) 
-0.18 
(-1.09, 0.73) 
62 77 -4.20  
(-7.42, -0.99) 
-0.59  
(-1.08, -0.10) 
109 236 - - - - 
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3.4 Discussion 
3.4.1 Clinical significance of results 
Overall the results of my systematic review and meta-analysis show that children born 
preterm with or without CLD have a lower O2max than term-born controls. The majority of 
individual studies did not show a significant difference but the pooled results show a 
significant although small effect size.  An effect size of -0.33 is between ‘small’ (-0.2) and 
medium (-0.5) and accounts for a 13% difference between preterm and term-born groups 
(Cohen 1988).  Thus it is likely that there is very little clinical significance of these results, 
despite preterm-born children having reduced lung function, they are still capable of achieving 
near normal exercise capacity.  The differences were similar between all preterm-born groups 
ranging from -2.20 (-3.70, -0.70) ml/kg/min (SMD -0.33 95%CI -0.58, -0.09) in the preterm-born 
group to -3.05 (-5.93, -0.18) ml/kg/min (SMD -0.44 95%CI -0.87, -0.02) in the CLD36 group. 
There was much variation for the absolute values of O2max which ranged from 31.1 (8.42) 
to 50.3 (5.9) ml/kg/min in the term group and from 29 (SD 9.73) to 48.8 (7.92) ml/kg/min in 
the preterm-born group, however this was accounted for by using the standardised mean 
differences to assess the effect size between studies.  The lower values for O2max were 
associated with cycle ergometry and higher ones with treadmill testing as has previously been 
shown in studies using the same subjects (Hermansen and Saltin 1969, Abrantes, Sampaio et 
al. 2012).  Our sensitivity analysis also shows that treadmill testing is more likely to identify 
differences in O2max compared to cycle ergometry.   
O2max is affected by gender, age, body size and composition, training status and 
hereditary factors.  Absolute values of O2max (litres/min) show an increasing trend from 8 to 
V
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16 years in girls of 80% and 150% in boys (Armstrong and Welsman 1994).  The conventional 
method to express O2max is as a ratio per kilogram body mass, which should control for the 
differences in body size during growth from early childhood through to adulthood.  Boys 
O2max relative to body mass stays the same from 8-18 years whereas for girls the relative 
O2max decreases with increasing age (Armstrong and Welsman 2007).  Reported values for 
healthy children are approximately 38±7 ml/min/kg for girls aged 6-11 years and 34±4 
ml/kg/min for girls >11 years old; and approximately 42±6 ml/kg/min in boys <13 years old and 
50±8 ml/kg/day in older boys (Cooper, Weiler-Ravell et al. 1984).  The difference in gender for 
exercise capacity results may be due to boys having a greater muscle mass and higher 
haemoglobin concentration, particularly during adolescence (Armstrong, Tomkinson et al. 
2011). 
The importance of being able to achieve a near to normal exercise capacity means that 
children born preterm are able to reduce their risk of cardiovascular disease in later life.  It has 
been shown that children and adolescents who are less active or exercise less are more likely 
to become adults who are inactive and this may place them at greater risk of cardiovascular 
morbidity (Lakka, Venäläinen et al. 1994, Telama, Yang et al. 2005, Kjønniksen, Torsheim et al. 
2008).  On reviewing the studies included, the influence of age, gender of subjects, and the 
method of exercise testing used can be clearly seen, as studies with older subjects and more 
male participants have higher relative values of O2max.  It is also important to note that 
studies included subjects from different eras (birth years in the 1980s, 1990s and 2000s), 
which means the neonatal management may have affected their outcomes.  In our previous 
systematic review on lung function in survivors of preterm birth we were able to identify a 
pattern of improvement for the year of birth, which may imply that children born more 
V
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recently have better outcome for lung function than those born in the 1970s, 1980s or 1990s 
(Kotecha, Edwards et al. 2013).  This may be due to the changes in neonatal practise that have 
occurred over the last 30 years or due to the evolving pathology of CLD, which is often now 
termed ‘new’ or ‘old’ BPD (Kramer 2008).  For the systematic review on exercise capacity I was 
not able to perform analyses based on the year of birth, age of participants or testing method 
used.  So the use of the SMD as an effect size helps to remove these differences in study 
design and indicates that overall there is a small difference in O2max between subjects born 
preterm and term controls.  Of note Clemm et al showed no difference in aerobic capacity 
between subjects born preterm and at term and this had not changed over the 2 decades 
studied (Clemm, Roksund et al. 2012). 
Of the excluded studies most of them did not give results for O2max so could not be 
included in the meta-analysis.  However, contacting the authors of excluded studies may have 
provided data to allow them to be included in the systematic review and meta-analysis.  
Narang et al showed no difference for exercise capacity between preterm-born subjects and 
term-born controls, however they measured O2max in ml/min/m
2 and I was unable to 
convert the data to ml/kg/min (Narang, Bush et al. 2009).   Also the accuracy of using 
estimated body surface area in children is not clear, as it has been shown to be inaccurate in 
obese adults and should be used with caution in children who are underweight (Sharkey, 
Boddy et al. 2001, Verbraecken, Van de Heyning et al. 2006).  Other excluded studies showing 
a significant difference, however used different methods of exercise testing.  For example 
Rogers et al assessed ELBW adolescents using the modified Canadian Aerobic Fitness Test, 
which gives a calculated result for aerobic capacity and they identified a significantly reduced 
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exercise capacity in adolescents born ELBW compared to those born normal weight and at 
term (Rogers, Fay et al. 2005).   
The pulmonary ventilation at maximal exercise also showed a moderate difference 
between the preterm groups and term-born controls (SMD -0.54; 95%CI -0.75, -0.33).  Adults 
have resting VE values of 6-10 l/min and VEmax ranges from 100-170 l/min in most adults.  
Normally the VE is adjusted for weight in children (l/min/kg) but this was not available in all 8 
studies that gave VE max results, so it is difficult to assess the significance of having a lower 
VEmax. Also there was a great deal of heterogeneity between the studies included, so it is not 
possible to discuss in detail how ventilatory thresholds affect the exercise capacity of children 
born preterm.  Those studies that have included ventilatory measures appear to suggest that 
exercise capacity is not affected by any reduction/abnormality in ventilatory response during 
exercise.   
3.4.2 Respiratory symptoms, body composition and activity levels  
Preterm-born children have been shown to have increased respiratory symptoms, 
decreased lung spirometry values particularly of the large and medium sized airways (Kotecha, 
Watkins et al. 2012, Kotecha, Edwards et al. 2013). They may also have increased respiratory 
infections in infancy (Greenough, Limb et al. 2005) and have been reported to have increased 
arterial systolic blood pressure in childhood (de Jong, Monuteaux et al. 2012). Furthermore, 
they have altered body composition (Bott, Beghin et al. 2006) and O2max as expressed in 
terms of body mass has a tendency to be underestimated in heavier subjects and favour 
lighter subjects (Owens and Gutin 1999). Taken together these deficits could potentially have 
an effect on these children’s exercise capacity especially those who developed CLD. However, 
our findings in children with CLD36 show a maximum deficit of -3.05 ml/kg/min with a SMD of -
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0.44 (95%CI -0.87, -0.02). These findings are unlikely to be of great clinical significance 
especially as only eight of the 22 studies included showed a significant difference between the 
preterm and term-born groups.  On reviewing the details of the studies with significant results, 
they included all three exercise-testing methods; children aged 8-12 years of age and birth 
years from 1981-1995.  They did all have average gestational age of <30 weeks for their 
preterm groups and so it might be those born extremely preterm have a lower exercise 
capacity compared to term-born controls.   
Self-reported activity in preterm-born children especially those who had BPD in infancy has 
been reported to be lower (Joshi, Powell et al. 2013), although formal assessment of activity in 
preterm-born infants has been less thoroughly investigated with the EPICure study showing no 
differences in physical activity measures using accelerometers (Welsh, Kirkby et al. 2010). 
More recently Lowe et al have also shown no difference in physical activity for different 
gestational groups using data from the ALSPAC study (Lowe, Watkins et al. 2015).  Pianosi et al, 
who reported lower O2max in preterm-born subjects (mean gestational age 28.3 weeks), 
concluded that preterm-born children have reduced lean body mass and that this may be the 
reason for lower oxygen uptake by muscles during exercise (Pianosi and Fisk 2000).  Other 
factors that may influence physical activity include the child’s coordination abilities.  Burns et 
al demonstrated reduced O2max in an extremely low birth-weight cohort (mean gestational 
age 26.5 weeks) and showed this correlated strongly with poor motor coordination but did not 
measure respiratory function (Burns, Danks et al. 2009).  A review of the literature by 
Armstrong et al did not find any relationship between physical activity and O2max, although 
O2max can be increased with exercise training (Armstrong, Tomkinson et al. 2011).  Welsh et 
al reported significantly lower O2max in preterm-born subjects (mean gestational age 25 
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weeks) but noted that physical activity levels did not explain these differences. Instead, they 
showed that poor growth and development were associated with lower exercise capacity 
(Welsh, Kirkby et al. 2010).  Santuz et al demonstrated the greatest difference in O2max 
from the included studies, but only for preterms with BPD, suggesting that the underlying 
neonatal lung injury may lead to longer term deficits of gas exchange (Santuz, Baraldi et al. 
1995).    
A lower O2max may indicate a problem with gas exchange in children born preterm 
especially those with CLD, but the overall meta-analysis data would suggest this is likely to be 
marginal.  The majority of children born preterm have near to normal exercise capacity, 
although it has been shown that there are changes in their ventilatory patterns during exercise 
especially those with BPD (Pianosi and Fisk 2000, Bhandari and McGrath-Morrow 2013, Joshi, 
Powell et al. 2013).  Surprisingly despite the reduced lung function (%FEV1) in preterm-born 
children there is only a minimal reduction in O2max and thus some remodelling of the 
pulmonary alveolar-capillary apparatus is very likely as suggested by recent reports using 
hyperpolarised helium with MRI scanning (Narayanan, Owers-Bradley et al. 2012). So despite 
the evidence of small and large airway deficits in preterm-born survivors the exercise capacity 
is near to normal.  However in some studies the preterm-born participants have shown a 
normal VEmax, which would suggest the ventilation and oxygenation are not the limiting 
factors for exercise capacity (Vrijlandt, Gerritsen et al. 2006, Welsh, Kirkby et al. 2010).   
3.4.3 Study limitations 
There was a large amount of heterogeneity in the included studies. Factors including 
different exercise protocols, differing populations, varying ages of the study participants at 
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time of testing, different methods for reaching maximal exercise and variation in the neonatal 
management during different epochs are likely to explain the heterogeneity. The accuracy of 
the recording/measurement of gestational age at birth used by each study may not be reliable 
as the gold standard would be to assess using antenatal u/s scan and some studies were 
conducted prior to u/s dating scans.  All the studies have excluded subjects with severe 
disabilities due to the coordination and physical strength needed to complete the exercise 
tests.  Preterm-born subjects with physical disabilities may have severe CLD and their inclusion 
may have had a significant impact on the results, however many studies included in our review 
excluded all patients with physical disabilities.  Also the definitions of CLD/BPD used by each 
included study varied and there were differences, which means the severity of CLD of the 
included participants ranged from mild to severe, which may have skewed the results of the 
data for the CLD groups.  I comprehensively reviewed the literature and am confident of 
having included all major studies. There was little publication bias thus I am confident of the 
overall findings of this review. The quality of the studies included in our analysis was 
reasonable. I was limited by the quality of the published information. One study with data 
from two separate cohorts, only presented results in graph format and the data were 
estimated, so this may have led to small errors, which are unlikely to substantially affect the 
main results (Clemm, Roksund et al. 2012). 
There is considerable variation in the value of O2max (29-50 ml/kg/min) between studies 
possibly reflecting different exercise protocols used and the different populations studied 
(from 5 to 21 years old), however these values are within the normal range.  Studies 
comparing the methods used to predict O2max have shown that a treadmill-running test 
gives higher results by 5-15% than the cycle ergometer test and the sensitivity analysis 
V
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confirmed this finding (Keren, Magazanik et al. 1980, Grant, Corbett et al. 1995, LeMura, von 
Duvillard et al. 2001, Abrantes, Sampaio et al. 2012).  The ability of preterm-born individuals to 
perform exercise capacity tests may be affected not only by their physical abilities but also the 
cognitive impairment associated with preterm birth (Bhutta, Cleves et al. 2002).  This is 
especially for the shuttle run test which requires a higher degree of concentration and 
attention from participants, so preterm-born subjects maybe at a disadvantage, given they 
have been shown to have difficulties with their executive function and attention levels 
(Mulder, Pitchford et al. 2009).  The shuttle run test was designed as a field test for athletes 
and so it is not recommended for research testing for a cohort of children or adults with 
possible physical difficulties, although it has been shown to be a reliable substitute for lab-
based tests in children with developmental difficulties (Cairney, Hay et al. 2010).  Also the 
results of tests are based on estimates and so is an indirect measure of the O2max . In my 
review only two studies used the shuttle run test and both identified a significant difference, 
but they are only included in the analysis for the first group (all preterm-subjects including CLD 
– therefore mixed cohorts) when the two studies are removed from the analysis this did not 
alter the message as the result continued to show a significant difference even with the two 
studies removed.   Three studies from my systematic review assessed children younger than 8 
years old using the cycle ergometry test and it has been suggested that cycle ergometry be 
avoided in younger children as they may have under developed knee extensors (Roitman 
2001).  It has been suggested that younger children may be better suited to doing the treadmill 
test, which may give more accurate results as shown by van der Cammen-van Zijp (van der 
Cammen-van Zijp, Ijsselstijn et al. 2010).  However LeMura et al showed that both cycle 
ergometer and treadmill are effective tests for assessing exercise capacity in children aged 5-6 
years (LeMura, von Duvillard et al. 2001).  
V
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3.5 Conclusion 
Despite the limitations, the meta-analysis for O2max shows that preterm-born subjects 
with or without CLD have marginally lower (<13%) exercise capacity than term-born control 
subjects.  The differences in O2max are small (-2.20 ml/kg/min to -3.05 ml/kg/min; SMD -
0.33 to -0.44) and it would appear that despite the reduced lung function of preterm-born 
subjects with or without CLD, they are able to adapt and achieve near normal exercise 
capacity. However this may be at the expense of the preterm-born subjects, especially those 
with CLD, using more of their ventilatory reserve as shown by Joshi et al (Joshi, Powell et al. 
2013). The follow up programs of preterm-born infants should aim to use similar exercise 
testing protocols with well-defined populations and clear criteria for maximal exercise testing.  
Future research needs to assess the longer-term impact of the slightly reduced deficit in 
exercise capacity.  The physical activity of preterm-born children also requires further 
investigation, to review whether training can improve the exercise capacity and possibly the 
lung function of those born preterm.  Finally it is important to assess the same cohorts of 
participants in later life to analyse for evidence of tracking.  This would help to answer the 
research question: does a small difference in O2max in younger life equate to a much larger 
difference in later life and could this potentially be prevented? 
 
3.6 Summary of Chapter Three 
This chapter has outlined a systematic review and meta-analysis of exercise capacity of 
children and adults born preterm and shown that there is only a minor reduction in exercise 
V
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capacity due to preterm birth, despite survivors of preterm birth having reduced lung function.  
The systematic review also identified the difficulties surrounding the three types of exercise 
testing used and how there needs to be a standardized international protocol so that in the 
future a more accurate meta-analysis can be performed.  Importantly it is evident that 
preterm-born survivors can achieve near normal exercise capacity and so they should be 
encouraged to partake in physical activity as this may have a beneficial effect for their health 
in the long term.  
Future research needs to specifically focus on the exercise capacity of preterm-born 
adults, particularly those older than 30 years and to assess whether their O2max remains 
within normal range from longitudinal studies.  Recently Clemm et al re-assessed the exercise 
capacity of their cohort of extremely preterm-born young adults (aged 25 years) and showed 
that O2max decreased similarly in both preterm and term-born subjects, but was still within 
normal range (Clemm, Vollsaeter et al. 2014).  Interestingly they showed no association 
between poor lung function, either %FEV1 or FVC, and reduced O2max.  However they did 
show that individuals, born preterm or at term, who were involved in regular physical activity 
had a positive relationship with O2max.  Thus it is important that an international 
standardised method of exercise testing is adopted by all researchers and then future research 
in this area, needs to focus on the impact of physical activity on exercise capacity in adults 
born preterm and whether exercise helps to reduce risk of developing cardiovascular disease 
or helps to improve lung function.   
 
 
V
V
V
V
  
 
134 
 
4.0 CHAPTER FOUR: RESPIRATORY OUTCOMES OF CHILDREN BORN 
PRETERM STUDY 
 
This chapter presents the analysis of RANOPS data, specifically looking at the respiratory 
outcomes of children born preterm.  I wrote the research protocol and established the cohort 
of study participants, which included setting up a large database of respiratory outcomes and 
other health related information from the included participants.  The study has been published 
with myself as the first author online in Plos One in May 2016 (copy in the appendix, pages 
264-71). The co-authors include my doctoral supervisors and the child health research team at 
Cardiff University. The main hypothesis for the research in this chapter and the next was: 
To test the hypothesis that children who were born preterm have greater respiratory 
morbidity, such as wheezing and hospital admissions, compared to children born at term. The 
main aims were: 
1. To establish a Welsh cohort of preterm-born children with matched term-born 
controls (RANOPS) to investigate the long-term health outcomes according to 
gestational age at birth. 
2. Specifically for this chapter was to use the data from RANOPS, to test if children 
born preterm have increased respiratory symptoms, increased treatment with 
inhalers and increased health care utilisation, mainly due to respiratory morbidity, 
in infancy and early childhood compared to term-born controls.   
It should be noted that when the protocol for the RANOPS study was written the standard 
definition for term birth was 37 to 43 weeks of gestation and so chapter 4 compares the 
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preterm-born groups to this definition of term birth.  However in the last few years new 
terminology has been suggested and now term birth is subdivided into early term (37-38 
weeks of gestation), full term (39-41 weeks of gestation) and late term (>42 weeks of 
gestation), so I re-analysed the data from RANOPS to assess for any associations with early 
term birth.   
 
4.1 Introduction 
The long-term health outcomes of children born extremely preterm, especially those with 
CLD, have been well documented.  This includes data from cohorts of preterm-born children 
from eras that were pre- and post- the introduction of surfactant and the modernization of 
ventilatory techniques on neonatal intensive care units in developed countries.  However data 
on the health outcomes of children born late or moderate preterm are limited, even though 
they make up 75% of all preterm births (Moser, Macfarlane et al. 2007).  As mentioned in the 
Introduction chapter, the rates of preterm birth in some developed countries is rising, 
although in the England and Wales preterm births account for 6-7% of the total live birth rate 
each year and this has remained the same for the last decade. In the US a charity for newborn 
babies, March of Dimes, has set a challenge to reduce the preterm birth rate in the US to 5.5% 
by 2030 as they recognise the lifelong morbidities and disabilities associated with being born 
preterm (McCabe, Carrino et al. 2014). Thus the future morbidity of these preterm-born 
children is an important worldwide issue that requires good quality research, so that the 
potential additional burden on health services can be identified. Our Child Health research 
group has already published several articles on the respiratory outcomes of survivors of 
preterm birth, and has shown reduced lung function in childhood and adulthood, including 
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those born late preterm (Kotecha, Watkins et al. 2012, Kotecha, Edwards et al. 2013).  We 
noted that the changes in respiratory physiology may lead to a greater risk of respiratory 
symptoms such as wheezing, and suggested further research into the symptoms and potential 
respiratory diseases of these children was required.  Paranjothy et al also identified an 
increased risk of acute respiratory admissions to hospital up to 5 years of age for those born 
preterm, but were unable to account for the symptoms or treatment of these individuals 
(Paranjothy, Dunstan et al. 2013). 
The main respiratory symptom in children is wheezing and childhood wheezing is a 
worldwide problem with increasing prevalence and on-going debate over the use of diagnostic 
labels, such as asthma, especially for young children (Patel, Järvelin et al. 2008, Anandan, 
Nurmatov et al. 2010, Granell, Sterne et al. 2012). Recently a systematic review and meta-
analysis concluded that prematurity at birth is associated with increased risk of wheezing 
disorders during childhood, including asthma (Been, Lugtenberg et al. 2014). In many studies, 
the respiratory outcome assessed is given the label ‘asthma’, but it would appear that 
wheezing and other respiratory symptoms associated with preterm birth have a separate 
phenotype.  (Even the use of the term phenotype has caused discussion amongst researchers 
with some using it to represent the underlying disease process and others the symptoms and 
features of the disease (Spycher, Silverman et al. 2010).)  Thus the resulting respiratory 
morbidity from long-term survival of preterm birth requires a new diagnostic label, which 
reflects the long-term effects on health outcomes of being born prematurely. A possibility is to 
use the term prematurity-associated wheeze as this clearly states the wheezing is associated 
with preterm birth.  In terms of the use of diagnostic labels, it should be noted that some of 
the outcome data to date have been based on identifying preterm-born subjects by inhaler 
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medication use from population-based registries, which has a risk of selection bias and thus 
potential over diagnosis of asthma and higher rates of treatment (Damgaard, Hansen et al. 
2015).  
Identifying and establishing a cohort of all preterm-born subjects within a population is 
important as many studies are now showing a gradient effect with gestational age, so that the 
lower the gestational age the greater the risk of morbidity (Boyle, Poulsen et al. 2012).  More 
recently some studies are only reporting the outcomes of children born late preterm (>32 
weeks of gestation) compared to term controls and not giving any data on very preterm-born 
children.  This may be due to the fact that when assessing extremely preterm-born children, 
they are more likely to have underlying chronic lung disease of prematurity (CLD) and 
therefore be at greater risk of respiratory related problems (Jobe 2011, Kotecha, Watkins et al. 
2012). The studies by Kotecha et al and Paranjothy et al analysed their data by gestational 
groups showing that late and moderate preterm-born (32-36 weeks of gestation) children 
were also at risk of having deficits in %FEV1 and were more likely to have frequent admissions 
to hospital for respiratory related illnesses when compared to term-born children (Kotecha, 
Watkins et al. 2012, Paranjothy, Dunstan et al. 2013). Other studies have assessed preterm-
born children as a whole cohort (all those born less than 37 weeks of gestation) compared to 
term-born controls.  Thus Rosas-Salazar et al reported preterm birth is strongly associated with 
atopic asthma, although in a highly selected cohort of Puerto Rican children (Rosas-Salazar, 
Ramratnam et al. 2014). However, Astle et al did not show a difference for risk of developing 
asthma in young children born preterm with CLD compared to children born preterm without 
CLD (Astle, Broom et al. 2015).  Thus it is important in any research involving preterm-born 
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subjects to include the whole range from 23-42 weeks of gestation and to identify those with 
additional problems such as CLD. 
 Alongside preterm birth as a risk factor for wheezing in childhood there has also been 
much interest in other modifiable risk factors and consequently understanding the influence of 
early life events on respiratory health in childhood (Visser, Garcia-Marcos et al. 2010, Liu, 
Olsen et al. 2014). The main factors associated with an increased risk of childhood wheezing 
include male gender, family history of atopy, and exposure to cigarette smoking, indoor air 
pollution and early respiratory infections such as rhinovirus or respiratory syncytial virus (RSV) 
(Greenough, Limb et al. 2005, Broughton, Thomas et al. 2007, Jackson, Gangnon et al. 2008, 
Herr, Just et al. 2012, Blanken, Rovers et al. 2013).  The link between these risk factors, 
preterm birth and childhood wheezing is not clear as has already been discussed.  The pattern 
of wheezing and these associated risk factors are frequently used to categorise children for 
research purposes with few studies including large cohorts of preterm-born children compared 
to term-born controls from the same community.  It may be that a common genetic or 
environmental factor is part of the pathway leading to both the reason for the preterm birth 
and the eventual outcome of childhood wheezing. Kumar et al suggested that chorioamnionitis 
can lead to preterm birth and also be the trigger for recurrent wheezing in childhood (Kumar, 
Yu et al. 2008).   
A recent systematic review and meta-analysis shows strong evidence that preterm birth 
increases the risk of ‘asthma’ and wheezing disorders in childhood, but indicates the need for 
further research into understanding better the impact of early-life events on childhood 
wheezing disorders (Been, Lugtenberg et al. 2014).  Therefore, it is important to establish the 
characteristics of preterm-born children across the whole gestational range, plus those with 
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and without CLD, who are at increased risk of respiratory symptoms and disease (such as 
childhood wheezing disorders) throughout childhood and to what extent confounding factors, 
such as a family history of atopy and mode of delivery play a role.  It is also important to try 
and establish if these children are being treated appropriately with medication, such as inhaled 
bronchodilators. 
4.2 Hypothesis and aims 
To assess these respiratory symptoms and health related problems of children born 
preterm, I developed a study to evaluate the respiratory and neurological outcomes in children 
born preterm (RANOPS).  This was initially set up to review the outcomes of children born late 
preterm in comparison to term-born controls and those born very preterm, however as the 
study progressed it became evident that it is important to assess the whole gestational age 
range for health outcomes.  It would also help to establish a study cohort of children and 
families in Wales for on-going research into the long-term effects of being born preterm.    
My study hypotheses and aims were to answer questions based on a cohort of children 
born preterm with a comparison group of those born at term.  Thus I hypothesised that 
children born preterm (24 to 36 weeks of gestation):  
1. have increased respiratory symptoms and disease; 
2. have increased health care utilisation, mainly due to respiratory morbidity, in 
infancy, in the pre-school and early school years, when compared to age-matched 
term-born children (control group).  Their symptoms/problems would show a 
gradient with gestational age at birth. 
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3. have the same rate of family history of atopy as term-born controls and thus atopy 
would not be affected by gestational age at birth. 
4. are treated more frequently with inhaler medication and this would also show a 
gradient effect with gestational age at birth. 
5. have different risk factors for childhood wheezing compared to term-born 
controls. 
4.2.1 Specific aims 
a) to test whether being born preterm had any effect on respiratory symptoms in 
childhood compared to being born full term.  These symptoms included wheezing, coughing 
and rattling during the day and night time based on responses to questionnaires. 
b) to test the risk of health care utilisation (possibly due to respiratory morbidity 
secondary to being born preterm) in infancy and up to 9 years of age when compared to age-
matched term-born control children. 
c) to report on the prevalence of wheezing disorders in all preterm-born children 
compared to term-born controls and to assess the risk factors associated with wheezing in 
these children. To report any difference, between children born preterm with a family history 
of atopy and term-born controls, in treatment with inhaler medication. 
d) to test if CLD accounts for the risk of wheezing in children born very preterm. 
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4.3 Methodology 
The data for this study came from two areas, viz. the well-linked health databases in 
Wales, and results from health questionnaires sent out to families with preterm-born children 
aged 1, 2, 3, 5, 7 and 9 years old and also sent out to matched term-born control children in 
2013. The initial study mailed 26,722 questionnaires to families across Wales and established a 
large cohort of children born preterm for a prospective study of respiratory and neurological 
outcomes.  During the set up of my research project there were a few delays due to the 
arduous process of applying for Research and Development approval in all seven health boards 
across Wales, gaining ethical approval and Caldicott governance approval from NWIS.  This 
meant the study protocol was adapted and revised several times to gain approval from each of 
the 9 committees that reviewed my project.  It took 9 months to complete this process.   
4.3.1 Study design summary 
The study is a large cross-sectional survey of children born in Wales from January 1 2003 to 
December 31 2011, who were identified from birth records with data collection being 
predominantly retrospective in nature. As mentioned this study was originally set up to assess 
the outcomes of preterm-born infants and so this study addressed (a) respiratory morbidity via 
a questionnaire study, and (b) hospitalisation, especially due to respiratory reasons, via the 
well-linked health databases in Wales. Matched term-born controls were also recruited as a 
comparison group.   
4.3.2 Questionnaires 
I opted to use questionnaires to assess the outcomes of the children born preterm, as this 
would allow for potentially easier recruitment of subjects thus leading to a larger sample size.  
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The use of questionnaire items to assess respiratory outcomes in preterm infants has been 
shown to perform well in terms of test-retest reliability and convergent validity (Boggs, Minich 
et al. 2013). Also it is common practice in large-scale epidemiological studies to use validated 
questionnaires to assess the prevalence of asthma and other wheezing disorders as shown by 
the International Study of Asthma and Allergies in Children (ISAAC) (1998).  The questionnaires 
in the RANOPS study were designed to be age-appropriate (one for <5 years of age and 
another for 5-9 years of age) and their suitability and acceptability were assessed in a pilot 
study of local children and parents (n=25), before they were mailed out to the study cohort.  
There was also the possibility of setting up a website with details of the study and also items 
explaining the definition of wheezing with videos to help families to understand the terms 
used in the questionnaire.  However it was felt that this might lead to bias in the results as 
some families may not have access to the Internet and may answer questions differently to the 
families who had reviewed the videos. 
 The two age appropriate questionnaires I designed by combining validated questionnaires 
based on respiratory symptoms and neurodevelopmental problems for preschool and school 
aged children, which are available in the literature (Asher, Keil et al. 1995, Greenough, Giffin et 
al. 1996, Jones, Guildea et al. 2002, Powell, McNamara et al. 2002, Greenough, Limb et al. 
2005, Trinick, Southern et al. 2012).  So for the respiratory aspect of the RANOPS study, a 
modified ISAAC questionnaire focussing on the respiratory symptoms (rather than allergy), 
which would be used to assess the respiratory health outcomes in children over 5 years of age 
including wheezing, drug usage and physical activity as well as visits to hospitals and general 
practitioners (Asher, Keil et al. 1995). Then to assess the respiratory outcomes of the younger 
children, those less than 5 years of age included in the study, the Liverpool Respiratory 
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Symptom Questionnaire was used, which has been validated in a group of young children with 
cystic fibrosis (Powell, McNamara et al. 2002, Trinick, Southern et al. 2012).  Both 
questionnaires also included items about the neurodevelopmental outcomes of the child, 
however the results of those questions will not be reviewed in this thesis.   A copy of the 
questionnaire mail packs sent out to families with pre-school children and the packs sent to 
families with school age children can be seen in the appendix (pages 281-294). 
4.3.3 Study numbers 
In Wales, the average number of live-born deliveries over the last 5 years up to 2012 was 
34,464 per annum (John, Rolfe et al. 2014).  Approximately 2,000 each year were live-born 
prematurely with 500 born very preterm and 1,500 33-36 weeks of gestation (see table 14).  So 
I planned to send 2,000 of the validated questionnaires for each age group for the preterm–
born groups (including 1,500 late preterm-born and 500 very preterm-born children) together 
with a similar number for age- and geography-matched term-born controls. The matching of 
the term-born controls was to be based on sex and chronological age, although in the analysis 
of the data, the corrected age of the preterm infants would be taken into account as a 
potential confounding factor. The estimated total of 24,000 questionnaires was to be sent to 
families using data from health records managed via the NHS Wales Informatics Service 
(NWIS). Children were selected from the following birth years; 2003, 2005, 2007, 2009, 2010 
and 2011.  A range of birth years was chosen to include a wide range of age groups in the 
study (1 – 10 years of age).  During this period, from 2003 to 2011, there were 305,894 live 
births in Wales, of which 13,361 preterm-born and 13,361 term-born children were invited to 
take part in our study.   This was the total number of preterm-born children in those six 
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selected birth years (this number differs to the total calculated from table 14 due to the 
exclusion of some families).   
 
Table 14: Total number of survivors at 1 year of age in Wales 
AWPS data: Total number of survivors at 1 year of age per year of birth and gestational age in 
Wales 
Year of birth 2003 2005 2007 2009 2010 2011 
Gestational age       
23-32 weeks 436 507 503 471 513 492 
33-36 weeks 1781 1719 1976 1980 1926 1913 
37-43 weeks 26448 30063 31545 31933 33277 32819 
Other/unknown 2303 226 279 323 171 334 
Total 30968 32515 34303 34707 35887 35558 
 
Sample size: For a question with binary response (e.g. symptom present or absent), 
assuming a 30% response rate to the questionnaire, we had 0.99 power for identifying a 
difference (if P<0.001) between the preterm- and term-born children if the true symptom rate 
was 15% in preterm and 10% in term children.   I initially estimated the response rate would be 
quite high at around 50%, which was based on previous similar studies in Wales (Burr, Wat et 
al. 2006, Fox and Minchom 2008).  However both these studies included smaller numbers of 
participants and used different methods including phone calls to remind families to complete 
their questionnaires. 
In the end a total of 26,722 survey packs were sent out to the parents or guardians of 
every child identified by NWIS to be eligible to take part in the study.  Surveys were sent in 
April 2013 and families who had not responded received a reminder pack in June 2013. As 
already mentioned, we sent out two different packs: one for families with children aged one, 
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two and three years-of-age (pre-school group) and another for children five, seven and nine 
years-of-age (school age group).   In order to encourage families to respond we also involved 
the media to help promote our study.  So in February 2013 the Western Mail published an 
article in their paper and online, entitled ‘study is launched to check on health of babies born 
early’, which described the research project and gave our contact details (appendix, page 278).  
Then in April 2013 ITV Wales interviewed Professor Kotecha and myself for a news item on our 
study while discussing the long-term impact of being born preterm.  This was at the same time 
that we had sent out our questionnaires and several other news programmes such as BBC 
Wales also picked up on the news item and put articles on the websites.  Also the Western 
Mail ran a feature item in their paper and online, entitled ‘premature births mum helps study 
of breathing’, in which a family was interviewed and gave details of their story about preterm 
birth (appendix, page 279).  And finally in June 2013, to coincide with the second mailing of 
questionnaires, the Western Mail published another article on our study to help encourage 
families to respond (appendix, page 280).   
4.3.4 NWIS collaboration 
After undergoing a separate ethical review, I worked closely with Louise Richards, an 
Information Analyst, at NWIS to initially establish the list of potential participants for my study 
and then later to gather further healthcare related information on the families who consented 
to take part in the study (see flowchart, Figure 16).  NWIS has expertise for identifying subjects 
from the Welsh NHS administrative register and other databases.  In order to get data and 
support from NWIS it was first necessary to have gained approval from their Privacy Advisory 
Committee (PAC).  The committee required us to have a local Paediatrician from each health 
board in Wales as part of our research team.  This was to ensure we had the legal rights to 
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access patient information and so requests to join the study were sent from the local 
consultant paediatrician based upon where the family was residing at the time the 
questionnaires were sent out.  At the same time as gaining approval from the PAC, ethics 
approval was gained from the South East Wales Ethics committee and also R&D approval was 
gained from the seven Health boards in Wales via their Research and Development 
departments.   
The first step in my project was to liaise with the team at NWIS and request them to 
identify children born between 1/01/2003 to 31/12/2011.  The protocol for creating the 
RANOPS mailing list database can be seen in the appendix (pages 276-277). NWIS identified all 
the preterm-born infants for each age group (1,2,3,5,7 and 9 years of age) using the national 
database, which includes data from Patient Episode Database for Wales (PEDW), the National 
Community Child Health Database (NCCHD) and the Welsh Demographics Service (WDS).  
These databases contain health information including patient clinical data on all admissions to 
hospital (PEDW), birth registration and child health examinations (NCCHD) and social 
demographics including registered GP (WDS).  These databases are from health records 
completed by NHS healthcare professionals, at the time patients are seen in hospital, in the 
community or in a GP clinic in each local health board in Wales.  Louise Richards at NWIS 
selected the term-born controls by identifying gender-matched children born on the same day 
and in the same geographical area (hospital or midwifery led unit) as each preterm-born 
infant.  So there were approximately 2,000 term controls for each age group.  For each age 
(1,2,3,5,7 and 9 years of age) there were three groups; children born at full term (37-43 weeks 
of gestation), children born late preterm (33-36 weeks of gestation) and children born very 
preterm (≤32 weeks of gestation).  Each child was assigned a unique study number. 
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Once the list of participants had been created this was then passed on to the mailing 
company, DST (a private communication company with expertise in printing, sorting and 
mailing questionnaires).  NWIS supplied the mailing house with a study database, containing 
name, age, group and address of each study participant.  So all the questionnaire packs were 
sent via DST and only anonymised data was released to the child health research team at 
Cardiff University. The mailing house printed the individual questionnaires for each family (by 
using the study ID numbers) and invitation letters.  These were sent to the families with 
stamped addressed envelopes (so that completed questionnaires could be returned to our 
research department).  No personal data was released by NWIS to the research team at this 
stage.  To ensure that no families were contacted unnecessarily or to avoid distressing 
bereaved families we carried out checks prior to completing the mailing list, so that children 
who had moved from the area (outside of Wales) or had died were identified and excluded. 
This was partly completed by using data from the All Wales Perinatal Survey (AWPS), which 
maintains data on all infants in Wales, who have passed away before their first birthday, and is 
directed by Professor Sailesh Kotecha (Kotecha et al., 2011).   
After the first set of questionnaire packs had been sent in April 2013, I was given the study 
ID numbers with the gestational age and actual age in years of each of the children.  This was 
so that I could organise the questionnaires returned for scanning into the two age groups.  
Families were given 4 to 8 weeks to return the questionnaires.  A list of families (study ID 
numbers) who had returned questionnaires was uploaded to a secure NWIS site in late May 
2013.  NWIS, following a re-check of the health database for any deaths, then created an up-
dated list of any families that had not returned a questionnaire.  This up-dated study database 
was given to the mailing company and a reminder pack was sent to these families in June 
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2013.  No further contact was to be made with families who had not returned questionnaires 
after the second reminder pack had been sent.   
The returned questionnaires provided me with both prospective and retrospective health 
related data on the children including their current respiratory symptoms.  Also NWIS supplied 
information on the families by using the linked databases (including the Patient Episode 
Database for Wales (PEDW) and the National Community Child Health Database, NCCHD) for 
both general practice and hospital episodes.  From these data, I was able to identify the 
general health service usage of the included children.  Some of the information gathered from 
PEDW and NCCHD was available for the entire cohort and this allowed me to determine the 
representativeness of the participants returning questionnaires compared to non-participants. 
Further details on the data available in our study database will be discussed below. 
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Figure 16: RANOPS study protocol: Questionnaire delivery process 
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4.3.5 Processing returned questionnaires 
Returned questionnaires were processed by myself through a scanner and specialised 
software (Remark Office OMR 8, Gravic Inc. Malvern, PA).  The questionnaires were coded by 
the software, which also identified any problems such as missing information.  Myself and 
three other members of the child health research team reviewed all errors detected by the 
software.  Many of these errors were due to the forms being completed incorrectly.  So I 
created a set of rules for correcting the errors detected by the software, which involved the 
original questionnaire being reviewed by a member of the research team and altering the 
database as necessary.  This formed part of the data quality control checks with the data being 
validated and checked for accuracy. In total, it was less than 5% of the returned forms that had 
more than one error.  The majority of the returned questionnaires were scanned with no 
errors detected.  A random selection of the original questionnaires were reviewed and the 
information checked on the database, this allowed for a further data quality control check.  All 
data from the study was stored securely in the research office at the University Hospital of 
Wales, Heath Park, Cardiff.  By returning the completed questionnaires it was assumed that 
the family had given consent to take part in the study.  There was also a consent section on the 
questionnaires requesting permission to allow additional data to be gathered from the 
healthcare databases and also consent to contact the family for further information if 
required.  It was clearly stated in the information leaflet what would happen with the data 
collected.  The families were also able to provide contact details if they wanted to be 
contacted again with regards to this research, or the family could request not to be contacted 
again.   
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4.3.6 Questionnaire and Healthcare database information 
The two sets of age-dependent questionnaires were sent out to the selected families.  
They had different sets of questions to assess the respiratory symptoms of the children with 
only a few questions being identical on both sets of questionnaires.  This meant that as a single 
database was created, only some variables had responses from all participants, however the 
majority of responses had either only responses from children over 5 years of age or only 
responses from children less than 5 years of age.  Much of the analysis of the data was split 
into the two age groups and performed separately, as detailed below.  The questionnaire for 
children less than 5 years of age provided the following data on respiratory outcomes:   
 Wheezing ever (wheezing at any time in the child’s life) 
 Recent wheezing (wheezing in the last 3 months) 
 Association of wheezing and other respiratory symptoms with colds or activity 
 Other respiratory symptoms such as cough, short of breath, rattly chest or snuffle. 
All the questions on respiratory symptoms including wheezing had ordinal 
responses (none, few days, some days, most days and every day of the week).  
These were recoded to binary (yes or no) responses and to categorical (none, mild 
or severe symptoms).   
 Use of inhalers for wheezing 
 Hospital admissions for chest related problems in the last 12 months 
 Doctor diagnosis of asthma 
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 Family history of atopy (based on parental reporting of first degree relatives 
having a history of asthma, eczema and hay fever) 
 Details of smoking in the family (including maternal smoking during pregnancy) 
The questionnaire for children older than 5 years of age provided the following data on 
respiratory outcomes:   
 Wheezing ever (wheezing at any time in the child’s life) 
 Recent wheezing (wheezing over the last 12 months) 
 Association of wheezing with exercise, while sleeping or with a cold/chest 
infection 
 Use of inhalers for wheezing and antibiotic use for chest infections 
 Hospital admissions for chest related problems in the last 12 months 
 Doctor diagnosis of asthma 
 Family history of atopy (based on parental reporting of first degree relatives 
having a history of asthma, eczema and hay fever) 
 Details of smoking in the family (including maternal smoking during pregnancy) 
Diagnosis of CLD was based on parental reporting and checked with the data from NWIS. 
Parents were asked if their child had any breathing problems and responded in a free text box.  
Physical disability was based on parental reporting and parents were asked if their child had 
  
 
153 
 
any difficulties with movement or using their hands.  NWIS supplied additional data for every 
child who returned a questionnaire, which included gestational age at birth, birth weight, 
mode of delivery, birth order, hospital of birth, the initiation of breast-feeding following birth, 
hospital admissions in first year of life with diagnosis on discharge, admissions to the neonatal 
unit, ethnicity, and Welsh Index of Multiple Deprivation score (WIMD) at the time of birth and 
at the time of being invited to take part in the study.  The social status of a family was 
determined by location of the family home and linking this to the closest score/rank for the 
welsh index for multiple deprivation child index 2011. WIMD is a measure of social deprivation 
based on eight separate measures that include income, employment, education, health, access 
to services, community safety, physical environment and housing, with a range of 1 (most 
deprived) to 1909 (least deprived) (Government 2015 (accessed August 2014)). A copy of both 
sets of questionnaires can be seen in the appendix (pages 281-294).   
The main exposure of interest, gestational age at birth, was based on antenatal ultrasound 
scans and maternal reporting and recorded in completed weeks of gestation. It was 
categorized into four groups: 24 to 32 weeks (very preterm), 33 to 34 weeks (moderate 
preterm), 35 to 36 weeks (late preterm) and 37 to 43 weeks (term controls). The data were 
analysed according to gestational groups based on the WHO definitions of preterm birth 
(Blencowe, Cousens et al. 2013).  Birth weight was used as a continuous variable and z-scores 
were calculated using the LMS Growth program (Pan H and TJ. 2012 (accessed August 2014)), 
which takes into account gestational age and gender. Intrauterine growth restriction (IUGR) 
was defined as <10th centile for birth weight and was compared to children with birth weights 
between 20-80th Centile. Participants with birth weights outside ±3.5 SDs or with unknown 
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gestational age were excluded. Of the 7,149 responders, 97 children were excluded due to 
implausible or missing data on birth weight or gestational age at birth.  
4.3.7 Statistical analysis 
The statistical analysis was performed using PAWS (version 18.0. SPSS Inc. Chicago, IL).  
The uploaded responses from the questionnaires were transferred from Remark Office OMR 8 
(Gravic Inc. Malvern, PA) onto an SPSS database and were carefully merged with excel 
database files from NWIS containing demographic and health related data.  The responses for 
each question were recoded into binary or categorical (ordinal) variables.  I kept a record of all 
the variables, how they were coded and named.  I also created rules for creating new variables 
and have kept records with details of how and from what data new variables were created.  
Each variable was checked for missing data and it was decided that if parents had responded 
as unsure to a question these responses would be re-coded as no.  During my analysis of the 
data, I checked to see what effect this would have on the results and it made no difference, as 
only a small percentage of responses were answered with unsure.  All missing data were 
reviewed and data correction conventions were followed so, when possible, self-evident 
correction was applied.  The use of multiple imputations was also considered for sporadic 
items of missing data but this made no difference to the results.  So in all the plans for analyses 
of the data I opted for the principal of parsimony, so that the simplest methods were used to 
analyse the data and I attempted to avoid complex modelling so that results would be easy to 
understand and communicate to clinicians and other healthcare professionals.    
Firstly, I used descriptive analysis to summarize the characteristics of the study cohort. This 
involved assessing the following characteristics of the included participants: their age, gender, 
gestational age, birth weight, WIMD score, maternal age and maternal smoking during 
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pregnancy.  Then I did a comparison of some of the characteristics between participants and 
non-participants. Statistical testing of the comparisons was done using parametric and non-
parametric tests, depending on the nature of the variables being assessed, e.g. birth weight 
had a near normal distribution and was compared using T-tests, however gender was 
compared using chi-square tests.  Throughout this study, statistical significance is taken to be 
p<0.05.  The first step of my inferential analysis involved calculating the prevalence rates of 
respiratory symptoms (wheeze ever or recent wheeze), diagnosis of respiratory illness (such as 
asthma) and treatment with inhalers. These were analysed according to gestational groups in 
cross tabulations using chi-square tests. Separate univariate models were constructed for 
children less than five years-of-age and those five years-of-age and older.  Statistical model fits 
were assessed using log-likelihood ratio chi-square and deviance statistics. 
A bivariate logistic regression analysis was then performed to identify all possible risk 
factors for wheezing for the whole population (1-10 years of age). These were then included in 
a multivariate logistic regression analysis, which used all significant risk factors that may affect 
the outcome variables (wheeze ever or recent wheeze). The results were reviewed to test if 
there was any statistical difference between including and excluding participants with missing 
values for any variable.  No differences were noted and so participants with missing values 
were included in the final analysis as this allowed for a greater number of participants’ data to 
be included in the modelling.  Generalised linear models were performed with wheezing as the 
outcome variable and the data was categorized into gestational groups with confounding or 
modifying variables included.  In order for a variable to be considered as a confounder: i) the 
variable must be a risk factor and thus independently associated with the outcome; ii) the 
variable must also be associated with the exposure under study in the study population; iii) it 
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should not lie on the causal pathway between exposure and the outcome.  A variable that has 
a different effect for the outcome of different groups is known as an effect modification and 
these variables have also been included in the modelling along side confounding factors. The 
goodness of fit of the models was assessed using Nagelkerke R2. 
Further bivariate logistic regression analyses were performed to identify the risk factors for 
wheezing in children born preterm and then in children born term (both in the groups of 
children less than five years-of-age, and those five years-of-age and older). I used the 
Nagelkerke R2 to determine if the risk factors were statistically significant or not.  The main risk 
factor of interest was family history of atopy and how this adjusted the results for gestational 
age.  This factor was created by family responding yes to all four questions about family history 
on atopy i.e. the participant has a positive family history of asthma, eczema, hay fever and 
allergies. So a separate multivariate analysis was performed to assess ONLY the impact of 
family history of atopy and gestational age at birth on childhood wheezing.  
I also produced Venn diagrams to explore the relationship between a family history of 
atopy and treatment with inhalers for those children who had ever wheezed in their lifetime.  
Venn diagrams allow for an assessment of the logical relationship between multiple different 
groups.  So I was able to explore the differences between having a family history of atopy and 
being born preterm on treatment with inhalers and wheezing.  This was performed for both 
age groups and the children were compared preterm to term with odds ratios’.  I also 
displayed the results as bar charts as this allowed two Venn diagrams to be combined as one 
(the preterm only and the term only diagrams), showing all the results together.      
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Finally a sub-group analysis of the very preterm group was performed to assess the 
differences in prevalence of wheezing and inhaler treatment between children with CLD and 
those without CLD. 
4.3.8 Ethics approval and Funding 
The project was granted ethical and R&D approval from within Wales in 2011. The global 
governance check reference is IRAS 91349 and the Ethics reference is 12/WA/0155.  I applied 
and gained ethics and R&D approval.  The sponsor for the project is Cardiff University 
(SPON1038-11).  
4.4 Results  
4.4.1 Characteristics of study cohort 
The survey packs were sent out to 26,722 children living in the seven health boards across 
Wales (Figure 17).  The final response rate was 26.7% (n=7,149), of which, 4,283 participants 
were born preterm (32% response rate for those born preterm), including 1,028 born 23 to 32 
weeks (37% response rate for those born very preterm), 952 born 33 to 34 weeks (33% 
response rate for those born moderate preterm), and 2,304 born 35 to 36 weeks (30% 
response rate for those born late preterm).  The characteristics of participants are shown in 
Tables 15 and 17 with characteristics of non-participants shown in Tables 16 and 18  
(comparison of participants to non-participants can be seen in tables 16 and 18).  Comparing 
preterm-born children to term controls showed no significant difference for gender or age of 
child or maternal age at time of delivery, however the WIMD rank was lower for preterm-born 
children and they showed higher rates of maternal smoking during pregnancy and higher rates 
of caesarean section delivery.  
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Figure 17: Consort flow diagram showing returns of completed questionnaires (RANOPS) 
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Table 15: Characteristics of responders <5 years of age according to gestational groups 
 Very Preterm 
N =519  
Moderate Preterm 
N=486 
Late Preterm 
N=1149 
Full Term 
N=1403 
Gestational age, weeks 
(mean, 95%CI) 
29.66  
(29.46,29.85) 
33.65  
(33.61,33.69) 
35.65  
(35.62,35.67) 
39.61  
(39.55,39.68) 
Birth weight, kg 
(mean, 95%CI) 
1.452  
(1.406, 1.498) 
2.176  
(2.136, 2.216) 
2.635  
(2.607, 2.663) 
3.459  
(3.433, 3.485) 
Male (%) 260 (50.1%) 275 (56.6%) 621 (54%) 743(53%) 
WIMD rank latest 
(median) Range: 1-1909 
898 929 934 997 
Age, years 
(mean, 95% CI) 
2.24  
(2.16, 2.32) 
2.22  
(2.14, 2.30) 
2.29  
(2.24, 2.35) 
2.24  
(2.19, 2.28) 
Mother smoke (in 
pregnancy)  
72 (14.1%) 56 (11.6%) 136 (11.9%) 133 (9.6%) 
Maternal age, years 
(mean, 95%CI) 
30.5 
(29.98, 31.10) 
30.5 
(29.97, 31.00) 
30.1 
(29.72, 30.45) 
30.31 
(29.99, 30.62) 
Mode of delivery (CS or 
not) Missing data 
288 (55.5%) 
33 (6.4%) 
263 (54.1%) 
23 (4.7%) 
505 (44%) 
60 (5.2%) 
378 (26.9%) 
46 (3.3%) 
 
 
Table 16: Characteristics of non-responders <5 years of age according to gestational groups 
 Very Preterm 
N =905 
Moderate Preterm 
N=1006 
Late Preterm 
N=2894 
Full Term 
N=5554 
Gestational age, weeks 
(mean, 95%CI) 
29.68  
(29.53, 29.82) 
33.63  
(33.60, 33.66) 
35.65  
(35.63, 35.67) 
39.70  
(39.66, 39.73)*  
P = 0.028 
Birth weight, kg 
(mean, 95%CI) 
1.495  
(1.46, 1.53) 
2.176  
(2.148, 2.205) 
2.618  
(2.601, 2.636) 
3.449  
(3.436, 3.462) 
Male (%) 501 (55.4%) 
P = 0.055 
560 (55.7%) 
P>>0.05 
1555 (53.7%) 
P>>0.05 
3027 (54.5%) 
P>>0.05 
WIMD rank latest 
(median) Range: 1-1909 
616* 
P=<0.001 
644* 
P=<0.001 
639* 
P=<0.001 
745* 
P=<0.001 
Age, years  
(mean, 95%CI) 
2.96 (2.91, 3.01)* 
P=<0.001 
2.99 (2.94, 3.04)* 
P=<0.001 
2.98 (2.95, 3.01)* 
P=<0.001 
2.99 (2.97, 3.01)* 
P=<0.001 
 
* indicate a significant difference between responders (in Table 15) and non-responders (in 
Table 16) 
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Table 17: Characteristics of responders' ≥5 years of age according to gestational groups 
 Very Preterm 
N =509  
Moderate Preterm 
N=466 
Late Preterm 
N=1155 
Full Term 
N=1462 
Gestational age, weeks 
(mean, 95%CI) 
29.78  
(29.58, 29.97) 
33.60  
(33.56, 33.65) 
35.63  
(35.60, 35.65) 
39.63  
(39.57, 39.70) 
Birth weight, kg  
(mean, 95%CI) 
1.446  
(1.403, 1.490) 
2.218  
(2.175, 2.261) 
2.637  
(2.609, 2.666) 
3.460  
(3.435, 3.486) 
Male (%) 301 (59.1%) 260 (55.8%) 626 (54.2%) 775 (53%) 
WIMD rank latest 
(median) Range: 1-1909 
997 938 1017 1110 
Age, years (mean, 95%CI) 7.14  
(6.99, 7.28) 
7.13  
(6.97, 7.28) 
7.27  
(7.17, 7.37) 
7.23  
(7.14, 7.32) 
Mother smoke (in 
pregnancy)  
76 (16%) 67 (15.5%) 175 (16.2%) 184 (13.7%) 
Maternal age, years 
(mean, 95%CI) 
29.7 
(29.13, 30.32) 
30.4 
(29.81, 30.98) 
30.1 
(29.69, 30.41) 
30.4 
(30.09, 30.7) 
Mode of delivery (CS or 
not) Missing data 
269 (52.8%) 
53(10.4%) 
229 (49.1%) 
41 (8.8%) 
439 (38%) 
76 (6.6%) 
344 (23.5%) 
162 (11.1%) 
 
 
Table 18: Characteristics of non-responders ≥5 years of age according to gestational groups 
 Very Preterm 
N =833 
Moderate Preterm 
N=956 
Late Preterm 
N=2496 
Full Term 
N=4949 
Gestational age, weeks 
(mean, 95%CI) 
29.68  
(29.53, 29.83) 
33.61  
(33.58, 33.64) 
35.64  
(35.62, 35.65) 
39.67  
(39.64, 39.71) 
Birth weight, kg 
(mean, 95%CI) 
1.515  
(1.477, 1.553)* 
P=0.023 
2.192  
(2.160, 2.223) 
2.624  
(2.605, 2.643) 
3.434  
(3.420, 3.448) 
P=0.077 
Male (%) 448 (53.8%) 
P=0.055 
519 (54.3%) 
P>>0.05 
1340 (53.7%) 
P>>0.05 
2716 (54.9%) 
P>>0.05 
WIMD rank latest 
(median) Range: 1-1909 
641* 
P=<0.001 
710* 
P=<0.001 
723* 
P=<0.001 
810* 
P=<0.001 
Age, years (mean, 95%CI) 7.90 (7.79, 8.01)* 
P=<0.001 
7.87 (7.76, 7.97)* 
P=<0.001 
7.90 (7.83, 7.96)* 
P=<0.001 
7.90 (7.85, 7.94)* 
P=<0.001 
* indicate a significant difference between responders (in table 17) and non-responders (in 
table 18) 
 
 
4.4.2 Prevalence of respiratory symptoms 
The prevalence of wheezing ever in children less than five years-of-age was 64.7% in the 
very preterm group, 55.5% in the moderate preterm group, 51.4% in late preterm group and 
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40.7% in the term controls with ORs’ of 2.67 (95%CI 2.2, 3.3), 1.82 (95%CI 1.5, 2.2) and 1.54 
(95%CI 1.3, 1.8) respectively (Table 19).  Slightly higher ORs’ were found for recent wheeze 
(over the last three months), severity of wheezing (both mild and severe), use of inhaler 
medication including corticosteroids and admissions to hospital over the last 12 months with a 
breathing related problem.  It should be noted that the results for severe wheeze in the 
moderate preterm group were not significant (OR 1.8; 95%CI 0.9, 3.5) and this may be due to 
the lower numbers in the moderate preterm-born group compared to the other preterm 
groups and thus this may be a type 2 error.  Family history of atopy in children less than five 
years-of-age showed prevalence of 26.1% (OR 0.95; 95%CI 0.8, 1.2) in the very preterm group, 
24% (OR 0.85; 95%CI 0.7, 1.1) in the moderate preterm group, 31.4% (OR 1.2; 95%CI 1.04, 1.5) 
in the late preterm group and 27.1% in the term controls.  Only the late preterm group showed 
a statistically significant difference to the term controls (p = 0.018).  When wheezing ever was 
analysed in linear modelling with prematurity and family history of atopy, there was an OR 
2.75 (95%CI 2.2, 3.4) for the very preterm group and OR 1.88 (95%CI 1.5, 2.3) for the moderate 
preterm group compared to the term controls. 
The prevalence of wheezing ever in children five years-of-age and older was 55.8% in the 
very preterm group, 41.3% in the moderate preterm group, 37.7% in late preterm group and 
27.7% in the term controls with ORs’ of 3.29 (95%CI 2.7, 4.1), 1.84 (95%CI 1.5, 2.3) and 1.58 
(95%CI 1.3, 1.9) respectively (Table 20).  Similar ORs’ were found for recent wheeze (over the 
last 12 months), doctor diagnosis of asthma, use of inhaler medication including 
corticosteroids and admission to hospital over the last 12 months with a breathing related 
problem.  A family history of atopy in children five years-of-age and older showed a prevalence 
of 18.4% (OR 0.8; 95%CI 0.6, 0.99) in the very preterm group, 21.8% (OR 0.95; 95%CI 0.7, 1.2) 
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in the moderate preterm group, 24.2% (OR 1.1; 95%CI 0.9, 1.3) in the late preterm group and 
22.7% in the term controls.  Only the very preterm group showed a marginal statistically 
significant difference to the term controls with a lower prevalence of family history of atopy (p 
= 0.046). When wheezing ever was analysed by linear modelling with prematurity and atopy 
only there was an OR 3.49 (95%CI 2.8, 4.3) for the very preterm group, OR 1.88 (95%CI 1.5, 
2.4) for the moderate preterm group, and OR 1.58 (95%CI 1.3, 1.9) for the late preterm group 
compared to the term controls.   
The adjusted ORs’ for wheezing ever and recent wheeze for both age bands by gestational 
groups can be seen in Tables 19 and 20.  The following variables were used as covariates and 
confounding factors in general linear models; gender, FH of atopy, maternal smoking during 
pregnancy, CS, maternal history of asthma, breastfeeding at birth, current maternal smoking, 
social status, ethnicity, and other family member smoking.  Each of these variables were found 
to be risk factors for wheezing in the whole cohort of children.  
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Table 19: Respiratory outcomes for all children less than 5 years of age 
 Very Preterm 
N =502*  
Moderate Preterm 
N=479* 
Late Preterm 
N=1130* 
Full Term 
N=1402* 
Wheeze ever (%) 
OR (95% CI) 
P value 
aOR (95% CI)# 
aOR (95% CI)^ 
325 (64.7%) 
2.67(2.2, 3.3) 
<0.001 
2.61(2.1, 3.3) 
2.75(2.2, 3.4) 
266 (55.5%) 
1.82 (1.5, 2.2) 
<0.001 
1.75 (1.4, 2.2) 
1.88 (1.5, 2.3) 
581 (51.4%) 
1.54(1.3, 1.8) 
<0.001 
1.44(1.2, 1.7) 
1.51(1.3, 1.8) 
571 (40.7%) 
Current wheeze (%) 
OR (95% CI) 
P value 
aOR (95% CI)# 
aOR (95% CI)^ 
201 (40%) 
2.92(2.3, 5.7) 
<0.001 
2.77(2.2, 3.5) 
3.02(2.4, 3.8) 
160 (33.4%) 
2.19 (1.7, 2.8) 
<0.001 
2.11 (1.6, 2.7) 
2.29 (1.8, 2.9) 
326 (28.8%) 
1.77(1.5, 2.1) 
<0.001 
1.65 (1.4,2.0) 
1.74 (1.4,2.1) 
261 (18.6%) 
Mild wheeze (%) 
OR (95% CI) 
P value 
183 (36.5%) 
2.8 (2.2, 3.5) 
<0.001 
146 (30.5%) 
2.1 (1.7, 2.7) 
<0.001 
291 (25.8%) 
1.7 (1.4, 2.1) 
<0.001 
238 (17%) 
Severe wheeze (%) 
OR (95% CI) 
P value 
18 (3.6%) 
2.2 (1.2, 4.2) 
<0.05 
14 (2.9%) 
1.8 (0.9, 3.5) 
0.1 
35 (3.1%) 
1.9 (1.1, 3.3) 
<0.05 
23 (1.6%) 
Family history of atopy (%) 
OR (95% CI) 
P value 
131 (26.1%) 
0.95 (0.8,1.2) 
0.662 
115 (24%) 
0.85 (0.7, 1.1) 
0.184 
355 (31.4%) 
1.2 (1.04, 1.5) 
0.018 
380 (27.1%) 
Any inhaler medication use (%) 
OR (95% CI) 
P value 
167 (33.3%) 
3.7 (2.9, 4.7) 
<0.001 
95 (19.8%) 
1.8 (1.4, 2.4) 
<0.001 
222 (19.6%) 
1.8 (1.5, 2.5) 
<0.001 
167 (11.9%) 
Steroid inhaler medication use (%) 
OR (95% CI) 
P value 
52 (10.4%) 
3.8 (2.5, 5.9) 
<0.001 
27 (5.6%) 
2.0 (1.2, 3.3) 
0.007 
76 (6.7%) 
2.4 (1.6, 3.5) 
<0.001 
41 (2.9%) 
Hospital admission with breathing 
related problem (last 12 months) (%) 
OR (95% CI) 
P value 
110 (21.9%) 
 
4.8 (3.5, 6.6) 
<0.001 
58 (12.1%) 
 
2.4 (1.7, 3.4) 
<0.001 
112 (9.9%) 
 
1.9 (1.4, 2.6) 
<0.001 
77 (5.5%) 
* Participants with birth weights < or > 3.5 SD or with unknown gestational age were excluded from 
analysis. 
#
Confounding factors – gender, FH of atopy, maternal smoking during pregnancy, CS, maternal 
history of asthma, breastfeeding at birth, current maternal smoking, social status, ethnicity, and other 
family member smoking. 
^
Adjusted for Family history of atopy only. 
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Table 20: Respiratory outcomes for all children 5 years of age and older 
 Very Preterm 
N = 495*  
Moderate Preterm 
N= 450* 
Late Preterm 
N= 1138* 
Full Term 
N= 1456* 
Wheeze ever (%) 
OR (95% CI) 
P value 
aOR (95% CI)# 
aOR (95% CI)^ 
276 (55.8%) 
3.29 (2.7, 4.1) 
<0.001 
3.28 (2.6, 4.1) 
3.49(2.8, 4.3) 
186 (41.3%) 
1.84 (1.5, 2.3) 
<0.001 
1.73 (1.4, 2.2) 
1.88 (1.5, 2.4) 
430 (37.8%) 
1.58 (1.3, 1.9) 
<0.001 
1.53 (1.3, 1.8) 
1.58 (1.3, 1.9) 
403 (27.7%) 
Current wheeze (%) 
OR (95% CI) 
P value 
aOR (95% CI)# 
aOR (95% CI)^ 
146 (29.5%) 
2.39 (1.9, 3.0) 
<0.001 
2.47 (1.9, 3.2) 
2.55 (2.0, 3.3) 
92 (20.4%) 
1.47 (1.1, 1.9) 
0.006 
1.36 (1.01, 1.8) 
1.495 (1.1, 2.0) 
227 (19.9%) 
1.41 (1.2, 1.7) 
0.001 
1.36 (1.1, 1.7) 
1.40 (1.1, 1.7) 
217 (14.9%) 
Doctor diagnosis of asthma (%) 
OR (95% CI) 
P value 
127 (25.7%) 
2.4 (1.9, 3.1) 
<0.001 
78 (17.3%) 
1.5 (1.1, 2.0) 
<0.001 
197 (17.3%) 
1.5 (1.2, 1.8) 
<0.001 
182 (12.5%) 
Family history of atopy (%) 
OR (95% CI) 
P value 
91 (18.4%) 
0.8 (0.6, 0.99) 
0.046 
98 (21.8%) 
0.95 (0.7, 1.2) 
0.694 
275 (24.2%) 
(0.9, 1.3) 
0.363 
330 (22.7%) 
Any inhaler medication use (%) 
OR (95% CI) 
P value 
109 (22%) 
2.3 (1.8, 3.0) 
<0.001 
66 (14.7%) 
1.4 (1.0, 1.9) 
0.032 
162 (14.2%) 
1.4 (1.1, 1.7) 
0.011 
159 (10.9%) 
Steroid inhaler medication use (%) 
OR (95% CI) 
P value 
66 (13.3%) 
2.3 (1.6, 3.2) 
<0.001 
36 (8%) 
1.3 (0.9, 1.9) 
0.21 
92 (8.1%) 
1.3 (0.97, 1.8) 
0.08 
92 (6.3%) 
Hospital admission with breathing 
related problem (last 12 months) (%) 
OR (95% CI) 
P value 
 
17 (3.4%) 
2.2 (1.2, 4.2) 
0.014 
 
16 (3.6%) 
2.3 (1.2, 4.4) 
0.012 
 
23 (2%) 
1.3(0.7, 2.3) 
0.397 
 
23 (1.6%) 
* Participants with birth weights < or > 3.5 SD or with unknown gestational age were excluded from 
analysis 
#
Confounding factors – gender, FH of atopy, maternal smoking during pregnancy, CS, maternal history of 
asthma, breastfeeding at birth, current maternal smoking, social status, ethnicity, and other family 
member smoking. For wheeze ever - Nagelkerke R
2
 = 0.09; for recent wheezing - Nagelkerke R
2
 = 0.081. 
^
Adjusted for Family history of atopy only. 
 
4.4.3 Risk factors for wheezing in childhood 
The most significant risk factor for wheezing for the whole of the RANOPS cohort was 
lower gestational age at birth followed by a family history of atopy.  All the following were 
independently and significantly (p<0.05) associated with increased rates of wheezing in the 
whole population of children less than five years-of-age (table 21): lower gestational age at 
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birth, male gender, maternal smoking during pregnancy, current maternal smoking, other 
family member current smoking, maternal history of asthma, delivery by caesarean section, 
family history of atopy, and lower WIMD rank. Being breast-fed was associated with reduced 
rates of wheezing in childhood.  The results were similar for the whole population of children 
five years-of-age and older, however breast feeding did not show a significant association with 
reduced rates of current wheezing in the older children (Table 24).  
When the cohort was separated into preterm and term only groups, I noted that a family 
history of atopy was consistently associated with higher rates of wheezing in all groups.  The 
factors most strongly (p<0.001) associated with wheezing in only preterm-born children less 
than five years-of-age were having a family history of atopy, having a physical disability (based 
on parental reporting of movement disorders such as cerebral palsy), being breast fed, 
ethnicity and admission to the neonatal unit (Table 22).  Admission to the neonatal unit is an 
outcome of being born preterm (although not all preterm births are admitted to the neonatal 
unit), however admission to the neonatal unit has been shown to increase risk of wheezing in 
childhood (Kiechl-Kohlendorfer, Horak et al. 2007). The factors most strongly associated with 
wheezing in only term-born children less than five years-of-age were family history of atopy 
and gender (Table 23).  In preterm-born children five years-of-age and older, the most strongly 
associated factors with wheezing were family history of atopy, having a physical disability and 
gender (Table 25).  For term-born children five years-of-age and older the most strongly 
associated factor with wheezing was family history of atopy (Table 26).
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           Table 21: Risk factors for wheezing in children less than 5 years of age for the whole population 
 Children less than 5 years-of-age 
 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
Gestational age          Very Preterm 
                           Moderate Preterm 
                                   Late Preterm 
                                               Term 
325/502 
266/479 
581/1130 
571/1402 
2.7 (2.2,3.3) 
1.8 (1.5,2.2) 
1.5 (1.3,1.8) 
0.037 
P <0.001 
201/502 
160/479 
326/1130 
261/1402 
2.9 (2.3,5.7) 
2.2 (1.7,2.8) 
1.8 (1.5,2.1) 
0.043 
P <0.001 
Family history of Atopy               Yes 
                                                       No 
602/981 
1141/2532 
1.9  
(1.7, 2.3) 
0.028 
P <0.001 
369/981 
579/2532 
2.0  
(1.7, 2.3) 
0.031 
P <0.001 
Physical disability                    Yes 
                                                   No 
139/189 
1598/3310 
3.0  
(2.1, 4.1) 
0.018 
P <0.001 
93/189 
851/3310 
2.8  
(2.1, 3.8) 
0.018 
P <0.001 
Breast feeding (birth)              Yes 
                                                   No 
 934/2025 
561/1037 
0.7  
(0.6, 0.8) 
0.009 
P <0.001 
486/2025 
321/1037 
0.7  
(0.6,0.8) 
0.009 
P <0.001 
Gender                                    Male 
                                            Female 
1002/1879 
741/1634 
1.4  
(1.2, 1.6) 
0.008 
P <0.001 
559/1879 
389/1634 
1.4  
(1.2, 1.6) 
0.006 
P <0.001 
Current maternal smoking      Yes 
                                                     No 
308/530 
1429/2972 
1.5  
(1.2, 1.8) 
0.007 
P <0.001 
187/530 
758/2972 
1.6  
(1.3, 1.9) 
0.009 
P <0.001 
Lower social class   Most deprived 
                                Least deprived 
351/632 
332/729 
1.5 (1.2,1.9) 0.007 
P 0.001 
196/632 
177/729 
1.4  
(1.1, 1.8) 
0.005 
P 0.006 
Mode of delivery                   LSCS 
                                         Non-LSCS 
512/1004 
667/1412 
1.2  
(0.98,1.4) 
0.005 
P 0.001 
292/1004 
348/1412 
1.3  
(1.0, 1.5) 
0.005 
P <0.001 
Maternal asthma                      Yes 
                                                     No 
69/105 
1674/3408 
2.0  
(1.3, 3.0) 
0.004 
P 0.001 
44/105 
904/3408 
2.0  
(1.3, 3.0) 
0.005 
P 0.001 
Maternal smoking during        Yes 
pregnancy                                   No 
219/393 
1503/3079 
1.3  
(1.1, 1.6) 
0.003 
0.01 
129/393 
803/3079 
1.4  
(1.1, 1.7) 
0.003 
P 0.006 
Current other adult smoking   Yes 
                                                      No 
55/86 
1688/3427 
1.8  
(1.2, 2.9) 
0.003 
P 0.008 
36/86 
912/3427 
2.0  
(1.3, 3.1) 
0.004 
P 0.002 
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 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
Ethnicity                         Caucasian 
                                Non-Caucasian 
1547/3056 
83/142 
1.7  
(1.3, 2.3) 
0.001 
P <0.001 
840/3056 
50/225 
1.3 
(0.96, 1.8) 
0.000 
P 0.087 
IUGR                          <10th centile 
                               20th-80th centile 
173/341 
1015/2069 
1.1  
(0.9, 1.3) 
0.000 
P 0.57 
100/341 
543/2069 
1.2  
(0.9, 1.5) 
0.000 
P 0.23 
 
Current paternal smoking        Yes 
                                                      No 
407/799 
1336/2714 
1.1  
(0.9, 1.3) 
0.000 
P 0.4 
227/799 
721/2714 
1.1  
(0.9, 1.3) 
0.000 
P 0.3 
Hospital admission 1st year of life    
                            Respiratory only  
 Any diagnosis (except respiratory)                                
                                No admissions 
 
506/690 
566/1163 
671/1660 
 
4.1  
(3.3, 4.9) 
 
0.08 
P <0.001 
 
310/690 
319/1163 
319/1341 
 
3.4  
(2.8, 4.2) 
 
0.063 
P <0.001 
Neonatal admission                  Yes 
                                                      No 
733/1276 
840/1935 
1.8 
(1.5, 2.0) 
0.025 
P <0.001 
431/1276 
414/1935 
1.9 
(1.6, 2.2) 
0.027 
P <0.001 
 
           Table 22: Risk factors for wheezing in children less than 5 years of age (preterm-born only) 
 Children less than 5 years-of-age 
Preterm only  
 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
Family history of Atopy               Yes 
                                                       No 
409/601 
763/1510 
2.086 
(1.7, 2.5) 
0.034 
P<0.001 
268/601 
419/1510 
2.096 
(1.7, 2.6) 
0.035 
P <0.001 
Physical disability                    Yes 
                                                   No 
114/150 
1053/1952 
2.704 
(1.8, 4.0) 
0.018 
P<0.001 
77/150 
607/1952 
2.337 
(1.7, 3.3) 
0.016 
P <0.001 
Breast feeding(birth)                Yes 
                                                   No 
589/1127 
583/984 
0.753 
(0.6, 0.9) 
0.007 
P 0.001 
333/1127 
354/984 
0.746 
(0.6, 0.9) 
0.007 
P 0.002 
Gender                                    Male 
                                            Female 
666/1136 
506/975 
1.313 
(1.1, 1.6) 
0.006 
P 0.002 
402/1136 
285/975 
1.326 
(1.1, 1.6) 
0.006 
P 0.003 
  
168 
 
 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
Current maternal smoking      YES 
                                                  NO 
227/357 
945/1754 
1.495 
(1.2, 1.9) 
0.007 
P 0.001 
141/357 
546/1754 
1.444 
(1.1, 1.8) 
0.006 
P 0.002 
Lower social class   Most deprived 
                                Least deprived 
251/413 
218/427 
1.5 
(1.1, 2.0) 
0.008 
P 0.005 
155/413 
126/427 
1.435 
(1.1, 1.9) 
0.006 
P 0.014 
Mode of delivery                   LSCS 
                                      Non-LSCS 
579/1033 
524/965 
1.073 
(0.9, 1.3) 
0.000 
P 0.43 
349/1033 
296/965 
1.153 
(0.96, 1.4) 
0.002 
P 0.14 
Maternal asthma                      YES 
                                                  NO 
48/70 
1124/2041 
1.78 
(1.1, 3.0) 
0.003 
P 0.027 
34/70 
653/2041 
2.007 
(1.2, 3.2) 
0.005 
P 0.004 
 
Maternal smoking during        YES 
pregnancy                                  NO 
156/260 
1016/1851 
1.233 
(0.9, 1.6) 
0.002 
P 0.12 
93/260 
594/1851 
1.178 
(0.9, 1.5) 
0.001 
P 0.24 
Current other adult smoking   YES 
                                                  NO 
40/54 
1132/2057 
2.335 
(1.3, 4.3) 
0.005 
P 0.007 
27/54 
660/2057 
2.117 
(1.2, 3.6) 
0.005 
P 0.007 
Ethnicity                         Caucasian 
                                Non-Caucasian 
1046/1833 
49/132 
2.251 
(1.6, 3.2) 
0.001 
P<0.001 
615/1833 
31/132 
1.645 
(1.1, 2.5) 
0.004 
P 0.018 
IUGR                          <10th centile 
                               20th-80th centile 
137/244 
655/1192 
1.05 
(0.8, 1.4) 
0.000 
P 0.73 
81/244 
379/1192 
1.066 
(0.8, 1.4) 
0.000 
P 0.67 
Current paternal smoking        YES 
                                                  NO 
275/496 
897/1615 
0.996 
(0.8, 1.2) 
0.000 
P 0.97 
166/496 
521/1615 
1.056 
(0.9, 1.3) 
0.000 
P 0.62 
Hospital admission 1st year of life    
                            Respiratory only  
 Any diagnosis (except respiratory)                                
                                No admissions 
 
399/525 
459/904
314/682 
 
3.7 (2.9, 4.8) 
0.079 
P <0.001 
 
257/525 
263/904 
167/682 
 
2.957 
(2.3, 3.8) 
0.056 
P <0.001 
Neonatal admission                  Yes 
                                                  No 
633/1077 
369/732 
1.402 
(1.2, 1.7) 
0.009 
P <0.001 
378/1077 
206/732 
1.381 
(1.1, 1.7) 
0.007 
P 0.002 
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                        Table 23: Risk factors for wheezing in children less than 5 years of age (term-born only) 
 Children less than 5 years-of-age 
Term only 
 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
Family history of Atopy               Yes 
                                                       No 
193/380 
378/644 
1.758 
(1.4, 2.2) 
0.021 
P<0.001 
101/380 
160/1022 
1.95 
(1.5, 2.6) 
0.024 
P <0.001 
Physical disability                    Yes 
                                                   No 
25/39 
545/1358 
2.664 
(1.4, 5.2) 
0.009 
P 0.004 
16/39 
244/1358 
3.176 
(1.7, 6.1) 
0.013 
P 0.001 
Breast feeding(birth)                Yes 
                                                   No 
345/898 
226/504 
0.767 
(0.6, 0.96) 
0.005 
P 0.019 
153/898 
108/504 
0.753 
(0.57, 0.99) 
0.005 
P 0.043 
Gender                                    Male 
                                            Female 
336/743 
235/659 
1.49 
(1.2, 1.8) 
0.013 
P<0.001 
157/743 
104/659 
1.43 
(1.1, 1.9) 
0.008 
P 0.01 
 
Current maternal smoking      YES 
                                                  NO 
81/173 
490/1229 
1.328 
(0.96, 1.8) 
0.003 
P 0.08 
46/173 
215/1229 
1.708 
(1.2, 2.5) 
0.009 
P 0.004 
Lower social class   Most deprived 
                                Least deprived 
100/219 
114/302 
1.386 
(0.97, 2.0) 
0.005 
P 0.07 
41/219 
51/302 
1.134 
(0.7, 1.8) 
0.006 
P 0.6 
Mode of delivery                   LSCS 
                                      Non-LSCS 
165/378 
386/978 
1.188 
(0.9, 1.5) 
0.002  
P 0.16 
76/378 
177/978 
1.139 
(0.8, 1.5) 
0.001 
P 0.15 
Maternal asthma                      YES 
                                                  NO 
21/35 
550/1367 
2.228 
(1.1, 4.4) 
0.005 
P 0.022 
10/35 
251/1367 
1.778 
(0.8, 3.8) 
0.002 
P 0.13 
Maternal smoking during        YES 
pregnancy                                  NO 
63/133 
508/1269 
1.348 
(0.9, 1.9) 
0.003 
P 0.1 
36/133 
225/1269 
1.722 
(1.1, 2.6) 
0.007 
P 0.009 
Current other adult smoking   YES 
                                                  NO 
15/32 
556/1370 
1.292 
(0.6, 2.6) 
0.000 
P 0.48 
9/32 
252/1370 
1.736 
(0.8, 3.8) 
0.002 
P 0.17 
Ethnicity                         Caucasian 
                                Non-Caucasian 
501/1223 
34/93 
1.204 
(0.8, 1.9) 
0.000 
P 0.41 
225/1223 
19/93 
0.878 
(0.5, 1.5) 
0.000 
P 0.63 
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 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
IUGR                          <10th centile 
                               20th-80th centile 
36/97 
360/877 
0.848 
(0.5, 1.3) 
0.001 
P 0.45 
19/97 
164/877 
1.059 
(0.6, 1.8) 
0.000 
P 0.83 
Current paternal smoking        YES 
                                                  NO 
132/303 
439/1099 
1.161 
(0.9, 1.5) 
0.001 
P 0.26 
61/303 
200/1099 
1.133 
(0.8, 1.6) 
0.001 
P0.44 
Hospital admission 1st year of life    
                            Respiratory only  
 Any diagnosis (except respiratory)                                
                                No admissions 
 
107/165 
107/259
357/978 
 
3.209 
(2.3, 4.5) 
0.044 
 
P<0.001 
 
53/165 
56/259 
152/978 
 
2.572 
(1.8, 3.7) 
0.028 
 
P<0.001 
Neonatal admission                  Yes 
                                                  No 
100/199 
471/1203 
1.57 
(1.2, 2.1) 
0.008 
P 0.003 
53/199 
208/1203 
1.737 
(1.2, 2.5) 
0.01 
P 0.002 
 
           Table 24: Risk factors for wheezing in children over 5 years of age for the whole population 
 Children 5 years-of-age and older 
 Wheeze 
ever 
OR 
(95% CI) 
Nagelkerke 
R2 
Current 
Wheeze 
OR 
(95% CI) 
Nagelkerke 
R2 
Gestational age         Very Preterm 
                          Moderate Preterm 
                                   Late Preterm 
                                               Term 
276/495 
186/450 
430/1138 
403/1456 
3.3 (2.7,4.1) 
1.8 (1.5,2.3) 
1.6 (1.3,1.9) 
0.05 
P <0.001 
146/495 
92/450 
226/1138 
217/1456 
2.4 (1.9,3.0) 
1.5 (1.1,1.9) 
1.4 (1.2,1.7) 
0.022 
P <0.001 
Family history of Atopy              Yes 
                                                      No 
391/794 
903/2744 
2.0  
(1.7, 2.3) 
0.026 
P <0.001 
242/794 
439/2744 
2.3  
(1.9, 2.8) 
0.034 
P <0.001 
Gender                                   Male 
                                            Female 
782/1930 
512/1608 
1.5  
(1.3, 1.7) 
0.011 
P <0.001 
412/1930 
269/1608 
1.4  
(1.1, 1.6) 
0.006 
P <0.001 
Physical disability                    Yes 
                                                  No 
86/153 
1204/3370 
2.3  
(1.7, 3.2) 
0.01 
P <0.001 
49/153 
630/3370 
2.0  
(1.4, 2.9) 
0.007 
P <0.001 
Lower social class   Most deprived 
                                Least deprived 
222/567 
282/844 
1.3  
(1.03, 1.6) 
0.005 
P 0.027 
129/567 
120/844 
1.8  
(1.3, 2.3) 
0.012 
P <0.001 
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 Wheeze 
ever 
OR 
(95% CI) 
Nagelkerke 
R2 
Current 
Wheeze 
OR 
(95% CI) 
Nagelkerke 
R2 
Mode of delivery                  LSCS 
                                      Non-LSCS 
256/633 
343/1057 
1.4  
(1.2, 1.7) 
0.005  
P 0.001 
141/633 
178/1057 
1.4  
(1.1, 1.8) 
0.003 
P 0.01 
Maternal asthma                     YES 
                                                  NO 
32/59 
1263/3480 
2.1  
(1.2, 3.5) 
0.003 
P 0.005 
20/59 
662/3480 
2.2  
(1.3, 3.8) 
0.003 
P 0.005 
Breast feeding(birth)                Yes 
                                                  No 
635/1840 
422/1093 
0.8  
(0.7, 0.9) 
0.003 
P 0.007 
337/1840 
344/1698 
0.9  
(0.7, 1.1)  
0.001 
P 0.13 
Current paternal smoking       YES 
                                                  NO 
319/787 
976/2752 
1.2  
(1.1, 1.5) 
0.003 
P 0.009 
183/787 
499/2752 
1.4  
(1.1, 1.7) 
0.005 
P 0.001 
Current maternal smoking      YES 
                                                  NO 
245/594 
1042/2923 
1.3 
(1.1, 1.5) 
0.003 
P 0.01 
120/594 
561/2923 
1.1  
(0.9, 1.3) 
0.000 
P 0.53 
IUGR                          <10th centile 
                              20th-80th centile 
136/324 
763/2081 
1.3 (0.99,1.6) 0.002 
P 0.068 
84/324 
380/2081 
1.6  
(1.2, 2.1) 
0.007 
P 0.001 
Current other adult smoking   YES 
                                                  NO 
37/87 
1258/3452 
1.3  
(0.8, 2.0) 
0.001 
P 0.25 
26/87 
656/3452 
1.8  
(1.1, 2.9) 
0.003 
P 0.012 
Maternal smoking during       YES 
pregnancy                                 NO 
198/493 
1018/2791 
1.2  
(0.96, 1.4) 
0.001 
P 0.076 
115/493 
566/2791 
1.3  
(1.1, 1.7) 
0.003 
P 0.014 
 
Ethnicity                        Caucasian 
                                Non-Caucasian 
1017/2857 
66/158 
0.8  
(0.6, 1.1) 
0.001 
P 0.12 
538/2857 
44/158 
0.6  
(0.4, 0.9) 
0.003 
P 0.006 
Regular physical activity         Yes 
                                                  No 
1124/3107 
164/411 
0.9  
(0.7, 1.1) 
0.001 
P 0.14 
576/3107 
103/411 
0.7  
(0.5, 0.9) 
0.004 
P 0.002 
Hospital admission 1st year of life    
                         Respiratory only Any 
diagnosis (except respiratory)                                
                              No admissions 
 
338/598 
478/1329 
478/1611 
 
3.1  
(2.5, 3.7) 
 
0.05 
P <0.001 
 
178/598 
261/1068 
242/1369 
 
2.4  
(1.9, 3.0) 
 
0.026 
P <0.001 
Neonatal admission                  Yes 
                                                  No 
588/1428 
559/1813 
1.6 
(1.4, 1.8) 
0.016 
P <0.001 
317/1428 
290/1813 
1.5 
(1.3, 1.8) 
0.01 
P <0.001 
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           Table 25: Risk factors for wheezing in children 5 years of age and older (preterm-born only) 
 Children 5 years-of-age and older 
preterms 
 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
Family history of Atopy               Yes 
                                                       No 
259/464 
633/1619 
1.968 
(1.6, 2.4) 
0.026 
P<0.001 
162/464 
303/1619 
2.33 
(1.9, 2.9) 
0.037 
P <0.001 
Physical disability                    Yes 
                                                   No 
77/130 
812/1943 
2.024 
(1.4, 2.9) 
0.01 
P<0.001 
43/130 
420/1943 
1.792 
(1.2, 2.6) 
0.006 
P 0.003 
Breast feeding(birth)                Yes 
                                                   No 
410/1002 
482/1081 
0.861 
(0.7, 1.0) 
0.002 
P 0.091 
209/1002 
256/1081 
0.849 
(0.7, 1.0) 
0.002 
P 0.12 
Gender                                    Male 
                                            Female 
545/1161 
347/922 
1.466 
(1.2, 1.7) 
0.012 
P <0.001 
285/1161 
180/922 
1.341 
(1.1, 1.7) 
0.006 
P 0.006 
Current maternal smoking      YES 
                                                  NO 
181/396 
711/1687 
1.156 
(0.9, 1.4) 
0.001 
P 0.20 
89/396 
376/1687 
1.011 
(0.8, 1.3) 
0.000 
P 0.94 
Lower social class   Most deprived 
                                Least deprived 
160/347 
184/463 
1.3 
(0.98, 1.7) 
0.003 
P 0.07 
95/347 
76/463 
1.92 
(1.4, 2.7) 
0.012 
P <0.001 
Mode of delivery                   LSCS 
                                      Non-LSCS 
399/914 
413/1005 
1.111 
(0.9, 1.3) 
0.001 
P 0.26 
210/914 
216/1005 
1.09 
(0.9, 1.4) 
0.000 
P 0.44 
Maternal asthma                      YES 
                                                  NO 
20/36 
872/2047 
1.684 
(0.9, 3.3) 
0.002 
P 0.12 
13/36 
452/2047 
1.995 
(1.0, 4.0) 
0.003 
P 0.049 
Maternal smoking during        YES 
pregnancy                                  NO 
143/309 
749/1774 
1.179 
(0.9, 1.5) 
0.001 
P 0.18 
86/309 
379/1774 
1.419 
(1.1, 1.9) 
0.004 
P 0.012 
Current other adult smoking   YES 
                                                  NO 
33/64 
859/2019 
1.438 
(0.9, 2.4) 
0.001 
P 0.15 
22/64 
443/2019 
1.863 
(1.1, 3.2) 
0.004 
P 0.02 
Ethnicity                         Caucasian 
                                Non-Caucasian 
698/1654 
46/96 
0.794 
(0.5, 1.2) 
0.000 
P 0.27 
368/1654 
29/96 
0.661 
(0.4, 1.0) 
0.003 
P 0.072 
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 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
IUGR                          <10th centile 
                               20th-80th centile 
104/231 
500/1173 
1.102 
(0.8, 1.5) 
0.000 
P 0.50 
63/231 
241/1173 
1.45 
(1.1, 2.0) 
0.005 
P 0.024 
Current paternal smoking        YES 
                                                  NO 
223/493 
669/1590 
1.137 
(0.9, 1.4) 
0.001 
P 0.22 
129/493 
336/1590 
1.323 
(1.0, 1.7) 
0.004 
P 0.019 
Hospital admission 1st year of life    
                            Respiratory only  
 Any diagnosis (except respiratory)                                
                                No admissions 
 
266/443 
370/945
256/695 
 
2.6 (2.0, 3.3) 
 
0.043 
P <0.001 
 
140/443 
196/945 
129/695 
 
2.048 
(1.6, 2.7) 
 
0.02 
P <0.001 
Neonatal admission                  Yes 
                                                  No 
486/1100 
258/685 
1.31 
(1.1, 1.6) 
0.006 
P 0.007 
258/110 
132/685 
1.284 
(1.0, 1.6) 
0.004 
P 0.038 
Regular physical activity         Yes 
                                                  No 
766/1819 
121/253 
0.794 
(0.6, 1.0) 
0.002 
P 0.086 
387/1819 
76/253 
0.629 
(0.5, 0.8) 
0.007 
P 0.002 
            
                           Table 26: Risk factors for wheezing in children 5 years of age and older (term-born only) 
 Children 5 years-of-age and older 
Term only 
 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
Family history of Atopy               Yes 
                                                       No 
132/330 
271/1126 
2.103 
(1.6, 2.7) 
0.03 
P<0.001 
80/330 
137/1126 
2.31 
(1.7, 3.1) 
0.032 
P <0.001 
Physical disability                    Yes 
                                                   No 
9/14 
392/1035 
1.697 
(0.7, 4.0) 
0.01 
P 0.22 
6/23 
210/1427 
2.045 
(0.8, 5.2) 
0.002 
P 0.14 
 
Breast feeding(birth)                Yes 
                                                   No 
225/838 
178/618 
0.907 
(0.7, 1.1) 
0.001 
P 0.41 
128/838 
89/618 
1.072 
(0.8, 1.4) 
0.000 
P 0.64 
Gender                                    Male 
                                            Female 
238/770 
165/686 
1.413 
(1.1, 1.8) 
0.008 
P 0.004 
128/770 
89/686 
1.337 
(1.0, 1.8) 
0.005 
P 0.051 
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 Wheeze 
ever 
OR 
 (95% CI) 
Nagelkerke  
R2  
Current 
wheeze 
OR 
(95%CI) 
Nagelkerke  
R2 
Current maternal smoking      YES 
                                                  NO 
64/198 
339/1258 
1.295 
(0.9, 1.8) 
0.002 
P 0.12 
31/198 
186/1258 
1.07 
(0.7, 1.6) 
0.000 
P 0.75 
Lower social class   Most deprived 
                                Least deprived 
62/220 
98/381 
1.133 
(0.78, 1.6) 
0.006 
P 0.5 
34/220 
44/381 
1.4 
(0.95, 2.3) 
0.015 
P 0.17 
Mode of delivery                   LSCS 
                                      Non-LSCS 
102/341 
253/954 
1.182 
(0.9, 1.6) 
0.00 
P 0.23 
59/341 
132/954 
1.3 
(0.9, 1.8) 
0.003 
P 0.12 
Maternal asthma                      YES 
                                                  NO 
12/23 
391/1433 
2.907 
(1.3, 6.6) 
0.006 
P 0.01 
7/23 
210/1433 
2.548 
(1.0, 6.3) 
0.004 
P 0.042 
Maternal smoking during        YES 
pregnancy                                  NO 
55/184 
348/1272 
1.132 
(0.8, 1.6) 
0.001 
P 0.18 
29/184 
188/1272 
1.079 
(0.7, 1.7) 
0.000 
P 0.73 
Current other adult smoking   YES 
                                                  NO 
4/23 
399/1433 
0.546 
(0.2, 1.6) 
0.001 
P 0.27 
4/23 
213/1433 
1.206 
(0.4, 3.8) 
0.000 
P 0.74 
Ethnicity                         Caucasian 
                                Non-Caucasian 
319/1203 
20/62 
0.758 
(0.4, 1.3) 
0.002 
P 0.28 
170/1203 
15/62 
0.516 
(0.3, 0.9) 
0.006 
P 0.031 
IUGR                          <10th centile 
                               20th-80th centile 
32/93 
264/909 
1.282 
(0.8, 2.0) 
0.002 
P 0.28 
21/93 
140/909 
1.6 
(0.95, 2.7) 
0.005 
P 0.075 
Current paternal smoking        YES 
                                                  NO 
96/294 
307/1162 
1.35 
(1.02, 1.8) 
0.004 
P 0.033 
54/294 
163/1162 
1.379 
(0.98, 1.9) 
0.004 
P 0.063 
Hospital admission 1st year of life    
                            Respiratory only  
 Any diagnosis (except respiratory)                                
                                No admissions 
 
72/155 
108/384
223/917 
 
2.7 
(1.9, 3.8) 
 
0.029 
P <0.001 
 
38/155 
65/384 
114/917 
 
2.288 
(1.5, 3.5) 
 
0.018 
P <0.001 
Neonatal admission                  Yes 
                                                  No 
102/328 
301/1128 
1.24 
(0.95, 1.6) 
0.002 
P 0.12 
59/328 
158/1128 
1.347 
(0.97, 1.9) 
0.004 
P 0.076 
Regular physical activity         Yes 
                                                  No 
358/1288 
43/158 
1.03 
(0.7, 1.5) 
0.000 
P 0.88 
189/1288 
27/158 
0.834 
(0.5, 1.3) 
0.001 
P0.42 
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4.4.4 Inhaler use in wheezing children born either at term or preterm 
On reviewing data from the Venn diagrams assessing the use of inhalers in wheezing 
children, there are four groups being compared: preterm-born atopic wheezers compared to 
term-born atopic wheezers, and preterm-born non-atopic wheezers compared to term-born 
non-atopic wheezers.  Figure 18 shows the percentages of children from the total of preterm-
born children who have ever wheezed (<5 years-of-age) and the odds ratios’ compared to 
term-born children who have ever wheezed.  This means a significant difference between the 
two groups is due to the difference in gestational age at birth excluding any confounding 
factors.  First it is important to note that a significant difference is shown between all children 
who have ever wheezed, who are born-preterm and being treated with inhalers compared to 
children born full term, who have ever wheezed and are being treated with inhalers (OR 1.7, 
95% CI 1.4, 2.1).  This basically shows that children born preterm who develop wheezing 
symptoms are treated with inhalers more frequently than children born term who develop 
wheeze.  However I was unable to identify whether these children were being treated 
appropriately with inhalers or if the children responded to inhalers either bronchodilators or 
inhaled corticosteroids.    
I was able to show that if a family history of atopy is included as a confounding factor then 
the atopic (family history of atopy positive) preterm-born wheezers, who are on inhalers, have 
an OR of 1.5 (95% CI 1.1, 2.0) compared to the atopic term-born wheezers who are on inhalers.  
Of note those children with no family history of atopy also show a significant difference so 
when the non-atopic preterm-born wheezers who are on inhalers are selected compared to 
term-born wheezers who are on inhalers the OR is 1.6 (95% CI 1.2, 2.1).  So whether preterm-
born children have a family history of atopy or not, they have wheezing symptoms more 
frequently than term-born controls and also when wheezy are treated with inhalers more 
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frequently.  Interestingly there were no significant differences when assessing the 
relationships in the Venn diagram for wheezy children five years-of-age and older (Figure 19).  
Also when the children were selected by doctor diagnosis of asthma, and compared by 
preterm-born children with asthma to term-born controls with asthma, there was still no 
significant difference in the children over 5 years of age (Figure 20). 
To further explore the relationship between being born preterm and having a family 
history of atopy, I used bar charts to demonstrate the differences between the four groups of 
children (preterm with atopy, preterm without atopy, term with atopy and term without 
atopy).  From these bar charts it can be seen that preterm-born children who have a family 
history of atopy had a greater risk for wheezing than born-term children with a family history 
of atopy (OR 2.0, 95%CI 1.6, 2.4). However, preterm-born children without a family history of 
atopy also had a greater risk of wheezing than children born term without a family history of 
atopy (OR 1.9, 95%CI 1.7, 2.1) suggesting that atopy did not play a part in the prematurity-
associated wheeze (Figure 21). Similarly, preterm-born children with wheezing and a family 
history of atopy were treated with inhalers more frequently than term-born children with 
wheeze and a family history of atopy (OR 1.4, 95%CI 1.1, 1.8) which was similar for the 
comparison between preterm and term groups with wheezing and no family history of atopy 
(OR 1.3, 95%CI 1.1, 1.6) (Figure 22). Thus these charts show that preterm-born children 
probably have a separate mechanism leading to wheeze in childhood than children born full 
term, who are more likely to have asthma relating to atopy or wheeze associated with viral 
infections.  
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 Figure 18: Venn diagram assessing the relationship between a family history of atopy and treatment with inhalers in children less than five years of age, who ever had wheeze. 
   
 
The odds ratios’ are comparing preterm children 
to term-born controls. 
187/1172 (16%) 
FH of atopy and 
inhaler 
treatment 
OR 1.5 (1.1, 
2.0)  
FH of Atopy  
409/1172 (34.9%) 
OR 1.1 (0.9, 1.3) 
222/1172 (18.9%) 
FH of Atopy only 
OR 0.8 (0.6, 1.03) 
271/1172 (23.1%) 
Inhaler treatment 
only 
OR 1.6 (1.2, 2.1) 
Rx Inhalers 
458/1172 (39.1%) 
OR 1.7 (1.4, 2.1) 
492/1172 (42%) 
Wheeze ever only 
 OR 0.7 (0.6, 0.9) 
<5 years old Wheeze Ever 
Preterm group 
1172/2079 (56.4%) 
OR 1.8 (1.6, 2.1) p<0.0001 
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Figure 19: Venn diagram assessing the relationship between a family history of atopy and treatment with inhalers in children five years of age and older, who ever had wheeze. 
 
  
 
FH of atopy and 
inhaler 
treatment 
 116/891 (13%) 
0.9 (0.6, 1.3) 
FH of Atopy 
259/891 (29.1%) 
OR 0.8 (0.7, 1.1)  
FH of Atopy only 
143/891 (16%) 
0.8 (0.6, 1.1) 
Inhaler treatment only 
214/891 (24%) 
0.97 (0.7, 1.3) 
Rx Inhalers 
330/891 (37%) 
OR 0.9 (0.7, 1.2) 
Wheeze ever only 
418/891 (46.9%) 
1.2 (0.9, 1.5) 
 
The odds ratios’ are comparing preterm children 
to term-born controls. 
≥ 5 years old Wheeze Ever 
Preterm group 
891/2068 (43%) 
OR 2.0 (1.7, 2.3) p<0.0001 
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Figure 20: Venn diagram assessing the relationship between family history of atopy and treatment with inhalers in children five years of age and older with a 
diagnosis of asthma. 
 
     
 
FH of atopy 
and inhaler 
treatment 
 103/402 
(25.6%) 
OR 0.8 (0.6, 
1.2) 
FH of Atopy 
141/402 (35.1%) 
OR 0.8 (0.6, 1.1)  
FH of Atopy only 
38/402 (9.5%) 
OR 0.8 (0.5, 1.4) 
Inhaler treatment only 
179/402 (44.5%) 
OR 0.9 (0.7, 1.4) 
Rx Inhalers 
282/402(70.1%) 
OR 0.8 (0.5, 1.2) 
Asthma only 
82/402 (20.4%) 
OR 1.6 (0.99, 2.6) 
P= 0.055 
 
The odds ratios’ are comparing 
preterm children to term-born 
controls. 
≥ 5 years old Dr diagnosis 
Asthma 
Preterm group 
402/2038 (19.3%) 
OR 1.7 (95%CI 1.4, 2.0) 
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Figure 21: Prevalence of ever having wheeze for the whole cohort 
 
Bars denote the percentage of children having ever wheezed who have a family history of atopy (blue bars) or not (green bars) and 
for both gestational groups, preterm or term. 
Figure 22: Prevalence of inhaler treatment for the whole cohort 
   
Bars denote the percentage of wheezy children being treated with inhalers who have a family history of atopy (blue bars) or not 
(red bars) and for both gestational groups, preterm or term. 
62.70% 
45.80% 44.60% 
30.20% 
Preterm (24-36 weeks) Term (37-43 weeks) 
FH of Atopy No FH of atopy 
29.20% 
17.70% 
16.30% 
9.30% 
Preterm (24-36 weeks) Term (37-43 weeks) 
FH of Atopy No FH of atopy 
OR 2.1 
(95%CI 1.8, 2.4) 
OR 2.0 
(95%CI 1.6, 2.3) 
OR 2.0 
(95%CI 1.6, 2.4) 
OR 1.0 
(95%CI 0.8, 1.1) 
OR 3.9 
(95%CI 3.3, 4.5) 
OR 1.9 
(95%CI 1.7, 2.1) 
OR 2.1 
(95%CI 1.8, 2.5) 
OR 2.1 
(95%CI 1.7, 2.7) 
OR 2.0 
(95%CI 1.6, 2.4) 
OR 0.9 
(95%CI 0.7, 1.1) 
OR 4.0 
(95%CI 3.3, 4.9) 
OR 1.9 
(95%CI 1.6, 2.5) 
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4.4.5 Influence of CLD in children born very preterm 
To assess whether preterm-born children are on a spectrum of disease associated with 
CLD, I evaluated the role of CLD in children born preterm. Children with CLD (based on 
parental reporting and discharge diagnosis from NICU) were confined to the very preterm 
group in this cohort; they had lower birth weight and gestational age than very preterm 
without CLD (Table 27). The CLD group had greater rates of wheezing ever (71.7%), inhaler use 
(37.5%) and hospital admissions (17.1%) compared to term-born controls (Table 28). However 
the children who were born very preterm without CLD also had significantly greater rates of 
wheezing (58.2%), inhaler use (25.6%) and hospital admissions (12%) compared to term-born 
controls. The children with CLD had significantly greater rates of wheezing and inhaler use 
compared to very preterm group without CLD. Family history of atopy was marginally lower 
(p<0.05) in children with CLD (17.8%) compared to term-born controls, but similar between 
very preterm children without CLD (23.1%) and term-born controls (24.8%).  
Table 27: Characteristics of very preterm-born children with and without CLD compared to full-
term-born controls. 
 CLD 
N=152 
No CLD 
N= 845 
Full Term 
N=2858 
Gestational age, weeks 
(mean, 95%CI) 
27.11  
(26.8, 27.5) 
30.2 
(30.1, 30.3) 
39.6 
(39.6, 39.7) 
Birth weight, kg 
(mean, 95%CI) 
0.98 (0.93, 1.03) 1.48 (1.46, 1.51) 
 
3.46 
(3.44, 3.48) 
Male (%) 87 (57%) 457 (54%) 1513 (53%) 
WIMD rank latest 
(median) 
927 967 1056 
Age, years 
(mean, 95% CI) 
4.2 (3.78, 4.66) 4.8 (4.57, 4.95) 4.8 (4.67, 4.89) 
(7.1, 7.3) 
Mother smoke (in 
pregnancy) 
24 (15.8%) 116 (13.7%) 317 (11.1%) 
Maternal age, years 
(mean, 95%CI) 
29.0 (27.9, 30.1) 30.3 (29.9, 30.8) 30.4 (30.1, 30.6) 
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Table 28: Childhood wheezing, family history of atopy, inhaler use and hospital admissions for 
very preterm-born children with or without CLD compared to full term-born controls 
 CLD 
N = 152 
No CLD 
N= 845 
Full term 
N=2,858 
Wheeze ever (%) 
OR (95% CI) 
 
109 (71.7%) 
4.9 (3.4, 7.0) 
<0.001 
492 (58.2%) 
2.7 (2.3, 3.2) 
<0.001 
974 (34.1%) 
Family history of atopy (%) 
OR (95% CI) 
P-value 
27 (17.8%) 
0.65 (0.4, 0.999) 
0.049 
195 (23.1%) 
0.9 (0.8, 1.1) 
N.S. 
710 (24.8%) 
Any inhaler medication use (%) 
OR (95% CI) 
 
57 (37.5%) 
4.7 (3.3, 6.6) 
<0.001 
219 (25.95%) 
2.7 (2.2, 3.3) 
<0.001 
326 (11.4%) 
Hospital admission with breathing 
related problem (last 12 months) (%) 
OR (95% CI) 
 
26 (17.1%) 
5.7 (3.6, 9.1) 
<0.001 
101 (12%) 
3.7 (2.8, 5.0) 
<0.001 
100 (3.5%) 
 
Comparisons are between the very preterm group with CLD and without CLD groups against 
the term group.  
 
4.5 Discussion 
Preterm birth is associated with increased respiratory symptoms throughout childhood as 
shown in this large population based study exploring the respiratory health outcomes of 
children born preterm. My results confirm that children born very preterm have the highest 
prevalence of respiratory symptoms and wheezing disorders throughout childhood (1 to 10 
years-of-age).  The study also shows that children born moderate and late preterm have an 
increased prevalence of respiratory symptoms when compared to term-born controls 
throughout childhood.  Thus a gradient effect across the gestational age groups is observed, 
with the highest odds ratios between the very preterm and term groups, and the lowest 
between the late preterm and term groups.  For all preterm-born children less than five years-
of-age the overall risk of wheezing was 1.8 (95% CI 1.6, 2.1). This confirms the findings of other 
cohort studies and is also in keeping with a recent systematic review, which found preterm 
birth (<37 weeks) was associated with wheezing disorders, OR 1.71 (95% CI 1.57, 1.87) (Been, 
Lugtenberg et al. 2014).  My study confirms that there continues to be a higher prevalence of 
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respiratory morbidity in preterm-born children despite improved standards of neonatal care 
over the last decade.   
It is known that many survivors of preterm birth have poor lung function and this is 
reflected by increased prevalence of respiratory symptoms and disease throughout childhood 
(Kotecha, Edwards et al. 2013). This study supports this knowledge and in addition shows that 
the preterm-born children are also receiving inhaler treatment more frequently than term-
born controls, although it is not possible to identify if the treatment is appropriate or not. Also 
it is unclear whether the inhaler treatment helps to resolve symptoms or improve lung 
function as shown in our recent systematic review on the effect of bronchodilators on %FEV1 in 
preterm-born subjects, which indicated an improvement in %FEV1 following short term use of 
bronchodilators (Kotecha, Edwards et al. 2015).  The systematic review evaluated the efficacy 
of inhaled bronchodilator and identified 21 studies, but only one study from 1997, assessed 
longer-term response to terbutaline, which showed an improvement (Pelkonen, Hakulinen et 
al. 1997). The remaining studies only assessed responses to single doses of inhaled 
bronchodilators. Similarly studies assessing the role of inhaled corticosteroids in this group of 
children are also limited (Pelkonen, Hakulinen et al. 2001). Whether long term use of 
bronchodilators or corticosteroids is of benefit requires further research, particularly as 
preterm-born children may go on to develop chronic obstructive pulmonary disease in 
adulthood (Broström, Akre et al. 2013, Bolton, Bush et al. 2015).  
Other studies have identified an increased number of prescriptions for inhaler medication 
in the preterm-born population.  It should be noted that in these studies the participants were 
identified from registries by selecting patients on inhaler treatment, so it is not clear whether 
the children in these studies are receiving treatment appropriately for wheezing disorders or 
not (Yuan, Fonager et al. 2003, Källén, Finnström et al. 2013).  From our data preterm-born 
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children had a greater severity of respiratory symptoms compared to term-born controls and 
were being treated more frequently with corticosteroids, however we could not show whether 
treatment had improved symptoms or not. Thus it is clearly important that further research 
assesses the efficacy of inhaler treatment in preterm-born children and whether the long-term 
consequences can be altered or avoided (Bolton, Bush et al. 2015).   
4.5.1 Mechanisms of prematurity associated wheeze 
The mechanisms underlying the development of childhood wheezing disorders, 
particularly secondary to preterm birth are not clear.  Children with atopic asthma have 
obstructive airflow secondary to airway inflammation and bronchial hyper responsiveness, 
which is reversible with bronchodilators and corticosteroids.  However preterm-born children 
with respiratory symptoms are likely to have an alternative pathological mechanism occurring, 
which may not respond in the same way to therapies such as bronchodilators and steroids.  
Being born preterm affects the structure of the airways, as they are mostly born during the 
saccular stage of lung development (see Table 1).  It is unlikely that the postnatal lung 
development continues in the same way as antenatal.  In adult survivors of CLD the underlying 
lung pathology more closely resembles that of pulmonary emphysema than asthma (Wong, 
Lees et al. 2008).  Furthermore preterm-born children are at increased risk of respiratory 
infections and other damaging factors, making these children more susceptible to developing 
long-term respiratory disorders. The term ‘chronic obstructive pulmonary disease of 
prematurity’ has been suggested to describe the respiratory problems in childhood associated 
with being born preterm rather than diagnosing these children as asthmatic (Filippone, Carraro 
et al. 2013). Narang et al showed that preterm born survivors in adulthood have increased 
respiratory symptoms however also used tracking to show that lung function had improved, 
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which would imply a different mechanism leading to the increased symptoms (Narang, 
Rosenthal et al. 2008).  
There are alternative mechanisms that have been suggested.  Some studies have shown 
that maternal antibiotic use during pregnancy increases the risk of childhood wheezing 
disorders in early childhood suggesting a disturbance in the bacterial ecology of the foetus may 
lead to childhood wheezing disorders (Stensballe, Simonsen et al. 2013).  This may only be in 
relation to ‘asthma’ and as prematurity-associated wheezing has a different phenotype there 
are probably different mechanisms involved (Filippone, Carraro et al. 2013, Martin, Prakash et 
al. 2013).   Other possible mechanisms include early exposure to respiratory viral infections, 
accelerated postnatal growth and swallowing dysfunction leading to recurrent aspiration 
(Sheikh, Allen et al. 2001, Blanken, Rovers et al. 2013, Sonnenschein-van der Voort, Arends et 
al. 2014).  Each of these may be associated with increased wheezing in childhood, and also 
children born preterm may be more likely to suffer from viral infections, may also have greater 
postnatal growth and are more likely to have swallowing difficulties.  Thus it is possible that all 
of these factors, which contribute to the increased risk of wheezing, are the result of being 
born preterm and thus the prematurity is the main risk for wheezing. However in any future 
studies it would be important to include these as potential risk factors to be assessed. 
4.5.2 Risk factors of prematurity associated wheeze 
In our study we noted the risk factors most strongly associated with wheezing were being 
born preterm and a family history of atopy.  There was some evidence from our data that 
these factors interact and their combined effect exacerbates the risk of wheezing in childhood, 
particularly in those who were born very or moderately preterm.  This has been previously 
shown in a small case-control study of Puerto Rican children, who had significantly higher rates 
of atopic asthma in children born preterm (Rosas-Salazar, Ramratnam et al. 2014). However 
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they show no difference for prematurity and asthma in non-atopic children.  In both studies 
the prevalence of atopy in preterm-born children was the same as children born term.  But in 
our study the very preterm-born children greater than five years-of-age show a lower 
prevalence of family history of atopy compared to term-born controls.  However in my study 
family history of atopy was not significantly associated with respiratory symptoms when 
included in the regression models.  This may suggest there are separate pathologies for atopic 
wheezing and the wheezing associated with preterm birth.  In our study, other risk factors 
associated with wheeze ever in preterm-born children were the mode of delivery and 
intrauterine growth restriction for both age groups. Mode of delivery is likely to be associated 
with the degree of prematurity but IUGR has been reported to be associated with increased 
respiratory disease in preterm-born infants in the neonatal period (Lal, Manktelow et al. 2003) 
and in term-born children (Kotecha, Watkins et al. 2010). 
In our study we also noted that for the whole cohort, children with the following risk 
factors were more likely to be wheezy: being male compared to female, having a mother who 
smoked during pregnancy or who currently smokes compared to non-smoking mothers, having 
a physical disability compared to being able bodied or having a mother with asthma compared 
to a non-asthmatic mother. These risk factors have been noted in previous studies and several 
of these factors have been linked to increased risk of preterm birth as well as the increased 
risk of childhood wheezing (Greenough, Limb et al. 2005, Holditch-Davis, Merrill et al. 2008, 
Robison, Kumar et al. 2012, Stocks, Hislop et al. 2013).   Thus there may be a common genetic 
and environmental link between preterm birth and wheezing (Su, Tung et al. 2012).  I also 
noted that breast-feeding was associated with a reduced risk of wheezing although only in the 
children less than five years-of-age and being involved in regular physical activity was also 
associated with a reduced risk of wheezing in preterm-born children over five years of age.  
However it is not possible to place causation on either breast-feeding or exercise as protective 
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mechanisms from my study findings, I can only show an association.  It may be that children 
who wheeze exercise less, however the results could be interpreted as increased exercise 
helps to reduce wheeze, which is stating causation and can only be an assumption and not 
fact.  Also breast-feeding in the younger age group shows an association with reduced 
wheezing rates, however this may reflect improved nutrition in those children who were 
breast fed, better social circumstances as breast feeding is more common in the higher socio-
economic groups, or an immune-mediated response secondary to breast-feeding (Oddy, Holt 
et al. 1999, Kelly and Watt 2005). 
My study also showed that atopic and non-atopic preterm-born children, who have ever 
wheezed and are less than five years-of-age are being treated more frequently with inhalers 
than term-born controls. However in children five years-of-age and older the rates of inhaler 
treatment are the same for preterm wheezers whether atopic or non-atopic.  It may be that 
the older preterm-born children have shown no response to inhalers and so are no longer on 
treatment, even though they still show higher rates of respiratory symptoms compared to 
term-born children.   When only children, greater than five years-of-age, with a doctor 
diagnosis of asthma, are analysed it is noted that the non-atopic preterm-born asthmatics are 
treated less frequently than term-born non-atopic asthmatics.  This also points towards a 
separate wheezing phenotype for those born preterm with no history of atopy, because those 
with atopy probably respond to inhaler treatment and our study shows they are being treated 
throughout childhood.  However the non-atopic preterm-born children maybe show poor 
response to inhaler treatment and so are treated less in later childhood. 
These risk factors should help primary care physicians when assessing children with 
respiratory symptoms.  Currently only paediatricians ask about early life factors when 
assessing children with respiratory disease (Bolton, Bush et al. 2012).  So to improve childhood 
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wheezing outcomes and reduce the risk of death from childhood wheezing disorders such as 
asthma, it is essential healthcare professionals identify these risk factors and initiate 
appropriate treatment early (Anagnostou, Harrison et al. 2012).  It is not possible to alter a 
child’s risk of being born preterm or having a family history of atopy.  However, if these risks 
are identified it is clear these children should receive closer healthcare observation and 
possibly early initiation of inhaler medication.  Three randomised controlled trials on preschool 
wheezing children have shown that using corticosteroids to try and prevent later respiratory 
disease is not effective (Bisgaard, Hermansen et al. 2006, Guilbert, Morgan et al. 2006, Murray, 
Woodcock et al. 2006).  Bisgaard et al assessed intermittent inhaled corticosteroid therapy at 
an early age in children with episodic wheezing, but showed no effect on the number of 
children going on to persistent wheezing (Bisgaard, Hermansen et al. 2006).  Guilbert et al 
conducted a similar study of preschool children at high risk of developing asthma and found 
the use of continuous inhaled corticosteroids did not prevent the progression to asthma, 
however treatment did reduce the burden of the disease (Guilbert, Morgan et al. 2006).   Also 
Chan et al showed in a small group of LBW children no improvement in respiratory symptoms 
when treated with inhaled corticosteroids (Chan and Silverman 1993).   The use of inhaled 
corticosteroids to prevent BPD in preterm born infants has mixed findings as Bassler et al have 
shown that infants treated with inhaled budesonide had lower rates of BPD (Bassler, Plavka et 
al. 2015).  However, Clouse et al in their systematic review of inhaled bronchodilator and 
corticosteroid therapies in infants with BPD were unable to demonstrate a clear outcome and 
concluded that further research is required to assess the benefits of inhaled corticosteroids for 
infants with BPD (Clouse, Jadcherla et al. 2016).  Our systematic review on the effect of 
bronchodilators on FEV1 in preterm-born survivors showed there may be a short-term benefit, 
however there were only a small number of studies and a lack of data on the long-term effects 
on lung function (Kotecha, Edwards et al. 2015).  Preterm-born children probably have a fixed, 
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variable obstructive airway disease with little inflammation and so current treatment regimes 
for asthma, maybe not be effective.  So an appropriately designed study is urgently required to 
identify the underlying mechanisms of respiratory symptoms in preterm-born children and 
assess the benefits of early inhaler therapy to ameliorate these symptoms.   
4.5.3 Study Limitations of RANOPS 
Our study has a several limitations.  It is a cross-sectional study of preterm and term-born 
children taken at one time point that relies upon parental reporting of symptoms.  Thus there 
is the potential for recall bias and as a subjective measure the answers of the parents may be 
influenced by the history of preterm birth and also the parent’s educational status.  This may 
have affected the wheezing rates for children over 5 years of age, which reports a lower rate of 
wheezing ever than children less than 5 years of age.  It may also have affected the accuracy of 
the diagnosis of asthma, CLD, physical disabilities and family history of atopy, as each of these 
were based on parental reporting. Of note the diagnosis of atopy was based on families 
responding positively to four separate questions of family history of asthma, eczema, allergies 
or hay fever and so this does not allow for accurate diagnosis of atopy in the child, which 
should ideally be confirmed by blood tests or skin prick testing.   Also it has been noted 
previously that parents often misinterpret the term wheeze, especially families were English is 
not their first language and those from more deprived backgrounds, which reduces the 
reliability of my findings (Michel, Silverman et al. 2006).  However, previous studies have 
suggested that parental recall of acute illness is correlated with medical records (D'Souza-
Vazirani, Minkovitz et al. 2005, Vernacchio, Vezina et al. 2007) and although the diagnosis may 
not be correct it has been shown that parental reporting of respiratory illness correlates with 
later respiratory morbidity (Watkins, Burton et al. 1982). Also our study includes information 
from health database to provide a more complete assessment and this allowed some of the 
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data such as diagnosis of certain conditions to be checked.  Ascertainment bias may have 
overestimated our results, as children born preterm are known to present more frequently for 
healthcare reviews and this may mean they are more likely to be diagnosed with a wheezing 
disorder or be started on inhaler medication. Also, the respondents to our survey may 
overestimate our results, as worried parents of children with health problems are more likely 
to reply.  However, this should be the same in both the preterm and term-born groups.   
Unfortunately there was a low response rate at 26.7%, even though previous studies had 
shown a good response from families in Wales (Burr, Wat et al. 2006). It should be noted the 
response rate for preterm-born children was 32%.  This may have resulted in recruitment bias 
and as shown by our comparison between responders and non-responders, there is a 
difference in the social circumstances as responders had higher WIMD scores.  So families 
from poorer backgrounds were possibly under represented in this study cohort.  We did 
account for this in our analysis, by using the WIMD score as a confounding factor in the 
analysis.  So it may be argued that the cohort is not truly representative of the whole 
population.  However there were a large number of preterm-born children included and also 
term-born controls from across the whole of Wales, so the cohort are representative of a good 
proportion of the population.  There was also a lack of functional data such as %FEV1 in 
association with the respiratory symptoms and also skin prick testing in association with the 
history of atopy, however the same cohort of children will be invited to take part in future 
studies that may well include spirometry and atopy investigations such as skin prick testing.  
However any future studies on the same cohort will suffer from attrition bias, which results 
from participants dropping out, and so the cohort becomes less representative of the whole 
population.    
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4.6 Conclusion 
 This large population-based study has confirmed that preterm-born children have 
increased prevalence of respiratory symptoms and wheezing disorders.  The interaction 
between family history of atopy and preterm birth further exacerbates these symptoms, but 
the exact nature of this interaction requires further exploration.  The majority of children with 
wheezing in this study, whether they were born preterm or term appear to have received 
appropriate treatment.  However children with wheezing and no family history of atopy were 
being treated with inhaler medication less frequently. Future research needs to focus on the 
mechanisms and aetiology of wheezing in the preterm-born population, especially those with 
no history of atopy, and whether inhaler medication, particularly corticosteroids, have a 
modifiable effect on lung function and respiratory symptoms.  Also research needs to assess 
whether it is possible to prevent the long-term development of COPD.   
 
4.7 Summary of Chapter Four 
Chapter four outlines the details of establishing a large cohort of preterm born children 
with term-born controls in Wales in 2013.  It also presents the results of the data analysis for 
the respiratory outcomes of the children born preterm and clearly shows a gradient effect with 
decreasing gestational age at birth relating to increased respiratory symptoms and increased 
inhaler treatment during childhood (up to 10 years of age). A closer review of the children 
born early term and possible confounding factors for their increased respiratory symptoms in 
childhood will be explored in the next chapter.  This cohort of children should now be 
recruited to take part in future studies assessing their ongoing respiratory health, which will 
provide important longitudinal data on disease progression.  
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5.0 CHAPTER FIVE: RESPIRATORY OUTCOMES OF CHILDREN BORN EARLY 
TERM 
This chapter presents the analysis of RANOPS data on the respiratory outcomes of children 
born early term.  I wrote the research protocol and established the cohort of study 
participants and set up the database.  The study has been published with myself as the first 
author in the Journal of Allergy and Clinical Immunology in June 2015 (copy in the appendix).  
The co-authors include my doctoral supervisors and the child health research team at Cardiff 
University.   The main hypothesis and aims of the research for this chapter were: 
To test the hypothesis that children born early term have increased respiratory morbidity, 
such as wheezing and hospital admissions, compared to children born at full term.  The specific 
aims were: 
1.  By using data from the RANOPS cohort I set out to test if children born early term have 
increased respiratory morbidity in childhood compared with full term-born controls. 
2.  And by using the same data from the RANOPS cohort I set out to test if the increased 
respiratory morbidity in children born early term is due to increased rates of family history of 
atopy and/or due to mode of delivery. 
 
5.1 Introduction to early term birth 
The RANOPS cohort, described in chapter 4, was established to assess the outcomes of 
children born preterm, however during my analysis using gestational age as a continuous 
variable it became evident that children born at 37 to 38 weeks of gestation also have 
increased respiratory symptoms compared to those born at 39-41 weeks of gestation.  I 
therefore explored the data for this group of children in more detail.  So on reviewing the 
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literature I noted that the American College of Obstetricians and Gynecologists has recently 
redefined full term delivery as 39 to 41 weeks’ gestation and early term deliveries are defined 
as 37 to 38 weeks’ gestation (ACOG_No_579 2013).  This is due to evidence of increased 
morbidity in the neonatal period of infants born prior to 39 weeks’ gestation (Tita, Landon et 
al. 2009, Fleischman, Oinuma et al. 2010, ACOG_No_561 2013) and due to increased mortality 
in infancy, childhood and young adulthood of those born at 37 to 38 weeks’ gestation 
compared to those born at full term (Crump, Sundquist et al. 2013).  However there is limited 
data on the long-term respiratory outcomes of children and adults born early term, although 
some recent studies have focused on the respiratory outcomes of the late preterm population, 
as discussed in chapter 4 (Hibbard, Wilkins et al. 2010, Kotecha, Dunstan et al. 2012, Kotecha, 
Watkins et al. 2012) and have included early term in their analyses (Boyle, Poulsen et al. 2012). 
It should be noted that data on the health outcomes of infants born early term beyond five 
years-of-age is very limited.  There has also been debate over the possible cause of morbidity 
in those born early term and that it could relate to mode of delivery.  For example, Caesarean 
section has been shown to increase the risk of ‘asthma’ (childhood wheezing disorders) in 
childhood (Thavagnanam, Fleming et al. 2008). 
5.1.1 The epidemiology of early term birth 
It is important to re-iterate the size of the problem, because there is the potential for large 
numbers of children to develop respiratory symptoms in association with early term birth.  In 
England and Wales, nearly 139,352 (19%) of the 726,572 live births in 2012 were born early 
term (ONS).  Several studies have shown increased admissions to neonatal units for infants 
born early term, especially those born by elective Caesarean section (CS) (Sengupta, Carrion et 
al. 2013, Parikh, Reddy et al. 2014), which places a significant burden on the health care 
system.  In 2012, nearly a quarter of all CS in England were performed at 37 to 38 weeks’ 
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gestation, which accounted for a third of all early term deliveries (Hospital Episode Statistics 
Analysis (2013).  Many of these were elective CS with a low indication for delivery prior to 39 
weeks.  Only a small proportion of these early term-born infants need to develop respiratory 
morbidity in the long term to result in a marked burden on health care services.  Thus the size 
of the problem is potentially far greater than the number of children born preterm, which only 
accounts for 7% of the total live birth rate.  However it has been suggested that the early term 
birth rate is high due to delivery by CS, which occurs more frequently in mothers at 38 weeks 
or less of gestation.  Also it should be noted that children born following CS have been 
observed to have greater respiratory symptoms in childhood.  
Studies show that infants born early term by elective CS have greater respiratory morbidity 
when compared to infants delivered by vaginal delivery (VD – normal and instrumental 
deliveries) (Hansen, Wisborg et al. 2007, Hansen, Wisborg et al. 2008).  A recent meta-analysis 
has showed an increased risk of wheezing disorders in childhood following delivery by either 
elective or emergency CS (analysed separately and combined) (Huang, Chen et al. 2015). 
However it is still unclear from this meta-analysis, whether the increased risk of childhood 
wheezing disorders is independent of gestational age at birth (37-42 weeks’ gestation) or due 
to the underlying reason leading to CS or whether the association is due to the increased risk 
of neonatal respiratory morbidity such as transient tachypnoea of the newborn (TTN) in those 
born by CS (Adams and Doull 2008).  So there are numerous risk factors for these children born 
early term that may contribute to them developing respiratory symptoms.  Furthermore, a 
family history of atopy may also add to the risk of childhood respiratory symptoms for which 
there are few reports assessing its role in early term-born children.  So to further understand 
the role of gestational age at birth on later respiratory symptoms, I performed further analysis 
of the RANOPS data specifically reviewing the data on children born at 37-42 weeks of 
gestation.  
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5.1.2 Aims and Objectives of the RANOPS study for children born early term 
The main aim was to examine the independent and the combined effects of early term 
birth, mode of delivery (elective CS, emergency CS or instrumental) and family history of atopy 
on respiratory morbidity in childhood.   I wanted to assess the impact of each factor on the risk 
of developing respiratory symptoms in childhood and to see if the term-born children, in the 
RANOPS cohort, had increased symptoms due to early term birth or CS or a combination of 
both.  
 So I hypothesized that children born early term have increased respiratory morbidity in 
childhood compared with full term-born controls.  Furthermore, I postulated that any 
respiratory morbidity would remain even with the inclusion of mode of delivery and family 
history of atopy as confounding factors.   
 
5.2 Methods 
To briefly recapitulate, I conducted a cross-sectional population-based study of children in 
Wales to explore the association between gestational age at birth and the risk of respiratory 
illness, hospital admissions and other health-related outcomes in the first ten years of life.  The 
full details of the RANOPS study can be read in chapter 4.  In 2013 I invited 13,361 preterm-
born children and 13,361 term-born matched controls, with birth dates from 1st January 2003 
to 31st December 2011, to complete a survey on respiratory and neurological health based 
outcomes.  Two different sets of questionnaires, based on validated surveys, were mailed to 
families with children less than five years-of-age (Powell, McNamara et al. 2002, Trinick, 
Southern et al. 2012), and children five years-of-age and older (Asher, Keil et al. 1995, Joshi, 
Powell et al. 2013).  Additional information was available from national health database 
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systems.  The focus of this chapter is to assess the outcomes of the children born at term 
(n=2,851). 
5.2.1 Gestation groups and Participants 
Gestational age at birth was used to categorize the children into early term (37 to 38 
weeks gestation) and full term (39 to 42 weeks gestation).  The gestational age was based on 
maternal reporting of last menstrual period and antenatal ultra sound scans. Standardized z-
scores were calculated for birth-weight by correction for gender and gestational age at birth 
using the LMS method (Pan H 2012); participants with a mean birth-weight outside of ±3.5 SDs 
were excluded as these were deemed implausible. Of the 2,851 term-born (37 to 42 weeks 
gestation) participants in RANOPS, four were excluded for having implausible birth-weights 
and two for missing birth-weights.  Anonymised data on birth-weight, gestational age at birth, 
social status and gender were available for the whole population from the NHS Wales 
Informatics Service, which manages healthcare databases in Wales.  Additional perinatal 
information, such as date of birth, mode of delivery, maternal details and admissions to the 
neonatal unit, was also available for the participants.   Main outcomes of interest focused on 
respiratory symptoms based on parental responses.  The data on mode of delivery came from 
NWIS and provided information such as caesarean section, vaginal delivery, elective, 
emergency, instrumental etc.  The data were recoded into all caesarean sections (CS – this 
included elective and emergency), all vaginal deliveries (VD – this included induced, 
instrumental and normal) and normal vaginal deliveries (NVD – this only included normal 
vaginal deliveries).   
5.2.2 Statistical analysis 
Chi-squared and Mann-Whitney U tests were used to compare differences of the 
characteristics between the responders and non-responders, and between the early term-born 
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and full term-born participants.  A p-value of <0.05 was considered statistically significant.  
Missing data were handled by single-value imputation by recoding into a no/negative response 
and were included in all analyses.  A comparison of including or excluding participants with 
missing data was made and the results were similar. Some of the data have been analysed 
separated into the two age groups (<5 years of age and ≥5 years of age), to allow for the 
different questions being assessed.  First, I used univariate logistic regression analysis to 
investigate differences between the two gestational groups for health related outcomes such 
as wheezing ever, recent wheezing, use of inhalers, and hospital admissions.  Next, I 
performed further analyses to adjust for variables that may account for the difference 
between children born early term and those born at full term. Multivariate logistic regression 
analyses were performed to adjust for mode of delivery at birth (CS or VD delivery) only and 
then to adjust for confounding factors, which included the WIMD score (an area-based 
measure of multiple deprivation), gender, maternal smoking during pregnancy, family history 
of atopy, ethnicity, and maternal age at time of delivery in a single model using main effects 
only.  More complex models that included other factors such as IUGR, current maternal 
smoking, and maternal history of asthma, were also performed with similar results.  However, 
the results from the simplest model have been presented in the tables.  In secondary analyses, 
using logistic regression modelling, I stratified the children by mode of delivery and compared 
the differences in rates of wheezing and neonatal admissions between children born early 
term with children born full term.  I also compared the differences in rates of wheezing 
between children born early term that did or did not have a family history of atopy with 
children born full term that did or did not have a family history of atopy or no atopy.  The 
statistical analysis was performed using PAWS/SPSS (version 18.0. SPSS Inc. Chicago, IL.).   
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5.3 Results 
5.3.1 Characteristics of responders 
From 13,361 term-born children invited to take part, 2,845 (21.3%) were included in the 
analyses after exclusion of six respondents. Responders had similar characteristics to non-
responders except for higher WIMD scores (Tables 29-32).  So the families who returned their 
questionnaires come from a less deprived socioeconomic background.  Comparing early term-
born children (both age groups) to full term-born controls did not show a statistically 
significant difference for gender, age, WIMD score, ethnicity, maternal smoking during 
pregnancy or maternal age at time of birth.  The early term-born children had a significantly 
higher rate of CS delivery, particularly by elective CS, compared to the full term-born controls 
(37% vs. 25.7% in <5 years-of-age group with OR 1.7; 95%CI 1.3, 2.3; and 43.3% vs. 22.5% in 
the ≥5 years-of-age group with OR 2.6; 95%CI 2.0, 3.5). There were missing data for mode of 
delivery that could not be recoded, so analyses were performed with cases excluded, which 
was 206 in total (38/545 early term and 168/2300 term). The rates of family history of atopy 
were 23.9% and 28% (OR 0.8, 95%CI 0.6,1.1) for the <5 years-of-age group and 27.5% and 
21.5% (OR 1.4, 95%CI 1.0,1.9) for the ≥5 years-of-age group for early term and full term groups 
respectively.  
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Table 29: Characteristics of responders <5 years of age comparing early term to full term 
 Early term 
N=272 
Full term 
N=1123 
Gestational age, weeks 
(mean, 95%CI) 
37.7* 
(37.6, 37.7) 
40.1 
(40.0, 40.1) 
Birth-weight, kg 
(mean, 95%CI) 
3.10* 
(3.05, 3.16) 
3.55 
(3.52, 3.57) 
Male (%) 147 
(54%) 
592 
(52.7%) 
WIMD rank latest 
(median) Range: 1-1909 
977 1009 
Age, years 
(mean, 95% CI) 
2.3 
(2.2, 2.4) 
2.2 
(2.2, 2.3) 
Maternal age, years (at 
time of delivery) (mean, 
95%CI) 
30.5 
(29.7, 31.2) 
30.3 
(29.9, 30.6) 
Ethnicity Caucasian  232/253 
(91.7%) 
984/1056 
(93.2%) 
Family history of atopy 65 (23.9%) 
 
314 (28%) 
(OR 0.8, 95%CI 0.6, 1.1)^ 
Mother smoke (in 
pregnancy)  
30 
(11%) 
101 
(9%) 
Mode of delivery (CS or 
not) 
97/262 
(37%)* 
279/1087 
(25.7%) 
Mode of delivery  
Elective, Emergency CS, 
Instrumental or NVD 
55 
(21%)* 
42 
(16%) 
29 
(11%) 
136 
(52%)* 
117 
(11%) 
162 
(15%) 
134 
(12%) 
674 
(62%) 
* p <0.05  
^Odds ratio for early term against full term 
 
 
Table 30: Characteristics of non-responders <5 years of age comparing early term to full 
term 
 Early Term 
N=1005 
Full Term 
N=4521 
Gestational age, weeks 
(mean, 95%CI) 
37.7 
(37.7, 37.7) 
40.1 
(40.1, 40.2) 
Birth-weight, kg 
(mean, 95%CI) 
3.13 
(3.10, 3.16) 
3.52 
(3.51, 3.53) 
Male (%) 
 
551 
(54.8%) 
2463 
(54.5%) 
WIMD rank latest 
(median) Range: 1-1909 
741* 748* 
Age, years (mean, 95%CI) 2.95 
(2.90, 3.00)* 
3.00 
(2.98, 3.03)* 
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Table 31: Characteristics of responders >5 years of age comparing early term to full term 
 Early Term 
N=273 
Full term 
N=1177 
Gestational age, weeks 
(mean, 95%CI) 
37.7* 
(37.6, 37.7) 
40.1 
(40.0, 40.1) 
Birth-weight, kg  
(mean, 95%CI) 
3.13* 
(3.08, 3.19) 
3.53 
(3.51, 3.56) 
Male (%) 142 
(52%) 
623 
(52.9%) 
WIMD rank latest 
(median) Range: 1-1909 
1111 1117 
Age, years (mean, 95%CI) 7.1 
(6.9, 7.3) 
7.2 
(7.1, 7.3) 
Maternal age, years (at 
time of delivery) (mean, 
95%CI) 
31.0 
(30.3, 31.7) 
30.3 
(29.9, 30.6) 
Ethnicity Caucasian (%) 228/239 
(95.4%) 
973/1023 
(95.1%) 
Family history of atopy 75 (27.5%)* 253 (21.5%) 
(OR 1.4, 95%CI 1.0, 1.9) 
Mother smoke (in 
pregnancy)  
33 
(12.1%) 
150 
(12.7%) 
Mode of delivery (CS or 
not) 
106/245 
(43.3%)* 
235/1045 
(22.5%) 
Mode of delivery  
Elective, Emergency CS, 
Instrumental or NVD 
64 
(26%)* 
42 
(17%) 
25 
(10%) 
114 
(47%)* 
90 
(9%) 
145 
(14%) 
129 
(12%) 
681 
(65%) 
* p <0.05  
^Odds ratio for early term against full term 
 
 
Table 32: Characteristics of non-responders >5 years of age comparing early term to full 
term 
 Early Term 
N=944 
Full Term 
N=3982 
Gestational age, weeks 
(mean, 95%CI) 
37.7 
(37.7, 37.8) 
40.1 
(40.1, 40.1) 
Birth-weight, kg 
(mean, 95%CI) 
3.111 
(3.08, 3.14) 
3.509 
(3.49, 3.52) 
Male (%) 544 (57.6%) 2160 (54.2%) 
WIMD rank latest 
(median) Range: 1-1909 
742* 825* 
Age, years (mean, 95%CI) 7.89 
(7.78, 7.99)* 
7.90 
(7.85, 7.95)* 
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5.3.2 Outcomes for children less than 5 years-of-age 
The prevalence of wheeze ever was 48.2% in the early term-born children less than five 
years-of-age, and 39% in the full term-born controls with OR of 1.5 (95% CI 1.1, 1.9) (Table 33).  
Similar results were noted for the following respiratory symptoms: recent wheeze (OR 1.7; 
95%CI 1.3, 2.4), recent daytime coughing (OR 1.7; 95%CI 1.3, 2.2) and recent chest infections 
(OR 1.3; 95%CI 1.0, 1.8).  Early term-born children also had twice the odds of inhaler 
medication use (OR 2.0; 95%CI 1.4, 2.9); higher neonatal unit admission rates in first 28 days of 
life (OR 1.7; 95%CI 1.2, 2.5); and higher admission rates to hospital in the first year of life (OR 
1.6; 95%CI 1.2, 2.1). The adjusted odds ratio for all respiratory symptoms, treatment with any 
inhaler and admissions to the neonatal unit or hospital, remained similar to the unadjusted 
results, when mode of delivery alone or when all confounding factors were included in the 
analysis.  
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Table 33: Respiratory outcome results for all children <5 years of age 
 Early Term 
N=272* 
Full Term 
N=1123* 
Admission to Neonatal Unit first 28 days of life (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
55 (20.2%) 
1.7 (1.2, 2.5) 
1.7 (1.2, 2.4) 
1.8 (1.3, 2.5) 
143 (12.7%) 
p=0.002 
p=0.004 
p=0.001 
Admission to hospital in first year of life (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
105 (38.6%) 
1.6 (1.2, 2.1) 
1.6 (1.2, 2.1) 
1.6 (1.2, 2.1) 
316 (28.1%) 
p=0.001 
p=0.002 
p=0.001 
Wheeze ever (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
131 (48.2%) 
1.5 (1.1, 1.9) 
1.4 (1.1, 1.9) 
1.5 (1.1, 1.9) 
438 (39%) 
p=0.006 
p=0.01 
p=0.005 
Recent wheeze (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
71 (26.1%) 
1.7 (1.3, 2.4) 
1.7 (1.3, 2.4) 
1.7 (1.3, 2.4) 
189 (16.8%) 
p=<0.001 
p=0.001 
p=0.001 
Recent daytime cough (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
163 (59.9%) 
1.7 (1.3, 2.2) 
1.7 (1.3, 2.2) 
1.8 (1.3, 2.3) 
527 (46.9%) 
p=<0.001 
p=<0.001 
p=<0.001 
Chest infections over the last year (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
98 (36%) 
1.3 (1.0, 1.8) 
1.3 (0.99, 1.7) 
1.3 (1.0, 1.8) 
333 (29.7%) 
p=0.042 
p=0.052 
p=0.053 
Inhaler medication use (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
51 (18.8%) 
2.0 (1.4, 2.9) 
2.1 (1.4, 3.0) 
2.1 (1.4, 3.0) 
115 (10.2%) 
p=<0.001 
p=<0.001 
p=<0.001 
* Participants with birth-weights < or > 3.5 SD or with unknown gestational age were excluded 
from analysis 
~ Adjusted for mode of delivery (CS or not) 
^Adjusted for family history of atopy, gender, maternal smoking during pregnancy, ethnicity, 
WIMD score & maternal age at time of birth.  
 
 
 
 
 
 
 
 
5.3.3 Children 5 years-of-age and older 
The prevalence of wheeze ever in children five years-of-age and older was 33.3% in the 
early term- born children and 26.4% in the full term-born controls with OR 1.4 (95% CI 1.05, 
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1.8) (Table 34).  Similar results were noted for recent wheeze (OR 1.4; 95%CI 1.02, 2.0), doctor 
diagnosis of asthma (OR 1.4; 95%CI 1.0, 2.1), exercise-induced wheezing (OR 1.8; 95%CI 1.2, 
2.8) and chest infection over the last year (OR 1.7; 95%CI 1.2, 2.3).  Of note children born early 
term had higher inhaler medication use (OR 1.6; 95%CI 1.1, 2.3), treatment with antibiotics 
over the last year (OR 1.7; 95%CI 1.3, 2.2), admissions to neonatal unit in the first 28 days of 
life (OR 1.5; 95%CI 1.1, 2.1), and admissions to hospital in the first year of life (OR 1.6; 95%CI 
1.2, 2.1).   For all the results, when adjusted for mode of delivery, the odds ratios were 
unchanged or marginally lower compared to the unadjusted odds ratios.  When adjustment 
was made for all confounding factors, the results remained similar.  It should be noted that the 
confidence intervals for some of the results of the older children are close to 1, with most 
showing statistically significance (p<0.05), however doctor diagnosis of asthma was marginal 
(unadjusted: p=0.05; non-significant with adjustment). 
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Table 34: Respiratory outcome results for all children >5 years of age 
 Early Term 
N=273* 
Full Term 
N= 1177* 
Admission to Neonatal Unit first 28 days of 
life (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
79 (28.9%) 
1.5 (1.1, 2.1) 
1.4 (1.0, 1.8) 
1.7 (1.2, 2.2) 
248 (21.1%) 
p=0.005 
p=0.045 
p=0.001 
Admission to hospital in first year of life (%) 
OR (95%CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
126 (46.2%) 
1.6 (1.2, 2.1) 
1.4 (1.1, 1.9) 
1.8 (1.4, 2.4) 
411 (34.9%) 
p=0.001 
p=0.007 
p=<0.001 
Wheeze ever (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
91 (33.3%) 
1.4 (1.05, 1.8) 
1.4 (1.03, 1.9) 
1.4 (1.0, 1.8) 
311 (26.4%) 
p=0.02 
p=0.031 
p=0.043 
Recent wheeze (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
52 (19%) 
1.4 (1.02, 2.0) 
1.4 (0.98, 2.0) 
1.4 (0.93, 1.9) 
165 (14%) 
p=0.037 
p=0.065 
p=0.110 
Doctor diagnosis of asthma (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
44 (16.1%) 
1.4 (1.0, 2.1) 
1.4 (0.96, 2.0) 
1.4 (0.9, 2.0) 
138 (11.7%) 
p=0.05 
p=0.079 
p=0.11 
Exercise induced wheezing (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
35 (12.8%) 
1.8 (1.2, 2.8) 
1.7 (1.1, 2.6) 
1.7 (1.2, 2.7) 
87 (7.4%) p=0.004 
p=0.013 
p=0.015 
Inhaler medication use – any (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
41 (15%) 
1.6 (1.1, 2.3) 
1.5 (1.0, 2.2) 
1.5 (1.0, 2.2) 
118 (10%) 
p=0.018 
p=0.039 
p=0.036 
Chest infections over the last year (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
65 (23.8%) 
1.7 (1.2, 2.3) 
1.6 (1.1, 2.2) 
1.6 (1.1, 2.2) 
187 (15.9%) 
p=0.002 
p=0.007 
p=0.007 
Treatment with antibiotics over the last 
year of life (%) 
OR (95% CI) 
Adjusted~ OR (95% CI) 
Adjusted^ OR (95% CI) 
135 (49.5%) 
1.7 (1.3, 2.2) 
1.6 (1.2, 2.1) 
1.6 (1.2, 2.1) 
437 (37.1%) 
p=<0.001 
p=0.001 
p=<0.001 
* Participants with birth-weights < or > 3.5 SD or with unknown gestational age were excluded 
from analysis 
~ Adjusted for mode of delivery (CS or not) 
^Adjusted for family history of atopy, gender, maternal smoking during pregnancy, ethnicity, 
WIMD score & maternal age at time of birth.  
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5.3.4 Prevalence of respiratory symptoms by mode of delivery and family history of 
atopy 
In my stratified analysis by mode of delivery and family history of atopy, the results for 
children less than five years-of-age and for children five years-of-age and older were similar, so 
both age groups were analysed together.  When wheeze ever was compared between the 
early term-born (208/507) and full term-born (695/2132) groups as a whole, OR 1.4 (95%CI 
1.2, 1.8) was significant.  However, when wheeze ever was compared between those delivered 
by CS (266/717) and those delivered by VD (637/1922) groups, OR 1.02 (0.99, 1.24) was 
borderline insignificant between the groups. On additional subgroup analyses of all children, 
early term-born children who were delivered by CS had marginally increased risk of wheeze 
ever than term-born children delivered by CS (OR 1.3, 95%CI 0.95, 1.8) (Figure 23). Those born 
by VD were significantly different between the groups (OR 1.5, 95%CI 1.1,1.9) but there was no 
significant difference for wheeze ever between children born early term by CS and children 
born early term by VD (OR 1.1, 95%CI 0.7, 1.5) or between children born full term by CS and 
children born full term by VD (OR 1.2, 95%CI 0.9, 1.4).  These results strongly suggest that the 
mode of delivery has limited association with wheeze ever when comparing children born 
early term and full term.  
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Figure 23: Prevalence of ever having wheeze for early term-born children born by 
caesarean section or vaginal delivery. 
 
Bars denote the percentage of term-born children ever having wheeze who were born by CS 
(white bars) or vaginal delivery (grey bars). Only relevant odds ratios between groups are 
shown. 
 
 
 
85/203 
42% 
181/514 
35% 
123/304 
40% 
514/1618 
32% 
       Early Term (37-38 weeks)                          Full Term (39-42 weeks)  
OR 1.3 
95%CI 0.95, 1.8 
OR 1.5 
95%CI 1.1, 1.9 
OR 1.1 
95%CI 0.7, 1.5 
OR 1.2 
95%CI 0.95, 1.4 
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Figure 24: Neonatal unit admissions for early term and full term-born children born by 
caesarean section or vaginal delivery 
 
Bars denote the percentage of term-born children having wheeze ever who were born by CS 
(white bars) or vaginal delivery (dark bars).  Only relevant odds ratios between groups are 
shown. 
 
 
 
However, early term-born infants delivered by either VD or CS had greater rates of 
neonatal admission compared to full term-born infants delivered by VD (OR 1.5, 95%CI 1.1, 
2.0) or CS (OR 1.4, 95%CI 0.99, 2.1) (Figure 24).  Furthermore, early term-born children with or 
without a family history of atopy were both associated with increased risk of wheeze ever 
(with family history: OR 1.4, 95%CI 1.0, 2.1; without family history: OR 1.4, 95%CI 1.1, 1.8) 
(Figure 25) suggesting that atopy is unlikely to play a part in the increased rates of respiratory 
symptoms in early term-born children. 
 
 
60/203 
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23% 64/304 
21% 
244/1618 
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Figure 25: Prevalence of ever having wheeze for term-born children with or without a 
family history of atopy 
 
Bars denote the percentage of term-born children ever having wheeze who have a family 
history of atopy (white bars) or not (dark bars).  Only relevant odds’ ratios between groups are 
shown. 
 
I next used a multivariate model to assess the role of mode of delivery in future 
development of wheezing in the two age groups. First I compared all CS to VD (Tables 35 and 
37) and in a more detailed analysis (Tables 36 and 38) I compared emergency CS, elective CS 
and instrumental delivery to NVD. When rates of wheezing were analysed in children less than 
five years-of-age comparing CS to VD, the difference was not significant for wheeze ever (1.2, 
95% CI 0.9, 1.5) and recent wheezing over last three months (1.1, 95% CI 0.8, 1.5), but was 
significant for admission to the neonatal unit (1.5, 95% CI 1.1, 2.1) and admission to hospital in 
the first year of life (1.3, 95%CI 1.0, 1.7).  These results remained essentially unchanged after 
adjustment for gestational group at birth (table 35).  When the prevalence of wheezing were 
compared by the four different modes of delivery (emergency CS, elective CS, instrumental D 
75/140 
54% 
249/567 
44% 
147/405 
36% 
500/1733 
29% 
OR 2.0  
95%CI 1.4, 3.0 
OR 1.9 
95%CI 1.6, 2.3 
OR 1.4 
95%CI 1.1, 1.8 
          Early Term (37-38 weeks)                      Full Term (39-42 weeks) 
OR 1.4 
95%CI 1.0, 2.1 
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and normal vaginal delivery [NVD]) the differences were not significant for wheeze ever, 
although borderline for elective CS (1.0 95%CI 0.8, 1.4; 1.3 95%CI 0.99, 1.9; 0.9 95%CI 0.7, 1.3, 
respectively) and all non-significant for recent wheeze.  However results were significant for 
admission to the neonatal unit for emergency CS and instrumental delivery (2.4 95%CI 1.6, 3.5; 
2.1 95%CI 1.4, 3.2, respectively), and admission to hospital in the first year of life (1.5 95%CI 
1.1, 2.1; 1.5 95%CI 1.1, 2.1, respectively), but not significant for elective CS (1.1 95%CI 0.7, 1.9 
and 1.4 95%CI 0.99, 2.0) (Table 36). 
Table 35:Wheezing in children less than 5 years of age comparing CS to VD 
 CS 
N=376 
VD 
N=973 
OR for early/ 
full term 
Admission to neonatal unit (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
69 (18.4%) 
1.5 (1.1, 2.1) 
1.4 (1.0, 2.0) 
126 (12.9%) 
p=0.012 
p=0.027 
1.7(1.2,2.4) 
p=0.004 
Admission to hospital first year of life (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
131 (34.8%) 
1.3 (1.0, 1.7) 
1.3 (0.99, 1.7) 
279(28.7%) 
p=0.028 
          p=0.06 
1.6(1.2,2.2) 
p<0.001 
Wheeze ever (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
164 (43.6%) 
1.2 (0.9, 1.5) 
1.1 (0.9, 1.4) 
385 (39.6%) 
p=0.18 
p=0.27 
1.4 (1.1,1.9) 
p = 0.01 
Recent wheeze (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
75 (19.9%) 
1.1 (0.8, 1.5) 
1.1 (0.8, 1.4) 
177 (18.2%) 
p=0.46 
p=0.69 
1.7 (1.2, 2.4) 
p < 0.001 
* Adjusted for gestational age group at birth 
 
 
Table 36: Wheezing in children less than 5 years of age comparing method of delivery 
 Emergency CS 
N=204 
Elective CS 
N=172 
Instrumental 
N=175 
NVD 
N=810 
Admission to neonatal unit (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
47 (23%) 
2.4 (1.6, 3.5) 
2.3 (1.6, 3.5) 
22 (12.8%) 
(0.7, 1.9) 
1.0 (0.6, 1.7) 
37 (21.1%) 
2.1 (1.4, 3.2) 
2.2 (1.4, 3.4) 
91 (11.2%) 
Admission to hospital first year of life (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
73 (35.8%) 
1.5 (1.1, 2.1) 
1.5 (1.1, 2.1) 
58 (33.7%) 
1.4 (0.99, 2.0) 
1.3 (0.9, 1.8) 
63 (36%) 
1.5 (1.1, 2.1) 
1.6 (1.1, 2.2) 
219 (27%) 
Wheeze ever (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
83 (40.7%) 
1.0 (0.8, 1.4) 
1.0 (0.7, 1.4) 
81 (47.1%) 
1.3 (0.99, 1.9) 
1.2 (0.9, 1.7) 
67 (38.3%) 
0.9 (0.7, 1.3) 
0.9 (0.7, 1.3) 
322 (39.8%) 
Recent wheeze (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
35 (17.2%) 
0.9 (0.6, 1.4) 
0.9 (0.6, 1.4) 
40 (23.3%) 
1.3 (0.9, 2.0) 
1.2 (0.8, 1.8) 
29 (16.6%) 
0.9 (0.6, 1.4) 
0.9 (0.6, 1.4) 
149 (18.4%) 
 
* Adjusted for gestational age group at birt 
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In children five years of age and older, when relating the CS vs. VD to rates of wheezing, 
the difference was not significant for wheeze ever (1.2, 95%CI 0.9, 1.6) and recent wheezing 
over last 12 months (95% CI 1.3, 0.9, 1.8) but was significant for admission to a neonatal unit 
(1.9, 95% CI 1.5, 2.6) and admission to hospital in the first year of life (1.8, 95%CI 1.4, 2.4).  The 
results remained the same after adjustment for gestational age at birth (Table 37).   When the 
rates of wheezing were compared according to the four different modes of delivery 
(emergency CS, elective CS, instrumental D and NVD) the differences were not significant for 
wheeze ever, although borderline for elective CS (1.0 95%CI 0.7, 1.5; 1.4 95%CI 0.99, 2.1; 1.1 
95%CI 0.7, 1.5, respectively) and all non-significant for recent wheeze.  However results were 
significant for admission to the neonatal unit (1.5 95%CI 1.1, 2.2; 2.3 95%CI 1.6, 3.4; 1.5 95%CI 
1.0, 2.3 respectively), and admission to hospital in the first year of life (1.6 95%CI 1.1, 2.1; 2.2 
95%CI 1.5, 3.1; 1.4 95%CI 0.98, 2.0, respectively) (Table 38). 
Table 37: Wheezing in children 5 years of age and older comparing CS to VD 
 CS 
N=341 
VD 
N=949 
OR for early 
/full term 
Admission to neonatal unit (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
107 (31.4%) 
1.9 (1.5, 2.6) 
1.8 (1.4, 2.4) 
182 (19.2%) 
p=<0.001 
p=<0.001 
1.3 (1.0, 1.8)              
p= 0.085 
Admission to hospital first year of 
life (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
164 (48.1%) 
1.8 (1.4, 2.4) 
1.7 (1.3, 2.3) 
317 (33.4%) 
p=<0.001 
p=<0.001 
1.5 (1.1, 2.0) 
p=0.006 
Wheeze ever (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
102 (29.9%) 
1.2 (0.9, 1.6) 
1.1 (0.8, 1.5) 
252 (26.6%) 
p=0.23 
p=0.42 
1.4 (1.0, 1.9) 
p=0.03 
Recent wheeze (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
59 (17.3%) 
1.3 (0.9, 1.8) 
1.2 (0.9, 1.7) 
132 (13.9%) 
p=0.13 
p=0.25 
1.5 (1.0, 2.1) 
p=0.04 
Doctor diagnosis of asthma (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
50 (14.7%) 
1.2 (0.9, 1.8) 
0.99 (0.89, 1.1) 
115 (12.1%) 
P=0.23 
P=0.82 
1.4 (0.9, 2.1) 
p=0.07 
Recent wheeze (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
75 (19.9%) 
1.1 (0.8, 1.5) 
1.1 (0.8, 1.4) 
177 (18.2%) 
p=0.46 
p=0.69 
1.7 (1.2, 2.4) 
p < 0.001 
* Adjusted for gestational age group at birth 
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Table 38: Wheezing in children 5 years of age and older comparing method of delivery 
 
 Emergency CS 
N=187 
Elective CS 
N=154 
Instrumental 
N=154 
NVD  
N=870 
Admission to neonatal unit (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
51 (27.3%) 
1.5 (1.1, 2.2) 
1.5 (1.1, 2.2) 
56 (36.4%) 
2.3 (1.6, 3.4) 
1.9 (1.3, 2.8) 
42 (27.3%) 
1.5 (1.0, 2.3) 
1.6 (1.1, 2.3) 
327 
(19.7%) 
Admission to hospital first year 
of life (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
83 (44.4%) 
1.6 (1.1, 2.1) 
1.5 (1.1, 2.1) 
81 (52.6%) 
2.2 (1.5, 3.1) 
1.9 (1.3, 2.8) 
64 (41.6%) 
1.4 (0.98, 2.0) 
1.4 (1.0, 2.0) 
294 
(33.8%) 
Wheeze ever (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
50 (26.7%) 
1.0 (0.7, 1.5) 
1.0 (0.7, 1.5) 
52 (33.8%) 
1.4 (0.99, 2.1) 
1.3 (0.9, 1.9) 
42 (27.3%) 
1.1 (0.7, 1.5) 
1.1 (0.7, 1.6) 
228 
(26.2%) 
Recent wheeze (%) 
OR (95% CI) 
Adjusted* OR (95% CI) 
31 (16.6%) 
1.3 (0.8, 2.0) 
1.3 (0.8, 2.0) 
28 (18.2%) 
1.4 (0.9, 2.3) 
1.3 (0.8, 2.0) 
23 (14.9%) 
1.1 (0.7, 1.8) 
1.1 (0.7, 1.9) 
117 
(13.4%) 
 
 
* Adjusted for gestational age group at birth 
 
5.4 Discussion 
In this chapter my aim was to assess the respiratory related outcomes for children who 
were born early term compared to those born at full term and to determine the additional 
independent effects of CS and family history of atopy, by using data from the cross-sectional 
survey, RANOPS. My results showed that children, up to 10 years-of-age, born at early term 
(37 to 38 weeks of gestation) have up to 70% greater risk of respiratory symptoms and up to 
50% increased risk of inhaler use, when compared to those born at full term (39 to 42 weeks of 
gestation).  Also children born early term who were 5 years-of-age and older had increased risk 
of chest infections and antibiotic use, compared to those born at full term. The risk of 
respiratory symptoms and treatment with inhalers throughout childhood were independent of 
family history of atopy and mode of delivery in my cohort.  I have also confirmed previous 
reports of increased admissions to neonatal units of early term-born infants that had 
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previously been partially explained by greater delivery by CS (Fleischman, Oinuma et al. 2010, 
Parikh, Reddy et al. 2014).  
5.4.1 Early term birth and respiratory morbidity 
There have been few studies assessing the long-term respiratory health outcomes of 
children born early term.  Goyal et al have showed increased risk of respiratory illness in those 
born late preterm (35 to 36 weeks gestation) and early term (37 to 38 weeks gestation) in early 
childhood (up to 18 months-of-age)(Goyal, Fiks et al. 2011). Boyle et al and Paranjothy et al 
have both reported increased risk of respiratory disease in children born early term up to five 
years-of-age, which I have confirmed (Boyle, Poulsen et al. 2012, Paranjothy, Dunstan et al. 
2013).  My study confirms and extends these observations by collecting respiratory morbidity 
data and treatment data for early term-born children. The data suggests that respiratory 
symptoms continue into early school years for early term-born children when compared to full 
term-born children and that these children are receiving increased treatment with inhaler 
medication.   It is unclear whether this treatment is beneficial and also the mechanisms leading 
to the increased respiratory symptoms are unknown.  It is also important to understand 
whether the increased respiratory morbidity is due to early term birth or CS or both and this 
will be discussed in more detail.   
Harju et al also assessed the impact of gestational age at birth and the risk of developing 
‘asthma’ in childhood, and showed that early term and late preterm deliveries contribute most 
to the additional cases of ‘asthma’ compared to those born at 39 to 40 weeks gestation, 
although they only assessed the risk of ‘medically diagnosed asthma’ relying on registry-
collected data but were unable to comment on symptoms or severity (Harju, Keski-Nisula et al. 
2014).  I have shown that early term-born children have more wheezing than full term-born 
controls and this remains significant when gender, mode of delivery and family history of 
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atopy were included in the analysis. Whether the increased prevalence of respiratory 
symptoms is due to a “traditional” asthma diagnosis or is a consequence of earlier delivery 
hence marginally earlier stage of lung growth and development remains to be seen.  For 
doctor diagnosis of asthma, in children 5 years of age and older there was no difference noted 
between those born early term and those born at full term.  As discussed in chapter 4 there 
may be other risk factors involved such as antibiotic usage during pregnancy, early viral 
respiratory infections, and/or swallowing difficulties (Sheikh, Allen et al. 2001, Jackson, 
Gangnon et al. 2008).  
The mechanisms underlying these increased respiratory symptoms in children born early 
term is not known but maybe relate to delivery at marginally earlier stage of lung growth and 
development when surfactant production may not be optimal.  This may be secondary to a 
structural immaturity as infants born only a few weeks of gestation early are still in the 
saccular stage of lung development (Joshi and Kotecha 2007) and therefore these children may 
have symptoms relating to reduced lung capacity.  However the respiratory symptoms may be 
secondary to a functional problem, such as respiratory distress syndrome (RDS) or transient 
tachypnoea of the newborn, caused by reduced surfactant production and/or poor lung fluid 
clearance prior to birth (Edwards, Kotecha et al. 2013).  If the respiratory symptoms in 
childhood are secondary to a functional abnormality at the time of birth, there is the potential 
to prevent neonatal respiratory morbidities with the use of antenatal maternal corticosteroids.  
It has been suggested that for medically indicated CS prior to 39 weeks gestation, mothers 
should receive antenatal glucocorticoids to decrease the risks of neonatal morbidity 
(Stutchfield, Whitaker et al. 2005).  Corticosteroids administration to the mother prior to 
elective CS at term appears to decrease neonatal respiratory symptoms in the neonatal period, 
most likely via their effects on clearance of lung fluid and enhanced surfactant production 
(Stutchfield, Whitaker et al. 2005, De Luca, Boulvain et al. 2009).  Whether this intervention 
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decreases later morbidity including respiratory outcomes will need further evaluation 
(Stutchfield, Whitaker et al. 2013). 
5.4.2 Mode of delivery and early term birth 
My study has shown and confirms that over a third of children born at 37 to 38 weeks’ 
gestation are delivered by CS (nearly 60% were elective), which has previously been shown to 
be an independent risk factor for later respiratory disease (Roduit, Scholtens et al. 2009).  
However, my results did not find a difference between children born via CS compared to VD 
for respiratory symptoms throughout childhood, replicating the results of two previous studies 
(Werner, Ramlau-Hansen et al. 2007, Menezes, Hallal et al. 2011).  Children born early term by 
CS or VD had higher rates of wheezing compared to full term-born children by VD and 
marginally increased rates for children born early term by CS compared to children born full 
term by CS.  However there was no difference in rates between children born early term by CS 
and those born early term by VD and the same for full term-born children, which suggest that 
birth by CS, unlike previous observations, does not substantially affect later respiratory 
outcomes.  In contrast, early term-born or full term-born infants delivered by CS were 
associated with greater admissions to the neonatal when compared to those born early term 
or full term delivered by VD.   
Furthermore, the results stratified by age groups have shown that those delivered by CS 
have increased neonatal admissions and admissions to hospital in the first year of life 
compared to those delivered by VD with the results remaining unchanged after adjustments 
for gestation. Tita et al and Wilmink et al, both showed similar findings in their studies and 
supported the call to delay elective CS until after 38 weeks gestation (Tita, Landon et al. 2009, 
Wilmink, Hukkelhoven et al. 2010). However, their results were unadjusted for gestation, 
although De Luca et al and Parikh et al, both also showed that infants born secondary to CS 
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have increased neonatal problems with adjustment for gestational age at birth, including those 
at 37 to 38 weeks’ gestation (De Luca, Boulvain et al. 2009, Parikh, Reddy et al. 2014).  When 
mode of delivery was categorized into four, the results were interesting.  Children born via 
emergency CS and instrumental delivery showed increased admissions for both age groups 
and no association with respiratory symptoms in childhood.  However children born via 
elective CS in the younger age group did not show any association with neonatal admission, 
and showed only a marginal increase risk of admission in the first year of life and for wheeze 
ever.  In the older age group the children born via elective CS showed increased neonatal 
admissions, admissions to hospital in the first year of life and a marginal increased risk of 
wheeze ever.  This may reflect the changing patterns in the management of elective CS.  In 
recent years, pregnant women who plan to have a CS, are more likely to be offered delivery 
closer to 39 weeks and may also be offered antenatal steroids.   
5.4.3 Early term birth and health care usage 
A recent review of the literature by Kuzniewicz et al concluded that there is limited data on 
health care utilization by children born early term, however my data have shown these 
children have increased treatment with inhalers, increased treatment with antibiotics and 
increased hospital admissions (Kuzniewicz, Parker et al. 2013).   It would appear that children 
born early term are being treated more frequently for their increased respiratory symptoms 
with inhalers, have increased antibiotic use and hospital admissions.  Whilst the early term 
group had increased use of bronchodilators, it will be important to ensure that this treatment 
is appropriate, which will require investigation of the underlying mechanisms of increased 
wheeze I have reported in early term-born children. There are no previous reports on the 
differences in treatment of children born early term and full term, which suggests that 
clinicians need to consider the importance of gestational age at birth when reviewing all 
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children with respiratory symptoms (Bolton, Bush et al. 2012).  There is growing recognition 
that not only children born preterm, but also those born early term are at greater risk of 
poorer respiratory health in later life (Ananth, Friedman et al. 2013) thus deliveries should be 
delayed to 39 weeks gestation unless medically indicated.  My results support the view that 
full term delivery should be redefined as 39 to 41 weeks gestation (Marlow 2012, 2013) thus 
avoiding delivery at ≤38 weeks’ gestation potentially decreasing future respiratory morbidity.  
5.4.4 Study Limitations 
The data were gathered from parent-completed questionnaires and from hospital 
database records, so I was able to analyse multiple health outcomes.  The data have the same 
limitations as discussed in chapter 4 with regards to the response rate of the questionnaires, 
the missing data and the questionnaires were returned and completed by families with similar 
characteristics to non-responders except for lower deprivation score.  This may lead to 
underestimation of results, as children from deprived areas are more likely to have respiratory 
morbidity; however, since the comparison was between those born at different gestational 
ages, the results are likely to remain robust. As only very few cases had missing data, the data 
are unlikely to affect the main conclusions. It was however limited by the lack of data on 
indications for delivery prior to 39 weeks gestation. These indications such as maternal sepsis, 
prolonged rupture of membranes, may also be the cause for increased rates of admissions and 
also later respiratory symptoms by affecting the immune system (Bendiks and Kopp 2013).   
There was also a lack of information on maternal disease and maternal treatment with 
antenatal steroids. It is known that mothers with more severe illnesses are more likely to be 
delivered early although where antenatal steroids have been used infants have a reduced risk 
of neonatal respiratory morbidity.  However, maternal age was included in the multivariate 
logistic analyses and increasing maternal age is associated with increased risk of maternal 
  
217 
 
disease. It is often suggested that gestational age should be used as a continuous variable in 
analyses, however I feel our analysis supports the notion of grouped gestational ages into 
categories such as early term, late preterm, term etc. (Marlow 2012).  Also it could be 
questioned as to whether the numbers of early term children analysed were sufficient to show 
a significant difference.  The OR for wheeze ever, when comparing CS to VD was 1.2 for both 
children less than 5 years and older than 5 years, which is similar to the results of the most 
recent systematic review on CS and asthma (Huang, Chen et al. 2015). However, the results 
were non-significant and when the data was analysed by gestational group with mode of 
delivery as a confounding factor, the ORs were unchanged or marginally lower compared to 
the unadjusted ORs.  This suggests that mode of delivery has little effect on the long-term 
respiratory morbidity of those born by CS.  
 
5.5 Conclusion 
Our data suggests that delivery at 37 – 38 weeks gestation is associated with increased 
respiratory symptoms throughout childhood, and increased use of health care services 
(neonatal admissions, admissions in first year of life, inhalers and antibiotic use).  These 
findings appeared to be independent of atopy and of delivery by CS suggesting that alternative 
mechanisms, such as immaturity of the lungs, rather than those for asthma (i.e. the hygiene 
hypothesis) may be responsible for the increased rates of wheeze noted in this group of 
children. The underlying mechanisms need to be clarified so that targeted therapy can be 
sought.  Also the long-term implications of early term birth on respiratory morbidity in later 
childhood and beyond are unclear, so require investigation. However it is clear from our data 
that delivery at 37 – 38 weeks gestation should be avoided, as recommended by NICE (NICE 
2013), unless medically indicated.  
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5.6 Summary of Chapter Five 
In this chapter the medium term effects of being born early term have been reviewed 
using data from the RANOPS cohort.  The data have shown increased respiratory symptoms 
and confirmed increased neonatal morbidity in those born at 37 to 38 weeks of gestation, 
which is currently still referred to as ‘term births’ within the UK.   Importantly the study has 
identified that the increased morbidity was independent of mode of delivery, including 
caesarean section, and family history of atopy. Thus a discussion needs to be sought amongst 
obstetricians as to the appropriateness of elective deliveries prior to 39 weeks of gestation.   
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6.0 CONCLUSION: 
In the conclusion for this thesis I will briefly summarise the salient points from the three 
interlinked research projects that reviewed the respiratory and vascular outcomes of children 
born preterm.  I will also put the findings from my research in the context of the current 
literature and will discuss the clinical implications of my research and suggest areas of possible 
future work. 
 
6.1 Prematurity and cardiovascular outcomes 
6.1.1 Principal findings of the study on vascular function measurements in children born 
preterm 
The hypothesis for this research project was that children born preterm would have 
abnormal vascular function and arterial wall stiffness compared to term-born controls when 
measured using non-invasive markers, which were FMD, DC and PWV, and this was rejected by 
my research findings.   So the background to this hypothesis was that a large systematic review 
and meta-analysis has shown that children and adults born preterm are at greater risk of 
developing hypertension (de Jong, Monuteaux et al. 2012).  My research showed that systolic 
BP was higher in children born preterm compared to term-born controls and that the mean 
difference of 4.59 mmHg (95%CI 2.33, 6.85 mmHg) for the very preterm compared to term 
groups, was similar to the mean difference of 2.5 mmHg (95%CI 1.7, 3.3 mmHg) reported in de 
Jong’s meta-analysis (de Jong, Monuteaux et al. 2012, Edwards, Watkins et al. 2014).    
There have been many theories as to the possible underlying cause for this increased risk 
of hypertension, which in turn may lead on to later cardiovascular disease such as coronary 
heart disease or cerebrovascular stroke.  Thus in my study I set out to establish if the precursor 
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for the cause of hypertension in preterm-born children could be detected by measurement of 
changes in arterial stiffness or endothelial function.  However my study, using data from 
ALSPAC, showed no association of preterm birth with arterial stiffness and/or endothelial 
function, when assessed using FMD, PWV or DC (Edwards, Watkins et al. 2014).  This finding 
was also supported by my systematic review of vascular function in survivors of preterm birth.   
This set out to answer the question: is there any association between the gestational age at 
birth and arterial stiffness and/or endothelial dysfunction in later life? The articles reviewed 
did not conclusively identify an association between preterm birth and endothelial dysfunction 
or arterial disease.   
Thus the findings from my study led me to question whether arterial stiffness or 
endothelial dysfunction has any role to play in the increased blood pressure in children or 
adults born preterm, although this may not be the case for those born with IUGR.  However it 
is difficult to separate the effects of preterm birth independent of LBW or IUGR and also the 
effects of the underlying cause of preterm birth such as maternal smoking, which are also 
associated with increased blood pressure in childhood.  Of note it appears that IUGR is 
associated with arterial stiffness and endothelial dysfunction, thus indicating the mechanisms 
leading to CVD in prematurity and IUGR may be different (Visentin, Grumolato et al. 2014).  
6.1.2 Strengths and weaknesses of the study 
The main strengths of the vascular study were the large number of children assessed, 
which was 7,557, that three different methods of vascular assessment were performed, which 
were FMD, PWV and DC, and that I was able to identify the same findings with all three 
measurements.  Also a comprehensive literature review was performed that identified a great 
deal of discrepancy in the findings from published studies.  My research findings support the 
evidence of increased systolic BP in preterm born children.  However, they conclude there 
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were no differences in vascular assessment using a large, longitudinal cohort study that allows 
for the adjustment in analysis of many confounding variables.    
 There were a few limitations to this study.  We did not include the stage of pubertal 
development; however, most children, aged <11 years old, were unlikely to have been in 
advanced stages of puberty at the time of measurement (Bellis, Downing et al. 2006). As with 
all cohort studies, bias can occur due to non random loss to follow-up, but several studies 
indicate that this may introduce only minimal bias into a number of exposure–outcome 
associations (Wolke, Waylen et al. 2009, Greene, Greenland et al. 2011, Pizzi, De Stavola et al. 
2011). The methodology for the vascular assessment was standardized as previously reported, 
but did not restrict the children's diet or caffeine intake prior to the measurements (Donald, 
Charakida et al. 2010). In the literature review, several studies did not accurately report the 
gestational ages and even those that did included relatively mature preterm infants. We 
therefore ensured that we studied infants who were born at different stages of prematurity. 
Another potential weakness of the vascular studies is that the measurements used, FMD, 
PWV and DC, which may not have been robust enough to detect a difference.  Other studies 
have demonstrated a difference between children born preterm and children born term, using 
the vascular measurement, augmentation index (McEniery, Bolton et al. 2011). It may be that 
my study did not have large enough numbers of preterm-born children to detect a difference 
and so a type II error could have affected the study.  However Boardman et al also recently 
used PWV and AI in a group of young adults born preterm and showed a significant difference 
for both measurements, but concluded that their findings do not lead to clinically relevant 
changes in vascular function (Boardman, Birse et al. 2015). It may be the birth era of the 
ALSPAC cohort affected the results.   
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6.1.3 Strengths and weaknesses of the study in relation to other studies 
In recent years there has been much discussion about the role of preterm birth and LBW 
on later cardiovascular morbidity and mortality (Norman 2013).   An important aspect of my 
research was that it assessed the vascular outcomes of children born preterm compared to 
term-born controls with birth weight included as a confounding factor.  This was due to the 
fact that many other studies have focused on the role of low birth weight and have thus 
assessed mixed cohorts of children born preterm and born term with IUGR.  Thus it is unclear 
whether both have a similar risk of later cardiovascular disease (CVD) or not (Norman 2008).  
Part of the difficulty is that infants born preterm are commonly IUGR compared to term-born 
infants.  Thus future adequately powered studies clearly need to distinguish between 
participants born term with normal birth weight, term with IUGR, preterm with normal birth 
weight and preterm with IUGR or small for gestational age (SGA).  As shown recently, by Steen 
et al, who compared VLBW preterm born adolescents to term born controls, concluding that 
preterm birth may be a greater risk factor for hypertension than IUGR (Steen, Bonamy et al. 
2015).   However, as mentioned, it will be difficult to completely disentangle the effects of 
gestational age at birth and LBW on later cardiovascular risk, as both have a role to play and 
interact with each other.  Some studies, which were included in the systematic review and 
assessed vascular function, have shown that preterm birth and IUGR may have a combined 
role to play in later vascular disease (Skilton, Viikari et al. 2011).  
The main weakness from my study and the studies assessed in the systematic review was 
that it is unclear what mechanisms link preterm birth with higher blood pressure in early life 
and thus an increased risk of CVD in later life.  Some studies show an association between 
impaired nephrogenesis and new vascular growth, possibly secondary to increased oxidative 
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stress (Yeung 2006), which may lead to the development of CVD.  Other factors that influence 
the growth and maturation of the foetal vascular system include the maternal diet and 
maternal stressors on umbilical blood flow such as smoking (Grazul-Bilska, Borowicz et al. 
2010, Leach 2011, Reynolds, Vonnahme et al. 2013, Clough 2015).  Boardman et al have 
confirmed that changes in global arterial stiffness, as assessed by pulse wave velocity, seem 
unlikely to account for increased cardiovascular and cerebrovascular risk in adults born 
preterm (Boardman, Birse et al. 2015).   
Another aim of my study was to assess the association of the reduced lung function in the 
children born preterm from the ALSPAC cohort with the hypothesised poor vascular function, 
but I was unable to perform this analysis due to a lack of differences in vascular function 
between preterm born and term born children.  However, Sabit et al have linked reduced 
%FEV1 with arterial stiffness, by measuring PWV, in adults with COPD and have suggested this 
may be a reason for the increased risk of CVD (Sabit, Bolton et al. 2007).  Bolton et al showed 
in the EPICure cohort of extremely preterm born children that reduced %FEV1 is associated 
with increased AI, which indicates arterial stiffness, but no association of %FEV1 with 
peripheral BP (Bolton, Stocks et al. 2012). These findings were independent of gestational age 
at birth and birth weight.  A further study of adults with COPD reported a significant curvi-
linear relationship between AI and FEV1 (Janner, McAllister et al. 2012).  It may be the 
association between reduced FEV1 and poor vascular function is a reflection of some other 
pathological process and that there is no direct causality between reduced lung function to 
poor vascular function.   
My study was unable to take account of maternal nutrition and how this may affect the 
placenta and foetal nutrition as the data was not available.  The placenta may play a vital role 
in the development of the foetal vascular system and this can be affected by maternal 
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nutrition and health, which may also lead to IUGR and preterm birth.   So I would suggest that 
it is the developmental environment (the womb) that determines the future risk of 
cardiovascular disease in infants born preterm or term with or without IUGR.  There may also 
be an argument for genetic programming and that the disease processes relating to CVD are 
inherited and preterm birth or IUGR are the triggers for factors that play a role in the adaption 
of the individual’s phenotype. 
6.1.4 Meaning of the study and future research 
My research aimed to identify non-invasive measurements that could be used in clinical 
practice as early markers for an indication of risk for later CVD in children born preterm.  In my 
findings I did not detect any differences when using FMD, PWV or DC and so currently only 
systolic BP could be used as a possible measure of later disease, although it is not sensitive 
enough to be used as a screening tool.  Other studies have shown an association with markers 
of vascular disease and also associated the increased arterial stiffness with poor lung function 
in those born extremely preterm with CLD.  Thus future research needs to assess if preterm-
born (the whole range of gestational age from 24 to 37 weeks) children with poor lung 
function have associated arterial stiffness and not just those born less than 28 weeks with or 
without CLD.  However, the arterial or endothelial measurements used need to be sensitive 
enough to identify a difference, so standardised assessments of arterial stiffness and 
endothelial function need to be introduced (Poon, Edwards et al. 2013).  Researchers need to 
agree to use a single, simplified and standardised method for assessing the vascular system so 
that comparisons across study cohorts can be made more easily.  This will help to build a 
stronger evidence base to support or refute the hypothesis that preterm birth and/or LBW are 
associated with an increased risk of CVD secondary to vascular changes.    
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Future research also needs to assess if the markers of vascular disease could be used to 
screen children born preterm or IUGR for early signs of disease.  Recently Lewandowski et al. 
identified several possible biomarkers for early signs of micro-vascular disease in young adults 
born preterm (Lewandowski, Davis et al. 2015).  If reliable markers of early disease in those 
born preterm or LBW are identified, then those children with greater risk could be offered 
possible interventions, e.g. dietary, pharmacological or physical, to reduce their risk of 
developing later CVD.  We also need to consider reducing the risk of developing COPD, which 
may also reduce the risk of later CVD.  It is also important for studies to take into account as 
many confounding or contributing factors as possible, which should include maternal factors 
such as health and nutrition as well as family details and possible genetic markers.   
6.2 Prematurity and exercise capacity 
6.2.1 Principal findings of the systematic review and meta-analysis of exercise capacity in 
preterm born children 
The systematic review and meta-analysis of exercise capacity in preterm-born children set 
out to answer the question: ‘‘does being born preterm, either with or without CLD, result in 
decreased exercise capacity in later life compared with term-born controls?’   The overall 
results showed that children and adults born preterm with or without CLD have a lower 
O2max than term-born controls.  The majority of individual studies included did not show a 
significant difference, however the pooled results show a significant, although small effect size 
(Edwards, Kotecha et al. 2015). The differences were similar between all preterm-born 
participants ranging from −2.20 (−3.70, −0.70) ml/kg/min (SMD −0.33 95% CI −0.58, −0.09) in 
the preterm group which included studies with preterm born subjects with or without CLD, 
excluding groups biased towards CLD, to −3.05 (−5.93, −0.18) ml/kg/min (SMD −0.44 95% CI 
−0.87, −0.02) in the CLD36 group. 
V
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6.2.2 Strengths and weaknesses of the systematic review plus relation to other studies 
The main strength of my systematic review was that it set out to answer a clear research 
question, which was set, because it is known that preterm-born children and adults, especially 
those born extremely preterm with CLD, may have reduced lung function and may develop 
associated altered vascular function with increased BP, as discussed in my first study (de Jong, 
Monuteaux et al. 2012, Kotecha, Edwards et al. 2013).   These abnormal findings in survivors of 
preterm birth may therefore impact on an individual’s ability to undertake physical activity and 
therefore to achieve a normal exercise capacity.  It is obviously difficult to say whether 
preterm birth or the factors associated with preterm birth cause these problems.  However 
research has shown that routine exercise can reduce cardiovascular risk and also has other 
health benefits such as reduced risk of type 2 diabetes (Meyer, Kundt et al. 2006, Warburton, 
Nicol et al. 2006, Janssen and Leblanc 2010).  As a result it is important to establish if there are 
any physical limitations preventing those born preterm from undertaking physical activity.   
Another strength of my systematic review on preterm birth and exercise capacity was that 
it has shown there was a significant difference in the maximal exercise capacity of children 
born preterm, although this is unlikely to have any clinical relevance (Edwards, Kotecha et al. 
2015).  It should also be noted that Lowe et al had shown no difference in physical activity 
levels between children born preterm and term-born controls, despite clear differences noted 
in lung function (Lowe, Watkins et al. 2015) although more recently Lowe et al identified lower 
moderate to vigorous physical activity in boys born very preterm compared to term-born 
controls in a more recent cohort treated with surfactant at birth (Lowe, Watkins et al. 2016).  
Thus preterm-born children may take part in less vigorous exercise and also have lower 
exercise capacity, however both results are probably not of clinical relevance.  As mentioned 
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the overall values measured of exercise capacity for children and adults born preterm, of the 
studies included, were all within normal range.   
The main limitation of the review was the amount of heterogeneity between studies 
especially due to the birth era of the cohort, methodology and also the difference in exercise 
testing equipment used.  Those studies using treadmill-running test showed 5-15% higher 
results than cycle ergometer, which would suggest that study participants found it more 
difficult to attain maximal effort.  The lack of a gold standard for assessing exercise capacity in 
children, especially those with disabilities was a major weakness of the systematic review.  
Hence a further limitation of the studies included in the systematic review was that children or 
adults with physical disabilities were excluded, which may have excluded those with more 
severe lung disease and therefore potentially removing the children with the lowest exercise 
capacity.  The results of my systematic review may not be representative of all children and 
adults born preterm, only those with mild or no physical disabilities.  The birth year of the 
study cohorts also may have impacted on the results as this ranged from 1970’s to 2000’s and 
changes in neonatal management may have an impact on long-term health-related outcomes. 
Finally it was not possible to take into account the multiple confounding/conflicting factors 
that may affect a child or adult’s ability to achieve their maximal exercise capacity.    
6.2.3 Meaning of the systematic review and future research 
The clinical implications of my systematic review are that preterm birth does affect a 
child’s exercise capacity but this should not deter clinicians from actively promoting the 
benefits of physical activity, which appear to be reduced in those born preterm.  Clemm et al 
have recently shown in their Norwegian cohort of extremely preterm-born survivors that 
increased physical activity levels was associated with improved exercise capacity (Clemm, 
Vollsaeter et al. 2015).  This implies that the benefit of exercising should be encouraged in all 
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children including those born preterm. In future studies we need to assess the optimal form of 
physical activity and exercise to encourage those born preterm to undertake and also the level 
of intensity.  We then need to establish the most beneficial exercise programme for reducing 
future risk of cardiovascular and respiratory disease in all children, particularly those at greater 
risk, such as preterm-born and obese children including those with disabilities.  It is clear that 
we also need to establish a gold standard method of assessing exercise capacity, particularly in 
children or adults with some degree of disability.   
The systematic review on exercise capacity also identified studies that had assessed the 
response to bronchodilators.  The EPICure cohort were found to have a lower peak oxygen 
capacity (Welsh, Kirkby et al. 2010) and 27% had a positive bronchodilator response at rest, 
however the researchers noted that many of the children were not being treated with regular 
inhaler therapy (Fawke, Lum et al. 2010).  Joshi et al found significant bronchoconstriction with 
exercise in preterm-born children with CLD and showed this reversed when the children were 
given bronchodilators (Joshi, Powell et al. 2013).  In our recent systematic review on the 
effects of bronchodilators on %FEV1 in preterm born children we identified a lack of long-term 
data on the benefits or side effects of inhaler therapy (Kotecha, Edwards et al. 2015).  Thus 
future research on survivors of preterm birth should establish if the use of regular inhaler 
therapy such as corticosteroids or the use of bronchodilators prior to exercise, helps to 
improve exercise capacity and therefore may improve the long term health outcomes such as 
reducing risk of cardiovascular disease.  
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6.3 Prematurity and respiratory outcomes 
6.3.1 Principal findings of the RANOPS study: preterm cohort 
The hypothesis for the RANOPS study for the preterm born cohort, was to test if children 
born preterm have increased respiratory symptoms and increased health care utilisation, 
mainly due to respiratory morbidity, in infancy and early childhood compared to term-born 
controls.  The main finding from this large cross-sectional survey of children born over a 10 
year period in Wales, was that I identified that lower gestational age at birth was associated 
with increased risk of wheezing throughout childhood, confirming the findings of a recent 
systematic review and meta-analysis on asthma and wheezing in children born preterm (Been, 
Lugtenberg et al. 2014, Edwards, Kotecha et al. 2014).  In the RANOPS study, both the less than 
5 years of age and the greater than 5 years of age preterm-born children had higher reported 
rates of wheeze ever, recent wheezing and also increased usage of inhaler medication 
compared to term-born controls.  Our recent systematic review and meta- analysis had also 
shown that preterm-born survivors, even those in whom CLD does not develop, have 
moderate deficits in FEV1 compared with term-born controls (Kotecha, Edwards et al. 2013).   
The results from RANOPS show that a gradient across the gestational age groups was 
observed with those born very preterm having the highest prevalence rates of respiratory 
symptoms. Importantly, I showed that prematurity-associated wheeze appears to be 
independent of a family history of atopy (Edwards, Kotecha et al. 2016). Our results confirm 
that children born very preterm have significantly higher prevalence of respiratory symptoms 
including wheezing during pre-school aged years as previously reported (Boyle, Poulsen et al. 
2012, Vrijlandt, Kerstjens et al. 2013), but also during early school-aged years when compared 
to children born full term.  The prevalence of wheezing was also increased in the very preterm 
born children with CLD and in those without CLD when compared to the term population.  For 
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the whole population of preterm-born children aged less than five years, the overall odds ratio 
for wheeze-ever was 1.8 (95% CI 1.6, 2.1), which is remarkably similar to those reported 
previously (Been, Lugtenberg et al. 2014). 
 
6.3.2 Strengths and weaknesses of the RANOPS study 
The main strength of the RANOPS study was that I established a large cohort of preterm-
born children.  I have then used the data from this large population-based cohort to confirm 
that preterm-born children have increased prevalence of respiratory symptoms while taking 
into account several confounding and conflicting factors such as atopy.  This project continued 
on the theme from the first two projects, assessing the impact of being born preterm on the 
cardiorespiratory system by gathering data on the respiratory morbidity and also establishing a 
cohort of preterm children for future research.  Another important strength was that I have 
established a large database of health related information for the RANOPS cohort and have 
gained consent to contact the families for future studies.  The data from the RANOPS cohort 
can thus be used to support longitudinal studies on the long-term respiratory outcomes of 
those born preterm, which may include bringing the children for investigations such as lung 
function testing and assessment of exercise capacity.   
Another important point was that the data from the RANOPS cohort were also analysed to 
assess the role of family history of atopy in children born preterm with respiratory symptoms 
along with other factors such as mode of delivery.  It is known that preterm birth alters the 
normal lung development leading to poor lung function and respiratory symptoms however 
other factors may have a greater role to play in children born preterm. It is important to note 
that there are many possible risk factors for later respiratory disease in those born preterm, 
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which may occur during the antenatal or postnatal period or even early childhood, and some 
may be modifiable.  Assessing the contribution of these factors is important to try and 
establish a possible direct causal pathway and thus suggest preventative measures or 
therapies to improve outcome.  However many of the contributing factors associated with 
later respiratory disease may also associated with preterm birth, such maternal smoking, 
antenatal steroids, LBW, and neonatal ventilation.   
The RANOPS study has a few limitations. It is a cross-sectional study relying on parental 
reporting of symptoms and so there is potential for recall bias. This may have affected the 
wheezing rates for children over 5 years of age, which reports a lower rate of ever wheezing 
than children less than 5 years of age.   Also parental understanding of the term ‘wheeze’ has 
been questioned and may have influenced my findings.  Another weakness was that the 
diagnosis of atopy was based on families responding positively to four separate questions of 
family history of asthma, eczema, allergies or hay fever and so this does not allow for accurate 
diagnosis of atopy in the child, which should ideally be confirmed by blood tests or skin prick.  
However previous studies suggest that parental recall of acute illness correlates well with 
medical records (D'Souza-Vazirani, Minkovitz et al. 2005, Vernacchio, Vezina et al. 2007).  We 
also included additional information from the health database to provide more comprehensive 
assessment and confirm diagnoses such as CLD from doctor diagnosis.  Ascertainment bias 
may have overestimated our results, as preterm-born children are known to present more 
frequently for healthcare reviews thus may result in greater diagnosis and possibly subsequent 
inhaler medication. However this is likely to be applicable to both preterm and term-born 
groups and so unlikely to affect the overall results.  There was also a low response rate at 
26.7%.  This may have resulted in recruitment bias and as shown by my comparison between 
responders and non-responders in chapter 4 results section, there was a difference in the 
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social circumstances as responders had higher WIMD scores.  We did account for this in our 
analysis and it should be noted the response rate for preterm born children was 32%. 
 
6.3.3 Strengths and weaknesses of RANOPS in relation to other studies 
The RANOPS cohort identify several risk factors for later respiratory disease and recently 
there has been much interest in identifying early risk factors for wheezing and asthma in 
childhood.  Interestingly preterm birth is not included in the Asthma Predictive Index, which is 
a score used to predict the probability of young children with wheezing going on to develop 
asthma (Castro-Rodriguez 2010).  He et al have shown that preterm birth is associated with 
wheezing disorders in childhood using several different definitions in the same cohort of 
children, which adds to the growing evidence that preterm birth needs to be considered as a 
major risk factor for wheezing disorders in childhood (He, Butz et al. 2015).  However it would 
appear that prematurity associated wheeze is probably a separate entity to asthma and needs 
in depth research to establish the underlying pathology, which may be challenging given the 
close interaction between risk factors for childhood wheezing and preterm birth.   
I was unable to account for many potential confounding factors in my analysis and so I 
reviewed the literature to assess the relative impact of these factors on childhood wheezing.  
First a recent systematic review on the pre-natal or early life exposure to antibiotics as a risk 
factor for the development of wheezing disorders showed only a slight increase in risk of 
childhood ‘asthma’ (Murk, Risnes et al. 2011).  This points towards the idea of a change in the 
normal microbial flora within the developing lungs, which is affected by prenatal antibiotic use 
and so is felt to be a confounding factor (Midulla, Lombardi et al. 2014).  However recent 
studies have shown that the previously published findings of a relationship between early life 
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exposure to antibiotics and wheezing disorders in childhood were probably due to 
confounding factors such as genetics (Ortqvist, Lundholm et al. 2014, Semic-Jusufagic, 
Belgrave et al. 2014).  This may mean that, although preterm-born children are more likely to 
have received antibiotics, the antibiotics are more likely to be a marker of developing later 
respiratory disease in those with underlying pathology.  The interaction between the lung 
microbiota and immune responses has also led researchers to suggest a connection with 
atopic asthma and other allergic diseases (Warner and Hamvas 2015). Changes to the normal 
microbial flora within the lungs may also be affected by preterm birth, due to mode of 
delivery, antibiotic exposure or exposure to antenatal steroids (Lohmann, Luna et al. 2014).  
There is a need for further research to explore the role of changes in the microbes of the lungs 
of those born preterm and the long-term respiratory outcomes.   
There has also been interest in the growth factors, such as transforming growth factor 
beta-1, that regulate normal lung development and in animal studies alterations in growth 
factor production may have a negative effect on lung development (Gauldie, Galt et al. 2003, 
Kramer, Deutsch et al. 2007).  An association between the development of CLD and levels of 
growth factor has also been noted in preterm infants, although it was noted this might be 
linked to pre-eclampsia or chorioamnionitis (Been and Zimmermann 2009, Been, Debeer et al. 
2010, Popova, Bentley et al. 2014).  I was unable to account for pre-eclampsia or 
chorioamnionitis in my modelling, although these often result in infants born with IUGR and 
this was included in the multivariable modelling. However chorioamnionitis and pre-eclampsia 
may account for the inflammatory process that caused the old understanding of CLD, which 
was described as a secondary lung injury with inflammation and fibrosis (Northway, Rosan et 
al. 1967).   However the advances in neonatal care and our understanding of the 
pathophysiology of CLD have suggested that CLD is now a developmental arrest of lung growth 
(Jobe 2011).    
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In my study children with CLD had the highest rates of respiratory symptoms, showing they 
are at the severe end of the spectrum in terms of the developmental arrest of lung growth.  
Clearly there was an association with the gestational age at birth and it would appear that 
some alteration in either the process of lung development or some inflammatory event or a 
combination leads to the long –term respiratory outcomes of those born prior to full term 
delivery.  Increased levels of exhaled nitric oxide are associated with asthma and lung 
inflammation.  Exhaled nitric oxide studies on children born preterm with CLD have not 
consistently shown any increases in symptomatic children suggesting that eosinophilic 
dominant disease (‘asthma’) is unlikely to explain the wheezing in preterm children with CLD 
and Baraldi et al also showed no reversibility with bronchodilators (Baraldi, Bonetto et al. 
2005).  Also Teig et al assessed the induced sputum of very preterm born children and found 
poor lung function and neutrophilic lower airway inflammation, while Filipone et al identified 
oxidative stress injury from increased 8-isoprostane concentrations in exhaled breath 
condensate in their preterm born subjects (Filippone, Bonetto et al. 2012, Teig, Allali et al. 
2012).  However these were small studies that need confirming and, more importantly, it 
needs to be assessed whether the findings are more related to CLD rather than prematurity, 
and also if the changes in the lungs are modified by regular use of inhaled medications such as 
corticosteroids, which one small study has suggested they may not be of benefit (Chan and 
Silverman 1993). 
Researchers have also speculated that early rhinovirus or respiratory syncytial virus (RSV) 
infection could be part of the process that leads to wheezing in early childhood and it is noted 
that children born preterm are more susceptible to severe RSV infection (Welliver 2003).  
During early childhood the development of bronchiolitis secondary to rhinovirus or respiratory 
syncytial virus (RSV) has been associated with increased risk of wheezing throughout 
childhood, including in those born preterm (Jackson, Gangnon et al. 2008, Stensballe, 
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Simonsen et al. 2009, Blanken, Rovers et al. 2013). However, as with early antibiotic use, this is 
most likely a risk factor or marker of underlying respiratory disease and the viruses, Rhinovirus, 
RSV and others are unlikely to be causative factors of developing long-term wheezing disorders 
in childhood.  Recently Carbonell-Estrany et al have shown that the association between RSV 
respiratory infection and childhood wheezing is linked to moderate and late preterm birth, not 
just those born very preterm (Carbonell-Estrany, Perez-Yarza et al. 2015).  Currently the 
recommendation is to passively immunise only high-risk children such as those born very 
preterm, however those born at 32-36 weeks of gestation without CLD would not necessarily 
be offered the vaccine (England 2015).  Thus future studies need to assess the impact on 
respiratory disease in later life by passively immunising all preterm born children against RSV.   
 
6.3.4 Meaning of the RANOPS study: preterm cohort, and future research 
From the RANOPS study I showed that children born preterm with or without a family 
history of atopy had a higher prevalence of wheezing and were more frequently on inhaler 
treatment when compared to term-born children. Hence I have speculated that prematurity-
associated wheeze is likely to be a separate entity to the wheezing observed in term-born 
children especially as delivery occurs at an earlier stage of lung growth, which may affect 
subsequent lung development. Prematurity associated wheeze may be part of the spectrum of 
childhood wheezing disorders such as ‘asthma’ or may be a distinct disease process that 
responds differently to inhaler treatment such as salbutamol.  In the RANOPS cohort it was 
evident that children born preterm were being treated more frequently with inhalers 
compared to those born at term, however the benefits of the different treatment modalities 
requires further research.  In order to establish the best management for these children future 
research work needs to be conducted to assess these questions and show whether there is or 
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is not a beneficial response to inhaler treatment.  Currently there are multiple phenotypes and 
diagnoses for pre-school wheezing and differing treatment strategies as discussed by Bush et 
al (Bush and Nagakumar 2016).   As a result it is important that future research needs to focus 
on establishing the correct phenotype for prematurity associated wheeze and the most 
suitable management strategy.   
My research work was only able to assess association and the need to further study the 
possible causation is vital.  There is clearly a need to assess the underlying pathophysiological 
mechanisms leading to respiratory symptoms and disease in children born prematurely.  A 
greater knowledge of the on-going lung development from birth to childhood in those born 
preterm up to 38 weeks of gestation is required to fully understand the pathophysiological 
processes that are related to preterm birth.  We need to better understand the difference in 
lung development following preterm birth that clearly leads to reduced lung function and 
increased symptoms throughout childhood.  It is important to establish new cohorts of infants, 
who have been born in the current era of neonatal care, so that therapies and treatments can 
be aimed at improving their long-term survival.  However it is important that longitudinal 
cohorts are set up to collect all the relevant data, as Lenney et al noted in their review on 
identifying risk factors in childhood for chronic obstructive pulmonary disease (COPD) that 
studies tend to limit the variables included and therefore are unable to show a direct 
relationship between a causative factor and the outcome (Lenney, Gilchrist et al. 2014).   
Hopefully then by using the same cohort of preterm born children from the RANOPS study to 
further investigate the underlying lung pathology we will provide robust data, which will 
include multiple potential risk factors for respiratory symptoms and also assess the response 
to inhaler medication.   
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6.4 Early Term delivery, respiratory and health outcomes in childhood 
6.4.1 Principal findings of the RANOPS study: early term cohort 
The hypothesis for the project on early term-born children was to test if those born early 
term (37-38 weeks of gestation) have increased respiratory morbidity compared to full term-
born (39-42 weeks of gestation) controls.  It was also to test if increased respiratory morbidity 
in those born early term was due to increased rates of family history of atopy or increased 
rates of CS.  The main results from the RANOPS study assessing the early term birth cohort 
show that early term–born children up to 10 years of age had up to 70% greater risk of 
respiratory symptoms and up to 50% greater inhaler use than similarly aged term-born 
children. Early term–born children aged 5 years or greater also had increased risk of chest 
infections and antibiotic use when compared with those born at full term. The risk of 
respiratory symptoms and treatment with inhalers throughout childhood seemed to be largely 
independent of atopy and mode of delivery, which included CS.  I also confirmed previous 
reports of the increased admission to neonatal units of early term–born infants, which was 
partially explained by greater delivery by means of CS (Fleischman, Oinuma et al. 2010, Parikh, 
Reddy et al. 2014). 
6.4.2 Strengths and weaknesses of the RANOPS study: early term cohort and the relation 
to other studies 
The main strength of our study was that it included 2845 term-born children and 
supported the findings of previous studies that early-term birth leads to increased neonatal 
admissions. However the main strength was the novel finding that early term–born children 
reported more wheezing than full term–born children (39-42 weeks gestation). Furthermore, 
the wheezing was independent of mode of delivery, including CS, and family history of atopy.  
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On assessing the impact of full-term delivery, thus far the literature appears to suggest that 
wheezing and diagnosis of asthma in early childhood may be increased due to delivery by CS. 
Previously CS was thought to be a risk factor for childhood asthma as shown in two meta-
analyses by Thavagnanam et al in 2008 and then Huang et al in 2015 (Thavagnanam, Fleming 
et al. 2008, Huang, Chen et al. 2015). However many of the studies included in these reviews 
did not account for gestational age and, as shown by my study, early term birth is a risk factor 
for childhood wheezing and possibly accounts for the association noted with caesarean section 
(Edwards, Kotecha et al. 2015).  Thus our study analyses the data taking into consideration 
early term birth and I have argued and provided robust evidence that wheezing in childhood is 
due to the relative immaturity of the children at birth rather than delivery by caesarean 
section. Previous studies have either not included the concept of early term birth or have not 
assessed wheezing in the non-caesarean section group, which would suggest that early term 
birth regardless of mode-of-delivery results in wheezing in childhood.  
Our study has also shown that more than a third of children born at 37 to 38 weeks 
gestation are delivered by means of CS (nearly 60% of which were elective), which has 
previously been shown to be an independent risk factor for later respiratory disease (Roduit, 
Scholtens et al. 2009). However, our results did not find a difference between children 
delivered by means of CS compared with those delivered by means of VD for respiratory 
symptoms throughout childhood, which was similar to 2 previous studies (Werner, Ramlau-
Hansen et al. 2007, Menezes, Hallal et al. 2011).  Furthermore, the results stratified by age 
group have shown that those delivered by means of CS have increased neonatal admissions 
and admissions to the hospital in the first year of life compared with those delivered by means 
of VD, with the results remaining unchanged after adjustments for gestation. Tita et al and 
Wilmink et al both showed similar findings in their studies and supported the call to delay 
elective CS until after 38 weeks gestation (Tita, Landon et al. 2009, Wilmink, Hukkelhoven et al. 
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2010). However, their results were unadjusted for gestation, although De Luca et al and Parikh 
et al both also showed that infants born secondary to CS have increased neonatal problems 
with adjustment for gestational age at birth, including those at 37 to 38 weeks gestation (De 
Luca, Boulvain et al. 2009, Parikh, Reddy et al. 2014). 
The main limitations of my study are the same as those discussed for study using the 
RANOPS data and assessing the outcomes of those born preterm.  The data were gathered 
from parent-completed questionnaires and hospital database records, and therefore will be 
affected by parental recall and missing data. So this analysis on children born early term was 
limited by the lack of data on indications for delivery before 39 weeks' gestation. Indications, 
such as maternal sepsis and prolonged rupture of the membranes, can also result in increased 
rates of admissions and could affect longer-term respiratory outcomes (Bendiks and Kopp 
2013).  However, although these indications might be an important factor for a select group of 
babies who are delivered early by means of CS, our results show that the future risk for 
wheezing disorders was independent of mode of delivery. There was also a lack of information 
on maternal disease (although maternal age, which is strongly associated with increasing 
maternal disease, was included in multivariable logistic analyses) and for maternal treatment 
with antenatal corticosteroids (although this treatment is not routinely used in the United 
Kingdom for infants born ≥37 weeks' gestation). Questionnaires were completed by families 
with similar characteristics, except for higher rates of deprivation for the non-responders, 
which could lead to an underestimation of respiratory morbidity; however, because the 
comparison was between those born at different gestational ages, the results are likely to 
remain robust.  Because only very few cases had missing data, the data are unlikely to affect 
the main conclusions.  It is often suggested that gestational age should be used as a 
continuous variable in analyses; however, we believe our analysis supports the notion of 
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grouped gestational ages into categories, such as early term, late preterm, and term (Marlow 
2012). 
6.4.3 Meaning of the RANOPS study: early term cohort, and future research 
I believe that my study is an important one as it introduces newer concepts, of early term 
birth being primarily responsible for childhood wheezing in this cohort of children born early 
by only 1 or 2 weeks of gestation.  These observations suggests that delivery at 37 to 38 weeks’ 
gestation should be avoided where possible, but the underlying mechanisms for increased 
respiratory symptoms after early-term birth need clarification.  My study findings also 
challenge older concepts by questioning whether mode of delivery, especially by CS, is really 
important in the development of childhood wheezing and asthma.  As already mentioned, the 
concept of early term delivery leading to childhood wheezing is starting to be recognised and 
has been firmly supported by the meta-analysis published in January 2015 by Huang and 
colleagues commenting that “The risk of asthma was also higher in children born by 
instrumental vaginal delivery (OR 1.07, 1.04 – 1.11)” (Huang, Chen et al. 2015).  More recently 
Bruske et al found no association between mode of delivery and lung function or asthma at 15 
years of age in those born at full term (Bruske, Pei et al. 2015).  
The health outcomes of children born early term needs further assessment to establish the 
extent of the problem caused by being born just a few weeks early.  It has already been shown 
that infants born early term have increased rates of admission to neonatal intensive care units 
and I have confirmed this in my study and also shown increased respiratory symptoms through 
childhood.  So are these children also at greater risk of infections, cardiovascular disease and 
neurodisability as children born preterm?  Studies have already shown an association between 
poor school performance and early term birth, so research now needs to review the 
association with disability and other disease processes (MacKay, Smith et al. 2010, Quigley, 
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Poulsen et al. 2012).  There is also a need to change the clinical practise of delivering infants at 
less than 39 weeks of gestation for non-medical indications.   
 
 
6.5 Thesis Summary 
This thesis brings together data on the health outcomes of children born preterm from 
two cohort studies and two systematic reviews.  Of note it introduces the new concept of 
children born early term being considered at risk of the same long term problems as those 
born preterm, and so challenges the idea of preterm birth being defined as those born less 
than 37 weeks gestation.  Thus all future studies assessing the association of early life events 
on later health-related outcomes such as childhood wheezing, need to consider including an 
early term group or analysing their data with gestational age as a continuous variable.  My 
findings also show that being born preterm has an impact on later cardiovascular and 
respiratory health and support the findings of two recent systematic reviews: one assessing 
the effect of preterm birth on later lung function and the other reviewing the impact of 
preterm birth on systolic blood pressure (de Jong, Monuteaux et al. 2012, Kotecha, Edwards et 
al. 2013).  More specifically my research using data from the ALSPAC cohort has shown an 
increased BP in children born preterm, however there was no association with arterial stiffness 
nor endothelial dysfunction as assessed by FMD, PWV and DC.  Then my systematic review on 
arterial stiffness and/or endothelial dysfunction in survivors of preterm birth had no clear 
conclusion due to the disparity of the studies included.  I would recommend the need to 
establish longitudinal cohorts of preterm-born children to assess the tracking of their blood 
pressure and changes in arterial stiffness and endothelial function.   
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My second systematic review went on to assess the exercise capacity of children born 
preterm and showed decreased exercise capacity in survivors of preterm birth, but the results 
were all within normal limits.  However physical activity levels may be lower and there are 
greater respiratory symptoms compared to term-born children, so future studies need to 
assess if promoting physical activity can help to improve the health of the children born 
preterm.  My final project helped to establish a large cohort of preterm born children and 
showed a significant association between lower gestational age at birth and respiratory 
symptoms and increased treatment with inhalers throughout childhood.  The future research 
of the respiratory outcomes of children born preterm needs to urgently assess the safety and 
efficacy of inhaler therapy in those labelled with prematurity-associated wheeze.   
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Tables for initial data analysis on ALSPAC database (Chapter 2): 
General linear modelling for the Heart rate (pulse) measurement 
 Statistical investigation using backward (and forward) linear regression modelling for pulse 
showed that the following variables have a significant effect: 
  Major – Systolic BP & Sex 
  Minor – Skin temp at time of assessment, fried food in last two hours, caffeine in last 2 
hours, vaccination within last week & age in years (at 10). 
 Table shows the coefficients for the general linear model for pulse with the above variables 
including gestational groups: 
Parameter Estimates 
Dependent Variable:A_pre FMD pulse 
Parameter B Std. Error t Sig. 
95% Confidence Interval Partial Eta 
Squared Lower Bound Upper Bound 
Intercept 72.422 5.524 13.109 .000 61.592 83.251 .025 
[25-32 weeks] .833 1.322 .630 .529 -1.759 3.425 .000 
[33-34 weeks] 1.111 1.262 .880 .379 -1.364 3.585 .000 
[35-36 weeks] -.770 .693 -1.112 .266 -2.128 .588 .000 
[37-43 weeks] 0
a
 . . . . . . 
[Male] -4.380 .264 -16.569 .000 -4.898 -3.862 .040 
[Female] 0
a
 . . . . . . 
[Any fried food - yes] 4.037 .613 6.584 .000 2.835 5.239 .007 
[Any fried food - no] 0
a
 . . . . . . 
[Any caffeine - yes] 1.750 .505 3.469 .001 .761 2.740 .002 
[Any caffeine - no] 0
a
 . . . . . . 
[Any vaccinations - yes] -6.874 3.169 -2.169 .030 -13.086 -.661 .001 
[Any vaccinations - no] 0
a
 . . . . . . 
[SBP] .308 .014 21.470 .000 .280 .336 .066 
[Age in years] -2.430 .495 -4.911 .000 -3.400 -1.460 .004 
[Skin temp] -.168 .046 -3.665 .000 -.258 -.078 .002 
a. This parameter is set to zero because it is redundant. 
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 General linear modelling for systolic BP measurement 
 Statistical investigation using backward (and forward) linear regression modelling for SBP 
showed that the following variables have a significant effect: 
  Major – BMI (F10+) 
  Minor – Skin temp at time of assessment, room temp at time of assessment, age in years (at 
10), caffeine in last 2 hours & cases split into gestational groups. 
 Table shows the coefficients for the general linear model for SBP with the above variables 
(with gestational groups already included: 
Parameter Estimates 
Dependent Variable: Systolic blood pressure_AS 
Parameter B Std. Error t Sig. 
95% Confidence Interval Partial Eta 
Squared Lower Bound Upper Bound 
Intercept 82.576 4.611 17.909 .000 73.537 91.615 .047 
[25-32 weeks] 4.591 1.153 3.983 .000 2.332 6.851 .002 
[33-34 weeks] 1.911 1.050 1.820 .069 -.147 3.969 .001 
[35-36 weeks] 1.443 .585 2.467 .014 .296 2.590 .001 
[37-43 weeks] 0
a
 . . . . . . 
[Any caffeine - yes] 1.762 .408 4.316 .000 .962 2.562 .003 
[Any caffeine - no] 0
a
 . . . . . . 
[Room temp] -.469 .056 -8.408 .000 -.578 -.359 .011 
[Skin temp] -.246 .040 -6.109 .000 -.325 -.167 .006 
[Age in years] 2.774 .417 6.654 .000 1.957 3.592 .007 
[BMI] .589 .035 16.648 .000 .520 .658 .041 
a. This parameter is set to zero because it is redundant. 
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General linear modelling for diastolic BP measurement 
 Statistical investigation using backward (and forward) linear regression modelling for DBP 
showed that the following variables have a significant effect: 
  Major – Systolic BP  
Minor – Skin temp at time of assessment, room temp at time of assessment, fried food in last 
two hours, caffeine in last 2 hours, vaccination within last week, age in years (at 10), sex, 
recent infections, BMI at 10 & ethnic group. 
 Table shows the coefficients for the general linear model for DBP with the above variables 
including gestational groups: 
 
Dependent Variable: Diastolic blood pressure_AS 
Parameter B 
Std. 
Error t Sig. 
95% Confidence Interval Partial Eta 
Squared Lower Bound Upper Bound 
Intercept 17.202 3.577 4.810 .000 10.191 24.214 .004 
[25-32 weeks] -.418 .933 -.448 .654 -2.248 1.411 .000 
[33-34 weeks] -.528 .796 -.663 .507 -2.088 1.033 .000 
[35-36 weeks] -.195 .428 -.456 .649 -1.033 .643 .000 
[37-43 weeks] 0
a
 . . . . . . 
[Room temp] -.494 .041 -
12.03
1 
.000 -.575 -.414 .023 
[Skin temp] -.147 .030 -
4.861 
.000 -.207 -.088 .004 
[Age in years] .897 .313 2.866 .004 .283 1.510 .001 
[Any fried food - yes] -1.387 .379 -
3.660 
.000 -2.130 -.644 .002 
[Any fried food - no] 0
a
 . . . . . . 
[Any caffeine - yes] 1.071 .308 3.478 .001 .467 1.675 .002 
[Any caffeine - no] 0
a
 . . . . . . 
[Any recent infection - yes] .614 .219 2.804 .005 .185 1.044 .001 
[Any recent infection - no] 0
a
 . . . . . . 
[Male] -.872 .164 -
5.326 
.000 -1.192 -.551 .005 
[Female] 0
a
 . . . . . . 
[Ethnic group – non-white] -1.426 .597 -
2.390 
.017 -2.596 -.256 .001 
[Ethnic group- white] 0
a
 . . . . . . 
[SBP] .476 .009 52.51
8 
.000 .459 .494 .307 
[BMI] .111 .027 4.147 .000 .058 .163 .003 
a. This parameter is set to zero because it is redundant. 
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General linear modelling for brachial artery diameter measurement 
 Statistical investigation using backward (and forward) linear regression modelling for brachial 
artery diameter showed that the following variables have a significant effect: 
  Major – BMI (F10+), Sex & skin temp at time of assessment. 
Minor –Room temp at time of assessment, age in years (at 10), recent infections & IUGR. 
 Table shows the coefficients for the general linear model for brachial artery diameter with 
the above variables including gestational groups: 
 
Parameter Estimates 
Dependent Variable: brachial diameter 
Parameter B Std. Error t Sig. 
95% Confidence Interval Partial Eta 
Squared Lower Bound Upper Bound 
Intercept .622 .145 4.288 .000 .337 .906 .003 
[25-32 weeks] -.073 .035 -2.057 .040 -.142 -.003 .001 
[33-34 weeks] -.026 .034 -.785 .433 -.093 .040 .000 
[35-36 weeks] .032 .018 1.776 .076 -.003 .067 .001 
[37-43 weeks] 0
a
 . . . . . . 
[Room temp] .008 .002 4.832 .000 .005 .012 .004 
[Skin temp] .015 .001 12.110 .000 .013 .018 .024 
[Age in years] .066 .013 5.024 .000 .040 .092 .004 
[Any recent infection - yes] -.021 .009 -2.236 .025 -.039 -.003 .001 
[Any recent infection - no] 0
a
 . . . . . . 
[Male] .162 .007 23.193 .000 .148 .176 .082 
[Female] 0
a
 . . . . . . 
[BMI] .034 .001 29.717 .000 .031 .036 .128 
[IUGR] -.061 .012 -5.014 .000 -.084 -.037 .004 
a. This parameter is set to zero because it is redundant. 
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General linear modelling for FMD % measurement 
 Statistical investigation using backward (and forward) linear regression modelling for FMD% 
showed that the following variables have a significant effect: 
  Major – Sex & skin temp at time of assessment. 
Minor –Room temp at time of assessment, caffeine in last 2 hours & IUGR. 
 Table shows the coefficients for the general linear model for FMD% with the above variables 
including gestational groups: 
 
Parameter Estimates 
Dependent Variable: FMD% 
Parameter B Std. Error t Sig. 
95% Confidence Interval Partial Eta 
Squared Lower Bound Upper Bound 
Intercept 1.768 .580 3.049 .002 .631 2.905 .002 
[25-32 weeks] -.250 .424 -.590 .555 -1.082 .581 .000 
[33-34 weeks] .661 .420 1.574 .116 -.162 1.484 .000 
[35-36 weeks] -.182 .224 -.814 .416 -.620 .256 .000 
[37-43 weeks] 0
a
 . . . . . . 
[Room temp] .069 .022 3.192 .001 .027 .112 .002 
[Skin temp] .168 .016 10.844 .000 .138 .199 .019 
[Any caffeine - yes] .365 .158 2.302 .021 .054 .676 .001 
[Any caffeine - no] 0
a
 . . . . . . 
[Male] -.892 .086 -10.354 .000 -1.061 -.723 .017 
[Female] 0
a
 . . . . . . 
[IUGR] .186 .149 1.247 .212 -.107 .479 .000 
a. This parameter is set to zero because it is redundant. 
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General linear modelling for FMD measurement 
 Statistical investigation using backward (and forward) linear regression modelling for FMD 
showed that the following variables have a significant effect: 
  Major – Skin temp at time of assessment. 
Minor –Room temp at time of assessment, sex, BMI at 10, caffeine in last 2 hours & 
vaccination within the last week. 
 Table shows the coefficients for the general linear model for FMD with the above variables 
including gestational groups: 
 
Parameter Estimates 
Dependent Variable: absolute FMD 
Parameter B Std. Error t Sig. 
95% Confidence Interval Partial Eta 
Squared Lower Bound Upper Bound 
Intercept -.047 .015 -3.044 .002 -.076 -.017 .002 
[25-32 weeks] -.009 .011 -.811 .417 -.030 .013 .000 
[33-34 weeks] .014 .010 1.351 .177 -.006 .034 .000 
[35-36 weeks] .000 .006 -.063 .950 -.011 .011 .000 
[37-43 weeks] 0
a
 . . . . . . 
[Room temp] .002 .001 4.514 .000 .001 .004 .003 
[Skin temp] .006 .000 13.980 .000 .005 .006 .031 
[Any caffeine - yes] .009 .004 2.253 .024 .001 .017 .001 
[Any caffeine - no] 0
a
 . . . . . . 
[Any vaccinations - yes] -.048 .025 -1.938 .053 -.097 .001 .001 
[Any vaccinations - no] 0
a
 . . . . . . 
[Male] -.011 .002 -4.942 .000 -.015 -.006 .004 
[Female] 0
a
 . . . . . . 
[BMI] .002 .000 6.297 .000 .002 .003 .006 
a. This parameter is set to zero because it is redundant. 
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General linear modelling for PWV measurement 
 Statistical investigation using backward (and forward) linear regression modelling for PWV 
showed that the following variables have a significant effect: 
  Major – BMI at 10 & Room temp at time of assessment. 
Minor –Skin temp at time of assessment, systolic BP, sex,  age in years at 10, fried food within 
last two hours, caffeine in last 2 hours & recent infection. 
 Table shows the coefficients for the general linear model for PWV with the above variables 
including gestational groups: 
 
Parameter Estimates 
Dependent Variable: Pulse Wave Velocity (m/s) 
Parameter B Std. Error t Sig. 
95% Confidence Interval Partial Eta 
Squared Lower Bound Upper Bound 
Intercept 7.122 .636 11.202 .000 5.876 8.369 .019 
[25-32 weeks] .073 .158 .461 .644 -.237 .382 .000 
[33-34 weeks] .035 .141 .247 .805 -.242 .312 .000 
[35-36 weeks] .014 .079 .179 .858 -.140 .168 .000 
[37-43 weeks] 0
a
 . . . . . . 
[Room temp] -.046 .008 -6.119 .000 -.061 -.031 .006 
[Skin temp] -.017 .006 -3.048 .002 -.028 -.006 .001 
[Any fried food - yes] -.200 .070 -2.869 .004 -.336 -.063 .001 
[Any fried food - no] 0
a
 . . . . . . 
[Any caffeine - yes] .093 .057 1.633 .103 -.019 .205 .000 
[Any caffeine - no] 0
a
 . . . . . . 
[Any recent infection - yes] .083 .040 2.049 .040 .004 .162 .001 
[Any recent infection - no] 0
a
 . . . . . . 
[Male] .165 .030 5.468 .000 .106 .225 .005 
[Female] 0
a
 . . . . . . 
[SBP] .015 .002 8.821 .000 .011 .018 .012 
[BMI] -.074 .005 -15.109 .000 -.084 -.064 .034 
[Age in years] .169 .056 3.005 .003 .059 .280 .001 
a. This parameter is set to zero because it is redundant. 
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General linear modelling for brachial DC measurement 
 Statistical investigation using backward (and forward) linear regression modelling for brachial 
DC showed that the following variables have a significant effect: 
  Major – SBP. 
Minor – Room temp at time of assessment, age in years at 10,  BMI at 10 & vaccination within 
last week. 
 Table shows the coefficients for the general linear model for brachial DC with the above 
variables including gestational groups: 
 
Parameter Estimates 
Dependent Variable: brachial distensibility coefficient  
Parameter B Std. Error t Sig. 
95% Confidence Interval Partial Eta 
Squared Lower Bound Upper Bound 
Intercept .107 .033 3.214 .001 .042 .172 .002 
[25-32 weeks] -.005 .008 -.620 .535 -.021 .011 .000 
[33-34 weeks] -.010 .007 -1.390 .165 -.025 .004 .000 
[35-36 weeks] .010 .004 2.263 .024 .001 .018 .001 
[37-43 weeks] 0
a
 . . . . . . 
[Room temp] -.001 .000 -2.633 .008 -.002 .000 .001 
[Any vaccinations - yes] .028 .019 1.465 .143 -.010 .066 .000 
[Any vaccinations - no] 0
a
 . . . . . . 
[SBP] -.001 8.876E-5 -9.375 .000 -.001 -.001 .014 
[BMI] .001 .000 3.301 .001 .000 .001 .002 
[Age in years] .011 .003 3.605 .000 .005 .017 .002 
a. This parameter is set to zero because it is redundant. 
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Data extraction form for systematic review on vascular function in preterm-born 
subjects (Chapter 2): 
Source Y/N/not clear/not 
reported/comment 
Study ID number  
Report ID (surname of first author and year study undertaken)  
Title   
Authors names  
Journal  
Language published in  
Reviewed by  
Other comments  
Eligibility  
Confirm eligibility for review  
Gestation ≤ 32 weeks gestation  
Gestation 33-37 weeks gestation  
Other gestation please state  
Age at time of CVS testing  
Reason for exclusion  
Methods  
Study design  
Age of study groups  
Other comments  
Participants  
Total number  
Total number in prem group  
Total number in control group  
Total number excluded  
Reason why excluded  
Setting  
Birth weight – Mean (SEM) g  
Social status  
Rate of ventilation  
Personal smoking by the prem subjects  
Age at time of CVS testing  
Sex – girls/boys  
Weeks gestation, wk. mean (SEM)  
Maternal smoking  
Surfactant given and details  
Maternal steroids given and details  
Country  
Co-morbidity  
Ethnicity  
Year of birth of participants  
CLD/BPD and how defined  
Neonatal data information  
Date of study  
Other comments  
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Interventions  
Did study consider intervention  
Specific intervention  
Intervention details  
Is baseline data adequate  
Other comments  
Outcomes  
 
CVS test – ACh     
Total number in group     
Mean (PU)     
SEM     
Significance     
Method of measuring CVS  
Method of standardisation  
 
Miscellaneous  
Funding source  
Key conclusions  
Miscellaneous comments from authors  
References to other relevant studies  
Other comments  
 
Quality Score/ total 22 
Selection  
1) Representativeness of the exposed cohort  
a) truly representative of the average in the community 4 
b) Somewhat representative of the average in the  community 3 
c) Selected group of users e.g. nurses, volunteers 2 
d) no description of the derivation of the cohort 1 
2) Selection of the non exposed cohort  
a) Drawn from the same community 3 
b) Drawn from a different source 2 
c) no description of the derivation of the non exposed cohort 1 
3) Ascertainment of exposure (weeks gestation)  
a) secure record (scan +/- LMP) 3 
b) Written self report ( medical assessment) 2 
c) no description 1 
4) Demonstration that outcome of interest was not present at start of study  
a) yes 2 
b) no 1 
Outcome  
1) Assessment of outcome  
a) independent blind assessment 4 
b) record linkage 3 
c) self report 2 
d) no description 1 
2) Was follow-up long enough for outcomes to occur  
a) yes 2 
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b) no 1 
3) Adequacy of follow up of cohorts  
a) complete follow up all subject accounted for 4 
b) subjects lost to follow up unlikely to introduce bias 3 
c) follow up rate low and no description of those lost 2 
d) no statement 1 
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Journal article for Chapter 3:  
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Databases and information sources (Chapter 3) 
Bibliographic databases 
CINAHL 1982- 
Embase 1980- 
HMIC Health Management Information Consortium 1979 
Medline 1950- 
Medline in Process 
Scopus 
OpenSIGLE 
Web of Knowledge 
Science Citation Index Expanded 1981- 
Social Science Citation Index 1981- 
ISI Proceedings 1990- 
Data extraction form for systematic review on exercise capacity (Chapter 3) 
Source Y/N/not clear/not reported/comment 
Study ID number  
Report ID (surname of first author and 
year of publication) 
 
Title   
Authors names  
Journal  
Language published in  
Reviewed by  
Other comments  
  
Eligibility  
Confirm eligibility for review  
Gestation ≤ 32 weeks gestation  
Gestation 33-37 weeks gestation  
Other gestation please state  
Age at time of VO2 max testing   
Exercise test used  
VO2 max values reported compared to 
predicted values or term group 
comparison 
 
BPD/CLD group  
Reason for exclusion  
Need to write to authors  
Other comments  
  
Methods  
Study design  
Age of study groups  
Other comments  
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Participants  
Total number  
Total number in CLD/BPD group  
Total number in prem group  
Total number in control group  
Total number excluded  
Reason why excluded  
Setting  
Birth-weight  
Social status  
Rate of ventilation  
Personal smoking by the prem subjects  
Age at time of exercise testing  
Sex  
Weeks gestation  
Maternal smoking  
Surfactant given and details  
Maternal steroids given and details  
Country  
Co-morbidity  
Ethnicity  
Year of birth of participants  
CLD/BPD and how defined  
Neonatal data information  
Date of study  
Other comments  
  
Interventions  
Did study consider intervention  
Specific intervention  
Intervention details  
Is baseline data adequate  
Other comments  
  
Outcomes  
 
VO2 Max BPD/CLD Control Preterm 
Total number in 
group 
   
Mean (ml/kg/day)    
SEM    
range    
Significance    
Method of 
measuring  
 
Method of 
standardisation 
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VE BPD/CLD Control Preterm 
Total number in 
group 
   
Mean (l/min)    
SEM    
range    
Significance    
 
Miscellaneous  
Funding source  
Key conclusions  
Miscellaneous comments from authors  
References to other relevant studies  
Other comments  
 
Quality Scores Awarded  
Selection   
1) Representativeness of the exposed cohort   
a) truly representative of the average in the community 4  
b) Somewhat representative of the average in the  
community 
3  
c) Selected group of users e.g. nurses, volunteers 2  
d) no description of the derivation of the cohort 1  
2) Selection of the non exposed cohort   
a) Drawn from the same community 3  
b) Drawn from a different source 2  
c) no description of the derivation of the non exposed 
cohort 
1  
3) Ascertainment of exposure (weeks gestation)   
a) secure record (scan +/- LMP) 3  
b) Written self report ( medical assessment) 2  
c) no description 1  
Outcome   
1) Assessment of outcome   
a) independent blind assessment 4  
b) record linkage 3  
c) self report 2  
d) no description 1  
2) Was follow-up long enough for outcomes to occur   
a) yes 2  
b) no 1  
3) Adequacy of follow up of cohorts   
a) complete follow up all subject accounted for 4  
b) subjects lost to follow up unlikely to introduce bias 3  
c) follow up rate low and no description of those lost 2  
d) no statement 1  
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Journal article for Chapter 4:  
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RANOPS study protocol version (chapters 4 and 5) 
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NWIS database protocol (Chapters 4 and 5): 
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Newspaper articles for RANOPS study (Chapters 4 and 5): 
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Preschool study questionnaire pack (Chapters 4 and 5): 
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Information sheet Version 1.2           Date 12/10/12 
MREC number: 12/WA/0155 
2 
 
  
  include LHB logo 
Parent Information Sheet: 
 RANOPs 
Project title: Respiratory and neurological outcomes in children born preterm study  
Principal Investigator: Professor Sailesh Kotecha (Cardiff University).  Include Local PI depending on LHB. 
Thank you for reading this information sheet about the RANOPs study. 
We would like to invite you and your child to take part in our research study based at the Department of Child Health 
at Cardiff University in collaboration with local LHB child health department. Before you and your child decide whether 
to take part by completing the questionnaire, it is important for you to understand why the study is being performed 
and what it involves.  Please take time to read the following information and if you have any questions, please feel free 
to contact us. Thank you for taking the time to read this leaflet.   
 
What is the purpose of this study? 
We already know that some babies who are born very prematurely (i.e. more than 10 weeks early) sometimes develop 
breathing and developmental problems as a baby and as a child. However, it is not clear if babies who are born only 
slightly prematurely (4 – 8 weeks early) are also at risk of developing breathing and developmental problems. We 
would like to further study the symptoms of children who were born prematurely and compare their symptoms to those 
of children who were born on time. This will establish if children born only slightly prematurely need to be followed up 
more closely during childhood. 
Why have you been chosen to take part? 
You have been invited to take part in our study because your child was born between 1
st
 January 2003 and 31
st
 
December 2011. We are inviting families with children who were born prematurely and also families with children who 
were born on time. A total 24,000 children from Wales between the ages of 1 and 10 years old are being invited to 
take part in this study. 
Do I have to take part? 
It is entirely your own and your child’s decision whether you want to complete and return the questionnaire. If you 
decide to take part we would be delighted if you can complete the enclosed questionnaire. If possible and only if you 
agree, we would like to contact you if necessary to clarify any answers you give and also to invite you to take part in 
future similar studies. If, at any time you change your mind, you are free to withdraw any information you have given 
about your child and do not need to give a reason why. A decision to withdraw at any time, or a decision not to take 
part, will not affect the care that you or your child receives. 
 
What will I be asked to do if I decide to take part? 
If you decide to take part, please complete the enclosed questionnaire and return it to us in the pre-paid envelope. 
The questionnaire should only take you 15-20 minutes to complete but please do not hesitate to contact Dr Martin 
Edwards on telephone 02920 743927 or by email (edwardsmo@cardiff.ac.uk) if you have any queries. 
With your permission we would like to (i) contact you to clarify any questions that you may have answered, or (ii) to 
send questionnaires or invite you to future studies, and (iii) ask you if we may access information about your child 
specifically from the health database records such as National Community Child Health Database (NCCHD) and 
Patient Episode Database for Wales (PEDW). These are held here in Wales by NHS Wales Informatics Service 
Principal Investigator: Prof Sailesh Kotecha 
Department of Child Health 
Cardiff University 
Cardiff, CF14 4XN   
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School questionnaire study pack (Chapters 4 and 5):  
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  include LHB logo 
Parent Information Sheet: 
 RANOPs 
Project title: Respiratory and neurological outcomes in children born preterm study  
Principal Investigator: Professor Sailesh Kotecha (Cardiff University).  Include Local PI depending on LHB. 
Thank you for reading this information sheet about the RANOPs study. 
We would like to invite you and your child to take part in our research study based at the Department of Child Health 
at Cardiff University in collaboration with local LHB child health department. Before you and your child decide whether 
to take part by completing the questionnaire, it is important for you to understand why the study is being performed 
and what it involves.  Please take time to read the following information and if you have any questions, please feel free 
to contact us. Thank you for taking the time to read this leaflet.   
 
What is the purpose of this study? 
We already know that some babies who are born very prematurely (i.e. more than 10 weeks early) sometimes develop 
breathing and developmental problems as a baby and as a child. However, it is not clear if babies who are born only 
slightly prematurely (4 – 8 weeks early) are also at risk of developing breathing and developmental problems. We 
would like to further study the symptoms of children who were born prematurely and compare their symptoms to those 
of children who were born on time. This will establish if children born only slightly prematurely need to be followed up 
more closely during childhood. 
Why have you been chosen to take part? 
You have been invited to take part in our study because your child was born between 1
st
 January 2003 and 31
st
 
December 2011. We are inviting families with children who were born prematurely and also families with children who 
were born on time. A total 24,000 children from Wales between the ages of 1 and 10 years old are being invited to 
take part in this study. 
Do I have to take part? 
It is entirely your own and your child’s decision whether you want to complete and return the questionnaire. If you 
decide to take part we would be delighted if you can complete the enclosed questionnaire. If possible and only if you 
agree, we would like to contact you if necessary to clarify any answers you give and also to invite you to take part in 
future similar studies. If, at any time you change your mind, you are free to withdraw any information you have given 
about your child and do not need to give a reason why. A decision to withdraw at any time, or a decision not to take 
part, will not affect the care that you or your child receives. 
 
What will I be asked to do if I decide to take part? 
If you decide to take part, please complete the enclosed questionnaire and return it to us in the pre-paid envelope. 
The questionnaire should only take you 15-20 minutes to complete but please do not hesitate to contact Dr Martin 
Edwards on telephone 02920 743927 or by email (edwardsmo@cardiff.ac.uk) if you have any queries. 
With your permission we would like to (i) contact you to clarify any questions that you may have answered, or (ii) to 
send questionnaires or invite you to future studies, and (iii) ask you if we may access information about your child 
specifically from the health database records such as National Community Child Health Database (NCCHD) and 
Patient Episode Database for Wales (PEDW). These are held here in Wales by NHS Wales Informatics Service 
Principal Investigator: Prof Sailesh Kotecha 
Department of Child Health 
Cardiff University 
Cardiff, CF14 4XN   
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